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Abstract 
Background 
Foot-related conditions have been reported to be present in large numbers of 
inpatients.  The main foot-related conditions causing hospitalisation appear to be foot 
disease disorders.  Foot disease in those hospitalised has also been associated with 
long hospital stays, amputations and death.  Foot disease disorders include ulcers, 
infections and ischaemia and are typically precipitated by the common foot risk 
factors of peripheral arterial disease, peripheral neuropathy and foot deformity.  
These foot disease disorders and foot risk factors are generally the end result of 
chronic conditions such as diabetes, cardiovascular disease or kidney disease.  
Although foot disease appears to affect many people in hospital and has been 
investigated in diabetes specific inpatient populations, no study has yet quantified the 
overall burden that foot disease imposes on a representative inpatient population.  In 
order for policy makers, researchers and clinicians to begin to understand and 
address the overall burden that foot disease imposes on inpatient resources, it is 
necessary to determine the prevalence and associated factors of foot disease in 
representative inpatient populations.    
 
Aim 
The purpose of this thesis was to improve the understanding of the overall 
burden of foot disease in inpatient populations.  The main aim was to investigate the 
prevalence and associated factors of people with foot-related conditions, foot disease 
disorders and foot risk factors in a representative inpatient population.   
 
Methods 
Three different study designs were utilised in this thesis.  First, two literature 
reviews were conducted, including a systematic review and meta-analysis, to 
synthesise what was known from the existing literature investigating the prevalence 
of foot-related conditions and foot disease in inpatient populations.  Second, a 
validity and reliability study was conducted to test the accuracy and consistency of a 
new multi-item data collection instrument to identify foot disease disorders and foot 
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risk factors in representative populations.  Lastly, the major study of this thesis was a 
multi-site cross-sectional point-prevalence study of five hospitals considered to be 
representative of the different categories of Australian hospitals.  The aims were to 
investigate the prevalence and associated factors of foot-related conditions, foot 
disease disorders and foot risk factors in a large representative inpatient population.   
 
Results 
The literature reviews identified that foot disease disorders were the main foot-
related conditions causing hospitalisation in inpatient populations.  The systematic 
review identified studies that indicated up to 1.2% of representative inpatients had 
been hospitalised because of a foot disease disorder, up to 13% had a foot disease 
disorder present and up to 36% had a foot risk factor for developing foot disease.  No 
study was identified that had investigated the overall prevalence of foot disease or 
reported a data collection instrument to capture relevant foot disease items in a 
representative inpatient population.  A 46-item data collection instrument was 
developed and tested to collect foot disease data in representative populations.  
Criterion measure reliability of at least moderate categories of agreement (Kappa 
statistic >0.4; Intraclass Correlation >0.75) were reported in 91% of tested items. 
Criterion validity of at least moderate categories (Positive Predictive Value >0.7) 
were reported in 83% of tested items. Inter- and intra-rater reliability of at least 
moderate categories was also reported in 88% and 87% of tested items respectively. 
The major study recruited 733 (83%) of 883 eligible participants; mean(SD) 
age 62(19) years, male 55.8%.   Foot-related conditions were the primary reason for 
admission in 54 participants (7.4% (95% Confidence Interval: 5.7-9.5%)); including 
36 (4.9%) for foot disease and 15 (2.1%) for foot trauma.  Foot-related conditions 
were present in 86 participants (11.8% (95% Confidence Interval: 9.6-14.3%)); 
including 72 (9.8%) with foot disease (6.7% foot ulcers, 3.3% infections and 4.5% 
ischaemia) and 1.9% had undergone a new amputation procedure.  Foot risk factors 
for developing foot disease were present in 336 participants (46.0% (95% 
Confidence Interval: 42.4-49.7%)); including previous amputations (4.1%), previous 
foot ulcers (9.8%), peripheral arterial disease (21.0%), peripheral neuropathy 
(22.0%) and foot deformity (22.4%).  Being admitted for the primary reason of a 
foot-related condition was independently associated with foot infection, ischaemia, 
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ulcers, acute foot trauma and past foot treatment by a general practitioner or surgeon 
in the year prior to hospitalisation (p < 0.01).  Foot disease was predominantly 
associated with previous foot ulcers, acute foot trauma and past foot treatment by a 
surgeon prior to hospitalisation (p < 0.01).  New amputations were independently 
associated with foot infection (p < 0.01).  Foot risk factors for developing foot 
disease were predominantly associated with older age, diabetes, cerebrovascular 
accident history, arthritis, smoking, mobility impairment, other foot risk factors and 
past foot treatment prior to hospitalisation (p < 0.01). 
 
Conclusions 
The main findings of this thesis contribute the most robust, valid and 
generalizable estimates to date regarding the overall inpatient burden of foot disease.  
These findings suggest that nearly half of all hospitalised patients have a foot risk 
factor for developing foot disease (46%), one fifth of those have foot disease present 
(10%), one half of those have been hospitalised because of their foot disease (5%), 
and one third of those underwent an amputation (2%) during their admission.  The 
majority of foot-related hospitalisations were due to foot disease and people without 
diabetes made up more than half of those patients.  The main factors found to be 
independently associated with inpatient foot disease or foot risk factor outcomes 
were older age, diabetes, arthritis, cerebrovascular accident history, smoking, 
mobility impairment, acute foot trauma, previous ulcers, peripheral arterial disease, 
peripheral neuropathy and past foot treatment by a surgeon or podiatrist.  Even after 
controlling for diabetes these factors were very similar to those previously identified 
in the literature to predict foot disease in diabetes populations. Overall, the direct 
inpatient burden caused by foot disease is estimated to place foot disease in the top 
10 leading causes of hospitalisation in Australia at an annual cost of $AU1.6 billion. 
This thesis has made a number of recommendations to further investigate and 
intervene in this large, yet under-appreciated, inpatient burden of foot disease.   
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Chapter 1: Introduction 
This chapter outlines the background (section 1.1), context and concepts 
(section 1.2), purpose (section 1.3) and significance (section 1.4) for this thesis.   
Finally, section 1.5 briefly outlines the chapters and papers that make up this thesis. 
 
1.1 BACKGROUND 
Foot-related conditions appear to be present in considerable numbers of 
inpatients across the world [1-8]; yet, the exact prevalence and extent of the burden 
associated with foot-related conditions in inpatient populations is unknown.  The 
presence of foot-related conditions in those hospitalised has also been associated 
with extended hospital stays [1-6], amputations [1-6, 9-11], institutionalisation [12, 
13], high mortality rates [1, 2, 6, 14] and significant ongoing health care needs [1, 2].   
Foot-related conditions in the context of hospitalisation typically refer to either 
deteriorating chronic foot disease or major acute trauma affecting the foot [1-16].  
Foot trauma typically refers to limb-threatening injuries to the foot caused by high 
energy trauma [15, 16]. Whereas, foot disease is a term typically used to denote 
severe foot-related disorders that are likely to result in hospitalisation and amputation 
and most commonly refers to foot ulcers, infections and ischaemia [1, 2, 5, 10, 17].  
The most common foot risk factors for developing foot disease include peripheral 
arterial disease (PAD), peripheral neuropathy (PN) and foot deformity [1, 2, 5, 17-
20].  Foot disease disorders and foot risk factors have been found to typically result 
from the pathophysiology of specific chronic conditions [3, 4, 8, 9, 11], such as 
diabetes [1, 2, 5-7, 10, 12, 17, 20], cardiovascular disease [13, 21-23], chronic kidney 
disease [18, 19] and cancer [24, 25].  
Although the prevalence of foot disease in hospitalised populations appears to 
be considerable, no study has quantified this prevalence or the overall burden that the 
collective management of foot disease imposes on a representative inpatient 
population.  Studies investigating the prevalence of foot disease in hospitalised 
inpatients have predominantly focussed within a specific inpatient population, such 
as diabetes inpatients only [1, 5, 26-28].  Whereas some other studies have reported 
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the prevalence of a specific foot disease disorder within a more representative 
inpatient population that incorporates the diverse range of people typically 
hospitalised at any one time, such as foot wounds in all inpatients in a hospital [8, 
29].  Yet no studies have investigated the overall prevalence of a range of foot 
disease disorders, or the factors independently associated with foot disease disorders, 
within a representative inpatient population.  Thus, a precise understanding of the 
overall burden imposed by foot disease on representative inpatient populations 
remains unknown.  In order for policy makers, researchers and clinicians to begin to 
understand and address the burden that foot disease imposes on inpatient resources, it 
is necessary to determine the prevalence and associated factors of foot disease in 
representative inpatient populations.    
 
1.2 CONTEXT AND CONCEPTS 
In order to facilitate an understanding of any field of research it is important to 
firstly contextualise the field and define major conceptual terms.   Unfortunately, the 
major terms used in the existing literature to denote foot problems in inpatient 
populations vary.  Thus, this thesis has attempted to consolidate major terms and has 
used them as consistently as possible throughout the thesis.  However, in some 
chapters these major terms have had to vary due to the editorial preferences of 
journals in which manuscripts from this thesis were submitted for publication.   Thus, 
a basic conceptual framework for foot disease in inpatients has been created for this 
thesis to contextualise the field and the major terms used within this field (Figure 1-
1).  Furthermore, these terms have been defined and the different synonyms used 
throughout this thesis to mean these terms have been listed to help the reader.    
 
 “Foot-related hospitalisation” is a term typically used to denote a 
hospitalisation where a foot-related condition is the primary or secondary reason for 
admission of a person into inpatient hospital care.  Foot-related hospitalisation 
broadly includes deteriorating foot disease disorders or major acute trauma affecting 
the foot [1, 2, 4, 15, 16].  Synonyms for foot-related hospitalisation include “foot-
related admissions”, “foot-related condition hospitalisation”, “foot-related condition 
admissions”, “foot disease admissions”, “primary foot-related hospitalisation”, 
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“secondary foot-related hospitalisation”, “primary foot-related condition admission” 
and “secondary foot-related condition admissions”. 
 
Figure 1-1:  Basic conceptual framework for foot disease in inpatients  
 
“Foot disease” is a term typically used to denote severe foot-related disorders 
that are the end result of the pathophysiology of chronic conditions and are likely to 
result in hospitalisation or amputation, including foot ulcers and foot infections [1, 2, 
5, 10, 17].  However, “foot disease” is also commonly used as a catchall term that 
collectively includes foot ulcers, foot infection and other severe foot-related 
disorders such as ischaemia and Charcot Neuroarthropathy [1, 2, 17].   Synonyms for 
foot disease include “foot disease disorders”, “foot disease complications”, “foot 
complications” and “diabetic foot”. 
 
At Risk Populations 
Foot Risk Factors 
Foot Disease 
Foot-related Hospitalisation 
Inpatient Populations 
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“Foot risk factors” are those risk factors commonly reported to precipitate the 
development of foot disease and are typically intrinsic to the foot or lower leg, 
including peripheral arterial disease (PAD), peripheral neuropathy (PN) and foot 
deformity [1, 2, 5, 17-20].  However, if severe enough these foot risk factors can also 
become foot disease disorders in their own right [1, 2, 5, 10, 17, 20].  Synonyms for 
foot risk factors include “risk factors”, “high risk factors”, “high risk foot”, “high 
risk foot factors”, “at risk foot” and “foot complications”.   
 
“At risk populations” are typically those conditions demonstrated to cause 
disproportionately high rates of foot risk factors for foot disease.  The most 
commonly acknowledged “at risk population” in the literature are people with 
diabetes [3, 4, 6, 7, 9, 11].  However, other chronic conditions have also been shown 
to cause higher rates of these foot risk factors and include chronic kidney disease [18, 
19], cardiovascular disease [13, 21-23] and some cancers [24, 25]).  Synonyms for at 
risk populations include “chronic conditions”, “chronic disease”, “discrete 
populations”, “specific populations”, “condition-related populations” and “condition-
specific populations”. 
 
“Inpatient populations” are those people hospitalised for at least one night of 
hospital care for any reason [6, 30].  “Representative inpatient populations” 
typically incorporate the diverse range of people hospitalised in the majority of 
medical and surgical wards of a large general hospital, often with the exception of 
cognitively impaired, mental health, children’s and maternity wards [31-34].  
Synonyms for representative inpatient populations include “general inpatient 
populations”, “representative general inpatient populations”, and “representative 
inpatients”.  “Specific inpatient populations” in contrast are those that contain only 
inpatients with specific conditions, such as those with diabetes, affected by trauma or 
geriatric patients.  Synonyms for specific inpatient populations include “discrete 
inpatient populations”, “condition-specific inpatient populations”, “disease-specific 
inpatient populations”, “condition-related inpatient populations” and “medical 
condition-related inpatient populations”. 
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Lastly, the term “burden” in the context of this thesis typically refers to the 
impact of a disease on the hospital system [32, 35].  Thus, “burden” generally 
reflects the standard definition of ‘burden of disease’ meaning the collective health 
loss from morbidity and mortality caused by a disease within the health care system 
concerned [35].  In the case of foot disease in inpatients it typically comprises 
hospitalisations and amputations contributed to by foot disease on an inpatient 
population [1-3, 5, 6].  Synonyms for burden include “direct burden”, “indirect 
burden”, “overall burden”, “hospitalisation”, “admissions”, “hospital bed days”, 
“amputations” and “costs”.   
 
1.3 PURPOSE 
The purpose of this thesis was to improve the understanding of the overall 
burden of foot disease in inpatient populations.  The research questions were:  
1. What is the proportion of representative inpatient populations that have 
been hospitalised because of foot disease at one point in time? 
2. What is the proportion of representative inpatient populations that have a 
foot disease disorder or foot risk factor present at one point in time? 
3. What factors are independently associated with foot disease disorders or 
foot risk factors in representative inpatient populations? 
 
Thus, the aim of this thesis was to investigate the prevalence and associated 
factors of people with foot disease disorders or foot risk factors in a representative 
inpatient population.  The specific objectives were: 
1. To review previous literature investigating the prevalence of foot 
disease disorders and foot risk factors in inpatient populations  
2. To develop a valid and reliable data collection instrument to capture 
foot disease disorders and foot risk factors in representative populations 
3. To investigate the overall prevalence of foot disease disorders and foot 
risk factors in a large representative inpatient population 
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4. To investigate the associations between representative inpatients with 
foot disease disorders and a range of factors 
 
1.4 SIGNIFICANCE 
It has been recognised for some time that foot disease disorders make up a 
substantial burden of disease in specific inpatient populations, such as inpatients with 
diabetes [1, 2, 4-7, 26].  For example diabetes-related foot disease has been reported  
to be present in up to 20% of inpatients with diabetes [7], and 5% of representative 
inpatient populations in Australia [7], due to the fact that people with diabetes 
account for around 15-25% of the representative inpatient population [7, 32].  
However, to fully appreciate the overall burden that all foot disease imposes on 
hospitals, it was necessary to explore the proportion of people with foot disease in a 
large representative inpatient population.  This exploration of the burden of foot 
disease in a representative inpatient population had not occurred prior to this thesis.   
Thus, this thesis investigated the overall burden that patients with foot disease 
impose on a representative inpatient population at one point in time, and explored the 
common factors that were strongly linked with inpatient foot disease. Three different 
study designs were utilised.  First, two literature reviews were conducted, including a 
systematic review and meta-analysis, to synthesise what was known from the 
existing literature investigating the burden of foot disease in specific and 
representative inpatient populations.  Second, a validity and reliability study was 
conducted to test the accuracy and consistency of a new multi-item data collection 
instrument to identify foot disease disorders in representative populations.  Last, a 
multi-site cross-sectional point-prevalence study investigated the prevalence and 
associated factors of foot disease disorders in a large representative inpatient 
population.   
The key findings from this thesis provide the most robust, valid and 
generalizable understanding to date of the overall burden of foot disease in 
representative inpatient populations.  This improved understanding should empower 
policy makers, researchers and clinicians to more effectively forecast and plan future 
interventions and investigations to address the previously under-recognised inpatient 
burden of foot disease. 
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1.5 THESIS OUTLINE 
This thesis is presented by publication and contains eight chapters; an 
introduction, six manuscript chapters in different stages of publication or preparation, 
and a discussion chapter.  A brief outline of each chapter’s titles, aims and any peer-
reviewed publications is presented in Table 1-1.  Each of the six manuscripts were 
written to represent specific chapters of the thesis; Chapters 2 and 3 serve as the 
literature review chapters, Chapters 4 and 5 as the methodology chapters, and 
Chapters 5-7 as the results chapters.  Each chapter contains a preface section that 
briefly outlines the manuscript contained within the chapter and any additional 
information required to assist the reader with linking the previous chapter to the 
upcoming chapter.  Each manuscript was formatted according to the author 
guidelines for the particular journal in which it was submitted or is to be submitted. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Chapter 2: Introduction 8 
Table 1-1:  Summary of chapters, aims and publications 
Chapter Aim Peer-reviewed Publication 
Chapter 1.   
Introduction 
 
 
This introduction outlines the background, 
context and concepts, purpose and 
significance of this thesis.    
 
 
Not applicable for publication 
Chapter 2.   
Foot-related conditions in 
hospitalised populations  
 
 
This broad narrative literature review aimed to 
review studies reporting the prevalence of any 
foot-related conditions in any inpatient 
populations. 
 
Published in Wound Practice and 
Research, entitled “Foot-related 
conditions in hospitalised populations: a 
literature review” [36] 
 
Chapter 3.   
Prevalence of foot disease 
and risk factors in general 
(representative) inpatient 
populations 
 
 
This systematic review aimed to specifically 
review only studies reporting the prevalence 
of foot disease disorders or foot risk factors in 
representative inpatient populations 
 
Published in BMJ Open journal, entitled 
“Prevalence of foot disease and risk 
factors in general inpatient populations: 
a systematic review and meta-analysis” 
[37] 
 
Chapter 4.   
The Queensland High Risk 
Foot Form (QHRFF) – is it a 
reliable and valid clinical 
research tool for foot disease? 
 
 
This study aimed to develop and test the 
validity and reliability of a new foot disease 
data collection instrument. 
 
Published in Journal of Foot and Ankle 
Research, entitled “The Queensland 
High Risk Foot Form (QHRFF) – Is it a 
reliable and valid tool for foot disease?” 
[38] 
 
Chapter 5.  
Direct inpatient burden 
caused by foot-related 
conditions 
 
 
The aims of this point-prevalence study were 
to investigate a representative inpatient 
population to determine the prevalence of 
people admitted to hospital for the reason of a 
foot-related condition, and identify associated 
independent factors. 
 
 
Published in BMJ Open, entitled “Direct 
inpatient burden caused by foot-related 
conditions: a multi-site point-prevalence 
study” [39] 
Chapter 6.  
The silent overall burden of 
foot disease in a 
representative hospitalised 
population  
 
The aims of this study were to investigate the 
point prevalence, and associated independent 
factors, for foot disease (ulcers, infections and 
ischaemia) in a representative hospitalised 
population. 
 
 
Published in the International Wound 
Journal, entitled “The silent overall 
burden of foot disease in a 
representative hospitalised population” 
[40]  
 
Chapter 7.   
Previous foot disease and 
foot risk factors in 
representative inpatients 
 
 
The aims of this study were to investigate the 
prevalence and associates of previous foot 
disease and foot risk factors in a representative 
inpatient population. 
 
 
Ready to submit for publication, entitled 
“Previous foot disease and foot risk 
factors in representative inpatients”[41] 
 
Chapter 8.   
Discussion 
 
 
This discussion outlines the key findings, 
conceptual framework, strengths and 
limitations, key recommendations and 
conclusions of this thesis. 
 
 
Not applicable for publication 
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Chapter 2: Foot-related conditions in 
hospitalised populations: a 
literature review 
This chapter begins with a preface section that briefly explains the manuscript 
that makes up this first literature review chapter (section 2.1).  An adapted version of 
the manuscript published in the Wound Practice and Research journal, “Foot-related 
conditions in hospitalised populations: a literature review” is then presented; 
including abstract (section 2.2), background (section 2.3), methods (section 2.4), 
results (section 2.5), discussion (section 2.6) and conclusion sections (section 2.7). 
 
2.1 PREFACE 
In order to gain an understanding of any field of research it is important to 
firstly undertake a comprehensive review of the literature in that field to synthesise 
the contemporary understandings, context and any gaps in knowledge.  This chapter 
reviews the existing literature to begin to understand which foot-related conditions 
are prevalent in which inpatient populations and what proportion of these conditions 
are made up by foot disease.   Therefore, Chapter 2 uses a systematic search and 
extensive narrative review methodology to investigate the prevalence of any reported 
foot-related conditions (foot disease, foot trauma or other foot-related conditions) in 
any specific or representative inpatient population.  The definition of an “inpatient 
population” in this chapter was purposely left very broad to gain a broad 
understanding of the research that had already gone on in this field.  Studies were 
included if they either reported participants from a representative or a specific 
inpatient population, such as diabetes or geriatric inpatient population.  This chapter 
enabled an understanding of the conditions and factors associated with foot-related 
conditions in hospital populations.     
The manuscript that forms the basis of this chapter has been adapted from the 
manuscript published in the Wound Practice and Research journal: 
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Lazzarini PA, Hurn SE, Kuys SS, Kamp MC, Reed L. Foot-related conditions 
in hospitalised populations: a literature review. Wound Practice and Research 2016; 
24(1): 16-35 [36]. 
 
2.2 ABSTRACT 
Background:  No reviews have investigated foot-related conditions prevalence 
in hospitalised populations.  This literature review reports foot-related conditions 
(foot wounds, foot infections, amputations, other) and foot risk factors (peripheral 
arterial disease (PAD), peripheral neuropathy (PN), foot deformity) prevalence in 
representative or specific hospitalised populations. 
Methods:  Electronic databases were searched for publications between 1980 
and 2011. Keywords and synonyms relating to foot-related conditions, foot risk 
factors, inpatients and prevalence were used.  Studies reporting any foot-related 
conditions or foot risk factor prevalence in representative or specific hospitalised 
populations were included, and data were extracted. 
Results:  Of 3,297 records identified, 141 studies were included; 27 in 
representative and 114 specific inpatients.  Foot wound prevalence was: 0.9-8.3% in 
representative and 0.1-96.4% specific inpatients; foot infection: 0.1-1.1% 
representative inpatients; amputation: 0.1-1.5% representative, 0.2-82.5% specific 
inpatients; PAD: 2.1-25.0% representative, 9.0-72.0 specific inpatients; and PN: 0.2-
100% specific inpatients.   
Conclusions: This review suggests foot wounds are the main foot-related 
condition in hospitalised populations.  Indications are up to 25% of representative 
inpatients have a foot risk factor for a foot wound, up to 8% have a foot wound and 
up to 1.5% an amputation.  These rates were higher in specific inpatient populations, 
particularly those with chronic disease or major acute trauma.    
 
2.3 BACKGROUND 
Foot-related conditions appear to be present in many hospitalised patients and 
may result in amputation [1, 2, 4, 6, 8, 11].   Leading causes of foot-related condition 
hospitalisation include acute foot trauma and chronic foot disease disorders such as 
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foot wounds, foot infections and other severe foot-related conditions such as 
ischemia [1, 2, 4, 6, 8, 11].  These foot disease disorders are typically precipitated by 
common foot risk factors, such as peripheral arterial disease (PAD), peripheral 
neuropathy (PN), and foot deformity [1, 2, 6, 11].   
Much literature investigating foot-related conditions in hospital has been 
focused on inpatient groups with specific conditions. Diabetes is frequently 
acknowledged as the specific condition that is associated with most foot-related 
hospitalisations [1, 2, 4, 6, 11] and has been reported to account for up to 5% of total 
hospital bed days used in Australia [2, 6, 7].  Other specific chronic diseases have 
also been shown to cause foot-related hospitalisation, including chronic kidney 
disease [18, 19, 42], cardiovascular disease [21-23], cancer [24, 25] and arthritis [43, 
44].  Furthermore, other specific conditions, such as acute trauma [3, 11, 45], 
infections [29, 46] and hospital acquired complications [8, 47] have been reported to 
cause foot-related hospitalisation.   
Although foot-related conditions and foot risk factors appear to be present in a 
substantial proportion of hospitalised patients, prevalence estimates across 
representative and specific inpatient groups has not been ascertained.  Without this 
information it is difficult for clinicians, researchers and policy makers to understand 
the overall burden of foot-related hospitalisation.  This literature review aimed to 
search, review and tabulate the existing literature reporting prevalence of foot-related 
conditions (foot wounds, foot infections, other foot-related conditions and 
amputations) and foot risk factors (PAD, PN and foot deformity) in representative or 
specific hospitalised populations. 
 
2.4 METHODS 
Data sources 
Electronic databases (Medline, Embase, and CINAHL) were searched for all 
publications between 1980 and 2011 discussing prevalence of foot-related conditions 
and foot risk factors in hospitalised inpatient populations.  Broad keywords and 
synonyms were used combining: foot-related conditions or foot risk factors, 
inpatients and prevalence.  The search strategy is displayed in Figure 2-1.   
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Medline (EBSCOHOST) TI & AB Title & Abstract only 
(feet or foot) 
AND 
(problem* OR complication* OR disease* OR ulcer* OR wound* OR deform* OR infec* OR cellulitis OR 
amputation* OR diab* OR isch#mi* OR vascul* OR arter* OR gangr* OR neurop*) 
AND 
(inpatient* OR hospital* OR admi*) 
AND 
(questionnair* or survey or prevalence or incidence or risk* or factor or associat* or relationship* or correlat* or 
etiolog* or aetiolog* or caus* or develop* or predispos or demograph*) 
Humans 
1980 - 2011 
CINAHL (EBSCOHOST) TI & AB Title & Abstract Only 
(feet or foot) 
AND 
(problem* OR complication* OR disease* OR ulcer* OR wound* OR deform* OR infec* OR cellulitis OR 
amputation* OR diab* OR isch#mi* OR vascul* OR arter* OR gangr* OR neurop*) 
AND 
(inpatient* OR hospital* OR admi*) 
AND 
(questionnair* or survey or prevalence or incidence or risk* or factor or associat* or relationship* or correlat* or 
etiolog* or aetiolog* or caus* or develop* or predispos or demograph*) 
Humans 
1980 - 2011 
Embase TI & AB Title & Abstract Only 
(foot or feet) 
AND 
(problem* OR complication* OR disease* OR ulcer* OR wound* OR deform* OR infec* OR cellulitis OR 
amputation* OR diab* OR isch#mi* OR vascul* OR arter* OR gangr* OR neurop*) 
AND 
(inpatient* OR hospital* OR admi*) 
AND 
(questionnair* or survey or prevalence or incidence or risk* or factor or associat* or relationship* or correlat* or 
etiolog* or aetiolog* or caus* or develop* or predispos or demograph*) 
Human 
1980 - 2011 
Figure 2-1:  Literature review full search syntax used for electronic databases 
 
Study selection 
Figure 2-2 displays the PRISMA flow diagram of the search used.  All titles 
and abstracts retrieved were scanned by the first author (PAL) using an overarching 
initial screening question: Does the article appear to discuss prevalence of major 
foot-related conditions or foot risk factors within populations staying overnight in 
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hospital?   The full text was sought if the article appeared to address the screening 
question and was electronically available.   
As this was a narrative literature review, the inclusion eligibility criteria were 
quite broad.  Studies were eligible for inclusion if published in a peer-reviewed 
journal and referred to the prevalence or number of any foot-related conditions or 
foot risk factors (the numerator) in a defined inpatient population (the denominator).  
The numerator of foot-related conditions (foot wound, foot infection, amputation or 
other foot-related conditions such as ischaemia, Charcot, malignancy or fracture) or 
foot risk factors (PAD, PN or foot deformity) were defined as listing the foot-related 
condition or foot risk factor concerned (or a synonym) in the study.  The inpatient 
population denominator could have been either a representative or specific inpatient 
population. Representative inpatient populations were defined as those that 
incorporated the diverse range of people hospitalised in the majority of wards of a 
typical hospital.  Specific inpatient populations were a sub-group of inpatients with 
the same specific medical condition, such as those with diabetes or affected by 
trauma.  Exclusion criteria included case studies, literature reviews, validity or 
reliability studies; studies investigating populations of primarily children, outpatients 
or day elective surgery patients; and studies reporting prevalence or incidence in 
populations other than inpatient populations (e.g. amputation procedures per 100,000 
general population).  The eligibility assessment was undertaken by the first author 
(PAL) to determine final study inclusion.   
Papers that met the inclusion criteria were reviewed and grouped into 
representative or specific inpatient populations.  No formal quality assessment was 
performed as part of this literature review.  Data extracted and tabulated included 
sample size, age (mean or median), gender, study design and foot-related conditions 
or foot risk factors prevalence.   
 
Statistical analysis 
Descriptive statistics were reported on included studies.  If only numbers were 
reported, these were converted to a prevalence proportion using the ratio of the 
number of individuals with the foot-related condition or foot risk factor variables 
(numerator) and the number of the total sample size of the study (denominator).     
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2.5 RESULTS 
Search results 
Figure 2-2 displays the results of the literature review search strategy.  
Database searches yielded a total of 3,297 unique records of which 540 relevant 
records were identified for detailed evaluation.   Of these, 290 full texts were sourced 
electronically for evaluation and the remaining 250 could only be evaluated by title 
and abstract (conference papers, non-English papers or full text unavailable 
electronically).  After evaluation of the 540 records, 141 satisfied the inclusion 
criteria and were included in this review.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-2:  Literature review search results 
 
5,779 total records identified: 
 3,175 EMBASE 
 2,194 Medline 
 410     CINAHL 
 
2,482 duplicates removed 
3,297 unique records screened 
 
2,757 records excluded based on: 
o No relation to foot condition or foot risk 
factor 
o Primary populations reported were children, 
outpatients or day elective surgery patients 
o Study design was a case study, literature 
review, validity or reliability study 
 
540 records retrieved for detailed evaluation 
290 full text 
248 abstract only 
2 titles only 
 
399 full-text articles excluded based on: 
o 49 as per above screening exclusion criteria  
o 248 no inpatient denominator  number or 
prevalence reported  
o 58 no foot condition or foot risk factor 
numbers or prevalence reported 
o 42 non-specific population denominator only 
reported 
o 2 unable to obtain any detail electronically  
 
141 articles included  
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Study characteristics 
Table 2-1 summarises the 141 included studies grouped according to study 
inpatient population (representative or specific), while individual study 
characteristics are outlined in Tables 2-2 to 2-7.  Study characteristics varied 
considerably in terms of inpatient population, sample size, demographics, study 
design and the foot-related condition or foot risk factor outcome investigated.  
Sample sizes varied from 15 to 57 million.   There were a large range of average ages 
(22–79 years) and males proportions investigated (23–100%).  Ninety-three studies 
(66%) were retrospective, employing medical record audits or hospital discharge 
database analysis, whilst 48 (34%) were prospective audits using clinical 
examinations or self-reported questionnaires.  One hundred and seven studies were 
published after the year 2000, 23 in the 1990s and 11 in the 1980s.   Lastly, studies 
were conducted across the world, including 39 in Europe, 31 Africa, 28 Asia, 25 
North America, eight the Middle East, eight Australasia and two in South America. 
Included studies reported different foot-related conditions and foot risk factors 
in a wide variety of representative and specific inpatient populations.  Twenty-seven 
studies investigated a representative inpatient population; including five studies 
investigating foot-related conditions in representative inpatients, 16 investigating 
only diabetes-related foot conditions in representative inpatients and six investigating 
foot-related conditions in representative geriatric inpatient populations (Table 2-2).  
The other 114 studies investigated a specific inpatient population; including 38 in 
diabetes (Table 2-3), 21 other chronic diseases (Table 2-4), 28 trauma-related (Table 
2-5), 29 infection-related (Table 2-6) and seven in other specific populations (Table 
2-7).  
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Table 2-1:  Summary characteristics of 141 included studies grouped by representative or specific inpatient population  
Condition Studies 
k 
Sample  
Range n 
Age   
years+ 
Male 
% 
Prospective^ 
 Study Design % 
Wound  
% 
Inf 
% 
Other++ 
% 
PAD  
% 
PN  
% 
Amp  
% 
REPRESENTATIVE  27 44 – 57,629,889 49 - 85 36- 85 56 0.6 – 15.0 0.1 – 1.1 43.0 – 53.0 1.9 – 25.0 0.6 – 26.0 0.1 – 7.0 
All inpatients 21 200 – 57,628,889 49 - 75 46 - 85 53 0.9 - 8.3 0.1 - 1.1 - 2.1 - 25.0 0.6 0.1 – 1.5 
Geriatric patients  6 44 – 83,804 76 - 85 35 - 57 67 0.6 - 15.0 - 43.0 – 50.0* 1.9 – 19.2 25.8 – 26.0 0.4 – 7.0 
SPECIFIC 114 15 – 311,342 22 - 83 23 - 100 29 0.1 – 96.4 - 0.01 – 97.9 9.0 – 72.0 0.3 - 100 0.2 – 82.5 
Chronic Disease-related 59 37 – 311,342 45 - 83 27 - 72 36 5.0 – 59.8 - 0.01 – 70.0 9.7 – 45.7 0.3 - 100 0.4 – 28.9 
Diabetes patients  38 37 – 283,332 49 - 83 27 - 70  39 5.0 - 53.0 - - 19.0 - 45.7 12.4 – 81.2 0.6 – 8.6 
Cancer patients  11 44 – 311,342 53 - 56 29 - 50 45 - - 0.01 – 31.0 - - 0.4 - 22.7 
Cardiovascular disease patients 5 463 – 1,578 66 61 0 7.2 - 59.8 - - 9.7 – 20.5 - 3.4 - 28.9 
Arthritis patients  3 72 – 200 57 - 61 36 - 64 33 - - 20.0 – 70.0* - - - 
Chronic liver disease patients 2 50 - 519 45 - 49 60 - 72 0 - - 52.0 - 4.7 - 
Trauma-related 28 20 – 12,150 22 - 53 37 - 100 14 0.1 -96.4 - 2.8 – 97.9 12.0 – 72.0 0.3 – 17.0 0.2 – 82.5 
Animal trauma patients 9 20 – 12,150 25 - 32 48 - 87 11 0.1 - 22.0 - 36.0 – 82.0 - 0.3 – 17.0 1.3 – 3.6 
Accidents trauma patients 7 25 – 11,917 27 - 37 67 - 95 14 4.6 - 45.0 - 2.8 – 97.9 12.0 – 72.0 4.8 – 15.0 0.2 – 10.4 
Weapon trauma patients 6 80 – 757 22 87 - 96 0 47.5 – 96.4 - 47.5 – 73.0 39.1 1.2 10.3 - 82.5 
Burns trauma patients 4 32 – 1,255 31 - 40 74 - 100 25 6.8 – 92.9 - - - - 35.0 
Natural disaster patients 2 185 - 255 53 37 - 41 50 11.9 - 43.1 - - 0.8 
Infection-related 20 15 – 4,579 27 - 71 23 - 100 30 2.9 – 93.8 0.3 – 93.8 - 16.2 25.0 – 46.0 7.8 - 27.8 
Fungal infection patients 8 15 – 307 34 - 53 40 – 100 37 62.3 – 93.8 20.9 – 93.8 - - - 7.8 
Bacterial infection patients 7 18 –  4,579 38 - 71 23 - 67 0 2.9 - 33.3 0.7 – 93.3 - 16.2 - 27.8 
Parasitic infection patients 4 16 – 710 27 - 58 39 - 62 50 25.0 0.3 – 93.7 - - 46.0 - 
Viral infection patients 1 42 - 59 100 - - - - 25.0 - 
Others 7 29 - 766 22 - 79 33 -83 29 3.4 - 6.9 – 56.6* 9.0 45.9-100 - 
TOTAL 141 15 – 57,628,889 22 -85 23 -100 34 0.1 – 96.4 0.1 -93.8 0.01 – 97.9 1.9 – 72.0 0.3 - 100 0.1 – 82.5 
k = Study numbers; n: numbers in study; % prevalence; +Age range from the median or mean age of different studies; ^Prospective Study Design includes prospective longitudinal and cross-sectional studies; ++Other 
is either malignancy, combination of injuries or hand-foot-syndrome, unless otherwise specified (refer to Tables 2-7 for further details); *Foot deformity; - Not reported; Amp: Amputations; Inf: Infection; PAD: 
Peripheral Arterial Disease; PN: Peripheral Neuropathy. 
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Prevalence of foot-related conditions and foot risk factors  
Table 2-1 summarises the prevalence ranges from all 141 included studies for 
foot wounds, foot infections, other foot-related conditions, amputations, PAD, PN 
and foot deformity in representative and different specific inpatient populations.  
Data extracted from individual studies is presented in Tables 2-2 to 2-7.  Foot wound 
prevalence ranged from: 0.9-8.3% in representative inpatients, 0.6-15.0% in geriatric, 
5.0-53.0% in diabetes, 7.2–59.8% in other chronic diseases, 0.1-96.4 in different 
trauma-related and 2.9-93.8% in different infection-related specific inpatients.  Foot 
infection prevalence ranged from: 0.1-1.1% in representative inpatients and 0.3-
93.8% in different infection-related specific inpatients.  Other foot-related condition 
prevalence ranged from: 0.01-52.0% in other chronic disease and 2.8-97.9% in 
trauma-related specific inpatients.  Amputations occurred in 0.1-1.5% of 
representative inpatients, 0.4-7.0% geriatric, 0.6-8.6% diabetes, 0.4-28.9% other 
chronic disease, 0.2-82.5% trauma-related inpatients, 7.8-27.8% in infection-related 
specific inpatients.  PAD prevalence ranged from: 2.1-25.0% in representative 
inpatients, 1.9-19.2% in geriatric, 19.0-45.7% in diabetes and 12.0-72.0% in trauma-
related specific inpatients.  PN prevalence ranged from: 25.8-26.0% in geriatric 
inpatients, 12.4-81.2% in diabetes, 0.3-17.0% in trauma-related, 25.0-46.0 in 
infection-related and 45.9–100% in other mainly neurological specific inpatients.  
Lastly, foot deformity prevalence ranged from: 43.0-50.0% in geriatric inpatients, 
20.0-70.0% arthritis and 6.9-56.6% in the other mainly neurological specific 
inpatients.  
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Table 2-2: Characteristics of studies reporting foot disease and foot risk factors in representative inpatient populations 
Study [Country] Sample  
n 
Age 
years+ 
Male 
% 
Prospective 
Study Design 
Wound  
% 
Inf 
% 
PAD  
% 
PN  
% 
Deform 
% 
Amp  
% 
ALL FOOT-RELATED CONDITIONS           
Henke 2005 [US] [29] 57,628,889 60 59 no - 0.1* - - - 0.03* 
VanGilder 2010 [US] [8] 92,397 63 46 yes 5.4** - - - - - 
Shaikh 2006 [Qatar] [46] 8,084 49 76 no - 0.4^ - - - - 
Vowden 2009 [UK] [47] 1072 - - yes 2.7 - - - - - 
Khammash 2008 [Jordan] [48] 200 60 51 yes^^ - - 25.0# & 34.0## - - - 
DIABTES FOOT-RELATED CONDITIONS ONLY          
Ozkara 2008 [Turkey] [49] 1,620,600 58 57 no - 0.1* - - - - 
Todd 1996 [US] [50] 73,000 - - no - 1.1* - - - - 
Rayman 2011 [UK] [51] 12,191 75 - yes 0.3***  - - - - - 
Ogbera 2006 [Nigeria] [52] 7,253 58 62 no 1.3 - - - - 0.8 
Mohammad Akther 2011 [India] [53] 5,188  - 85 yes 1.06 - - - - - 
Leichter 1982 [US] [54] 2,940 - - no 1.3 - 2.1 0.6 - 0.1 
Masson 1992 [UK] [55] 1,309  - - yes 1.1 - - - - 0.2 
Daultrey 2011 [UK] [56] 810 - - yes 4.9^^^ - - - - - 
Lawrence 2004 [Australia] [7] 337 - - yes 4.7^^^ - - - - - 
Chijioke 2010 [Nigeria] [57] 15,320 - - no 1.4 - - - - - 
Ajayi 2009 [Nigeria] [58] 2,692 - - no 1.6 - - - - - 
Ogbera 2007 [Nigeria] [59] 1,327 - - yes 2.7 - - - - - 
Unachukwu 2007 [Nigeria] [60] 827 55 63 yes 7.0 - - - - 1.5 
Alashek 2009 [Libya] [61] 7,518 64 60 no 2.7 - - - - 0.7 
Asumanu 2010 [Ghana] [62] 966 54 53 yes 8.3 - - - - 1.4 
Nason 2011 [Ireland] [63] 333,610 - - no 0.9 - - - - - 
GERIATRIC INPATIENTS          
Reed 2004 [US] [4] 83804 85 35 no ^^ 0.6# & 1.7## - 1.9# & 3.2## - - 0.4# & 1.7## 
Pataky 2008 [Switzerland] [64] 426 76 43 yes - - 19.2 25.8 - - 
Bristianou 2011 [Greece] [65] 195 85 57 no 1.0 - - - - - 
Hung 1985 [Hong Kong] [66] 166 - - yes - - - - 50.0 - 
Burns 2002 [UK] [67] 65 82 40 yes 15.0 - 11.0 26.0 - - 
Jessup 2007 [Australia] [68] 44 - - yes 7.0 - - - 43.0 7.0 
Amp: Amputations; Deform: Foot Deformity; Inf: Infection; n: Numbers; PAD: Peripheral Arterial Disease; PN: Peripheral Neuropathy; % prevalence; +Median or mean age of sample; - Not reported; *Osteomyelitis 
only; ** Pressure ulcers only; *** New foot ulcers only; ^ Necrotising fasciitis only; ^^ Case-control study; # non-diabetes inpatients; ## diabetes inpatients; ^^^ Includes history of past ulcers. 
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Table 2-3: Characteristics of studies reporting foot disease and foot risk factors in diabetes specific inpatient populations 
Study [Country] Sample  
n 
Age 
years+ 
Male 
% 
Prospective 
Study Design 
Wound  
% 
Inf 
% 
PAD  
% 
PN  
% 
Deform 
% 
Amp  
% 
DIABETES INPATIENTS           
Buckley 2011 [Ireland] [28] 283,332 - - no - - - - - 0.6 
Yang 2011 [Singapore] [69] 44,917 - - no - - - - - 3.2 
Rayman 2010 [UK] [26] 14,259 - - yes 11.6* 
3.0** 
- - - - - 
Wang 2010 [China] [70] 4,615 - - no 9.7 - - - - - 
Benotmane 2004 [Algeria] [71] 3,521 59 60 no 9.8 - - - - 2.5 
Ewald 2001 [Australia] [72] 3,520 - - no 10.7 - - - - 1.3 
Hill 1999 (A) [US] [27] 2,020 64 53 no 13.8 - - - - 5.2 
Hill 1999 (B) [US] [27]# 341 64 53 no 81.5 - - - - - 
Kengne 2009 [Cameroon] [73] 1,841 58 67 no 13.0 - - - - 2.1 
Benotmane 2001 [Algeria] [74] 1,779 - - no 9.2 - - - - 2.4 
Richard 2008 [France] [75] 1,222 68 70 yes 15.4 - - - - 2.6 
Sulimani 1991 [Saudi Arabia] [76] 1,010 58 63 no 10.4 - - - - 3.0 
Muthuuri 2007 [Kenya] [77] 830 - - no 11.4 - - - - - 
Adem 2011 [Ethiopia] [78] 724 - 52 no 9.7 - - 12.4 - - 
Gulam-Abbas 2002 [Tanzania] [79] 627 53 65 yes 14.7 - - - - 4.3 
Traore 2011 [Ivory Coast] [80] 596 56 67 no 14.9 - - - - 5.4 
Kengne 2006 (A) [Cameroon] [81] 503 60 67 no 10.7 - - - - 1.8 
Thompson 1993 [New Zealand] [82] 503 - - no 13.7 - - - - - 
Wei 2002 [Taiwan] [83] 456 - - no 16.2 - - 33.5 - - 
Zubair 2011 [India] [84] 342 49 66 yes 29.8 - - - - 6.7 
He 2010 [China] [85] 295 52 54 no - - - 69.2 - - 
Sano 1998 [Burkina Faso] [86] 222 53 - no 18.9 - - - - 8.6 
Kengne 2006 (B) [Cameroon] [87] 207 57 - no 13.0 - - - - 2.4 
Feleke 2007 [Ethiopia] [88] 179 - - yes 15.6 - - - - - 
Patel 1989 [Papua New Guinea] [89] 160 - - no 30.0 - - - - - 
Shabbier 2010 [Pakistan] [90] 127 - - no 12.6 - 16.5^^ 16.5^^ - 4.7^^ 
Naheed 2002 [Pakistan] [91] 100 59 60 yes 5.0 - - 65.6 - 5.0 
Naicker 2009 [Malaysia] [92] 100 - - yes 53.0 - - - - - 
Millan-Guerrero 2011 [Mexico] [93] 80 54 36 yes - - 19.0 81.2 - - 
Abou-Seleh 2011 [UK] [94] 37 - - yes 16 - 30^^^ 30^^^ - 14^^ 
DIABETES SUB-GROUPS INPATIENTS          
Geriatric          
Weber 2002 [Czech Republic] [95] 705 79 - no 21.4 - - 25.6 - 6.1 
Paiva 2006 [Portugal] [96] 242 - 27 no 16.5 - - - - - 
Fletcher 1996 [UK] [97] 100 83 33 yes 7^^ - - 71^^^ - - 
Diagnoses > 10 years          
Khoharo 2009 [Pakistan] [98] 120 54 - yes 24.0 - - - - - 
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Type 1 Only          
Kozek 2003 [Poland] [99] 241 32 34 no 8.3 - - 29 - - 
Chronic Kidney Disease          
Schleiffer 1998 [Germany] [100] 565 - - yes 25.3  - 45.7  - - 7.3 
Alebiosu 2003 [Nigeria] [101] 465 - - yes 24.1 - 40.8  - - 2.0 
Anaemia          
Almoznino-Sarafian 2010 [Israel] [102] 3,145 - - yes 11.3 - - - - - 
Hyperglycaemia          
Ogberra 2009 [Nigeria] [103] 111 54 53 yes 18.0 - - - - - 
Amp: Amputations; Deform: Foot Deformity; Inf: Infection; n: Numbers; PAD: Peripheral Arterial Disease; PN: Peripheral Neuropathy;% prevalence; +Median or mean age of sample; - Not reported; * Includes 
history of past ulcers; ** New foot ulcers only; ^^ High risk foot (past ulcer or amputation); ^^^ At risk foot risk (PAD or PN); # Foot wounds only. 
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Table 2-4:   Characteristics of studies reporting foot disease and foot risk factors in other chronic disease specific inpatient populations 
Study [Country] Sample  
n 
Age 
years+ 
Male 
% 
Prospective 
Study Design 
Wound 
% 
Inf 
% 
Other++ 
% 
PAD  
% 
PN  
% 
Amp  
% 
CANCER INPATIENTS           
Oates 1986 [Zaire] [24] 794 - 49 yes - - 8.4 - - - 
Bone Cancer          
Uppin 2008 [India] [25] 1014 - - no - - 2.7 - - 0.4 
Sarcoma          
Mandong 2007 [Nigeria] [104] 2,353 - - yes - - 3.0 - - - 
Stratigos 1997 [Greece] [105] 311,342 - - yes - - 0.01 - - - 
Meis-Kindblom 1998 [Sweden] [106] # 44 53 50 yes - - 31.0# - - 22.7# 
Melanoma          
Bennett 1994 [US] [107] 4,562  - - no - - 3.0 - - - 
Seleye-Fubara 2005 [Nigeria] [108] 1,875 - - no - - 0.4 - - - 
Lamarao 1994 [Portugal] [109] 73 56 29 no - - 26.1 - - - 
Chemotherapy-induced Hand-foot-syndrome          
Hueso 2008 [Spain] [110] 2,186 - - no - - 2.0## - - - 
Chiu 2011 [Hong Kong] [111] 166 - - no - - 13.9## - - - 
Comandone 1993 [Italy] [112] 163 - - yes - - 7.3## - - - 
CARDIOVASCULAR DISEASE INPATIENTS           
Reed 2004 [US] [21] 1,578 66 61 no - - - 20.5 - 28.9 
Eckstein 2005 [Germany] [23] 1,165* - - no - - - - - 8.8 
Peripheral Arterial Disease           
Seuc 2009 [Cuba] [113] 463 - - no 59.8 - - - - 20.1 
Buerger’s Disease           
Laohapensang 2005 [Thailand] [114] 1,112 - - no 7.2 - - 9.7 - 7.0 
Matsushita 1998 [Japan] [115] 918** - - no 8.8 - - 13.7 - 3.4  
ARTHRITIS INPATIENTS           
Rheumatoid Arthritis           
Halla 1986 [US] [43] 200 57 36 yes - - 70.0^ - - - 
Septic Arthritis           
Dubost 1993 [France] [44] 120 60 64 no - - 20.0^ - - - 
Peters 1992 [Holland] [116] 72 61 49 no - - 19.4^ - - - 
CHRONIC LIVER DISEASE INPATIENTS           
Tareen 2011 [Pakistan] [117] 50 45 60 no - - 52.0^^ - - - 
Liver Transplant           
Kim 2007 [Korea] [118] 319 49 72 no - - - - 4.7 - 
Amp: Amputations; n: Numbers; PAD: Peripheral Arterial Disease; PN: Peripheral Neuropathy; % prevalence; +Median or mean age of sample; ++ Other is a malignancy or cancer located on the foot unless otherwise 
specified; - Not reported; *Median of 44 German Vascular Depts; ** Evaluated from mean yearly figures over 12 years); ^ Foot deformity only; ^^ Palmer Erythema only; #Acral sarcoma; ##Hand-foot syndrome 
located on foot 
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Table 2-5: Characteristics of studies reporting foot disease and foot risk factors in trauma-related specific inpatient populations 
Study [Country] Sample  
n 
Age 
years+ 
Male 
% 
Prospective 
Study Design 
Wound  
% 
Inf 
% 
Other++ 
% 
PAD  
% 
PN  
% 
Amp  
% 
ANIMAL ATTACKED  INPATIENTS           
Alavi 2008 [Iran] [45] 894  25 62 no 8.3  - 58.1 - 0.9 - 
Snake           
Chen 2000 [Taiwan] [119] 130 - - no - - 56.9 - - - 
Alkaabi 2011 [UAE & Oman] [120] 64 31 87 no 22.0 - 57.8 - 17.0 - 
Pineda 2002 [Columbia] [121] 56 14-44^ 54 no - - 82.0   3.6 
Thorson 2003 [US] [122] 79 31 75 no 7.6 - 36.0 - 10.1 1.3 
Scorpion           
Shahbazzadeh 2009 [Iran] [123] 12,150 6-45^ 48 yes 0.1 - 37.3 - 0.3 - 
Centipede          
de Medeiros 2008 [Brazil] [124] 98 32 - no - - 56.1 - - - 
Stonefish          
Grandcolas 2008 [France] [125] 61 31 - no - - 79.0 - - - 
Pig           
Barss 1988 [Papua New Guinea] [126] 20 - - no - - - - 5.0 - 
ACCIDENT-RELATED INPATIENTS           
Lawn Mower           
Costilla 2006 [US] [127] 11,917 40-59^ 84 no 45.0 - 84.5 - - 9.3 
Motorbike           
Jeffers 2004 [UK] [128] 1,239 32 92.5 yes - - 4.3 - - 0.2 
Forklift           
Thiagarajan 1998 [Singapore] [129] 48 37 94 no 22.9 - 97.9 - 14.6 10.4 
Tibial fractures            
McNutt 1989 [US] [130] 366 28 88.2 no 4.6 - 12.0 12.0 - 1.6 
Limb arterial injury           
Katsamouris 1995 [Greece] [131] 25 27 95.0 no - - 72.0 72.0 15.0 10.0 
Replantation           
Fukui 1994 [Japan] [132] 9,664 - - no - - 2.8 - - - 
High fall injury           
Ramos 1986 [US] [133] 147 21-30^ 67 no - - 6.3 - 4.8 - 
WEAPON-RELATED INPATIENTS           
War           
Has 2001 [Croatia] [134] 270 - - no 73.0 - 73.0 - - 10.3 
Dogan 2000 [Turkey] [135] 236 - - no 62.3 - - - - - 
Landmines           
Coupland 1991 [Asia] [136] 757 - 96 no 96.4 - - - - 33.3 
Khan 2006 [Pakistan] [137] 103 22 - no 92.3 - - - - 82.5 
Gunshot           
 Chapter 2: Foot-related conditions in hospitalised populations: a literature review 24 
Amp: Amputations; Inf: Infection; n: Numbers; PAD: Peripheral Arterial Disease; PN: Peripheral Neuropathy; % prevalence; +Median or mean age of sample; ++ Other is a combination of injuries located on the foot; 
- Not reported; ^Age range rather than mean age given. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Agarwal 1982 [US] [138] 115 5-52^ 87.5 no - - - 39.1 - - 
Woloszyn 1988 [US] [139] 80 - - no 47.5 - 47.5 - 1.2 - 
BURNS-RELATED INPATIENTS           
Memmel 2004 [US] [140] 1,255 39 74 no 17.7 - - - - - 
Chai 2003 [China] [141] 148 31 77 yes 6.8 - - - - - 
Electric: fishing           
Wang 2007 [China] [142] 42 40 100 no 92.9 - - - - - 
Frostbite           
Bruen 2007 [US] [143] 32 36 78 no 78.1 - - - - 35.0 
NATURAL DISASTER-RELATED INPATIENTS           
Earthquake           
Pang 2011 [Indonesia] [144] 255 53 37 yes - - 43.1 - - 0.8 
Hurricane           
Sjoberg 2007 [Grenada] [145] 185 - 41 no 11.9  - - - - - 
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Table 2-6:  Characteristics of studies reporting foot disease and foot risk factors in infection-related specific inpatient populations 
Study [Country] Sample  
n 
Age 
years+ 
Male 
% 
Prospective 
Study Design 
Wound  
% 
Inf 
% 
Other 
% 
PAD  
% 
PN  
% 
Amp 
% 
FUNGAL INFECTED INPATIENTS          
Diabetes populations          
Bouguerra 2004 [Tunisia] [146] 307 44 - yes - 38.0 - - - - 
Cancer populations          
Niebla 2007 [Mexico] [147] 98 - - yes - 31.6 - - - - 
Dermatology populations          
Kaminska-Winciorek  2005 [Poland] [148] 43 - 100 yes - 20.9  - - - - 
Mycetmoa          
Dieng 2003 [Senegal] [149] 130 35 87 no 62.3 62.3 - - - - 
Adoubryn 2010 [Ivory Coast] [150] 85 - 78 no 72.9 72.9 - - - - 
Negroni 2006 [Argentina] [151] 76 43 64 no 86.8 86.8 - - - 7.8 
Aram 2009 [Yemen] [152] 16 34 80 no 93.8 93.8 - - - - 
Elgallali 2010 [Tunisia] [153] 15 53 40 no 80.0 80.0 - - - - 
BACTERIAL INFECTED INPATIENTS           
Dermatology           
Trividic 2002 [France] [154] 4,579 71 - no - 0.7* - - - - 
Cellulitis           
Cisse 2007 [Guinea] [155] 244 38 23 no - 83.6 - - - - 
Saka 2011 [Togo] [156] 104 43 47 no - 93.3 - - - - 
Necrotising fasciitis            
Elliot 1996 [US] [157] 198 52 57 no 15.2 20.7 - 16.2 - 27.8 
Specific bacterial strains           
Falagas 2006 [Greece] [158] 34 58 - no 2.9 2.9 - - - - 
Kelly 1993 [Australia] [159] 22 42 67 no 21.2 30.8 - - - - 
Francioli 1983 [Switzerland] [160] 18  - - no 33.3 55.6 - - - - 
PARASITIC INFECTED INPATIENTS           
Tapeworm           
Cooney 2004 [Kenya] [161] 710 27 39 no - 0.3 - - - - 
Protozoan           
Hashim 1995 [Sudan] [162] 111 - - yes - - - - 46.0 - 
Hookworm           
Blackwell 2001 [UK] [163] 44 29 50 no - 51.0 - - - - 
Maggots           
Kumarasinghe 2000 [Sri Lanka] [164] 16 58 62 yes 25.0 93.7 - - - - 
VIRUS INFECTED INPATIENTS           
Human Immunodeficiency Virus           
Nair 2009 [India] [165] 42 31-40 59 yes - - - - 25.0 - 
Amp: Amputations; n: Numbers; PAD: Peripheral Arterial Disease; PN: Peripheral Neuropathy; % prevalence; +Median or mean age of sample; - Not reported; * Methicillin-resistant Staphylococcus aureus 
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Table 2-7:  Characteristics of studies reporting foot disease and foot risk factors in other specific inpatient populations 
Study [Country] Sample  
n 
Age 
years+ 
Male 
% 
Prospective 
Study Design 
Wound 
% 
Inf 
% 
PAD  
% 
PN  
% 
Deform  
% 
Amp  
% 
Guillian Barre Syndrome           
Fourrier 2011 [France] [166] 61 51 54 no - - - 45.9 - - 
Foster 2004 [US] [167] 33 34 63 no - - - 57.6 - - 
Dyspnoea           
Zhang 2011 [China] [168] 766 - - no - - - 67.3* - - 
Acromegaly           
Reid 2010 [US] [169] 324 46 51 no - - - - 39.9 - 
Dementia           
Leblhuber 2011 [Austria] [170] 33 79 33 yes - - 9.0 96.0 - - 
Friedreichs’ Ataxia           
Dulgeroglu 2003 [Turkey] [171] 30 22 70 no - - - 100 56.6 - 
Bed Bound > 7 days           
Schweinberger 2010 [US] [172] 29 63 83 yes 3.4 - - - 6.9 - 
Amp: Amputations; Deform: Foot Deformity; n: Numbers; PAD: Peripheral Arterial Disease; PN: Peripheral Neuropathy; % prevalence; +Median or mean age of sample; - Not reported; *PN symptoms 
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2.6 DISCUSSION 
This literature review suggests that no study has yet investigated the overall 
prevalence of foot-related conditions and foot risk factors within a representative 
inpatient population.  Overall, a very broad range of different specific conditions 
appeared to be associated with foot-related conditions in inpatient populations.  
Diabetes had by far the largest volume of specific inpatient literature in this foot-
related hospitalisation area; yet, multiple studies also investigated other chronic 
disease, trauma-related, infection-related and other neurological-related specific 
inpatients for foot–related condition prevalence.  All these specific inpatient 
populations appeared to be associated with a higher prevalence of foot-related 
conditions or foot risk factors than the average representative inpatient population 
indicating these specific conditions may be the leading causes of major foot-related 
conditions in representative inpatient populations.  Foot wounds were the most 
investigated foot-related condition and were present in approximately 1-8% of 
representative inpatients, rising to 5-53% in diabetes, 7-60% in other chronic 
diseases and 0-96% of those inpatients affected by acute trauma.  Foot risk factors 
were present in up to 25% of representative inpatients and up to 100% of specific 
inpatient populations.  The vast majority of studies identified from this review 
investigated specific inpatient populations, were retrospective in design and most 
studies did not appear to investigate the foot-related condition or foot risk factor as 
the primary outcome of the study.  However, as this was a narrative review, it is 
recommended that a more robust systematic review be performed to systematically 
identify all literature in the area, the quality of this literature and determine pooled 
prevalence estimates to more precisely determine the prevalence of foot-related 
conditions present in inpatient populations.  
No study identified in this review investigated a range of foot-related 
conditions and foot risk factors within a representative inpatient population.  Four 
studies investigated an individual foot-related condition in a representative inpatient 
population [8, 29, 46, 47].  Two studies reported a foot wound prevalence of 2.7% 
[47] and 5.4% [8]. Whilst the other two studies retrospectively investigated large 
national hospital discharge datasets reporting foot infection represented by an 
osteomyelitis prevalence of 0.1% [29] and a necrotising fasciitis prevalence of 0.4% 
[46]. Arguably, the closest study to report the prevalence of a range of foot-related 
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conditions and foot risk factors across the broadest cross-section of adult inpatient 
populations identified by this review was a US study by Reed and colleagues [4]. 
This 2004 study retrospectively interrogated a large national discharge dataset in two 
evenly matched random samples of patients aged 80 years or older to determine foot 
disease disorder and foot risk factor prevalence for representative geriatric patients 
discharged with diabetes and without diabetes [4].  The authors’ specifically 
analysed the dataset for codes representing foot ulcers, abscesses, infections, 
osteomyelitis, PAD and amputation [4].  A 3.1% prevalence of any foot disease was 
reported in geriatric inpatients with diabetes and 1.3% for geriatric inpatients without 
diabetes [4].  The foot risk factor of PAD was additionally reported in 3.2% of 
inpatients with diabetes and 1.9% of non-diabetes inpatients [4].  Individual foot 
disease disorder prevalence was different for diabetes and non-diabetes inpatients, 
including foot ulcers (1.7% vs. 0.6%), foot infection (0.04% vs. 0.02%), 
osteomyelitis (0.6% vs. 0.2%) and amputation (1.7% v 0.4%) [4]. Overall, the 
authors concluded that diabetes “in the octogenarian patient imposes an additive risk 
for (foot) complications” [4].  However, this study relied entirely on retrospective 
hospital discharge data.  The accuracy of such data capture for specific foot disease 
disorders and foot risk factors has been queried in other inpatient foot disease studies 
[5].  This was evident when comparing the very low reporting of PAD in this 
retrospective study (1.9 – 3.2%) [4] compared to most of the prospective studies 
reporting PAD in representative inpatients included in this review (11 – 34%)  [48, 
67].  Nevertheless, this study is arguably the most complete of the identified studies 
in this review. 
The main foot-related condition reported in inpatient populations was that of 
foot wounds.  Foot wound prevalence from this review ranged from 0.9 – 8.3% in 
representative inpatients [62, 63] and 0.6 – 15% in geriatric inpatients [4, 67].  
Diabetes-related foot wounds appeared to make up the majority of the foot wounds 
reported in the 0.9 -8.3% prevalence in representative inpatient population [62, 63].  
The higher 2.7 – 8.3% diabetes-related foot wound prevalence rates were reported in 
developing countries [59-62], whilst much lower 1 – 1.7% rates were reported in 
developed countries [54, 55, 63], with some studies reporting up to 4.9% of 
representative inpatients had either a current or past diabetes-related foot wound [7, 
56].  Interestingly, an interrogation of the studies in developed countries reporting 
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both diabetes and foot wound prevalence in representative inpatients indicates 
approximately 14 – 23% of representative inpatient have diabetes  [7, 51, 56] and of 
those foot wounds are present in 11 – 16% [27, 72, 75, 94].  These ranges suggest a 
perhaps more plausible diabetes-related foot wound prevalence of 1.5 – 3.7% in 
representative inpatients.  In general, diabetes contributed to the largest proportion of 
foot wound admissions identified from studies in this review [4, 27].  Interestingly, a 
retrospective US study suggested that diabetes-related foot wounds made up 
approximately 81% of all foot wound admissions [27].  However, a large pressure 
ulcer study indicated that pressure ulcers on the foot contributed up to 5% of 
representative inpatient admissions [8].  Furthermore, foot wounds were consistently 
reported to have long lengths of hospitalisation (7 – 60 days) [49, 50, 52, 56, 58, 60-
62], thus, potentially inflating this prevalence rate for an analysis of inpatient 
occupied hospital bed days; although a recent retrospective Irish study reported 
around 1% of beds were used for diabetes-related foot wound management [63].   
Most amputations were reported to result in people with a preceding foot 
wound from the studies included in this review [4, 27, 52, 53, 55, 60-62, 72, 75].  
With the exception of a few outliers, amputations appeared to occur in 12 – 38% of 
diabetes-related foot wound admissions, or contribute to approximately 0.1 – 1.5% of 
representative inpatient admissions in developed countries [52, 53, 55, 60-62].  
Interestingly, amputations in patients admitted with vascular disease also appeared to 
occur in 10 – 30% of cases [21, 23].  Most diabetes-related amputations seemed to be 
the result of severe infection or osteomyelitis of a foot wound [4]; thus it seems 
plausible that study results reported in this review had similar amputation [4, 52, 53, 
55] and osteomyelitis [4, 29, 46, 50] prevalence rates as a proportion of total 
representative inpatient admissions.   
The major foot risk factors for foot disease are PAD, peripheral neuropathy and 
foot deformity [1, 2, 18, 19].  PAD in this review was present in approximately 11 – 
46% of prospectively examined inpatient populations depending on the underlying 
specific condition [21, 48, 64, 93]; the highest prevalence occurred in inpatients with 
diabetes and kidney disease [100, 101].  Peripheral neuropathy was also highly 
prevalent in diabetes inpatients (12 – 81%) [64, 67, 78, 82, 85, 91, 95, 97, 99] and 
inpatients with other neurological conditions (46 – 100%), including Guillain-Barre 
Syndrome and Friedreich’s Ataxia [166, 167, 171].  Interestingly, in one study 
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peripheral neuropathy was reported to be highly prevalent in dementia inpatients; 
however, this study did state that eliciting a clinical response to neurological testing 
may have had limitations in this population [170].  Foot deformity was highly 
prevalent in geriatric inpatients and those with other neurological conditions [66, 68, 
166, 167, 171].  Although foot deformity criteria did differ in most studies, 
prevalence rates were around 43 – 50% in geriatric inpatients [66, 68], 20 – 70% in 
arthritic conditions [43, 44, 116] and around 50% of other neurological conditions 
[166, 167, 171]. 
Apart from diabetes, the other specific conditions that appeared to cause higher 
prevalence of foot-related conditions and foot risk factors in inpatients identified 
from this review included cancer [24, 25, 104, 107, 110], cardiovascular disease [21, 
23, 113], arthritis [43, 44, 116], acute trauma [123, 126, 127, 139, 140, 145], 
infection [149, 155, 157, 165] and different neurological conditions [166, 167, 171]. 
However, studies investigating these specific medical conditions were extremely 
heterogeneous, in terms of populations and foot-related conditions studied, sample 
sizes, and quality of methodology.  Foot-related condition and foot risk factors seem 
to be involved in similar proportions of each specific condition’s inpatient 
population.  For example, cancers located on the foot contributed to around 0.4 – 
3.0% of all bone cancers, sarcoma and melanoma admissions [25, 104, 107], 
excluding studies with small samples and one historical African study conducted 
over 25 years ago suggesting an 8.4% prevalence [24]. Furthermore, hand-foot-
syndrome, a hospital acquired complication of chemotherapy in cancer inpatients, 
was present in 2 – 13.9% of those particular inpatients [110, 112].  Lastly, the 
prevalence of acute foot trauma admissions seemed to contribute to 2.8 – 6.3% of 
admissions caused by the overall trauma investigated, such as replantation of severed 
body parts, motorbike accidents and high fall injuries [128, 132, 133].   
Other specific conditions with seemingly high prevalence of foot-related 
hospitalisations were conditions associated with the ground in developing nations 
with warm climates or those in war zones; such as animal attacks [45, 123], landmine 
injuries [136, 137], burns [140, 143], injuries from natural disasters [144, 145] and 
fungal infections [146, 149].  Animal attacks resulting in hospitalisation were mainly 
reported in developing nations, with injuries mostly occurring from snakes, scorpions 
and dogs [45, 119-121, 123-125], and affecting the feet in 36–82% of cases.  
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Landmine injury admissions affected the feet in up to 96% of admissions and were 
predominantly reported in nations that had been affected by war [134, 136, 137].  
Burns to the feet typically from walking on hot surfaces made up 7–17% of burns 
admissions in studies undertaken in both developing and developed nations [140, 
141].  Foot fungal infections occurred in 20–38% of different conditions admissions 
and again were reported in developing nations with a warmer climate [146-148], with 
a higher prevalence in medical conditions causing immunosuppression such as 
cancer and diabetes [146, 147].  Lastly, two studies reported foot-related conditions 
made up 12-43% of all hospitalisations caused by injuries following natural disasters 
[144, 145].  The main foot-related injuries following an earthquake were reported to 
be fractures, lacerations and contusions (Indonesia [144]), whilst diabetic foot 
wounds were the main foot-related condition requiring hospitalisation following a 
hurricane (Grenada [145]).  
Interestingly, no papers meeting criteria in this review specifically focussed on 
chronic kidney disease specific inpatient populations.  Outpatient populations with 
chronic kidney disease or end stage kidney disease have consistently been found to 
have foot disease disorders and foot risk factors that are similar to those found in 
diabetes populations [18, 19, 42].  However, kidney disease in this review was often 
found to be included as a sub-group of diabetes populations [100, 101].  A number of 
included studies investigated patients with diabetes together with chronic kidney 
disease and reported foot wound prevalence of 25%, and a PAD prevalence of 45% 
for this specific inpatient population [100, 101].  These studies also demonstrated 
diabetes patients on dialysis again had much higher rates of foot wounds (67 – 75%) 
[100, 101], PAD (72 – 77%) [100, 101] and amputations (approximately 7%) [69, 
100].  
Age and gender also appeared to influence foot-related condition and foot risk 
factor rates in inpatient populations.  Of the studies investigating representative 
inpatient populations for foot-related conditions, average age ranged from 49 – 75 
years and there were more males (46 – 85%) than females in these populations [8, 
29, 46, 48].  Patients admitted with diabetes-related foot disease also tended to 
demonstrate similar mean age ranges (49–83 years) and higher male proportions (52-
70%) [27, 49, 60-62, 71, 73, 75, 76, 79-81, 84, 87, 103].  Other chronic disease 
specific foot-related hospitalisations, occurred between the ages of 45 – 65 years, and 
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more evenly affected males and females (males 29-72%)  [24, 43, 44, 106, 112, 116].  
Whereas, foot-related hospitalisation due to acute trauma affected predominantly 
younger (mean age 22 – 53 years) male populations (37 – 100%) [45, 120, 133, 137, 
140].  Yet, foot infection admissions appeared to occur across a broad range of mean 
ages (27 – 71 years) depending on the type of infection and affect similar proportions 
of males and females [149, 155, 157, 161, 163].    
Only a limited number of studies reported on current or past foot treatment of 
inpatients with foot-related conditions.  This may have been due to the focus of this 
review being primarily on prevalence and not on treatment.  However, those studies 
reporting past foot treatment were mainly UK-based studies investigating diabetes 
complications in inpatients [26, 51, 55, 56, 97].  The only study that discussed past 
foot treatment prior to hospitalisation was a 1996 UK paper indicating 50% of 
diabetes specific inpatients had visited a podiatrist in the preceding 12 months 
irrespective of their foot-related condition or foot risk factor present [97].  However, 
several large point-prevalence cross-sectional studies conducted in UK diabetes 
inpatient populations indicate that less than one third of diabetes specific inpatients 
have their feet examined whilst in hospital [26, 55, 56].  Furthermore, around one 
quarter of hospitals did not have inpatient podiatry services or multi-disciplinary foot 
teams [26, 51]. 
  
Limitations 
There are a number of limitations to the methodology used for this review.  
First, the literature search was very broad, performed by one author only, was unable 
to obtain all full texts, did not hand-search reference lists of included papers, or 
contact prominent authors for any papers overlooked in the search; thus, there is a 
likelihood that papers may have been missed.  Second, no formal quality assessment 
of included papers was performed and only descriptive data were extracted.    Lastly, 
only papers published between 1980 and 2011 were included in this review and 
further applicable literature may have become available.  Although, a delay between 
the final search date and the publication date of large literature reviews is not ideal, 
in the field of foot disease this is not unusual [173, 174] as they still typically provide 
the first synthesis of the literature in a particular sub-field of the foot disease 
literature.  This review is also the first to synthesise the literature in this sub-field of 
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foot disease and provides a comprehensive understanding of foot-related 
hospitalisation; demonstrating that foot wounds are the main foot-related conditions 
in hospitalised populations.  
There were also several consistent limitations identified in the included papers 
reviewed for this narrative literature review.  First, the vast majority of identified 
studies were either retrospective analyses of large generic hospital discharge datasets 
or prospective investigations of specific condition-based inpatient populations.  The 
retrospective analyses of large generic datasets are likely to introduce a bias towards 
under-reporting the specific foot-related conditions of interest in this review; 
whereas, the prospective investigations of specific conditions have the potential to 
over-report foot-related conditions if they were the known primary outcomes of 
interest for the included study.  Second, the majority of papers were primarily 
investigating other non-foot outcomes and reported foot-related conditions or foot 
risk factors as minor additional outcome variables which potentially biases the study 
towards under-reporting the foot-related conditions.  Third, very few studies reported 
on social determinant factors such as socio-economic status or geographical 
remoteness which limits the ability to generalise findings to local regions of interest 
for the reader.  Fourth, very few studies reported on available inpatient and outpatient 
services which most likely would impact on the acuity of patients admitted to 
hospital, and therefore, the numbers and prevalence of foot-related conditions present 
in those hospitals.  Last, very few prospective papers reported the instruments used 
for data collection.  The only papers specifically reporting testing data collection 
instruments referred to piloting the instrument prior to the study but did not report 
any validity or reliability results.  Thus, overall the reliance on either retrospective 
datasets or prospective data collection instruments of unknown quality and 
reliability, poses the likely risk of under-reporting foot-related conditions [5].   
This literature review indicates a gap in the literature investigating the 
prevalence of foot-related conditions and foot risk factors in representative inpatient 
populations.  It also recommends further more robust systematic reviews are required 
to verify this gap and provide pooled prevalence estimates of the foot-related 
inpatients burden.  Additionally, it seems that no comprehensive data collection 
instrument designed to capture foot-related condition data in representative inpatient 
populations has been tested for validity and reliability. Thus, there is need to develop 
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and test such instruments in future and ensure the instrument includes the specific 
conditions identified from this review to be associated with higher prevalence of 
foot-related conditions.   Whilst large point-prevalence studies investigating foot-
related conditions and foot risk factors within diabetes specific inpatient populations 
are beginning to occur [26, 51, 55, 56], studies investigating foot-related conditions 
and foot risk factors in more representative inpatient populations are still required to 
fully appreciate the overall foot-related hospitalisation.   
 
2.7 CONCLUSION 
This review appears to be the first to synthesise the literature surrounding the 
prevalence of foot-related conditions and risk factors in hospitalised populations.  No 
individual study has investigated the overall foot-related inpatient burden.  Specific 
conditions reported to increase the likelihood of foot-related hospitalisation were 
diabetes, other chronic diseases, trauma, infection and some neurological conditions.  
It appears foot wounds have the largest impact on foot-related hospitalisation; 
contributing to an estimated 1–8% of representative inpatients.  Foot infection and 
amputation appears to complicate 10–40% of these foot wound admissions, whilst 
the foot risk factors of PAD and PN were present in up to 25% of all inpatients.  
Interestingly, foot disease-related hospitalisation appears to disproportionately affect 
50–80 year old males whilst acute foot trauma-related hospitalisation affects 20-50 
year old males. The majority of included papers analysed in this review were 
retrospective, investigated specific conditions and did not report foot-related 
conditions or foot risk factors as primary outcomes.  To more accurately understand 
the overall foot-related inpatient burden systematic reviews are required to provide 
more precise prevalence estimates. 
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Chapter 3: Prevalence of foot disease and risk 
factors in general inpatient 
populations: a systematic review 
and meta-analysis 
This chapter begins with a preface section that briefly explains the manuscript 
that makes up this second literature review chapter (section 3.1). An adapted version 
of the manuscript published in the BMJ Open journal, “Prevalence of foot disease 
and risk factors in general inpatient populations: a systematic review and meta-
analysis” is then presented; including abstract and article summary (section 3.2), 
introduction (section 3.3), methods (section 3.4), results (section 3.5), discussion 
(section 3.6) and conclusions section (section 3.7).  Lastly, using the findings from 
the two literature review chapters a new conceptual framework for foot disease in 
inpatients was constructed (section 3.8). 
 
3.1 PREFACE 
Chapter 2 reviewed the existing literature and suggested foot disease disorders 
were the most prevalent foot-related conditions in inpatient populations.  The chapter 
concluded that there was literature indicating up to 25% of representative inpatient 
populations had a foot risk factor for foot disease, up to 8% had a foot disease 
disorder and up to 1.5% an amputation.  Furthermore, it suggested these figures were 
higher in specific inpatient populations such as geriatric, diabetes, other chronic 
disease, trauma-related and infection-related inpatient populations.  However, this 
chapter also reported that these findings were from different studies of undefined 
quality and that a potential gap in the literature still existed regarding the prevalence 
of foot disease disorders in representative inpatient populations.  The chapter went on 
to recommend systematic reviews to verify this gap and meta-analyses to provide 
pooled prevalence estimates of foot disease disorders in representative inpatients if 
possible.  It should be noted that as the purposes of the Chapter 2 literature review 
had been achieved it was not considered necessary to update the search strategy after 
it was originally completed in 2012.  Those purposes were to provide the necessary 
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underlying broad understandings of this field and specific recommendations for 
future systematic reviews in this field.  These specific recommendations for future 
systematic reviews are the subject of Chapter 3. 
Chapter 3 incorporates a large published systematic review and meta-analysis 
that specifically investigated the prevalence of foot disease disorders and major risk 
factors in representative inpatient populations.  This chapter addressed the specific 
aforementioned recommendations for further systematic reviews emanating from 
Chapter 2. The definition of a “representative inpatient population” in this chapter 
was designed to be much tighter and represent the diverse range of people that are in 
hospital at any one time.  Studies were only included if they reported all participants 
from at least one general medical or general surgical hospital inpatient ward.  This 
chapter enabled a more specific understanding of the prevalence of foot disease 
disorders and major risk factors in representative inpatient populations.  The 
manuscript that forms the basis of this chapter has been adapted from the manuscript 
published in the BMJ Open journal: 
Lazzarini PA, Hurn SE, Fernando M, Jen S, Kuys SS, Kamp MC, Reed L. 
Prevalence of foot disease and risk factors in general inpatient populations: a 
systematic review and meta-analysis. BMJ Open 2015; 5: e008544 [37]. 
 
These two literature review chapters identified a number of common gaps and 
methodological deficiencies in the existing literature with regards to studies 
adequately investigating the prevalence and associates of foot-related conditions, and 
specifically foot disease disorders, in representative inpatient populations.  Lastly, a 
more detailed conceptual framework for foot disease in representative inpatient 
populations was constructed using the findings of the two literature review chapters 
(section 3.8).  This new conceptual framework for foot disease in inpatients formed 
the basis of this thesis’ subsequent studies (Chapter 3-7). 
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3.2 ABSTRACT AND ARTICLE SUMMARY 
Objective: To systematically review studies reporting the prevalence in 
general adult inpatient populations of foot disease disorders (foot wounds, foot 
infections, collective “foot disease”) and risk factors (peripheral arterial disease 
(PAD), peripheral neuropathy (PN), foot deformity). 
Methods: A systematic review of studies published between 1980 and 2013 
was undertaken using electronic databases (Medline, Embase and CINAHL).  
Keywords and synonyms relating to prevalence, inpatients, foot disease disorders 
and risk factors were used.   Studies reporting foot disease or risk factor prevalence 
data in general inpatient populations were included.  Included study’s reference lists 
and citations were searched and experts consulted to identify additional relevant 
studies.  Two authors, blinded to each other, assessed the methodological quality of 
included studies.  Applicable data were extracted by one author and checked by a 
second author.  Prevalence proportions and standard errors were calculated for all 
included studies.  Pooled prevalence estimates were calculated using random effects 
models where three eligible studies were available. 
Results: Of the 4,972 studies initially identified, 78 studies reporting 84 
different cohorts (total 60,231,517 participants) were included.  Foot disease 
prevalence included: foot wounds 0.01-13.5% (70 cohorts), foot infections 0.05-
6.4% (seven cohorts) and collective foot disease 0.2-11.9% (twelve cohorts).  Risk 
factor prevalence included: PAD 0.01-36.0% (ten cohorts), PN 0.003-2.8% (six 
cohorts) and foot deformity wasn’t reported.  Pooled prevalence estimates were only 
able to be calculated for pressure ulcer-related foot wounds 4.6% ((95% CI) 3.7–
5.4)), diabetes-related foot wounds 2.4% (1.5-3.4), diabetes-related foot infections 
3.4% (0.2-6.5) and diabetes-related foot disease 4.7% (0.3-9.2). Heterogeneity was 
high in all pooled estimates (I
2
 = 94.2 - 97.8%, p<0.001). 
Conclusions: This review found high heterogeneity, yet suggests foot disease 
was present in one in every twenty inpatients and a major risk factor in one in three 
inpatients.  These findings are likely an underestimate and more robust studies are 
required to provide more precise estimates.  
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Article Summary: Strengths and limitations of this study 
o This is the first systematic review and meta-analysis to investigate the 
prevalence of foot disease in general inpatient populations 
o A broad search strategy was used to minimise the risk of missing relevant 
studies 
o One author extracted data; however, this was checked by a second author 
o Studies reporting foot disease and risk factor prevalence in inpatient 
populations had high heterogeneity and thus pooled estimates should be 
interpreted with caution 
o Very few studies reported foot disease or risk factor data as the primary 
study outcome and most are likely to have under-reported 
 
3.3 INTRODUCTION 
Foot disease is a common result of the pathophysiology of chronic conditions 
[1, 2, 5, 8, 11, 19].  Foot disease disorders have been reported to be present in 
significant numbers of people hospitalised throughout the world [1, 2, 5, 8, 11, 19].  
The presence of foot disease disorders in those hospitalised has also been associated 
with extended hospital stays [1, 2, 5, 8, 11], amputations [1-3, 9, 11, 19, 175], 
institutionalisation [12, 13], high mortality rates [1-3, 14] and significant ongoing 
health care needs [1, 2, 17, 19, 20].   
 Foot disease is a term typically used to denote severe foot-related disorders 
that are likely to result in hospitalisation and amputation and most commonly refers 
to foot wounds and foot infections [1, 2, 14, 17, 20].  However, “foot disease” is also 
commonly used as a catchall term that collectively includes foot wounds, foot 
infection and other less common severe foot-related disorders, such as critical 
ischemia, and Charcot Neuroarthropathy [1, 2, 14, 17, 20].   The major risk factors 
for foot disease most commonly include peripheral arterial disease (PAD), peripheral 
neuropathy (PN) and foot deformity [1, 2, 5, 14, 17-20, 176].  However, these risk 
factors can also become foot disease disorders if severe and result in hospitalisation 
or amputation [1, 2, 5, 14, 17-20, 176].  Foot disease disorders and risk factors 
typically result from chronic conditions [3, 5, 9, 11, 19, 175]; such as diabetes [1-3, 
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9, 12, 14, 17, 20, 175], cardiovascular disease [13, 21-23], chronic kidney disease 
[18, 19, 42] and cancer [3, 24, 175].  
Studies investigating the presence of foot disease in hospital inpatients have 
predominantly focussed within discrete inpatient populations, such as only geriatric 
or diabetes patients [1, 2, 5, 12, 17, 140].  Fewer studies have reported the prevalence 
of foot disease across more representative general inpatient populations that include 
the diverse range of people typically hospitalised at any one time [8, 29].  Thus, 
precise estimates of the prevalence of foot disease in general inpatient populations 
are unknown [8, 29].  Furthermore, there have been no known systematic reviews 
investigating the prevalence of foot disease in inpatient populations.  In order for 
clinicians, researchers and policy makers to begin to quantify, understand and 
address the burden that foot disease imposes on inpatient care it seems necessary to 
determine the foot disease prevalence in general inpatient populations rather than 
discrete segments of the inpatient population.    
The primary aim of this study was to systematically review all studies reporting 
the prevalence in general adult inpatient populations of foot disease disorders (foot 
wounds, foot infections and collective “foot disease”) and risk factors (peripheral 
arterial disease (PAD), peripheral neuropathy (PN) and foot deformity).  Secondary 
aims were to determine the pooled prevalence estimates for each foot disease 
disorder and risk factor, and, investigate the prevalence of amputations from included 
studies. 
 
3.4 METHODS 
The authors have adhered to the PRISMA guideline reporting checklist (see 
Supplementary Table S3-1) and PRISMA flow diagram (see Figure 3-1) [177]. 
 
Search Strategy 
Electronic databases (Medline, Embase, and CINAHL) were systematically 
searched by the first author for all studies published between 1980 and 2013 
reporting the prevalence of foot disease disorders or risk factors in an inpatient 
population.  The year 1980 was chosen due to the advent of the first validated 
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outcome measures to investigate foot disease disorders at this time [178, 179].  The 
search strategy included broad keywords and synonyms combining the anatomical 
area (e.g. foot); disease (e.g. wounds, infection) or risk factors (e.g. PAD, PN); 
populations (e.g. inpatients); and epidemiological terms (e.g. prevalence) of interest.  
See Supplementary Table S3-2 for the full search syntax with truncation used for the 
electronic database search. 
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Supplementary Table S3-1: PRISMA guidelines reporting checklist  
Section/topic  # Checklist item  Reported on page # 
TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or both.  36 
ABSTRACT   
Structured summary  2 Provide a structured summary including, as applicable: background; objectives; data sources; study 
eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; 
limitations; conclusions and implications of key findings; systematic review registration number.  
37-38 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is already known.  38-39 
Objectives  4 Provide an explicit statement of questions being addressed with reference to participants, interventions, 
comparisons, outcomes, and study design (PICOS).  
39 
METHODS   
Protocol and registration  5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, 
provide registration information including registration number.  
NA 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years 
considered, language, publication status) used as criteria for eligibility, giving rationale.  
39-47 
Information sources  7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to 
identify additional studies) in the search and date last searched.  
39-47 
Search  8 Present full electronic search strategy for at least one database, including any limits used, such that it 
could be repeated.  
44-45; 
Supplementary Table S3-2 
Study selection  9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if 
applicable, included in the meta-analysis).  
46-47 
Data collection process  10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and 
any processes for obtaining and confirming data from investigators.  
48-49 
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Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any 
assumptions and simplifications made.  
48-49 
Risk of bias in individual 
studies  
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether 
this was done at the study or outcome level), and how this information is to be used in any data 
synthesis.  
47-48;  
Supplementary Table S3-3 
Summary measures  13 State the principal summary measures (e.g., risk ratio, difference in means).  49-50 
Synthesis of results  14 Describe the methods of handling data and combining results of studies, if done, including measures of 
consistency (e.g., I
2
) for each meta-analysis.  
49-50 
Risk of bias across studies  15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, 
selective reporting within studies).  
49-50 
Additional analyses  16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if 
done, indicating which were pre-specified.  
NA 
RESULTS   
Study selection  17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for 
exclusions at each stage, ideally with a flow diagram.  
50-51; Figure 3-1 
Study characteristics  18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up 
period) and provide the citations.  
52-60; Table 3-1 & 
Supplementary Tables  
S3-4 – S3-6 
Risk of bias within studies  19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12).  61-65; Table 3-2 & 
Supplementary Table S3-7 
Results of individual studies  20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for 
each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.  
52-60;  
Supplementary Tables  
S3-4 – S3-6 
Synthesis of results  21 Present results of each meta-analysis done, including confidence intervals and measures of consistency.  67-68; Tables 3-3 – 3-6 
Risk of bias across studies  22 Present results of any assessment of risk of bias across studies (see Item 15).  67-70;  
Supplementary Figures 
S3-1 – S3-2 
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Additional analysis  23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see 
Item 16]).  
NA 
DISCUSSION   
Summary of evidence  24 Summarize the main findings including the strength of evidence for each main outcome; consider their 
relevance to key groups (e.g., healthcare providers, users, and policy makers).  
71 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete 
retrieval of identified research, reporting bias).  
71-72 
Conclusions  26 Provide a general interpretation of the results in the context of other evidence, and implications for 
future research.  
72-78 
FUNDING   
Funding  27 Describe sources of funding for the systematic review and other support (e.g., supply of data); role of 
funders for the systematic review.  
79 
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Supplementary Table S3-2: Search strategy used for electronic databases 
Original Search Additional Search 
Medline Medline 
(feet or foot):ab pressure:ab 
AND AND 
(problem* OR complication* OR disease* OR ulcer* OR wound* OR deform* OR infec* OR cellulitis OR amputation* 
OR diab* OR isch#mi* OR vascul* OR arter* OR gangr* OR neurop*):ab 
(ulcer* OR wound*):ab 
AND AND 
(inpatient* OR hospital* OR admi*):ab (inpatient* OR hospital* OR admi*):ab 
AND AND 
(questionnair* or survey or prevalence or incidence or risk* or factor or associat* or relationship* or correlat* or etiolog* or 
aetiolog* or caus* or develop* or predispos or demograph*):ab 
prevalence:ab 
Limiters: Limiters: 
Date of Publication: January 1980 - December 2013 Date of Publication: January 1980 - December 2013 
Human (Studies Only) Human (Studies Only) 
CINAHL CINAHL 
(feet or foot):ab pressure:ab 
AND AND 
(problem* OR complication* OR disease* OR ulcer* OR wound* OR deform* OR infec* OR cellulitis OR amputation* 
OR diab* OR isch#mi* OR vascul* OR arter* OR gangr* OR neurop*):ab 
(ulcer* OR wound*):ab 
AND AND 
(inpatient* OR hospital* OR admi*):ab (inpatient* OR hospital* OR admi*):ab 
AND AND 
(questionnair* or survey or prevalence or incidence or risk* or factor or associat* or relationship* or correlat* or etiolog* or 
aetiolog* or caus* or develop* or predispos or demograph*):ab 
prevalence:ab 
Limiters: Limiters: 
Published Dates: January 1980 - December 2013 Published Dates: January 1980 - December 2013 
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Human (Studies Only) Human (Studies Only) 
Embase Embase 
(foot or feet):ab pressure:ab 
AND AND 
(problem* OR complication* OR disease* OR ulcer* OR wound* OR deform* OR infec* OR cellulitis OR amputation* 
OR diab* OR isch*mi* OR vascul* OR arter* OR gangr* OR neurop*):ab 
(ulcer* OR wound*):ab 
AND AND 
(inpatient* OR hospital* OR admi*):ab (inpatient* OR hospital* OR admi*):ab 
AND AND 
(questionnair* or survey or prevalence or incidence or risk* or factor or associat* or relationship* or correlat* or etiolog* or 
aetiolog* or caus* or develop* or predispos or demograph*):ab 
prevalence:ab 
Filters: Filters: 
Publication Years: 1980 - 2013 Publication Years: 1980 - 2013 
Study Types: Human Study Types: Human 
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Study selection 
All unique study abstracts identified were screened by the first author using an 
overarching initial screening question: Does the article appear to discuss original 
findings on the prevalence of foot disease or risk factors within adult populations 
staying overnight in a hospital?   The full text was sought if it appeared to address the 
screening question.   
A detailed eligibility assessment was then undertaken by the first author for 
final inclusion.  Studies were eligible for inclusion if they met all of the below 
inclusion criteria and did not meet any exclusion criteria.   Inclusion criteria were 
studies:  
• Indexed in the aforementioned electronic databases; 
• Published in peer-reviewed academic journals; 
• Available in full text; 
• Written in the English language; 
• Reporting a study population representative of a general adult inpatient 
population. General adult inpatient populations were defined as reporting 
all eligible participants from at least one general medical or surgical 
hospital inpatient ward; and 
• Reporting the number, or proportion, of a foot disease disorder or risk 
factor.  Foot disease disorders (foot wound, foot infection or collective 
“foot disease”) and risk factors (peripheral arterial disease (PAD), 
peripheral neuropathy (PN) or foot deformity) were defined as listing of 
the foot disease disorder or risk factor concerned (or a synonym) in the 
study.  Thus, no specific diagnostic criteria were used and reporting 
could have been elicited from a range of self-report, medical record audit 
or clinical examination methods.  “Foot disease” was defined as the 
collective reporting of foot wounds, foot infections and other severe foot-
related disorders together. 
 
However, studies were excluded if they met any of the following exclusion 
criteria:  
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• Studies reporting designs that were primarily case studies, literature 
reviews, case control, validity or reliability studies; and 
• Studies reporting a study population that was not defined as 
representative of a general adult hospital inpatient population; including 
studies investigating primarily children (<18 years), outpatients, geriatric 
inpatients (>65 years), long-term care inpatients or discrete condition-
related inpatients (such as only diabetes patients). 
At completion of the search strategy and study selection the first author hand 
searched the reference lists of all included studies and citation searched (Scopus) all 
studies citing the included studies.  Following this process it became apparent that all 
relevant studies had been identified, with the notable exception of pressure ulcers on 
very specific anatomical locations of the foot, such as the heel or ankle.  Thus, an 
additional search was conducted for all studies reporting only the prevalence of 
pressure ulcers in inpatient populations using a similar search strategy 
(Supplementary Table S3-2).  The hand searching of references lists and citation 
search process was repeated for any additional identified included studies from this 
additional search.  Lastly, the authors consulted six external content experts (e.g. 
physicians, surgeons, nurses, podiatrists) in the field.  The authors forwarded the 
systematic review abstract, search terms and a list of all identified included studies to 
the content experts and content experts provided any additional study titles they 
considered may have also met the inclusion criteria. 
 
Quality assessment 
A study quality assessment tool was used to perform the study quality 
assessments of all included studies [31].  This tool was originally designed to assess 
the methodological quality of pressure ulcer prevalence in inpatient populations [31].  
The authors made minor modifications to this tool to reflect the focus of foot disease 
rather than pressure ulcers.  See Supplementary Table S3-3 for the modified ten item 
questions used to evaluate the methodological quality of studies included in this 
review.  Each item was scored either as a “yes” (score = 1) or “no/not reported” 
(score = 0) with a total possible score of 10 [31].   
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Supplementary Table S3-3: Questions used to assess the methodological quality of 
included studies [31]  
Item Questions # 
1. Is the sample random or is the whole population (i.e. hospital) surveyed?  
2. Is the study design prospective?   
3. Is a physical examination performed for the foot outcome/s*?  
4. Is the sample size adequate (>300 subjects)?   
5. Are objective, suitable, standard methods used for measurement of foot outcome/s*?  
6. Is the foot outcome/s* measured in an unbiased fashion?  
7. Is the response rate adequate?   
8. Are the estimates of prevalence given with confidence intervals?  
9. Are the estimates of prevalence given in detail by subgroups?  
10. Are the study subjects and the setting described in detail?  
# Each question is scored 0 (no or not reported) or 1 (yes); * Foot outcome/s = foot wounds, foot infections, collective foot 
disease, peripheral arterial disease, peripheral neuropathy and/or foot deformity 
 
Two authors, blinded to each other’s assessments, assessed the methodological 
quality of all included studies using the aforementioned tool.  A research assistant 
independent of the authors redacted all identifying features (title, authors and journal 
details) of all included studies prior to forwarding studies in a random order to the 
authors individually for assessment.  At the conclusion of this process the overall 
agreement between the two blinded author’s scores were calculated and reported for 
all items.  Any differences in the original blinded assessments between the two 
authors were then resolved by consensus agreement between the two authors.  A 
third author was used to make a final adjudication if agreement could not be reached.  
Studies were given a total study quality score which was classified as either “poor” 
(total score = 0–3), “moderate” (total score = 4–6) or “good” (total score = 7-10) 
study quality.   
 
Data extraction 
Data extraction was completed for each included study by the first author using 
a custom-designed data extraction spreadsheet.  Data were extracted for total sample 
size, average age (mean or median), age range, proportion of males, and any numbers 
or prevalence data for the foot disease or risk factor variables.  Sample size data were 
also extracted on condition-specific sub-groups (diabetes or pressure ulcers) and 
amputations if reported.  All extracted data were then checked for accuracy and 
omissions by a non-blinded second author.  At the conclusion of this data extracting 
checking process the overall agreement between the second checking author’s 
findings and the original author’s findings was calculated and reported.  Any 
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differences in the data extraction finding between the two authors were then resolved 
by consensus agreement between the two authors.  A third author was used to make a 
final adjudication if agreement could not be reached.   
 
Statistical analysis 
Data were analysed using Stata version 13 (StataCorp LP, College Station, 
Texas, USA) and Microsoft Excel 2010 (Microsoft Corporation, Redmond, 
Washington, USA).  Descriptive statistics were reported on all included studies.  
Medians (interquartile ranges) were calculated for the study quality scores of groups 
of studies using similar study design and reporting the same foot disease disorder or 
risk factor.  Kruskal-Wallis and Mann-Whitney U tests were used to test study 
quality score differences between these groups.  For the purposes of measures of 
agreement between authors a percentage agreement and Kappa (K) statistic were 
used [180].  Kappa value (Standard Errors (SE)) strengths of agreement were 
categorised as: no agreement < 0; slight agreement = 0 – 0.20; fair agreement = 0.21 
- 0.40; moderate agreement = 0.41 – 0.6; substantial agreement = 0.61 – 0.8; and 
near perfect agreement = 0.81 – 1.0 [180]. 
The summary statistic used for each study’s foot disease disorder or risk factor 
variable was a prevalence proportion.  The standard error for each prevalence 
estimate was then calculated.  If a study only reported numbers these numbers were 
converted to a prevalence proportion using the ratio of the number of individuals 
with the foot disease disorder or risk factor variable reported (numerator) and the 
number of the total sample size of the study (denominator).  Studies reporting only 
numbers of a foot disease disorder or risk factor per total disorder (for example foot 
wounds per total wounds) were converted to numbers of patients with the foot 
disease disorder or risk factor for the purpose of this review.  This was performed 
using the ratio of the number of the foot disease disorder or risk factor and the 
number of total disorder, multiplied by the total sample size population.  These 
studies were excluded from any meta-analyses performed.   
 Meta-analyses were calculated where three or more studies of at least 
“moderate” methodological quality had reported the same foot disease disorder or 
risk factor using a similar study design [180].  Meta-analyses were used to calculate 
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pooled prevalence estimates for the foot disease disorder or risk factor using a 
random effects model [180].  Random effects were used to give an average estimate 
across heterogeneous studies weighted on total sample size [180].  The I2 test was 
used to test for heterogeneity across studies included in individual meta-analysis; I2 
values of <25%, 25 – 75% and >75% were rated as low, moderate and high 
heterogeneity respectively [180].  Scatterplots were used to investigate if individual 
meta-analysis prevalence estimates were influenced by factors, such as sample size 
or study quality [180]. 
 
3.5 RESULTS 
Search results 
Figure 3-1 displays the search strategy and study selection results.  The search 
strategy yielded a total of 4,972 unique records of which 698 studies were retrieved 
for detailed eligibility assessment.  Of those, 56 studies met the eligibility criteria and 
were included.  An additional 306 potentially eligible articles were identified from 
hand searching references and citation searching processes from the 56 included 
studies and 22 of those met eligibility criteria and were included.  Lastly, 30 further 
additional studies were identified by the external content experts and none of those 
met the eligibility criteria.  Overall, 78 studies, reporting 84 individual hospital 
cohorts, were included in this systematic review.   
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Figure 3-1: Search strategy and study selection results 
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Study characteristics 
Table 3-1 displays the summary characteristics of the 84 individual study 
cohorts from the 78 included studies.  Supplementary Tables S3-4 – S3-6 display the 
specific individual characteristics and citations for each of the 84 individual study 
cohorts.  Rather than presenting tables in alphabetical order the authors chose to 
group similar studies together for ease of comparison.  Study cohorts were grouped 
according to the foot disease disorder or risk factor reported and study design 
(prospective or retrospective) used due to the reported prevalence differences 
ascertained from different foot disease disorders, risk factors and study designs [181, 
182].   
The 84 included study cohorts included a total of 60,231,517 participants; 66 
(79%) prospective cohorts reported on a total of 643,141 participants and 18 (21%) 
retrospective cohorts reported on a total of 59,588,376 participants (Table 1).  
Sample sizes ranged from 59 – 57,639,000; 59-158,236 in prospective studies and 
167-57,539,000 in retrospective studies. Only 15 (18%) included study cohorts were 
investigated for foot disease disorders or risk factors as the primary aim of the study; 
eight in prospective cohorts and seven in retrospective cohorts.  Study cohorts 
reporting foot disease disorders included: 70 (83%) foot wounds, seven (8%) foot 
infection and twelve (14%) reported foot disease collectively.  Study cohorts 
reporting risk factors included: ten (12%) PAD, six (7%) PN and no studies reported 
foot deformity.  Study cohorts could be grouped into three distinct sub-groups of 
condition-related studies, including: eight (10%) reporting all-cause foot disease 
disorders or risk factors (Supplementary Table S3-4), 24 (29%) reporting diabetes-
related foot disease disorders or risk factors (Supplementary Table S3-5) and 52 
(62%) reporting pressure ulcer-related foot disease disorders or risk factors 
(Supplementary Table S3-6) in their general inpatient population sample.  Three 
studies reported both all-cause and diabetes-related foot disease disorders or risk 
factor prevalence in their general inpatient population sample. 
 
 
 
 
 Chapter 3: Prevalence of foot disease and risk factors in general inpatient populations: a systematic review and meta-analysis 53 
Table 3-1: Summary characteristics of included studies 
Group Study  
cohorts 
(k (%)) 
Total  
Sample  
(n) 
Sample  
(m) 
Sample  
Range 
Study  
Aim 
k (%) 
Study  
Quality 
(M (IQR)) 
k Foot 
Wound  
(%) 
k Foot 
Infection 
(%) 
k Foot 
Disease 
(%) 
k PAD  
(%) 
k PN  
(%) 
k Amp 
(%) 
TOTAL 84 (100%) 60,231,517 717,042 59 –  
57,639,000 
15 (18%)  5(4-7) 70 0.01 – 13.5 7 0.05 – 6.4 12 0.2 – 11.9 10 0.01 – 36.0 6 0.003 – 2.8  10 0.03-1.5 
Prospective 66 (79%) 643,141 9,745 59 –  
158,236 
8 (12%) 6(5-7) 63 0.3 – 13.5 4 0.09 – 6.4 3 1.1 – 8.3 3 0.2 – 36.0 1 2.80 3 0.2-1.5 
Retrospective 18 (21%) 59,588,376 3,310,465 167 –  
57,639,000 
7 (39%) 3(3-5) 7 0.01 – 2.3 3
  
0.05 – 0.5 9 0.2 – 11.9 7 0.01 – 0.5 5 0.003 – 2.8 7 0.03-0.4 
All- 
cause 
8 (10%) 58,122,891 7,265,361 291 –  
57,639,000 
4 (50%) 5(4.5-6) 3 0.7 – 4.2 2 0.09 – 0.5 2 0.2 – 1.2 4 0.3 – 36.0 1 0.2 3 0.03-0.2 
Prospective 4 (50%) 2,471 618 291 –  
990 
2 (50%) 6(4.5-7) 2 1.6 - 4.2 - - - - 2 29.6 – 36.0 - - - - 
Retrospective  4 (50%) 58,120,420 14,530,105 46,126 –  
57,639,000 
2 (50%) 5(4.5-5) 1 0.7 2 0.09 – 0.5 2 0.2 – 1.2 2 0.3 – 0.5 1 0.2 3 0.03-0.2 
Diabetes- 
related 
24 (29%) 1,965,035 81,876  167 –  
596,591 
8 (33%) 4(3-5) 15 0.01 – 7.0 5 0.05 – 6.4 10 0.2 – 11.9 6 0.01 – 0.4 5 0.003 – 2.8   7 0.04-1.5 
Prospective 10 (42%) 15,659 1,566 372 –  
5,188 
3 (33%) 4(4-5) 9 0.3 – 7.0 4 0.09 – 6.4 3 1.1 – 8.3 1 0.2 1 2.8 3 0.2-1.5 
Retrospective  14 (58%) 1,949,376 139,241 167 –  
596,591 
5 (36%) 3(3-4) 6 0.01 – 2.3 1 0.05 7 0.2 – 11.9 5 0.01 – 0.4 4 0.003 – 2.8 4 0.04-0.4 
Pressure  
ulcer-related  
52 (62%) 625,011 12,019 59 –  
158,236 
3 (6%) 7(5-8) 52 0.3 – 13.5 - - - - - - - - - - 
Per Person 15 (29%) 81,094 5,406 60 –  
37,307 
1 (7%) 7(6-8) 15 3.0 – 8.5 - - - - - - - - - - 
Per Ulcer 37 (71%) 543,917 14,700 59 –  
158,236 
2 (5%) 6(5-7) 37 0.3 – 13.5 - - - - - - - - - - 
k = Study cohort numbers; n = patient numbers; m = mean; M = Median; IQR = Interquartile range; % = prevalence; PAD = Peripheral Arterial Disease, PN = Peripheral Neuropathy; Amp = Amputation; - = Not 
reported; Study Aim: 1 = Investigating a foot disease disorder or risk factor is a primary aim of study, 0 = Investigating a foot disease disorder or risk factor is not a primary aim of study;  Study Quality: Total agreed 
study quality score from the methodological assessment performed in Table 2 (total possible score is 10)  
Chapter 3: Prevalence of foot disease and risk factors in general inpatient populations: a systematic review and meta-analysis 54 
Supplementary Table S3-4: Characteristics of included studies reporting all-cause foot disease disorders or risk factors in general inpatient 
populations # 
Study (Country) Sample 
(n) 
Age years 
(SD) 
Age years 
Range 
Male 
n (%) 
Study 
Aim 
Study 
Design 
Study 
Quality 
Foot 
Wound 
n (%) 
Foot 
Infection 
n (%) 
Foot 
Disease 
n (%) 
PAD 
n (%) 
PN 
n (%) 
Amp. 
n (%) 
Prospective              
Gottrup 2013 [34] 
(Denmark) 
830 - - - 0 Pt: M 3 13 
(1.56) 
- - - - - 
Gruen 1997 [183] 
(Australia) 
360 74.0(-) - ~238 
(66.0) 
0 Pt: S 6 15 
(4.17) 
- - - - - 
Antonopoulos 2005 [184] 
(Greece)  
990 71.2(9.1) >50 400 
(40.4) 
1 Per: S 6 - - - 356 
(36.0) 
- - 
Lacroix 2008 [185] 
(France) 
291 69.5(12.8) 43 - 97 153 
(52.6) 
1 Pt: S 8 - - - 86 
(29.6) 
- - 
Retrospective              
Currie 1998A [186] 
(Wales) 
~353,000 ~56.0(-)^ 0 – >75 - 1 Per: M 5 2,444 
(0.69) * 
1,856 
(0.53)* 
4,245 
(1.2)* 
1,138 
(0.32)* 
663 
(0.19)* 
235 
(0.07)* 
Henke 2005 [29] ** 
(USA) 
~57,639,000 60.0(19.0)^ - ~30,606 
(59.0)^ 
1 Per: M 4 - 
 
51,875 
(0.09) * 
- - - ~16,185 
(0.03)* 
Donnan 2000A [187] 
(Scotland) 
46,126 - - - 0 Per: M 5 - - - 247 
(0.54)* 
- 91 
(0.20)* 
Morgan 2010A [188] 
(Wales) 
82,294 - 0 - >85 - 0 Per: M 5 - - 141 
(0.17) 
- - - 
n = numbers; SD = Standard Deviation; % = Prevalence: PAD = Peripheral Arterial Disease, PN = Peripheral Neuropathy; Amp. = Amputations; # = No studies reported on foot deformity; - = Not reported; ~ = 
Determined from the calculation of different reported results; ^ Cases only; * = Primary reason for admission only; ** Osteomyelitis only. 
Study Aim: 1 = Investigating foot disease disorder or risk factor is a primary aim of study, 0 = Investigating a foot disease disorder or risk factor is not a primary aim of study; Study Design: Pt = Point prevalence, Per = 
Period prevalence; M = Multi-site, S = Single Site; Study Quality: Total agreed study quality score from the methodological assessment performed in Table 2 (total possible score is 10).  
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Supplementary Table S3-5: Characteristics of included studies reporting diabetes-related foot disease disorders or risk factors in general 
inpatient populations # 
Study 
(Country) 
Sample  
(n) 
Age years 
(SD) 
Age years 
Range 
Male 
n (%) 
Diabetes 
n (%) 
Study 
Aim 
Study 
Design 
Study  
Quality 
Foot 
Wound 
n (%) 
Foot 
Infection 
n (%) 
Foot  
Disease 
n (%)  
PAD  
n (%) 
PN  
n (%) 
Amp.  
n (%) 
Prospective               
Asumanu 2010 [62] 
(Ghana) 
966 
 
54.0(-)^ 20 – 79^ 42  
(52.5)^ 
- 1 Per: S 5 42  
(4.35) 
32  
(3.31) 
80  
(8.28) 
- ~27 
(2.80) 
14  
(1.45)  
Hurd 2009 [189] 
(Canada) 
3,099 - - - - 0 Pt: M 6 ~34 
(1.10) 
- - - - - 
Mahe 2006 [190] 
(France) 
624 60.2(-) 17-101 ~312 
(50.0) 
- 0 Pt: S 6 3  
(0.48)  
- - - - - 
Masson 1992 [55] 
(England) 
1,317 
 
~73(-)^ 26 - 94^ 51  
(46.4)^ 
93  
(7.06)  
0 Pt: M 4 15  
(1.14)* 
- - - - 3 
(0.23)* 
Mohammad  
Akther 2011 [53] 
(India) 
5,188 
 
55.6(12.0)^ <20 - 80^ 47  
(85.5)^ 
500  
(9.64) 
1 Per: S 5 55  
(1.06)  
32 
(0.62) 
55 
(1.06) 
9 
(0.17) 
- - 
Ogbera 2007 [59] 
(Nigeria) 
1,327 
 
55.0(14.0)^ 17 - 91^ ~128 
(61.5)^ 
206 
(15.52) 
0 Per: S 4 36  
(2.71) 
- - - - - 
Tait 2007 [191] 
(England) 
372 - - - - 0 Pt: S 3 4 
(1.08)+ 
- - - - - 
Unachukwu 2007 [60] 
(Nigeria) 
827 
 
54.6(14.7)^ 18 - 86^ 38 
(63.3)^ 
315 
(38.09) 
0 Per: S 4 58 
(7.01) 
~53 
(6.41) 
- - - 12 
(1.45) 
Wallymahmed 2005  
[192]  (England) 
1,129 ~72.1(-)^ 24 - 97^ 64 
(50.8)^ 
126 
(11.2)  
0 Pt: S 4 3  
(0.27)* 
1 
(0.09)* 
- - - - 
Daultrey 2011 [56] 
(England) 
810 
 
- - - 110  
(13.6)  
1 Pt: S 4 -  - 40  
(4.94) 
- - - 
Retrospective               
Ajayi 2009 [58] 
(Nigeria) 
2,696 
 
57.0(16.2) 18 - 96 1,509 
(56.0) 
118  
(4.4) 
0 Per: S 3 44  
(1.63) 
- - - - - 
Currie 1998B [186] 
(Wales) 
~353,000 67.0(-)^ 0 – >75 - 655  
(15.4)^ 
1 Per: M 5 323  
(0.09)* 
193  
(0.05)* 
655  
(0.19)* 
270  
(0.08)* 
62  
(0.02)* 
129  
(0.04)* 
Leichter 1982 [54] 
(USA) 
596,591 - - - 31,202 
(5.23)  
0 Per: M 2 37  
(0.006)* 
- - 61 
(0.01)** 
17  
(0.003)* 
- 
Mottini 2003 [193] 
(Congo) 
862 - 
 
23 - 81^ 38 
(45.8)^ 
83 
(9.63) 
0 Per: S 2 20 
(2.32) 
- - 3  
(0.35) 
3  
(0.35) 
3  
(0.35) 
Ogbera 2006 [52] 
(Nigeria) 
7,253 
 
- - - 
(62.5)^ 
827 
(11.40) 
1 Per: S 3 97 
(1.34) 
- - - - 26  
(0.36) 
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Otu 2013 [194] 
(Nigeria) 
3,882 - 0 - >70^ 166 
(55.9)^ 
297 
(7.65) 
1 Per: S 4 63 
(1.62) 
- - - 107 
(2.76) 
- 
Donnan 2000B [187] 
(Scotland) 
46,126 - - - 2,080  
(4.5) 
0 Per: M 5 - - - 43  
(0.09)* 
- 22  
(0.05)* 
Williams 1985 [195] 
(England) 
~171,000 - 0 - >65 777 
(45.3)^ 
1,633 
(0.95) 
0 Per: M 3 - -  180 
(0.10)* 
- - 
Chijioke 2010 [57] 
(Nigeria) 
15,320 
 
- 30 - 86^ 440  
(56.1)^ 
785  
(5.12) 
0 Per: S 3 - - 132  
(0.86) 
- - - 
Morgan 2010B [188] 
(Wales) 
82,294 - 0 - >85 - 7,618 
(9.26) 
0 Per: M 5 - - 801  
(0.97) 
- - - 
Nason 2013A [196] 
(Period: 2006-08) ** 
(Ireland) 
~334,000 - - - - 1 Per: S 3 - - 2,842 
(0.85) 
- - - 
Nason 2013B [196] 
(Period: 2008-10) ** 
(Ireland) 
~336,000 - - - - 1 Per: S 3 - - 2,485 
(0.74) 
- - - 
Sjoberg 2007A [145] 
(Period: 2003) 
(Grenada) 
167 35.5(-) - 109 
(65.3) 
- 0 Per: S 3 - - 6 
(3.59) 
- - - 
Sjoberg 2007B  [145] 
(Period: 2004) 
(Grenada) 
185 39.0(-) - 125 
(67.6) 
- 0 Per: S 3 - - 22 
(11.89) 
- - - 
n = numbers; SD = Standard Deviation; % = Prevalence: Amp. = Amputations, PAD = Peripheral Arterial Disease, PN = Peripheral Neuropathy; # = No studies reported on foot deformity; - = Not reported; ~ = 
Determined from the calculation of different reported results; ^ Cases only; * = Primary reason for admission only; ** Bed day figures only; + = Determined from formula = (foot wound numbers / total wound 
numbers) x total wound patients / sample numbers. 
Study Aim: 1 = Investigating a foot disease disorder or risk factor is a primary aim of study, 0 = Investigating a foot disease disorder or risk factor is not a primary aim of study; Study Design: Pt = Point prevalence, Per 
= Period prevalence; M = Multi-site, S = Single Site; Study Quality: Total agreed study quality score from the methodological assessment performed in Table 2 (total possible score is 10).  
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Supplementary Table S3-6: Characteristics of included studies reporting pressure ulcer-related foot disease disorders or risk factors in general 
inpatient populations # 
Study 
(Country) 
Sample  
(n) 
Age years 
(SD) 
Age years 
Range 
Male 
n (%) 
PU 
n (%) 
Study 
Aim 
Study 
Design 
Study  
Quality 
FPU  
 n (%) 
FPU / PU  
n (%) * 
Per Person           
Alja’afreh 2013 [197] 
(Jordan) 
190 63.0(-)^ <30 - >90 14 
(46.7)^ 
30 
(15.79) 
0 Per: S 2 7 (3.68) - 
Barrois 2008 [198] 
(France) 
37,307 72.3(-) 31 - 92 14,177 
(38.0) 
3,314 
(8.88) 
0 Pt: M 7 1,373 (3.68) 2,298/4,991 
(46.04) 
Brito 2013 [199] 
(Brazil) 
473 58.4(-) 18 - 103 251 
(53.1) 
80  
(16.91) 
0 Pt: M 6 22 (4.65) - 
Gallagher 2008 [200] 
(Ireland) 
672 69.0(-) 16 - 94 322 
(47.9) 
124 
(18.45) 
0 Pt: M 8 20 (2.98) - 
Gethin 2005 [201] 
(Ireland) 
506 - 18 - 100 244 
(48.2) 
78 
(15.41) 
0 Pt: S 7 15 (2.96) - 
Gunningberg 2005 [202] 
(Sweden) 
612 - 18 – >89 295 
(48.2) 
146 
(23.86) 
0 Pt: S 8 54 (8.82) - 
Gunningberg 2006 [203] 
(Sweden) 
369 71.5(16.6) 18 - 101 178 
(48.2) 
104 
(28.18) 
0 Pt: S 8 17 (4.61) - 
Gunningberg 2008 [33] 
(Sweden) 
632 - 18 – >89 308 
(48.7) 
145 
(22.94) 
0 Pt: S 8 41 (6.49) - 
Gunningberg 2013 [204] 
(Sweden) 
16,466 - 17 - >80 7,820 
(47.5) 
2,737 
(16.62) 
1 Pt: M 6 1,102 (6.69) 3,276 
House 2011 [205] 
(USA) 
60 - - - 6 
(10.00) 
0 Pt: S 4 3 (5.00)$ -  
Lahmann 2006 [206] 
(Germany) 
16,728 63.6(1.9) - ~9,334 
(55.8) 
1,766 
(10.56) 
0 Pt: M 7 ~537 (3.21)$ - 
(30.4)  
Tubaishat 2011 [207] 
(Jordan) 
302 - <12 – >89 176 
(58.3) 
36 
(11.92) 
0 Pt: M 8 9 (2.98) - 
Tubaishat 2013 [208] 
(Jordan) 
295 49.1(18.6) 18 - 87 162 
(54.92) 
48 
(16.27) 
0 Pt: M 7 23 (7.80) - 
Vanderwee 2007 [209] 
(5 x European Countries) 
5,947 - <39 – >89 2,750 
(46.2) 
1,078 
(18.13) 
0 Pt: M 7 261 (4.39)$ 633/1,860 
(34.03)  
Wann-Hansson 2008 [210] 
(Sweden) 
 
535 71.2(16.4) - 241 
(45.0) 
144 
(26.92) 
0 Pt: S 8 16 (2.99) - 
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Study 
(Country) 
Sample  
(n) 
Age years 
(SD) 
Age years 
Range 
Male 
n (%) 
PU 
n (%) 
Study 
Aim 
Study 
Design 
Study  
Quality 
FPU  
 n (%) 
FPU / PU  
n (%) * 
Per Ulcer           
Allcock 1994 [211] 
(England) 
714 - - 325 
(45.5) 
229  
(32.07)  
0 Pt: S 5 ~96 (13.45)+$ 212/505 
(42.00)  
Amlung 2001 [212] 
(USA) 
42,817 - 0 – >91^ 2,861 
(45.0)^ 
6,358 
(14.85) 
0 Pt: M 5 ~2,314 (5.40)+$ 3,820/10,495 
(36.40)  
Barczak 1997 [213] 
(USA) 
39,874 - 0 – >101^ 1,889 
(47.0)^ 
4,020 
(10.08) 
0 Pt: M 6 ~1,400 (3.51) +$ 2,300/6,603 
(34.83)  
Barrois 1995 [214] 
(France) 
12,050 68.0(17.0) - 4,700 
(39.0) 
630 
(5.23) 
0 Pt: M 5 ~277 (2.30) + 432/982 
(44.00) 
Bours 1999 [215]^^ 
(Holland) 
368 61.7(18.7) - 184 
(50.0) 
37 
(10.05) 
0 Pt: S 7 ~14 (3.80) + 24/65 
(37.50) 
Bours 2002A[216]^^ 
(University Hospital) (Holland) 
1,663 53.6(22.1)  - 815 
(49.0) 
220 
(13.20) 
0 Pt: M 7 ~104 (6.25) +$ ~175/370 
(47.20)  
Bours 2002B [216]^^ 
(General Hospital) (Holland) 
8,374 66.6(18.9) - 3,852 
(46.0) 
1,951 
(23.30) 
0 Pt: M 7 ~802 (9.58) +$ ~1,387/3,375 
(41.10)  
Charlier 2001 [217] 
(Australia) 
59 - <14 - >81 28 
(47.5) 
7 
(11.86)  
0 Pt: S 5 ~1 (1.69) +  2/13 
(15.38) 
Clark 1992 [218] 
(England) 
866 - - - 89 
(10.28) 
0 Pt: M 5 ~24 (2.77) +$ 27/102 
(26.47)  
Cole 2004 [219] 
(Canada) 
277 - - - 27 
(9.75) 
0 Pt: s 5 ~12 (4.33) +$ 15/33 
(45.45)  
da Silva Cardoso 2010 [220] 
(Brazil) 
716 - 16 - 96^ 43 
(55.1)^ 
78 
(10.89) 
0 Pt: S 5 ~21 (2.93) + 36/134 
(26.87) 
Dealey 1991 [221] 
(England) 
1,176 - - - 87 
(7.40) 
0 Pt: S 3 ~17 (1.45) + ~26/137 
(19.00) 
Dealey 1994 [222] 
(England) 
406 - - - 32 
(7.88)  
0 Pt: S 6 ~2 (0.49) + 3/46 
(6.52) 
Ek 1982 [223] 
(Sweden) 
1,776 - 17 - 96^ 26 
(36.6)^ 
71 
(4.00) 
0 Pt: M 3 ~9 (0.51) +$ 14/109 
(12.84)  
Galvan-Martinez 2012 [224] 
(Mexico) 
294 48.6(-) 32 - 85 127 
(43.2) 
50 
(17.01) 
0 Pt: M 7 ~10 (3.40) + - 
(20.00) 
Gawron 1994 [225] 
(USA) 
440 53.0(22.0) - ~238 
(54.0) 
~ 53 
(12.00) 
0 Pt: S 8 ~22 (5.00) +$ 35/85 
(41.18)  
Gosnell 1992 [226] 
(USA) 
 
1320 - 16 – 101^ ~47 
(42.0) 
111 
(8.41) 
0 Per: S 8 ~33 (2.50) +$ 57/190 
(30.00)  
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Study 
(Country) 
Sample  
(n) 
Age years 
(SD) 
Age years 
Range 
Male 
n (%) 
PU 
n (%) 
Study 
Aim 
Study 
Design 
Study  
Quality 
FPU  
 n (%) 
FPU / PU  
n (%) * 
Groeneveld 2004 [227] 
(Adults only) (USA) 
416 - 17 – >80 - 122 
(29.32) 
0 Pt: S 8 ~ 25 (6.01) +$ 50/242 
(20.66)  
Hopkins 2000 [228] 
(USA) 
498 - - - ~60 
(12.05) 
0 Pt: S 5 ~15 (3.01) +$ 21/86 
(24.42)  
Inan 2012 [229] 
(Turkey) 
404 51.2(0.8) - 209 
(51.7) 
42 
(10.4) 
0 Pt: M 8 ~7 (1.73) +$ 12/73 
(16.44)  
Jenkins 2010 [230] 
(USA) 
310 75.5(-)^ 48 – 95^ 20 
(40.8)^ 
49 
(15.81) 
0 Pt: S 5 ~13 (4.19) + - 
(26.00) 
Langemo 1990 [231] 
(USA) 
135 - - - 19 
(14.07) 
0 Pt: S 4 ~5 (3.70) +$ 7/29 
(24.14)  
Lepisto 2001 [232] 
(Finland) 
~2,563 75.6(16.6)^ 1 – 96^ 63 
(38.4)^ 
164 
(6.40) 
0 Pt: M 4 ~34 (1.33) + ~54/257 
(21.00)  
Meehan 1990 [233] 
(USA) 
34,987 - - 1,263 
(39.1)^ 
3,230 
(9.23) 
0 Pt: M 6 ~627 (1.79) + 1,062/5,467 
(19.43) 
Meehan 1994 [234] 
(USA) 
31,530 - - 1,582 
(45.4)^ 
3,487 
(11.06) 
0 Pt: M 6 ~1,257 (3.99) +$ 2,180/6,047 
(36.05)  
Nyquist 1987 [235] 
(England) 
2,513 - - 31 
(23.5)^ 
132 
(5.25) 
0 Pt: M 5 ~ 33 (1.31) +$ 58/233 
(24.89)  
O’Brien 1998 [236] ## 
(USA) 
959 - 30 – 91^ 64 
(53.3)^ 
120 
(12.51) 
0 Pt: S 5 ~ 19 (1.98) +$ 33/213 
(15.49)  
Pearson 2000 [237] 
(Australia) 
634 - 50 – >90^ 20 
(50.0)^ 
40 
(6.31)  
0 Pt: M 6 ~16 (2.52) +$ 27/69 
(39.13)  
Soldevilla 2006 [238] 
(Spain) 
5,483 - 1 – 99^ - 452 
(8.24) 
0 Pt: M 5 ~102 (1.86) +$ - 
(22.62)  
Thoroddsen 1999 [239] 
(Iceland) 
642 78.4(16.4)^ 30 – 102^ 277 
(43.1) 
57 
(8.88) 
0 Pt: M 6 23 (3.58) +$ 40/100 
(40.00)  
Uzon 2007 [240] 
(Turkey) 
344 51.7(164) 18 - 88 191 
(55.5) 
40 
(11.63) 
0 Pt: S 8 10 (2.9) +$ 12/47 
(25.53)  
Vanderwee 2011 [241] 
(Belgium) 
19,968  19 - >89 8,865 
(44.4) 
2,419 
(12.11) 
0 Pt: M 8 ~926 (4.64) + 1,184/3.091 
(38.30) 
VanGilder 2008 [242]**^^ 
(USA) 
74,401  
 
64.0(-) - 34,968 
(47.0) 
10,857 
(14.59) 
0 Pt: M 7 ~ 3,387 (4.55) 
+$ 
- 
(31.2)  
VanGilder 2010 [8]** 
(USA) 
92,397 
 
62.9(19.9) - ~42,503 
(46.0) 
11,365 
(12.30) 
0 Pt: M 7 ~2,884 (3.12) +$ 5,007/19,730 
(25.38)  
Whittington 2004 [243] ## 
(USA) 
158,236 - 0 – >95^ 11,128 
(46.7)^ 
23,818 
(15.05) 
0 Pt: M 4 ~6,028 (3.81) + 10.905/43,087 
(25.31) 
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Study 
(Country) 
Sample  
(n) 
Age years 
(SD) 
Age years 
Range 
Male 
n (%) 
PU 
n (%) 
Study 
Aim 
Study 
Design 
Study  
Quality 
FPU  
 n (%) 
FPU / PU  
n (%) * 
Young 2002 [244] ## 
(Australia) 
1,394 64.0(20.0) 15 - 99 665 
(47.7) 
 221 
(15.85) 
1 Pt: S 8 ~80 (5.74) +$ 114/316 
(36.08)  
Zhao 2010 [245] 
(China) 
2,913 43.9(21.2) 1 - 94 1,648 
(56.6) 
52 
(1.79) 
1 Pt: S 7 ~9 (0.31) +$ 13/79 
(16.46)  
n = numbers; SD = Standard Deviation; % = Prevalence; PU = Pressure Ulcer; FPU = Foot-related Pressure Ulcer; # = No studies reported on foot infections, collective foot disease, peripheral arterial disease, 
peripheral neuropathy or foot deformity; - = Not reported; ~ = Determined from the calculation of different reported results; ^ Cases only; * = Numbers of wounds rather than patients with wounds; ** Most recent year 
used only as time periods reported separately; ^^ = Hospital results only;  ## = Aggregated data from a number of years data; $ = Foot sites reported include heel + another site (e.g. ankle, toes); + = Determined from 
formula = (FPU numbers / PU numbers) x total PU patients / sample numbers.  
Study Aim: 1 = Investigating a foot disease disorder or risk factor is a primary aim of study, 0 = Investigating a foot disease disorder or risk factor is not a primary aim of study; Study Design: Pt = Point prevalence, Per 
= Period prevalence; M = Multi-site, S = Single Site; Study Quality: Total agreed study quality score from the methodological assessment performed in Table 2 (total possible score is 10).  
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Quality assessment 
Supplementary Table S3-7 displays the original methodological quality 
assessments from the two blinded authors for the 78 included studies.  The Kappa 
(SE) values calculated between the two blinded author’s assessments ranged from 
0.69(0.10) – 0.96(0.04) which corresponded to “substantial” or “near perfect” 
strengths of agreement for each item analysed.  The percentage agreements between 
the two blinded author’s assessments ranged between 86 – 99% with an overall 
agreement of 92% (720 of the 780 total items).  Table 3-2 displays the final agreed 
methodological quality assessment results for all included studies.  Overall, 25 (32%) 
studies had “good” methodological study quality scores, 40 (51%) had “moderate” 
study quality scores and 13 (17%) had “poor” study quality scores.   
Table 3-1 displays differences in median study quality scores between studies 
reporting different study designs and different condition-related foot disease 
disorders or risk factors.  Prospective studies reported statistically significant higher 
study quality scores (median (IQR)) (6(5-7)) than retrospective studies (3(3-5)) (p < 
0.05).  Studies reporting pressure ulcer-related foot disease or risk factors also 
reported statistically significant higher study quality scores (7(5-8)) than those 
reporting all-cause foot disease or risk factors (5(4.5-6)) or diabetes foot-related foot 
disease or risk factors (4(3-5)) (p < 0.05).  Table 3-2 displays the findings from the 
assessment of all ten individual methodological quality items used.  These findings 
revealed: 83% of studies reported a prospective design, 83% reported an 
appropriately sampled population, 88% recruited an adequate sample size (> 300 
participants), 68%  used a physical examination to determine the foot disease 
disorder or risk factor, 67% used a validated outcome measure and 60% had an 
adequate response rate of eligible participants.  It also revealed: only 22% reported 
measuring the foot disease disorder or risk factor in an unbiased manner and 0% 
reported foot disease or risk factor prevalence estimates with confidence intervals.   
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Supplementary Table S3-7: Original methodological quality assessment results from the two blinded authors for all included studies* 
Author Year Question 1 Question 2 Question 3 Question 4 Question 5 Question 6 Question 7 Question 8 Question 9 Question 10 Total Scores 
  A1 A2 A1 A2 A1 A2 A1 A2 A1 A2 A1 A2 A1 A2 A1 A2 A1 A2 A1 A2 A1 A2 
Antonopoulos  2005 0 0 1 1 1 1 1 1 1 1 0 0 0 0 0 0 1 1 1 1 6 6 
Currie  1998 1 1 0 0 0 0 1 1 0 0 0 0 1 1 0 0 1 1 1 1 5 5 
Donnan  2000 1 1 0 0 0 0 1 1 0 0 0 0 1 1 0 0 1 1 1 1 5 5 
Gottrup  2013 1 1 0 1 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 2 3 
Gruen  1997 1 1 1 1 1 1 1 1 0 0 0 0 0 1 0 0 0 0 1 1 5 6 
Henke  2005 1 1 0 0 0 0 1 1 0 0 0 0 1 1 0 0 1 1 0 0 4 4 
Lacroix  2008 1 1 1 1 1 1 0 0 1 1 1 1 1 1 0 0 1 1 1 1 8 8 
Morgan  2010 1 1 0 0 0 0 1 1 0 0 0 0 1 1 0 0 1 1 1 1 5 5 
Ajayi  2009 0 0 0 0 0 0 1 1 0 0 0 0 1 1 0 0 0 0 1 1 3 3 
Asumanu  2010 0 0 1 1 1 1 1 1 1 1 0 0 0 0 0 0 1 1 0 0 5 5 
Chijioke  2010 0 0 0 0 0 0 1 1 0 0 0 0 0 1 0 0 1 1 0 0 2 3 
Daultry  2011 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 4 4 
Hurd  2009 1 1 1 1 1 1 1 1 1 1 0 0 1 1 0 0 0 0 0 0 6 6 
Leichter  1982 0 0 0 0 0 0 1 1 0 0 0 0 1 1 0 0 0 0 0 0 2 2 
Mahe  2006 0 1 1 1 1 1 1 1 0 0 0 0 1 1 0 0 0 0 1 1 5 6 
Masson  1992 1 1 1 1 0 0 1 1 0 0 0 0 0 1 0 0 0 0 1 0 4 4 
Mohammad Akther  2011 0 0 1 1 1 1 1 1 1 1 0 0 0 0 0 0 1 1 1 0 6 5 
Mottini  2003 0 0 0 0 0 0 1 1 0 0 0 0 1 1 0 0 0 0 0 0 2 2 
Nason  2006 0 1 0 0 0 0 1 1 0 0 0 0 0 1 0 0 0 0 0 0 1 3 
Ogbera  2006 1 1 0 0 0 0 1 1 0 1 0 0 1 1 0 0 0 0 1 0 4 4 
Ogbera  2007 0 0 1 1 0 0 1 1 0 0 0 0 1 1 1 0 0 0 1 1 5 4 
Otu  2013 0 0 0 0 0 0 1 1 1 1 0 0 1 1 0 0 1 1 1 0 5 4 
Sjoberg  2007 0 0 0 0 0 0 1 1 0 0 0 0 1 1 0 0 0 0 1 1 3 3 
Tait  2007 1 1 1 1 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 3 3 
Unachukwu  2007 0 0 1 1 1 0 1 1 1 1 0 0 0 1 1 0 0 1 0 0 5 5 
Wallymahmed  2005 1 1 1 1 0 0 1 1 0 0 0 0 1 1 0 0 0 0 0 0 4 4 
Williams  1985 1 1 0 0 0 0 1 1 0 0 0 0 1 1 0 0 0 0 0 0 3 3 
Alja'afreh  2013 0 0 1 1 0 1 0 0 0 1 1 0 0 0 0 0 0 0 0 0 2 3 
Allcock  1994 1 1 1 1 1 1 1 1 0 0 0 0 1 1 0 0 0 0 0 0 5 5 
Amlung  2001 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 5 5 
Barczak  1997 1 1 1 1 0 1 1 1 1 1 0 0 0 0 0 0 0 0 1 1 5 6 
Barrois  1995 1 1 1 1 0 0 1 1 0 1 0 0 0 0 0 0 0 0 1 1 4 5 
Barrois  2008 1 1 1 1 0 0 1 1 1 1 0 0 1 1 0 0 0 1 1 1 6 7 
Bours  1999 0 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 1 1 6 7 
Bours  2002 1 1 1 1 1 1 1 1 1 1 0 1 0 0 0 0 0 0 1 1 6 7 
Brito  2013 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 1 1 6 6 
Charlier  2001 1 1 1 1 1 1 0 0 0 0 0 0 0 1 1 0 0 0 1 1 5 5 
Clark  1992 1 1 1 1 0 0 1 1 1 1 0 0 0 1 0 0 0 0 0 0 4 5 
Cole  2004 1 1 1 1 1 1 0 0 1 1 0 0 1 1 0 0 0 0 0 0 5 5 
da Silva Cardoso  2010 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 5 5 
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Author Year Question 1 Question 2 Question 3 Question 4 Question 5 Question 6 Question 7 Question 8 Question 9 Question 10 Total cores 
Dealey  1991 1 1 1 1 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 3 3 
Dealey  1994 1 1 1 1 0 1 1 1 1 1 0 0 0 1 0 0 0 0 0 0 4 6 
Ek  1982 0 1 1 1 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 2 3 
Gallagher   2008 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 1 1 8 8 
Galvan-Martinez  2012 1 1 1 1 1 1 0 0 0 1 0 1 1 1 0 0 0 0 1 1 5 7 
Gawron  1994 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 1 1 8 8 
Gethin  2005 0 1 1 1 1 1 1 1 1 1 0 0 1 1 0 0 0 0 1 1 6 7 
Gosnell  1992 1 1 1 1 1 0 1 1 1 1 1 1 0 1 0 0 1 1 0 0 7 7 
Groeneveld  2004 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 1 1 8 8 
Gunningberg  2005 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 1 1 8 8 
Gunningberg  2006 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 1 1 8 8 
Gunningberg  2008 1 1 1 1 1 1 1 1 1 1 0 1 1 1 0 0 0 0 1 1 7 8 
Gunningberg  2013 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 1 0 1 1 7 6 
Hopkins  2000 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 5 5 
House  2011 1 1 1 1 1 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 4 3 
Inan  2012 1 1 1 1 1 1 1 1 1 1 0 0 1 1 0 0 1 1 1 1 8 8 
Jenkins  2010 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 5 5 
Lahmann  2006 1 1 1 1 1 1 1 1 1 1 0 0 1 1 0 0 0 0 1 1 7 7 
Langemo  1990 1 1 1 1 1 1 1 0 1 1 1 0 0 0 0 0 0 0 0 0 6 4 
Lepisto  2001 1 0 1 1 1 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 4 2 
Meehan  1990 1 1 1 1 1 1 1 1 0 1 0 0 0 0 0 0 1 1 0 0 5 6 
Meehan  1994 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 1 1 0 0 6 6 
Nyquist  1987 1 1 1 1 1 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 5 3 
O'Brien  1998 1 1 1 1 1 1 1 1 0 1 0 0 0 0 0 0 0 0 1 0 5 5 
Pearson  2000 1 1 1 1 1 1 1 1 1 1 0 0 0 1 0 0 0 0 0 0 5 6 
Soldevilla  2006 1 1 1 1 0 0 1 1 1 1 0 0 1 1 0 0 0 0 0 0 5 5 
Thoroddsen  1999 0 1 1 1 0 0 1 1 0 1 1 0 1 1 0 0 0 0 1 1 5 6 
Tubaishat  2011 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 1 1 8 8 
Tubaishat  2013 1 1 1 1 1 1 0 0 1 1 1 1 1 1 0 0 0 0 1 1 7 7 
Uzun  2007 1 1 1 1 1 1 1 1 0 1 0 0 1 1 0 0 0 1 1 1 6 8 
Vanderwee  2007 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 1 1 7 7 
Vanderwee  2011 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 1 1 1 1 8 8 
Vangilder  2008 0 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 1 1 1 1 6 7 
Vangilder  2010 1 1 1 1 0 1 1 1 1 1 0 0 0 0 0 0 1 1 1 1 6 7 
Wann-Hansson  2008 1 1 1 1 1 1 1 1 1 1 1 0 1 1 0 0 1 1 1 1 9 8 
Whittington  2004 1 1 1 1 1 1 1 1 0 1 0 0 0 0 0 0 0 0 0 0 4 5 
Young  2002 1 1 1 1 1 1 1 1 0 1 1 1 1 1 0 0 0 0 1 1 7 8 
Zhao  2010 1 1 1 1 1 1 1 1 1 1 1 0 1 1 0 0 0 0 1 1 8 7 
Total Agreements (n) 70 77 69 77 67 70 68 75 74 73 720 
Total Agreements (%) 90% 99% 88% 99% 86% 90% 87% 96% 95% 94% 92% 
Kappa(Standard Error) 0.69(0.10) 0.96(0.04) 0.76(0.08) 0.93(0.07) 0.70(0.08) 0.70(0.10) 0.75(0.07) -- 0.87(0.07) 0.87(0.06)   
Strength of agreement Substantial Near Perfect Substantial Near Perfect Substantial Substantial Substantial -- Near Perfect Near Perfect  
* = Please see Table S3 for descriptions of each question; Score: 1 = “yes”, 0 = “no” or “not reported”; A1 = Independent assessor 1; A2 = Independent assessor 2 
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Table 3-2: Final agreed methodological quality assessment results for all included studies* 
Author Year Question 1 Question 2 Question 3 Question 4 Question 5 Question 6 Question 7 Question 8 Question 9 Question 10 TOTAL Score Quality* 
All-cause              
Antonopoulos  2005 0 1 1 1 1 0 0 0 1 1 6 Moderate 
Currie  1998 1 0 0 1 0 0 1 0 1 1 5 Moderate 
Donnan  2000 1 0 0 1 0 0 1 0 1 1 5 Moderate 
Gottrup  2013 1 1 0 1 0 0 0 0 0 0 3 Poor 
Gruen  1997 1 1 1 1 0 0 1 0 0 1 6 Moderate 
Henke  2005 1 0 0 1 0 0 1 0 1 0 4 Moderate 
Lacroix  2008 1 1 1 0 1 1 1 0 1 1 8 Good 
Morgan  2010 1 0 0 1 0 0 1 0 1 1 5 Moderate 
Diabetes-related              
Ajayi  2009 0 0 0 1 0 0 1 0 0 1 3 Poor 
Asumanu  2010 0 1 1 1 1 0 0 0 1 0 5 Moderate 
Chijioke  2010 0 0 0 1 0 0 1 0 1 0 3 Poor 
Daultry  2011 1 1 1 1 0 0 0 0 0 0 4 Moderate 
Hurd  2009 1 1 1 1 1 0 1 0 0 0 6 Moderate 
Leichter  1982 0 0 0 1 0 0 1 0 0 0 2 Poor 
Mahe  2006 1 1 1 1 0 0 1 0 0 1 6 Moderate 
Masson  1992 1 1 0 1 0 0 1 0 0 0 4 Moderate 
Mohammad Akther  2011 0 1 1 1 1 0 0 0 1 0 5 Moderate 
Mottini  2003 0 0 0 1 0 0 1 0 0 0 2 Poor 
Nason  2013 1 0 0 1 0 0 1 0 0 0 3 Poor 
Ogbera  2006 1 0 0 1 0 0 1 0 0 0 3 Poor 
Ogbera  2007 0 1 0 1 0 0 1 0 0 1 4 Moderate 
Otu  2013 0 0 0 1 1 0 1 0 1 0 4 Moderate 
Sjoberg  2007 0 0 0 1 0 0 1 0 0 1 3 Poor 
Tait  2007 1 1 0 1 0 0 0 0 0 0 3 Poor 
Unachukwu  2007 0 1 1 1 1 0 0 0 0 0 4 Moderate 
Wallymahmed  2005 1 1 0 1 0 0 1 0 0 0 4 Moderate 
Williams  1985 1 0 0 1 0 0 1 0 0 0 3 Poor 
Pressure Ulcer-related              
Alja'afreh  2013 0 1 1 0 0 0 0 0 0 0 2 Poor 
Allcock  1994 1 1 1 1 0 0 1 0 0 0 5 Moderate 
Amlung  2001 1 1 1 1 1 0 0 0 0 0 5 Moderate 
Barczak  1997 1 1 1 1 1 0 0 0 0 1 6 Moderate 
Barrois  1995 1 1 0 1 1 0 0 0 0 1 5 Moderate 
Barrois  2008 1 1 0 1 1 0 1 0 1 1 7 Good 
Bours  1999 1 1 1 1 1 1 0 0 0 1 7 Good 
Bours  2002 1 1 1 1 1 1 0 0 0 1 7 Good 
Brito  2013 1 1 1 1 1 0 0 0 0 1 6 Moderate 
Charlier  2001 1 1 1 0 0 0 1 0 0 1 5 Moderate 
Clark  1992 1 1 0 1 1 0 1 0 0 0 5 Moderate 
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Cole  2004 1 1 1 0 1 0 1 0 0 0 5 Moderate 
da Silva Cardoso  2010 1 1 1 1 1 0 0 0 0 0 5 Moderate 
Dealey  1991 1 1 0 1 0 0 0 0 0 0 3 Poor 
Dealey  1994 1 1 1 1 1 0 1 0 0 0 6 Moderate 
Ek  1982 1 1 0 1 0 0 0 0 0 0 3 Poor 
Gallagher  2008 1 1 1 1 1 1 1 0 0 1 8 Good 
Galvan-Martinez  2012 1 1 1 0 1 1 1 0 0 1 7 Good 
Gawron  1994 1 1 1 1 1 1 1 0 0 1 8 Good 
Gethin  2005 1 1 1 1 1 0 1 0 0 1 7 Good 
Gosnell  1992 1 1 1 1 1 1 1 0 1 0 8 Good 
Groeneveld  2004 1 1 1 1 1 1 1 0 0 1 8 Good 
Gunningberg  2005 1 1 1 1 1 1 1 0 0 1 8 Good 
Gunningberg  2006 1 1 1 1 1 1 1 0 0 1 8 Good 
Gunningberg  2008 1 1 1 1 1 1 1 0 0 1 8 Good 
Gunningberg  2013 1 1 1 1 1 0 0 0 0 1 6 Moderate 
Hopkins  2000 1 1 1 1 1 0 0 0 0 0 5 Moderate 
House  2011 1 1 1 0 1 0 0 0 0 0 4 Moderate 
Inan  2012 1 1 1 1 1 0 1 0 1 1 8 Good 
Jenkins  2010 1 1 1 1 1 0 0 0 0 0 5 Moderate 
Lahmann  2006 1 1 1 1 1 0 1 0 0 1 7 Good 
Langemo  1990 1 1 1 0 1 0 0 0 0 0 4 Moderate 
Lepisto  2001 1 1 1 0 1 0 0 0 0 0 4 Moderate 
Meehan  1990 1 1 1 1 1 0 0 0 1 0 6 Moderate 
Meehan  1994 1 1 1 1 1 0 0 0 1 0 6 Moderate 
Nyquist  1987 1 1 1 1 1 0 0 0 0 0 5 Moderate 
O'Brien  1998 1 1 1 1 1 0 0 0 0 0 5 Moderate 
Pearson  2000 1 1 1 1 1 0 1 0 0 0 6 Moderate 
Soldevilla  2006 1 1 0 1 1 0 1 0 0 0 5 Moderate 
Thoroddsen  1999 0 1 0 1 1 1 1 0 0 1 6 Moderate 
Tubaishat  2011 1 1 1 1 1 1 1 0 0 1 8 Good 
Tubaishat  2013 1 1 1 0 1 1 1 0 0 1 7 Good 
Uzun  2007 1 1 1 1 1 0 1 0 1 1 8 Good 
Vanderwee  2007 1 1 1 1 1 1 0 0 0 1 7 Good 
Vanderwee  2011 1 1 1 1 1 1 0 0 1 1 8 Good 
Vangilder  2008 1 1 1 1 1 0 0 0 1 1 7 Good 
Vangilder  2010 1 1 1 1 1 0 0 0 1 1 7 Good 
Wann-Hansson  2008 1 1 1 1 1 0 1 0 1 1 8 Good 
Whittington  2004 1 1 1 1 0 0 0 0 0 0 4 Moderate 
Young  2002 1 1 1 1 1 1 1 0 0 1 8 Good 
Zhao  2010 1 1 1 1 1 0 1 0 0 1 7 Good 
Total  (n)  65 65 53 69 52 17 46 0 20 39 426  
Total (%)  83.3 83.3 67.9 88.5 66.7 21.8 60.0 0 25.6 50.0 54.6  
* = Please see Table S3 for descriptions of each question; Score: 1 = “yes”, 0 = “no” or “not reported”;*Quality Category = Total study quality score was classified as either “poor” (total score = 0–3), “moderate” (total 
score = 4–6) or “good” (total score = 7-10) study quality score; Author = Primary author of included study; Year = Year included study was published. 
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Data extraction  
Overall percentage agreement between the findings of the two authors 
performing data extraction was 97% (720 of the 740 total items).  The 20 differences 
between the second author checking the data extraction findings of the first author 
included: eight rounding, eight data entry and four case definition errors.  All 20 
differences were errors originally made in the data extraction process by the first 
author. Table 1 and Supplementary Tables S4-S6 display the final agreed consensus 
findings from the data extraction process for all included studies.   
 
Prevalence of foot disease disorders and risk factors 
Table 1 reports the total and sub-groups of condition-related foot disease 
disorders and risk factor prevalence ranges in general inpatient populations.  Total 
foot disease disorder prevalence ranges included: 0.01-13.5% for foot wounds, 0.05-
6.4% for foot infections and 0.2-11.9% for collective foot disease.  Total risk factor 
prevalence ranges included: 0.01-36.0% for PAD, 0.003-2.8% for PN, and foot 
deformity was not reported.  Amputation prevalence ranges were 0.03-1.5%.  The 
prevalence ranges were different for sub-groups of condition-related foot disease 
disorders and risk factors reported.  Prevalence ranges for foot wounds included: 0.7-
4.2% for all-cause foot wounds; 0.01-7.0% for diabetes-related foot wounds and 0.3-
13.5% for pressure-ulcer related foot wounds.  Prevalence ranges for foot infections 
included: 0.09-0.5% for all-cause foot infection, 0.05-6.4% for diabetes-related foot 
infections and pressure ulcer-related foot infections was not reported.  Prevalence 
ranges for collective foot disease included: 0.2-1.2% for all-cause foot disease, 0.2-
11.9% for diabetes-related foot disease and pressure ulcer-related foot infections was 
not reported.  Prevalence ranges for PAD included: 0.3-36.0% for all-cause PAD and 
0.01-0.4% for diabetes-related PAD.  Prevalence ranges for PN included: 0.2 for all-
cause PN and 0.003-2.8% for diabetes-related PN.  Again prevalence was greater in 
prospectively designed studies for all condition-related foot disease or risk factors 
investigated in general inpatient populations, with the exception of collective foot 
disease and PN.   
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Meta-analyses  
Four foot disease disorders met the pre-specified minimum for meta-analysis 
calculation of three eligible studies with similar study designs.  Tables 3-6 report the 
pooled prevalence estimates from the meta-analyses calculations for pressure ulcer-
related foot wounds, diabetes-related foot wounds, diabetes-related foot infections 
and diabetes-related foot disease.  Table 3 reports a pooled prevalence estimate for 
pressure ulcer-related foot wounds based on 14 included studies reporting sample 
sizes ranging from 60 - 37,307 and study quality scores from 4 – 8.  The pooled 
prevalence estimate was 4.6% (95% Confidence Interval: 3.7–5.4, p < 0.001) (I2 = 
95.3%, p < 0.001).  Examination of scatterplots revealed a bias between higher 
reported pressure ulcer-related foot wound prevalence and those studies using an 
unbiased, reliable outcome measure (Supplementary Figure S3-1).   
 
Table 3-3: Pooled random effects estimates for pressure ulcer-related foot wound 
prevalence expressed as % (95% CI) 
Study  Sample  
Size 
Prevalence 
Estimates 
95% CI % 
Weighting 
Study  
Quality Score 
Barrois (2008)  37,307 3.7 3.5 – 3.9 9.86 7 
Brito (2013)  473 4.7 2.8 – 6.5 6.59 6 
Gallagher (2008)  672 3.0 1.7 – 4.3 8.05 8 
Gethin (2005)  506 3.0 1.5 – 4.4 7.59 7 
Gunningberg (2005)  612 8.8 6.8 – 11.4 5.89 8 
Gunningberg (2006)  369 4.6 2.5 – 6.7 6.04 8 
Gunningberg (2008)  632 6.5 4.6 – 8.4 6.53 8 
Gunningberg (2013)  16,466 6.7 6.3 – 7.1 9.71 6 
House (2011)  60 5.0 -0.5 – 10.5 1.88 4 
Lahmann (2006)  16,728 3.2 2.9 – 3.5 9.81 7 
Tubaishat (2011)  302 7.8 4.7 – 10.9 4.29 8 
Tubaishat (2013)  295 3.0 1.1 – 4.9 6.54 7 
Vanderwee (2007)  5,947 4.4 3.9 – 4.9 9.55 7 
Wann-Hannson (2008)  535 3.0 1.5 – 4.4 7.67 8 
     Pooled estimate  4.6 3.7 – 5.4 p < 0.001  
     I2  95.3%  p < 0.001  
CI = Confidence Intervals 
 
Table 3-4 reports a pooled prevalence estimate for diabetes-related foot 
wounds based on six included studies reporting sample sizes ranging from 624 – 
5,188 and study quality scores from 4 – 6.  The pooled prevalence estimate was 2.4% 
(CI: 1.5-3.4, p < 0.001) (I
2
 = 94.2%, p < 0.001).  Examination of scatterplots 
revealed sources of bias between higher reported diabetes-related foot wound 
prevalence and those studies either reporting smaller sample sizes, having lower 
study quality or studies conducted in developing countries (Supplementary Figure 
S3-2). 
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Table 3-4: Pooled random effects estimates for diabetes-related foot wound 
prevalence expressed as % (95% CI) 
Study Sample  
Size 
Prevalence  
Estimates 
95% CI % Weighting Study  
Quality Score 
Asumanu (2010)  966 4.3 3.1 – 5.6 14.60 5 
Hurd (2009)  3,099 1.1 0.7 – 1.5 18.99 6 
Mahe (2006)  624 0.5 -0.1 – 1.0 18.40 6 
Mohammad Akther (2011)  5,188 1.1 0.8 – 1.3 19.22 5 
Ogbera (2007)  1,327 2.7 1.8 – 3.6 16.84 4 
Unachukwu (2007)  827 7.0 5.3 – 8.8 11.95 4 
     Pooled estimate  2.4 1.5 – 3.4 p < 0.001  
     I2  94.2%  p < 0.001  
CI = Confidence Intervals 
 
Table 3-5 reports a pooled prevalence estimate for diabetes-related foot 
infections based on three included studies reporting sample sizes ranging from 827 – 
5,188 and study quality scores from 4 – 5.  The pooled prevalence estimate was 3.4% 
(CI: 0.2-6.5, p < 0.05) (I
2
 = 97.0%, p < 0.001).  Scatterplots were not evaluated due 
to the limited number of included studies.   
 
Table 3-5: Pooled random effects estimates for diabetes-related foot infection 
prevalence expressed as % (95% CI) 
Study Sample  
Size 
Prevalence  
Estimates 
95% CI % Weighting Study  
Quality Score 
Asumanu (2010)  966 3.3 2.2 – 4.4 33.42 5 
Mohammad Akther (2011)  5,188 0.6 0.4 – 0.8 34.82 5 
Unachukwu (2007)  827 6.4 4.7 – 8.1 31.76 4 
     Pooled estimate  3.4 0.2 – 6.5 p = 0.037  
     I2  97.0%  p < 0.001  
CI = Confidence Intervals 
 
Table 3-6 reports a pooled prevalence estimate for diabetes-related foot disease 
based on three included studies reporting sample sizes ranging from 810 – 5,188 and 
study quality scores from 4 – 5.  The pooled prevalence estimate was 4.7% (CI: 0.3-
9.2, p < 0.05) (I
2
 = 97.8%, p < 0.001).  Scatterplots were not evaluated due to the 
limited number of included studies.   
 
Table 3-6: Pooled random effects estimates for diabetes-related foot disease 
prevalence expressed as % (95% CI) 
Study Sample  
Size 
Prevalence  
Estimates 
95% CI % 
Weighting 
Study  
Quality Score 
Asumanu (2010) (40) 966 8.3 6.6 – 10.0 32.66 5 
Daultry (2011) (42) 810 4.9 3.4 – 6.4 33.05 4 
Mohammad Akther (2011) (47) 5,188 1.1 0.8 – 1.3 34.28 5 
     Pooled estimate  4.7 0.3 – 9.2 p = 0.038  
     I2  97.8%  p < 0.001  
CI = Confidence Intervals 
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Supplementary Figure S3-1:  Scatterplots of potential sources of bias affecting pressure ulcer-related foot wound prevalence  
 
These included A) Sample Size, B) Study Quality Score, C) Conducted in a developed country and D) Outcome measure was unbiased.
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Supplementary Figure S3-2:  Scatterplots of potential sources of bias affecting diabetes-related foot wound prevalence  
 
These included A) Sample Size, B) Study Quality Score and C) Conducted in a developed country 
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3.6 DISCUSSION 
Principal findings 
This study is the first systematic review to investigate the prevalence of foot 
disease in representative general inpatient populations.  The prevalence of foot 
disease disorders in general inpatient populations ranged from 0 – 13%, whilst, the 
prevalence of a major risk factor for foot disease ranged from 0 – 36%.  Meta-
analyses could only be calculated for four condition-related foot disease disorders.  
These pooled prevalence estimates indicated that 4.6% ((95% CI) 3.7-5.4) of all 
inpatients had a pressure ulcer present on their foot, 4.7% (0.3-9.2) had collective 
diabetes-related foot disease, 2.4% (1.5-3.4) had diabetes-related foot wounds and 
3.4% (0.2-6.5) had diabetes-related foot infections. Additional findings from this 
review suggested up to 1.2% of all inpatients had been hospitalised for the primary 
reason of foot disease.  However, this systematic review also revealed significant 
heterogeneity in the reported prevalence and study quality between the different 
studies reporting on the same foot disease disorder or risk factors of interest.     
 
Strengths and weaknesses  
The authors are cognisant of limitations in the methodology used to perform 
this systematic review.    Firstly, this review used broad inclusion criteria for foot 
disease disorders, risk factors and general inpatient population definitions and this 
may have contributed to the heterogeneity of findings.  Secondly, the original search 
strategy was performed by only one author and did not initially identify studies 
reporting pressure-ulcer related foot wounds on specific anatomical locations of the 
foot.   However, the authors believe this was addressed by conducting a broad initial 
search strategy, an extensive additional pressure ulcer-related search strategy, hard 
searching references of all included studies, citation searching all included studies 
and contacting external content experts to identify any remaining relevant studies.  
Thirdly, only one author extracted data.  However, a second author checked all data 
extraction finding and reported very high percentage agreement with the original data 
extraction findings.  Fourthly, the tool used to assess the methodological quality of 
included studies had not been tested for reliability and validity.  However, the tool 
reported substantial inter-rater reliability agreement between blinded authors in this 
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study, had high face validity and aligned with items reported to provide best practice 
methodological quality assessments for observational studies [246].  Lastly, the 
pooled prevalence estimates calculated in this review reported very high statistical 
heterogeneity and some may argue the value of reporting such heterogeneous 
findings [180].  However, the authors used conservative random-effects meta-
analyses models weighted on total sample size in an attempt to account for 
heterogeneity [180].  Furthermore the authors consider the reporting of 
heterogeneous pooled prevalence estimates, with the clear cautionary notes provided 
by the authors on interpretation, provide considerable additional value and 
transparency to the existing literature available in this field [180]. 
The findings of this systematic review should also be viewed in the context of 
several consistent limitations observed in the included studies of this review.  Firstly, 
most included studies reported foot disease disorders or risk factors as an additional 
outcome which potentially biases these studies towards under-reporting foot disease 
outcomes.  Secondly, no included studies reported confidence intervals or sample 
size calculations for foot disease findings which, along with the paucity of reporting 
of socioeconomic status and geographical remoteness, significantly limits the 
generalizability of results and thus use by local regions.  Thirdly, most included 
studies reported a condition-related (such as diabetes-related), rather than an all-
cause, foot disease disorder or risk factor in a general inpatient population which also 
potentially biases towards under-reporting the all-cause outcomes.  Fourthly, study 
quality scores varied considerably depending on the study design and foot disease 
disorder or risk factor investigated.  Fifthly, all-cause and diabetes-related foot 
disease disorder or risk factor findings were predominately reported from 
retrospective studies using generic hospital discharge datasets which again 
potentially biases towards under-reporting the identification of specific foot disease 
disorders.  Lastly, whilst studies reporting pressure ulcer-related foot disease were all 
prospective and mostly of high quality, a large proportion reported only pressure 
ulcers on the heel.  Overall, these limitations impact on the capture, precision and 
heterogeneity of findings and indicate included studies are likely to have under-
reported foot disease disorder and risk factor prevalence. 
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Interpretations of findings 
The most consistent deficiency in study quality identified in this review was 
that no studies reported confidence intervals for foot disease or risk factor prevalence 
findings.  This was most probably related to very few studies investigating a foot 
disease disorder or risk factor as their primary outcome of interest [29, 52, 53, 56, 57, 
63, 184-186, 194, 204, 244, 245].  Most studies reported foot disease or risk factors 
as an additional aim to the primary study aim of investigating the prevalence of a 
larger condition, such as the total pressure ulcer or diabetes prevalence.  This lack of 
focus on foot disease may have led to an under-reporting of prevalence findings as 
suggested in other similar studies [5, 181, 182].  Furthermore, seven of the fifteen 
study cohorts that were investigated primarily for a foot disease disorder or risk 
factor were retrospective studies [29, 52, 186, 194, 196].  Retrospective studies have 
been found to also considerably under-report prevalence compared to prospectively 
designed studies utilising validated outcome measures [5, 181, 182], and this also 
seemed to be the case in this review.  Only eight study cohorts were prospectively 
investigated for the primary reason of identifying a foot disease disorder or risk 
factor [53, 56, 62, 184, 185, 204, 244, 245], however, only one used an unbiased 
method of measurement [185].  This particular study investigated PAD using a 
reliable and validated non-invasive ankle brachial index method [185].  With nearly 
all studies either retrospective in design or investigating a foot disease disorder or 
risk factor as an additional outcome, it could be hypothesised that the pooled 
prevalence estimates reported in this review are likely to underestimate the actual 
burden of foot disease in inpatient populations. 
Foot wounds were by far the most identified and reported foot disease disorder 
arising from this systematic review.  Yet, only three studies reported on all-cause 
foot wound prevalence [34, 183, 186].  A large retrospective study by Currie et al 
investigating foot disease disorders and risk factors when they were the primary 
reason for admission was the only study with the primary aim of investigating all-
cause foot wounds and reported a foot wound prevalence of 0.7% [186].  The other 
two studies were prospective studies and reported all-cause foot wound prevalence of 
1.6% [34] and 4.2% [183], respectively.  However, the primary aims of these 
prospective studies were to investigate wound prevalence, and thus, identifying foot 
wounds was one of several additional aims investigating different wound locations 
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[34, 183].  Limitations in study numbers and quality calls into question the precision 
of all-cause foot wound prevalence estimates and meant pooled estimates could not 
be calculated. 
In contrast, the study numbers and quality were sufficient to perform meta-
analyses on diabetes-related foot wound and pressure ulcer-related foot wound 
prevalence.  The increased numbers of studies reporting these two condition-related 
areas is perhaps not unexpected considering aspects of diabetes and pressure ulcer 
management are commonly utilised internationally as key performance indicators of 
hospital care quality [247-251].  Foot wounds are major contributors to poor 
outcomes in both these conditions [188, 198, 209, 247, 249].  The pooled prevalence 
estimates for diabetes-related foot wounds (2.4%) and pressure ulcer-related foot 
wounds (4.6%) from this review indicate these foot wounds do contribute 
considerable burdens on the hospital inpatient system.  Whilst there were more 
studies investigating these two condition-related foot wounds in general inpatient 
populations again both pooled prevalence estimates had very high heterogeneity.  
This may be attributed to only “moderate “study quality scores being eligible for 
inclusion in the calculation of the diabetes-related foot wound pooled prevalence 
estimate.  However this was not the case for the pressure ulcer-related foot wound 
pooled prevalence estimate where overall included study quality scores were “good”.  
Interestingly, the only factor identified in the scatterplots to bias pressure ulcer-
related foot wound prevalence findings was the bias of the investigators themselves.  
This suggests in studies where investigators or data collectors investigated 
participants from their own hospitals pressure ulcer prevalence were under-reported.  
As this was the only factor identified to bias pressure ulcer-related foot wound 
prevalence from this review, it is therefore plausible, that the variation in pressure 
ulcer-related foot wound prevalence is largely affected by the quality of care 
provided by the individual hospital.  Thus, this would support the ongoing use of 
unbiased pressure ulcer prevalence as a key performance indicator of hospital care 
quality [33, 209, 247].   
It was apparent that most studies reporting pressure ulcer-related foot wounds 
did not exclude wounds of diabetes origin, and conversely, most studies reporting 
diabetes-related foot wounds did not exclude wounds of pressure ulcer-related origin.  
This potential cross-contamination suggests studies reporting pressure ulcer-related 
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foot wounds may inadvertently be a combination of the prevalence of pressure ulcer-
related and diabetes-related foot wounds. Furthermore, literature reports stage one 
pressure ulcers make up to 50% of the total pressure ulcer burden [33, 198, 209].  
Stage one pressure ulcers are defined as non-blanchable erythema without skin loss 
or a “pre-pressure ulcer” [33, 198].  This suggests the real pressure ulcer-related foot 
wound prevalence in those inpatients with skin loss may make up only 50% of the 
4.6% pooled prevalence estimate reported from this review.   Thus, it could be 
hypothesised that the real pressure ulcer-related wound prevalence may be closer to 
2.4% pooled prevalence estimate findings for diabetes-related foot wounds.  Again 
considering the high likelihood of cross-contamination of these two large condition-
related foot wound types, this hypothesis may extend to the suggestion that pressure 
ulcer-related foot wounds with skin loss could be a useful surrogate marker for all-
cause foot wound prevalence and a potential indicator of foot care quality.  However, 
these hypotheses need to be interpreted with much caution until further investigations 
support its use in this capacity.   
Foot infection was the other major foot disease disorder included in this review 
and was often reported to affect existing foot wounds [53, 59, 60].  The retrospective 
analysis by Currie et al was the only study primarily investigating all-cause foot 
infection prevalence and reported a rate of 0.5% [186].  Another retrospective study 
to primarily investigate foot infection reported a rate of 0.1%, however, this study 
only investigated foot osteomyelitis (bone infection) [29].  The remaining five 
cohorts reported diabetes-related foot infections [53, 60, 62, 186, 192].  The 
prospective pooled prevalence estimate for diabetes-related foot infection was 3.4% 
(0.2-6.5); yet, statistical heterogeneity was again high and needs to be interpreted 
with caution.  This is particularly the case considering the pooled prevalence estimate 
for diabetes-related foot infection was higher than for diabetes-related foot wounds.  
However, the findings from the three studies used to calculate the diabetes-related 
foot infection pooled prevalence estimate each individually found higher diabetes-
related foot wound prevalence than they did for diabetes-related foot infection 
prevalence [53, 60, 62]. 
The aforementioned study by Currie et al was also the only study to primarily 
investigate all-cause collective foot disease prevalence in a general inpatient 
population [186].  This retrospective study analysed the proportion of foot disease 
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that were the primary reason for admission from over 300,000 hospitalisations 
recorded in a Welsh national hospital discharge dataset [186].  Interestingly, even 
though the retrospective study design used in this large study make significant under-
reporting likely [5, 181, 182], it still identified that collectively foot disease was the 
primary reason for admission in 1.2% of hospitalisations [186].  Foot disease was 
also collectively reported in eleven other study cohorts with prevalence ranging from 
0.2% to 11.9%.  However, a pooled prevalence estimate of 4.7% [53, 59, 60, 62, 189, 
190] could only be calculated for diabetes-related foot disease and this was again a 
heterogeneous finding.  One factor that may have influenced these high 
heterogeneous findings was the different synonyms and inclusion criteria used to 
define collective foot disease disorders between studies.  The terms varied between 
“foot disease” [62], “foot problems” [56, 145], “diabetic foot” [57, 188] and an 
aggregation of different foot disease disorders [53, 186, 196].  The inconsistency of 
terms, definitions and the specific foot disease disorders included within these 
collective “foot disease” groups appears to be a major contributing factor in the 
heterogeneity of these findings.  It is recommended that a formal international 
consensus process is undertaken to determine an agreed foot disease definition so as 
to allow clinicians and researchers to compare homogenous “foot disease” outcomes 
in future.. 
The major risk factors for foot disease included in this study were PAD, PN 
and foot deformity.  PAD was the most reported risk factor in ten cohorts.  Two 
“moderate-to-good” quality prospective studies of all-cause PAD using similar gold 
standard non-invasive vascular outcome measures reported similar 29.6% and 36.0% 
prevalence findings [184, 185].  In contrast, other PAD studies were either 
retrospective in design or reported PAD using a non-valid or reliable method.  
However, the methodological deficiencies of these studies translated to poorer study 
quality scores and much lower PAD prevalence ranges of 0.01-0.5%.  Thus, using 
the most robust study quality evidence available, it could be hypothesised that PAD 
is present in approximately one third of general inpatient populations [184, 185].  PN 
was reported in six cohorts with the only study reporting all-cause PN prevalence 
(0.2%) again the retrospective study by Currie et al [186].  All other studies reported 
diabetes-related PN prevalence ranging from 0.003-2.8% in general inpatient 
populations [54, 62, 186, 193, 194]. The only study to primarily investigate diabetes-
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related PN identified that 2.8% of all inpatients had diabetes-related PN using a 
validated tool [62].  However, with only one retrospective study reporting all-cause 
PN and all other studies reporting condition-related PN, these low reported PN 
prevalence rates could again be considered to under-report the actual all-cause PN 
prevalence in inpatients.  Foot deformity was not identified by this review.  
Unfortunately, there were insufficient studies of satisfactory quality to enable the 
calculation of a pooled prevalence estimate for any risk factor.  Therefore, until 
further studies are conducted the best estimate of the proportion of general inpatient 
populations with a major risk factor for foot disease appears to be up to 36% [184, 
185].   
Lastly, amputation prevalence was reported in ten included study cohorts 
identified by this review ranging from 0.03 – 1.5% [29, 52, 55, 60, 62, 186, 187, 
193].  The only study primarily investigating all-cause amputation in this context was 
again the retrospective study by Currie et al suggesting 0.1% prevalence in general 
inpatient populations [186].  Most remaining studies reported diabetes-related 
amputation rates which ranged between 0.04 – 1.5% [52, 55, 60, 62, 186, 187, 193].  
Unfortunately there were insufficient studies to calculate a pooled prevalence 
estimate.  However, this prevalence range may not be exhaustive and needs to be 
interpreted with caution, as amputation was a secondary aim of this review, only 
reported from studies that also reported foot disease or risk factors and studies 
reporting amputation rarely differentiated between minor and major amputations 
which are performed for different clinical reasons and have different long-term 
implications. 
 
Implications for clinicians, researchers and policymakers 
Whilst reviews have been investigating the inpatient burden of major organ 
disease for some time, such as heart disease [252-254], this appears to be the first 
review to determine more precise estimates for foot disease in general inpatient 
populations.  This review has identified that foot disease is present in considerable 
proportions of the general inpatient population.  Primary findings indicate one in 
twenty inpatients had foot disease and one in three inpatients had a major risk factor 
for foot disease.  This review also supports existing evidence suggesting foot disease 
is present in large proportions of discrete inpatient populations, such as patients with 
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diabetes [1, 2, 11] and pressure ulcers [33, 209, 247].  Furthermore, additional 
findings indicate one in every 100 inpatients had been hospitalised because of foot 
disease and up to 1.5% of all inpatients were in hospital to have an amputation 
procedure. Although pooled prevalence estimates in this review had high 
heterogeneity they are the most precise prevalence estimates to date to quantify the 
burden of foot disease present in general inpatient populations.  Overall findings 
from this review appear to be very likely an under-estimate of this burden.   
With such a considerable proportion of foot disease present in inpatient 
populations it is perhaps surprising that more research has not been conducted to 
primarily investigate this potentially considerable burden.  However, this review 
does highlight the need for clinicians, researchers and policymakers to better 
understand and address this seemingly under-recognised burden in inpatient 
populations.  It is recommended that future studies in this field should be prospective 
in design, have a primary aim to investigate foot disease in inpatient populations and 
use unbiased, reliable and validated foot disease and risk factor outcome measures.  
Furthermore it is recommended the findings of this review should inform policy to 
more precisely address this under-recognised yet considerable burden of foot disease 
in inpatient populations. 
 
3.7 CONCLUSIONS 
This is the first known systematic review to synthesise the literature on foot 
disease in inpatient populations and provides the best estimates to date of this 
burden.  Findings from this review indicate up to 36% of all inpatients had a major 
risk factor for foot disease, 5% had foot disease and up to 1% were in hospital 
because of foot disease.  Due to the high heterogeneity of included studies, these 
estimates need to be interpreted with caution; however, they are more likely to 
under-report the inpatient foot disease burden.  This review highlights the urgent 
need for further research to more robustly quantify, and address, what appears to be a 
considerable burden of foot disease present in general inpatient populations. 
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3.8 CONCEPTUAL FRAMEWORK 
The comprehensive literature reviews contained in Chapters 2 and 3 have 
revealed that no previous study has investigated the total prevalence and associated 
factors for foot disease disorders in a representative inpatient population [36, 37].  
Furthermore, both chapters have identified major common deficiencies in the 
existing literature, including failure to provide precise prevalence estimates and 
associates for foot disease disorders in inpatient populations [36, 37].  Thus, both 
chapters recommend more robust studies are required to more precisely understand 
the inpatient burden of foot disease [36, 37].   
 Whilst these chapters identified deficiencies in the literature, they also 
identified a number of broad indicative prevalence ranges, and associated factors, for 
foot disease disorders in inpatient populations [36, 37].  Interestingly, these identified 
foot risk factors were similar to those foot risk factors implicated in the diabetes-
related foot disease disorder literature, such as PAD, PN, foot deformity, trauma and 
foot disease history [1, 2, 17, 20, 255].  In addition, at risk populations identified in 
these reviews were similar to those populations implicated in lower extremity 
amputation literature, such as older age, male sex, diabetes, cancer, cardiovascular 
disease, arthritis and major acute trauma [3, 9, 11, 175, 255, 256].  Furthermore, 
another recent systematic review has identified all common variables used in major 
cohort studies investigating diabetes-related foot disease [257].  Variables not 
identified in the two literature review chapters undertaken as part of this thesis 
included: education level achieved, socio-economic status, body mass index (BMI), 
alcohol consumption, diabetes therapy, depression, mobility impairment, visual 
impairment, footwear type and various other metabolic blood tests other than HbA1c 
[257].  As diabetes appears to be the leading medical condition precipitating foot 
disease disorders, these variables should be considered when investigating the 
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associated factors for foot disease in all inpatient populations.  All these foot risk 
factors and at risk populations can be grouped into similar domains to those 
previously described in conceptual framework models developed for lower extremity 
amputations [255, 256] or general determinants of health [258].   
Figure 3-2 outlines a new conceptual framework to explain the foot disease in 
inpatients construct.  This thesis has investigated the majority of the variables 
contained in this conceptual framework (Figure 3-2), with minor exceptions.  
Underlined variables were not collected either because similar domain variables were 
already collected (such as health service utilisation for health service access) or the 
variable was considered logistically difficult to collect within the resource constraints 
of this thesis (such as the extra time resources required in data collection to measure 
BMI or waist measurement in bed bound patients).  Data collection instruments to 
reliably capture the variables contained in Figure 3-2 are investigated in the next 
chapters (Chapter 4 and 5).   
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Figure 3-2:  Conceptual framework for foot disease in inpatients 
Foot Risk Factors: 
o History of foot disease 
o PN  
o PAD 
o Foot deformity 
o Trauma 
Social Determinants: 
o Education Levels 
o Area of residence 
o Socio-economic status 
o  
Self-Care Behaviour: 
o Cultural health beliefs 
o Impaired vision 
o Impaired mobility/activity 
o Footwear types 
o Depression 
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Health Service: 
o Multiple disciplines 
o Access 
o Availability 
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Chronic Disease: 
o Diabetes 
o Cardiovascular disease 
o Kidney disease 
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o Systemic arthritis 
Metabolic Syndrome: 
o Hypertension 
o Dyslipidaemia 
o Hyperglycaemia 
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Demographics: 
o Age 
o Sex 
o Ethnicity 
Foot-related Hospitalisation: 
o Amputation 
o Foot ulcer 
o Foot infection 
o Severe PAD 
o Severe PN 
o Severe Foot deformity 
Foot Disease: 
o Ulceration 
o Infection 
o Severe risk factors 
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Chapter 4: The Queensland High Risk Foot 
Form (QHRFF) – is it a reliable and 
valid clinical research tool for foot 
disease? 
This chapter begins with a preface section that briefly explains the manuscript 
that makes up this data collection instrument reliability and validity chapter (section 
4.1).  An adapted version of the manuscript published in the Journal of Foot and 
Ankle Research, “The Queensland High Risk Foot Form (QHRFF) – Is it a reliable 
and valid tool for foot disease?” is then presented; including abstract (section 4.2), 
background (section 4.3), methods (section 4.4), results (section 4.5), discussion 
(section 4.6) and conclusion sections (section 4.7).   
 
4.1 PREFACE 
To conduct any research that reports to be robust in methodology requires a 
data collection instrument with the appropriate reliability and validity for the 
construct in which it has been designed.  As reported in Chapters 2 and 3, whilst 
multiple tools exist for foot disease within specific populations such as diabetes, no 
data collection instrument was identified that captured multiple co-morbidities, foot 
disease disorders and foot risk factors in representative populations.  Thus, Chapter 4 
presents a manuscript describing in detail the development and testing of a new data 
collection instrument to capture multiple co-morbidities, foot disease disorders and 
foot risk factors in more representative populations; the Queensland High Risk Foot 
Form (QHRFF) (Appendix E).  It describes the findings from two methodological 
phases.  Phase one outlined the developmental procedures to create the new data 
collection instrument.  Phase two reported on the criterion validity and inter- and 
intra-rater reliability of the QHRFF when tested on clinicians representing different 
levels of clinical foot disease experience.   
It is noted that phase one was conducted by the candidate prior to enrolment in 
this PhD as part of the candidate’s employment at the time; however, phase two was 
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undertaken by the candidate for the purposes of this PhD with permission to use the 
new data collection instrument from Queensland Health (Appendix E).  Furthermore, 
it is also useful to note that the journal in which this manuscript was published 
preferred the terms “foot disease complications” and “high-risk factors” in 
preference to the preferred thesis terms of “foot disease disorders” and “risk factors”, 
respectively.  The manuscript that forms the basis of this chapter has been adapted 
from the manuscript published in the Journal of Foot and Ankle Research:  
Lazzarini PA, Ng V, Kinnear EM, Kamp MC, Kuys SS, Hurst C, Reed LF. 
The Queensland high risk foot form (QHRFF) - is it a reliable and valid clinical 
research tool for foot disease? Journal of Foot and Ankle Research 2014; 7: 7-7 [38].  
 
4.2 ABSTRACT 
Background:  Foot disease complications, such as foot ulcers and infection, 
contribute to considerable morbidity and mortality.  These complications are 
typically precipitated by “high-risk factors”, such as peripheral neuropathy and 
peripheral arterial disease.  High-risk factors are more prevalent in specific “at risk” 
populations such as those with diabetes, kidney disease and cardiovascular disease.  
To the best of the authors’ knowledge a tool capturing multiple high-risk factors and 
foot disease complications in multiple at risk populations has yet to be tested.  This 
study aimed to develop and test the validity and reliability of a Queensland High 
Risk Foot Form (QHRFF) tool. 
Methods:  The study was conducted in two phases.  Phase one developed a 
QHRFF using an existing diabetes foot disease tool, literature searches, stakeholder 
groups and an expert panel.  Phase two tested the QHRFF for validity and reliability.  
Four clinicians, representing different levels of expertise, were recruited to test 
validity and reliability.  Three cohorts of patients were recruited; one tested criterion 
measure reliability (n=32), another tested criterion validity and inter-rater reliability 
(n=43) and another tested intra-rater reliability (n=19).  Validity was determined by 
calculating sensitivity, specificity and positive predictive values (PPV).  Reliability 
was determined using Kappa, weighted Kappa and intra-class correlation (ICC) 
statistics.  
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Results:  A QHRFF tool containing 46 items across seven domains was 
developed.  Criterion measure reliability of at least moderate categories of agreement 
(Kappa > 0.4; ICC > 0.75) was seen in 91% (29 of 32) tested items. Criterion validity 
of at least moderate categories (PPV > 0.7) was seen in 83% (60 of 72) tested items. 
Inter- and intra-rater reliability of at least moderate categories (Kappa > 0.4; ICC > 
0.75) was seen in 88% (84 of 96) and 87% (20 of 23) tested items respectively. 
Conclusions:  The QHRFF had acceptable validity and reliability across the 
majority of items; particularly items identifying relevant co-morbidities, high-risk 
factors and foot disease complications.  Recommendations have been made to 
improve or remove identified weaker items for future QHRFF versions. Overall, the 
QHRFF possesses suitable practicality, validity and reliability to assess and capture 
relevant foot disease items across multiple at risk populations. 
 
4.3 BACKGROUND 
Foot disease contributes to considerable hospitalisation [2, 6, 198, 259], 
amputation [3, 9, 11, 175], institutionalisation [12, 13], and death [6, 14]; yet foot 
disease complications and these outcomes are largely preventable [11, 175, 260, 
261]. “High risk factors” (such as peripheral neuropathy, peripheral arterial disease 
or foot deformity) significantly increase the risk of developing “foot disease 
complications” (such as foot ulcers, infection or ischaemia) [18, 19, 259, 262]. 
Diabetes populations are frequently acknowledged as the leading “at risk population” 
for foot disease due to the increased risk of developing high risk factors, and in turn 
foot disease complications, from diabetes [9, 11, 20]. However, other chronic disease 
populations (such as chronic kidney disease [18, 19], cardiovascular disease [11, 21, 
22, 175] and some cancers [9, 11, 175]) have now been shown to cause comparable 
rates of high risk factors and foot disease complications to diabetes, and thus, are 
also becoming more readily identified as “at risk populations” for foot disease. 
Best practice foot disease management has been shown to significantly reduce 
hospitalisation, amputation, mortality and overall costs within different at risk 
populations [11, 249, 260, 261]. These multi-faceted best practice interventions 
commonly include screening for high-risk factors, multi-disciplinary management of 
foot disease complications, clinical training, evidence-based clinical pathway 
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utilisation and regular capture and analysis of foot disease clinical data [11, 175, 249, 
260, 261]. In consideration of the growing problem of foot disease, and the potential 
future improvements observed with best practice clinical management and research, 
it is imperative that any clinical tools to assess, capture, measure or analyse patient 
outcomes in at risk populations are valid and reliable. 
There are a multitude of studies that have investigated a specific high risk foot 
factor or foot disease complication within multiple at risk populations [11, 175, 198, 
263]. Furthermore, numerous studies have investigated multiple high risk factors and 
foot disease complications in specific at risk populations such as diabetes [6, 19, 20]. 
However, very few studies have investigated multiple high risk foot factors and foot 
disease complications in multiple at risk populations. This situation appears to be 
mirrored by the clinical tools available to measure and report on foot disease. For 
example many validated single-item tools are available which measure specific high-
risk factors or foot disease complications within multiple at risk populations [264-
266]; such as the ankle brachial index to capture and measure peripheral arterial 
disease within various at risk populations [264]. Furthermore, many validated multi-
item tools measuring multiple high-risk factors and foot disease complications in 
specific at risk populations have been developed [19, 267-270]; such as the 
University of Texas Diabetic Foot Classification System to capture and measure 
multiple high risk factors and foot disease complications in people with diabetes only 
[267]. However, to the best of the authors’ knowledge a multi-item tool designed to 
measure multiple high-risk factors and foot disease complications in multiple at risk 
populations is yet to be developed and tested for validity and reliability. 
Recently a Diabetic Foot Form (DFF) tool was developed to measure multiple 
high-risk factors and foot disease complications in people with diabetes only in 
diverse Queensland (Australia) settings [271]. The DFF was a multi-item tool 
developed from a number of existing clinical tools recommended in the literature to 
reliably capture various high-risk factors and foot disease complications in the 
diabetes population [271]. The implementation of the DFF in diverse Queensland 
clinical sites, in conjunction with other multi-faceted strategies, resulted in improved 
capture, measurement and management of high risk factors and foot disease 
complications and a corresponding reduction in outcomes such as hospitalisation and 
amputation [271, 272]. However, the tool was not tested for validity or reliability and 
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was designed only to measure multiple high-risk factors and foot disease 
complications in the specific at risk population of people with diabetes. 
In this study, we sought to modify the DFF tool to enable the measurement of 
multiple high risk factors and foot disease complications in multiple at risk 
populations. It was intended that the new multi-item tool would align with best 
practice principles for clinical tools including being easily interpreted, practical to 
use and possessing high face, content and criterion validity, and inter- and intra-rater 
reliability [273-275]. Thus, the aims of this study were firstly to develop a multi-item 
Queensland High Risk Foot Form (QHRFF) tool to capture multiple high risk factors 
and foot disease complications in multiple applicable at risk populations, and 
secondly, to investigate the validity and reliability of the tool’s individual items when 
used by clinicians representing different levels of foot disease expertise. 
 
4.4 METHODS 
The study was conducted in two phases. Phase one involved development of 
the Queensland High Risk Foot Form (QHRFF) tool and phase two tested the 
validity and reliability of the QHRFF tool (Appendix E). Approval was granted from 
Institutional Ethics Committees (Appendix C) and informed consent was obtained 
from all individual participants (patients and clinicians) for this study (Appendix D). 
 
Phase one – development of the tool 
Phase one primarily aimed to select items for the development of a QHRFF 
tool that were practical to collect in an Australian clinical setting, applicable to 
multiple 'at risk’ populations, and provided high face and content validity. The 
overarching procedures used for item selection included using the original DFF [271] 
as the starting tool to build the new QHRFF, searching the electronic literature for 
other recommended foot disease tools, establishing an expert panel to guide 
development and using several rounds of stakeholder consultation to refine the tool. 
The original DFF contained 64 items pertaining to the construct of foot disease 
in diabetes populations [271] and was used as the starting tool to modify into the 
QHRFF. The DFF was originally developed using similar procedures to those used in 
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this study and appeared to possess high practicality, face and content validity [271]. 
Furthermore, the DFF had been routinely used in over 25 High Risk Foot Service 
sites throughout Queensland for three years to collect standard clinical data on 
diabetes-related foot disease [272]. 
An electronic literature search was undertaken of relevant electronic databases 
including MEDLINE (all years to June 2011), CINAHL (all years to June 2011) and 
relevant professional websites to identify existing foot disease-related tools. The 
basic terms searched included tools to identify peripheral neuropathy, peripheral 
arterial disease, foot deformity, foot ulceration, foot infection and amputation or 
synonyms. 
An expert panel was established from members of the Queensland State-wide 
Diabetes Foot Working Group; a working group of the Queensland State-wide 
Diabetes Clinical Network. The panel comprised 14 expert clinicians, with between 
five and 25 years of experience in the area of foot disease management, from the 
fields of endocrinology, vascular surgery, podiatry, nursing, public health, quality 
improvement and research. The panel had the responsibility to decide upon the final 
items for the QHRFF tool after each round of consultation. 
Refinements of the tool were achieved through numerous rounds of 
consultation and trialling of draft QHRFF versions with external stakeholders in 
relation to practicality, face and content validity. Stakeholders included up to 200 
multidisciplinary professionals from sites registered to use the existing DFF, 
members of the Queensland Health State-wide Diabetes Clinical Network, State-
wide Renal Clinical Network and State-wide Podiatry Network. 
At the conclusion of phase one the expert panel and aforementioned network’s 
management committees determined, via consensus endorsement, that each item of 
the QHRFF possessed high practicality, face and content validity, and was applicable 
across multiple 'at risk’ populations (particularly diabetes, cardiovascular disease and 
chronic kidney disease) in Australian clinical settings. See Phase One Results for 
further details regarding the final QHRFF. 
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Phase two – validity and reliability 
The final endorsed QHRFF tool developed in phase one was then tested for 
validity and reliability. The general procedure for testing involved using podiatrists 
with different levels of foot disease expertise to assess patients with different levels 
and severity of high risk factors and foot disease. The authors decided to test only 
QHRFF items that directly related to the foot disease construct, thus, excluding items 
such as patients’ name, and facility. To test the validity of each item a general 
criterion measure (the agreement between two 'experts’) was initially assessed for 
reliability. Each item was then tested, using the podiatrists with different experience 
levels, against the criterion measure to evaluate magnitudes of concurrent criterion 
validity. The inter- and intra-rater reliability was also tested for the level of 
agreement on each item by podiatrists with different levels of experience. 
 
Setting and participants 
The testing was conducted within the High Risk Foot Services (HRFS), Metro 
North Hospital and Health Service, Brisbane, Australia. Eligible clinician 
participants were recruited from podiatrists practicing a minimum of one session per 
week in a HRFS. Four podiatrists were chosen as representative of the majority of 
clinicians managing foot disease within Queensland Health, and thus, potentially 
using the QHRFF in future. For the purposes of the study, levels of expertise were 
categorised using the Queensland Health 'Health Practitioner award’ [276]. Thus, 
expert clinicians were defined as either a 'consultant clinician’ (level 6) or 'specialist 
clinician’ (level 5) [276] and working in an acute hospital setting, plus, a member of 
the expert panel to ensure they understood the original intended construct for the 
QHRFF tool. General clinicians were defined as a 'senior clinician’ (level 4) or 
'clinician’ (level 3) [276], working in a community setting, and thought to be 
representative of the general podiatry clinical workforce managing foot disease in 
Queensland. One of each level was recruited; one level 6, one level 5, one level 4 and 
one level 3 (however, the level 3 had been acting in a level 4 position at the time of 
the study). Written informed consent was obtained from all participants (patients and 
clinicians) prior to commencement of their study participation. 
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Eligible patient participants were consecutively recruited from patients already 
attending Community HRFS clinics for the care of high risk factors or foot disease 
complications; defined as a previous or current foot ulcer. Exclusion criteria included 
patients with a cognitive deficit, signs or symptoms of a systemic infection, younger 
than 18 years of age, or unwilling to provide written consent to participate. The 
authors considered that patients with previous or current foot ulcers would ensure 
that the majority of high risk factors and foot disease items had the realistic 
possibility of being present or absent, and thus, could be suitably tested on each 
participant. Furthermore, it was thought this population should possess the moderate 
prevalence rates, yet unpredictable mixes and severities of each item, of different 
high risk factors and foot disease complications that are suggested in the literature to 
improve statistical robustness for validity and reliability studies [273]. 
Three different patient cohorts were used; one cohort to test the reliability of 
the criterion measures (agreement between 'experts’) (n = 32), another cohort to 
simultaneously test the criterion validity (an 'expert’ diagnosis against general 
clinicians) and inter-rater reliability (n = 43), and the last cohort to test the intra-rater 
reliability of a general clinician (n = 19). The recruitment of consecutive community 
patients did mean that patients may have been familiar to the level 3 or level 4 
clinicians; however, not to the expert 'gold standard’ clinicians working in the 
hospital setting. To minimise the risk of patients being familiar to the level 3 or level 
4 clinicians’ seven different Community HRFS clinics were used to recruit patient 
participants. The level 3 and level 4 clinicians had only worked at two of the seven 
clinics recruiting patients. 
 
Procedures 
A designated research assistant coordinated all procedures. Training of each 
clinician consisted of being provided with a QHRFF manual that gave a definition of 
each item [277], a 1–2 hour training session on instructions and tips to use the 
QHRFF tool, and each was encouraged to trial the tool on their existing patients and 
clarify any queries with the research assistant prior to testing. 
The general assessment procedure for each validity or reliability test consisted 
of patients having their feet examined by at least two different clinicians, blinded 
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from each other’s assessment, within the one clinical visit (validity and inter-rater 
reliability). However, to ensure all clinicians had an equal opportunity to determine 
the patient’s debridement and wound management needs, all were permitted to 
visually inspect the patient’s feet together for up to five minutes prior to any clinician 
ratings. In this initial inspection period, the clinicians were instructed to only visually 
inspect the need for debridement and previous wound dressings whilst not 
conversing with or touching the patient or each other. The order of clinician 
assessment after this inspection period was then at the discretion of the research 
assistant based on clinician availability. The first clinician would have the additional 
task of debriding the wound or callus if they deemed necessary and the last clinician 
the additional task of completing any clinical management. 
The research assistant ensured all clinicians were blinded from each other’s 
assessments in separate rooms and that all examination records were de-identified. 
Each clinician conducted the assessment of patient’s feet using the QHRFF to record 
their assessment and management recommendations. Demographic, medical history 
and medication information were available from the patients’ medical records or by 
direct communication with the patients themselves. To minimise assessment bias all 
historical foot-related records (including progress notes, DFF tools or QHRFFs tools) 
were removed from the medical record prior to each clinician’s assessment. 
 
Criterion measure 
The criterion measure was tested on the first cohort of patients. The criterion 
measure (i.e. 'gold standard’ diagnosis) for each QHRFF item in this study was 
defined by the authors as the diagnosis made by an expert clinician. Expert clinicians 
were pragmatically chosen as a general criterion measure for all items, instead of 
using multiple resource and time intensive individual gold standard-recognised 
criterion measures (such as nerve conduction studies for neuropathy), due to the 
resource and time constraints of the study. Best practice dictates that any criterion 
measure should be reliable, free from bias and measure the same item as the new tool 
[273]. Thus, the study’s criterion measure, of an expert clinician, required testing to 
determine its reliability, independence (free from bias) and applicability, prior to its 
use as a 'gold standard’ criterion measure in the criterion-related validity tests. The 
authors tested the criterion measure by testing the reliability of the agreement 
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between two independent (blinded from one another) experts (one level 6 and one 
level 5) to determine the magnitude of reliability of agreement on their 'gold 
standard’ diagnoses for each item on the same patient cohort. The “general 
assessment procedure” as described above was utilised for each patient. Once the 
criterion measure for each item was determined to be reliable, the criterion validity 
of each QHRFF item was tested. 
 
Criterion validity 
The criterion validity and inter-rated reliability was then tested simultaneously 
on a second cohort of patients. Criterion validity was tested using the concurrent 
criterion validity method by comparing the reliable criterion measure (one of the 
expert clinicians) against each of the two representative 'general’ clinicians (one level 
3 and one level 4). Thus, two separate criterion assessments were carried out for each 
item; one using the level 3 clinician against the criterion measure, and another the 
level 4 clinician against the criterion measure. Again the “general assessment 
procedure” as described above was utilised for each patient when testing for criterion 
validity. 
 
Inter-rater reliability 
Inter-rater reliability tests were performed simultaneously with the criterion 
validity tests on the same second cohort of patients and were tested using the expert 
clinician (level 5), senior clinician (level 4) and clinician (level 3). Thus, three inter-
rater reliability measures of agreements were carried out for each item; one testing 
the agreement between the level 5 and level 4 clinician, a second between the level 5 
and level 3 clinician, and a third between the level 4 and level 3 clinician. “General 
assessment procedures” as described above were again utilised for each patient when 
testing for inter-rater reliability. 
 
Intra-rater reliability 
Intra-rater reliability was tested on a third cohort of patients. The clinician with 
the least expertise (level 3) was used to test intra-rater reliability as it was 
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hypothesised that the clinician with the least expertise would have the most 
variability of the tested clinicians. The two different time points to test intra-rater 
reliability were between one and four weeks apart. This time period was chosen as it 
was considered that a minimum of one week (of full clinical load) would be 
necessary to adequately reduce recall bias in a clinician, plus, a maximum of four 
weeks would not be sufficient time for the majority of items to markedly change and 
thus items would remain stable between ratings. Any items that did not fit this 
criteria were excluded from intra-rater testing. Furthermore, this time period aligned 
with any necessary follow up treatment time period for patients, and thus, was 
convenient to patient participants. To control for any potential changes in foot ulcer 
characteristics over time (for example ulcer combined surface area and clinical signs 
of infection) digital images were used. Digital photographic images taken of foot 
ulcers at the first rating were used at the second rating to standardise the foot ulcer 
characteristics across two time points [278]. Images were taken perpendicular and 
30-60 cm away from ulcers at the first rating, and incorporated two calibrated 
measures across the length and width of the ulcer in the image. These images were 
reviewed by the clinician at the second rating to determine the foot ulcer 
characteristics only. 
 
Statistical analysis 
All data were analysed using SPSS 19.0 for Windows (SPSS Inc., Chicago, IL, 
USA) or GraphPad Software. Descriptive statistics were used to display the single 
demographic, medical co-morbidity, high-risk factors and foot disease variables for 
each cohort of patient participants; using means and standard deviations (SD) for 
continuous variables (which were normally distributed) or proportions for categorical 
variables. Each above descriptive cohort variable was collected from the clinician 
with most expertise or on the first rating of the intra-rater reliability cohort. Chi-
squared test of independence and ANOVA were used to test for differences between 
the three cohorts’ characteristics. A significance level of p < 0.05 was used 
throughout. 
All QHRFF items were tested for validity and reliability; except those stated 
items considered not to impact on the foot disease construct. Criterion validity was 
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tested by calculating sensitivity, specificity and positive predictive values. Ordinal 
variables were collapsed into dichotomous data to enable calculations of sensitivity, 
specificity and positive predictive values. All measures of agreements between 
clinicians were tested using Kappa (K) for dichotomous variables, weighted Kappa 
(wK) for ordinal variables and intra-class correlation (ICCs) (model 2, 1) for 
continuous variables [273, 279, 280]. Kappa and wK value (Standard Errors (SE)) 
strengths were categorised as: no agreement < 0; slight agreement = 0 – 0.20; fair 
agreement = 0.21 - 0.40; moderate agreement = 0.41 – 0.6; substantial 
agreement = 0.61 – 0.8; and near perfect agreement = 0.81 – 1.0 [273, 279, 280]. ICC 
(SD) strengths were categorised as: weak-moderate agreement < 0.75 and strong 
agreement > 0.75 [273]. 
 
4.5 RESULTS 
Phase one – development of the tool 
The literature search identified 174 papers that reported on tools to identify or 
measure foot disease complications and/or high-risk factors, with the majority of 
papers specifically relating to diabetes populations (90 (52%)). Tools reported in 
other populations were in conditions commonly identified in the literature to be 
associated with lower limb amputation [3, 9, 11, 175]. These included cardiovascular 
disease (peripheral arterial disease), chronic kidney disease, malignancy, infection 
and other neurological conditions [3, 9, 11, 175]. No tool was identified that was 
specifically designed to identify multiple high-risk factors and foot disease 
complications in multiple at risk populations. 
Fifty-nine individual tools were identified from the literature search; 23 were 
considered to have adequate practicality, face validity and applicability to an 
Australian clinical context to be considered for the QHRFF. These tools and the 
original DFF tool [271] were considered by the expert panel for QHRFF item 
selection. At this point, the expert panel determined that the tool should be divided 
into a clinical assessment record section that informed a separate data collection 
section, and thus, only the data collection section would require testing. 
Overall 87 items were initially identified from the considered tools. At the 
conclusion of phase one procedures the final endorsed QHRFF data collection tool 
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was made up of 46-items (excluding general identification items) covering seven 
domains (Figure 4-1 & Appendix E). The seven content domains included 
identifying general demographics, different health professionals attending, medical 
co-morbidity history, high-risk factor history, clinical diagnosis of high-risk factors, 
clinical diagnoses of foot disease complications, and clinical management principles 
performed. A QHRFF manual was developed to provide definitions and instructions 
on each item contained in the tool [277]. Table 4-1 outlines the tools or literature 
used to support each QHRFF item. At the conclusion of phase one, the expert panel 
concluded that the QHRFF tool’s items had the required high clinical practicality, 
applicability to multiple at risk populations, and good face and content validity. 
Subsequently, the tool was endorsed for use by the Queensland Health State-wide 
Diabetes, Renal and Podiatry Clinical Networks. Thus, the tool was ready for validity 
and reliability testing. 
   
Table 4-1:  Supporting tools or literature for QHRFF Items 
QHRFF Item Supporting tool or literature 
General Demographics* [277] 
Indigenous Status  [262] 
Health professionals attending* [262, 281] 
Medical co-morbidity history* [281, 282] 
Medical (diabetes) history [3, 9, 11, 175] 
Diabetes year diagnosed (duration)  [20, 283] 
Recent BGLs > 15mmol/L  [282, 283] 
HbA1c result  [282, 283] 
CKD [282, 284] 
ESRF [282, 284] 
High-risk factor history* [262, 277, 281] 
Clinical diagnoses of high-risk factors 
Neuropathy Monofilament test [259, 262, 265, 281, 285, 286] 
PAD  Foot pulses, ankle brachial index 
and/or toe systolic pressure [259, 262-264, 281, 287-290] 
Acute Charcot [262, 281] 
Foot deformity Six-point foot deformity scale [262, 291] 
Risk classification [262, 281, 292, 293] 
Clinical diagnoses of foot disease  
(Ulcer) Type  [262, 294, 295] 
Combined surface area mm
2
 [295-297] 
Combined surface area (change since last visit)  [296-300] 
Clinical signs of infection  [259, 295, 301, 302] 
UTWCS Grade  UTWCS tool [262, 303, 304] 
Ulcer Depth # [259, 262, 295] 
Clinical management principles performed*         [262, 281] 
*All items in this Domain cite the same references, unless otherwise stated; #Ulcer depth was not specifically an item recorded 
on the QHRFF, but can be directly extrapolated from the UTWCS Grade item. 
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Figure 4-1: Queensland High Risk Foot Form Data Collection Instrument 
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Phase two – validity and reliability 
Forty items were tested for validity and reliability unless otherwise stated. The 
items not tested were those considered not to impact on the foot disease construct; 
i.e. 'facility’, 'visit type’, 'todays visit to HRFS’, 'separation status’, and 'date of 
referral’. Table 4-2 displays the general demographic, medical co-morbidity history, 
high-risk factor history, clinical diagnoses of high-risk factors and foot disease 
complications variable prevalence for the three patient cohorts used. No significant 
differences were noted for these variables, except for diabetes duration and any other 
co-morbidity (p < 0.05). All cohorts contained variables with moderate prevalence 
rates (> 15%) [273], except for different health professionals attending previously, 
co-morbidity of end stage renal failure (ESRF), acute Charcot and ischaemic ulcers. 
 
Criterion measure 
Table 4-3 displays the reliability results for the criterion measure of expert 
clinicians. Thirty-two items were able to be statistically tested. Nine items (28%) 
recorded near perfect categories of agreement, nine (28%) substantial/strong 
categories, eleven (34%) moderate categories and three (9%) weak/fair categories. 
Thus, overall 29 (91%) of these items recorded at least a moderate category of 
reliability (K > 0.4; ICC > 0.75). The items recording weaker categories of reliability 
included other (non-listed) condition, University of Texas Wound Classification 
System (UTWCS) grade and optimum footwear. 
 
Criterion validity 
Tables 4-4 and 4-5 display the criterion validity results for both the senior 
(level 4) clinician and clinician (level 3) respectively tested against the criterion 
measure for each item. Thirty-six items were able to be statistically tested for 
sensitivity, specificity or positive predictive values (PPV) on both clinicians. Thus, 
72 different tests were each performed for sensitivity, specificity and PPV. Sixty-one 
(85%), 59 (82%) and 60 (83%) items recorded at least moderate categories (> 0.7) 
for sensitivity, specificity and PPV respectively. Conversely, three (8%), five (14%) 
and four (11%) out of the 36 items recorded weak categories (< 0.7) for sensitivity, 
specificity and PPV respectively on both clinicians tested. The items registering 
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weak categories of validity (sensitivity, specificity or PPV on both clinicians) 
included identifying a patient that had attended a GP, physician or surgeon; chronic 
kidney disease (CKD) or other (non-listed) condition; previous, current and new foot 
ulcer all had poor specificity in particular; and optimum footwear had poor PPVs. 
 
Inter-rater reliability 
Tables 4-4 – 4-6 display the inter-rater reliability results for all three tests. 
Ninety-six different tests were able to be statistically tested for inter-rater reliability 
across the three different pairs of clinician agreement. Twenty four items (25%) 
recorded near perfect categories of agreement, 43 (45%) substantial/strong 
categories, 17 (18%) moderate categories and 12 (12%) weak/fair categories. Thus, 
overall 84 (88%) of these items recorded at least moderate categories of reliability 
(K > 0.4; ICC > 0.75). The items recording weak categories of reliability across two 
or more agreements tested included other (non-listed) condition, previous foot ulcer 
and optimum footwear. 
 
Intra-rater reliability 
Table 4-6 also displays the intra-rater reliability results for the level 3 clinician. 
The median (interquartile range) period between the first and second ratings for the 
intra-rater reliability testing was 2 (1–2) weeks. Twenty-three items were able to be 
statistically tested. Six items (26%) recorded near perfect categories of agreement, 
ten (43%) substantial/strong categories, four (17%) moderate categories and three 
(13%) weak/fair categories. Thus, overall 20 (87%) of these items recorded at least a 
moderate category of reliability (K > 0.4; ICC > 0.75). Those items scoring weak 
categories of agreement were foot deformity, optimal offloading and optimal 
footwear. 
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Table 4-2:  Demographic, co-morbidity and high-risk foot complication data for 
each patient cohort (n (%) unless otherwise stated) 
 Criterion  
Measure 
Criterion validity*  
& Inter-rater reliability* 
Intra-rater  
reliability 
p Value 
General demographics     
Numbers  32 43 19  
Male  25 (78%) 37 (86%) 17 (90%) 0.501 
Age, mean (SD) (years) # 69 (13) 68 (13) 70 (15) 0.826 
Age range (years) 48 – 90 36 – 89 42 – 90  
Indigenous  1 (3%) 0 (0%) 1 (5%) NA 
Health professionals attending (in the past week)  
Podiatrist 32 (100%) 43 (100%) 19 (100%) 1.000 
GP 2 (6%) 10 (23%) 2 (11%) 0.103 
Nurse 3 (9%) 12 (28%) 4 (21%) 0.141 
Orthotist 0  0 0 NA 
Physician 2 (6%) 1 (2%) 1 (5%) NA 
Surgeon 1 (3%) 3 (7%) 0 NA 
Other 0 0 0 NA 
Medical co-morbidity history      
Diabetes (type 1 or 2)  28 (88%) 35 (81%) 16 (84%) 0.384 
Type 2 Diabetes  28 (88%) 31 (72%) 14 (74%) 0.256 
Diabetes duration (years) # 12 (7) 23 (11) 20 (14) 0.001** 
Recent BGLs > 15mmol/L  5 (16%) 4 (9%) 5 (26%) 0.220 
HbA1c (SD) # 9.2 (3.5) 8.1 (1.6) 8.4 (2.7) 0.450 
Hypertension 28 (88%) 30 (70%) 11 (58%) 0.053 
Dyslipidaemia 23 (72%) 25 (58%) 9 (47%) 0.201 
Smoker 5 (16%) 11 (26%) 3 (16%) 0.492 
CVD 21 (66%) 21 (49%) 9 (47%) 0.281 
CKD 5 (16%) 13 (30%) 5 (26%) 0.339 
ESRF 0 1 (2%) 0 NA 
Other (non-listed) 29 (91%) 36 (84%) 11 (58%) 0.013** 
High-risk history   
Neuropathy 31 (97%) 37 (86%) 18 (95%) 0.214 
PAD 14 (44%) 21 (49%) 8 (42%) 0.853 
Previous foot ulcer 27 (84%) 37 (86%) 17 (90%) 0.878 
Current foot ulcer 32 (100%) 42 (98%) 19 (100%) 0.549 
New foot ulcer 21 (66%) 42 (98%) 19 (100%) < 0.001** 
Previous amputation 16 (50%) 17 (40%) 7 (37%) 0.566 
Clinical diagnoses of high-risk factors 
Neuropathy 31 (97%) 38 (88%) 19 (100%) 0.146 
Any PAD  14 (44%) 22 (51%) 8 (42%) 0.735 
Acute Charcot 1 (3%) 1 (2%) 0 NA 
Foot Deformity 26 (81%) 33 (77%) 17 (90%) 0.501 
Acute Risk Classification 32 (100%) 42 (98%) 19 (100%) 0.549 
Clinical diagnoses of foot disease 
Ulcer type: Neuropathic 14 (44%) 14 (33%) 8 (42%) 0.572 
Ulcer type: Neuroischaemic 9 (28%) 16 (37%) 8 (42%) 0.555 
Ulcer type: Ischaemic 0 3 (7%) 1 (5%) NA 
Ulcer type: Other 9 (28%) 9 (21%) 2 (11%) 0.339 
Combined surface area (mm
2
)# 122 (191) 352 (899) 379 (1436) 0.469 
Any clinical infection  6 (19%) 14 (33%) 2 (11%) 0.125 
UTWCS (Grade 1A) 13 (41%) 14 (33%) 7 (37%) 0.770 
Deep ulcer (Grade 2 or 3)^ 8 (25%) 6 (14%) 2 (11%) 0.394 
*= Same participants used for three tests;  **= Statistically significant (p < 0.05);  # = Measure in mean (standard deviation);   
^ = Deep ulcer determined from the UTWCS Grade item;  NA = Not applicable to test as the assumption of Chi-squared test is 
violated as 2 cells had expected counts of < 5. 
GP = General Practitioner; CVD = Cardiovascular Disease; ESRF = End Stage Renal Failure; PAD = Peripheral Arterial 
Disease; UTWCS = University of Texas Wound Classification System 
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Table 4-3:  Criterion measure reliability – Measure of agreement between gold 
standard experts 
QHRFF Item % K (SE) 
 
Strength of  
Agreement [280] 
General demographics   
Indigenous Status *  77.4 0.45 (0.17) Moderate 
Health professionals attending (in the past week) 
Podiatrist 96.9 -- -- 
GP 81.2 0.78 (0.21) Substantial 
Nurse 84.4 0.47 (0.18) Moderate 
Orthotist 100 -- -- 
Physician 96.9 0.78 (0.21) Substantial 
Surgeon 100 1.00 (0.01) Near Perfect 
Other 100 -- -- 
Medical co-morbidity history   
Medical (diabetes) history 100 1.00 (0.01) Near Perfect 
Diabetes duration #  0.94 (0.88–0.98) Strong 
Recent BGLs > 15mmol/L*  90.6 0.81 (0.11) Near Perfect 
HbA1c result #  0.93 (0.79–0.98) Strong 
Hypertension 87.5 0.60 (0.17) Moderate 
Dyslipidaemia 75.0 0.46 (0.16) Moderate 
Smoker 96.9 0.89 (0.11) Near Perfect 
CVD 93.8 0.86 (0.10) Near Perfect 
CKD 100 1.00 (0.01) Near Perfect 
ESRF 96.9 -- -- 
Other (non-listed) 46.9 0.04 (0.09) Slight 
High-risk history  
Neuropathy 93.8 0.48 (0.31) Moderate 
PAD 84.4 0.68 (0.13) Substantial 
Previous foot ulcer 84.4 0.45 (0.21) Moderate 
Current foot ulcer 96.9 -- -- 
New foot ulcer 83.9 0.58 (0.15) Moderate 
Previous amputation 90.6 0.81 (0.10) Near Perfect 
Clinical diagnoses of high-risk factors  
Neuropathy 96.9 0.65 (0.32) Substantial 
PAD * 77.4 0.61 (0.12) Substantial 
Acute Charcot 100 1.00 (0.01) Near Perfect 
Foot deformity 81.3 0.46 (0.19) Moderate 
Risk classification * 96.8 -- -- 
Clinical diagnoses of foot disease  
Ulcer type * 87.5 0.85 (0.08) Near Perfect 
Combined surface area mm
2
 #  0.73 (0.52-0.86) Moderate 
Clinical signs of infection * 84.3 0.68 (0.15) Substantial 
UTWCS grade #  0.56 (0.28–0.76) Weak-Moderate 
Ulcer depth ^ 78.1 0.67 (0.13) Substantial 
Clinical management principles performed  
Debrided ulcer/callus *  93.8 -- -- 
Dressing optimum * 96.9 -- -- 
Antibiotics required *  84.4 0.47 (0.19) Moderate 
Off-loading optimum * 68.8 0.41 (0.14) Moderate 
Footwear optimum * 65.6 0.28 (0.16) Fair 
Educated patient * 100 -- -- 
K = Kappa; (SE) = Standard Error; % = Percentage agreement;  -- = Measure of agreement was unable to be calculated because 
at least one variable was a constant.  GP = General Practitioner; CVD = Cardiovascular Disease; ESRF = End Stage Renal 
Failure; PAD = Peripheral Arterial Disease; UTWCS = University of Texas Wound Classification System;  *= Weighted Kappa 
used for ordinal data;  # = Intraclass correlation (ICC) (Standard Deviation (SD)) for continuous data; ^ = Depth was 
determined from the UTWCS score. 
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Table 4-4:  Criterion validity summary statistics for Senior Clinician (Sensitivity, Specificity and Positive Predictive Value) & Inter-rater 
reliability between Expert and Senior Clinicians (Kappa and Strength of Agreement) 
QHRFF Field % K (SE) 
 
Strength of  
Agreement [280] 
Sensitivity 
(95% CI) 
Specificity 
(95% CI) 
PPV 
(95% CI) 
General demographics       
Any Indigenous Status  100 -- -- -- 1.00 (0.90-1.00) -- 
Health professionals attending (in the past week)    
Podiatrist 100 -- -- 1.00 (0.90-1.00) -- 1.00 (0.90-1.00) 
GP 86.0 0.64 (0.14)  Substantial 0.80 (0.44-0.96) 0.88 (0.71-0.96) 0.67 (0.35-0.88) 
Nurse 93.0 0.83 (0.09)  Near Perfect 0.92 (0.60-1.00) 0.94 (0.77-0.99) 0.85 (0.54-0.97) 
Orthotist 100 -- -- -- 1.00 (0.90-1.00) -- 
Physician 93.0 -- -- 0 (0 – 0.95) 0.95 (0.83-0.99) 0 (0 – 0.80) 
Surgeon 95.3 0.64 (0.24)  Substantial 0.67 (0.13-0.98) 0.98 (0.85-1.00) 0.67 (0.13-0.98) 
Other 100 -- -- -- 1.00 (0.90-1.00) -- 
Medical co-morbidity history     
Any medical (diabetes) history  100 1.00 (0.01) Near Perfect 1.00 (0.88-1.00) 1.00 (0.60-1.00) 1.00 (0.88-1.00) 
Diabetes duration #  0.90 (0.80– 0.95) Strong    
Recent BGLs > 15mmol/L  93.0 0.69 (0.16) Substantial 0.57 (0.20-0.88) 1.00 (0.88-1.00) 1.00 (0.40-1.00) 
HbA1c result #  1.00 (0.99–1.00) Strong    
Hypertension 93.0 0.83 (0.09)  Near Perfect 0.97 (0.81-1.00) 0.85 (0.54-0.97) 0.94 (0.77-0.99) 
Dyslipidaemia 95.3 0.90 (0.07)  Near Perfect 0.96 (0.78-1.00) 0.94 (0.71-1.00) 0.96 (0.78-1.00) 
Smoker 90.7 0.72 (0.13)  Substantial 0.64 (0.32-0.88) 1.00 (0.87-1.00) 1.00 (0.56-1.00) 
CVD 90.7 0.81 (0.09)  Near Perfect 0.86 (0.63-0.96) 0.95 (0.75-1.00) 0.95 (0.72-1.00) 
CKD 81.4 0.49 (0.15)  Moderate 0.46 (0.20-0.74) 0.97 (0.81-1.00) 0.86 (0.42-0.99) 
ESRF 1.00 1.00 (0.01) Near Perfect 1.00 (0.05-1.00) 1.00 (0.90-1.00) 1.00 (0.05-1.00) 
Other (non-listed) 57.1 0.09 (0.12)  Slight 0.57 (0.40-0.73) 0.57 (0.20-0.88) 0.87 (0.65-0.97) 
High-risk history     
Neuropathy 93.0 0.73 (0.15)  Substantial 0.95 (0.80-0.99) 0.83 (0.36-0.99) 0.97 (0.84-1.00) 
PAD  88.4 0.77 (0.10)  Substantial 0.86 (0.63-0.96) 0.91 (0.69-0.98) 0.90 (0.67-0.98) 
Previous foot ulcer 79.1 0.28 (0.18)  Fair 0.84 (0.67-0.93) 0.50 (0.14-0.86) 0.91 (0.75-0.98) 
Current foot ulcer 95.3 -- -- 0.98 (0.86-1.00) 0 (0 – 0.95) 0.98 (0.86-1.00) 
New foot ulcer 93.0 -- -- 0.95 (0.82-0.99) 0 (0 – 0.95) 0.98 (0.86-1.00) 
Previous amputation 97.7 0.95 (0.05)  Near Perfect 0.94 (0.69-1.00) 1.00 (0.84-1.00) 1.00 (0.76-1.00) 
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Clinical diagnoses of high-risk factors    
Neuropathy 97.7 0.90 (0.10)  Near Perfect 0.97 (0.85-1.00) 1.00 (0.46-1.00) 1.00 (0.88-1.00) 
Any PAD  93.0 0.86 (0.8) Near Perfect 0.91 (0.69-0.98) 0.95 (0.74-1.00) 0.95 (0.74-1.00) 
Acute Charcot 100 1.00 (0.01) Near Perfect 1.00 (0.05-1.00) 1.00 (0.90-1.00) 1.00 (0.05-1.00) 
Foot deformity 86.0 0.51 (0.16)  Moderate 1.00 (0.87-1.00) 0.4 (0.14-0.73) 0.85 (0.69-0.94) 
Acute risk classification 97.7 -- -- 1.00 (0.90-1.00) 0 (0 – 0.95) 0.98 (0.86-1.00) 
Clinical diagnoses of foot disease     
Ulcer type: Neuropathic 
(Neuropathic or neuroisch.) 
90.7 0.76 (0.11) Substantial 0.88 (0.72-0.96) 1.0 (0.63-1.00) 1.00 (0.86-1.00) 
Ulcer type: Ischaemic 
(Neuroisch. or ischaemic) 
79.1 0.58 (0.13) Moderate 0.75 (0.51-0.90) 0.83 (0.60-0.94) 0.79 (0.54-0.93) 
Combined surface area mm
2
 #  0.93 (0.87–0.96)  Strong    
Any clinical infection  88.4 0.72 (0.12) Substantial 0.71 (0.42-0.90) 0.97 (0.80-1.00) 0.91 (0.57-1.00) 
UTWCS (Grade 1A) 83.7 0.65 (12) Substantial 0.85 (0.56-0.97) 0.83 (0.64-0.93) 0.71 (0.44-0.89) 
Deep ulcer  
(Grade 2 or 3) ^ 
95.3 0.81 (0.13) Near Perfect 0.71 (0.30-0.95) 0.97 (0.84-1.00) 0.83 (0.36-0.99) 
Clinical management principles performed    
Ulcer debridement is required 95.3 0.66  (0.01) Substantial 1.00 (0.89-1.00) 1.00 (0.20-1.00) 1.00 (0.89-1.00) 
Dressing is optimum  100 -- -- 1.00 (0.90-1.00) -- 1.00 (0.90-1.00) 
Antibiotics are required 93.0 0.82 (0.10) Near Perfect 0.83 (0.51-0.97) 0.94 (0.77-0.99) 0.83 (0.51-0.97) 
Off-loading is optimum  93.0 0.80 (0.11) Substantial 0.80 (0.44-0.96) 0.97 (0.82-1.00) 0.89 (0.51-0.99) 
Footwear is optimum  72.1 0.31 (0.16) Fair 0.50 (0.20-0.80) 0.82 (0.64-0.92) 0.45 (0.18-0.75) 
Educated patient  97.7 -- -- 0.98 (0.86-1.00) --  1.00 (0.90-1.00) 
K = Kappa; (SE) = Standard Error; % = Percentage agreement; PPV = Positive Predictive Value;  -- = Measure of agreement was unable to be calculated because at least one variable was a constant;  GP = General 
Practitioner; CVD = Cardiovascular Disease; ESRF = End Stage Renal Failure; PAD = Peripheral Arterial Disease; UTWCS = University of Texas Wound Classification System; # = Intraclass correlation (ICC) 
(Standard Deviation (SD)) for continuous data;  ^ = Depth was determined from the UTWCS score. 
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Table 4-5:  Criterion validity summary statistics for Clinician (Sensitivity, Specificity and Positive Predictive Value) & Inter-rater reliability 
between Expert and Clinician (Kappa and Strength of Agreement) 
QHRFF Field % K (SE) 
 
Strength of 
Agreement [280] 
Sensitivity 
(95% CI) 
Specificity 
(95% CI) 
PPV 
(95% CI) 
General demographics       
Any Indigenous Status  100 -- -- -- 1.00 (0.90-1.00) -- 
Health professionals attending (in the past week)    
Podiatrist 88.4 -- -- 0.88 (0.74-0.96) -- 0.88 (0.74-0.96) 
GP 81.4 0.39 (0.17) Fair 0.40 (0.14-0.73) 0.94 (0.78-0.99) 0.67 (0.24-0.94) 
Nurse 79.1 0.37 (0.16) Fair 0.33 (0.11-0.65) 0.97 (0.81-1.00) 0.80 (0.30-0.99) 
Orthotist 100 -- -- -- 1.00 (0.90–1.00) -- 
Physician 97.6 0.66 (0.32)  Substantial 1.00 (0.05-1.00) 0.98 (0.86-1.00) 0.50 (0.03-0.97) 
Surgeon 90.7 0.45 (0.23)  Moderate 0.67 (0.13-0.98) 0.93 (0.79-0.98) 0.40 (0.07-0.83) 
Other 100 -- -- -- 0.98 (0.86-1.00) -- 
Medical co-morbidity history    
Any medical (diabetes) history 100 100 (0.01) Near Perfect 1.00 (0.88-1.00) 1.00 (0.60-1.00) 1.00 (0.88-1.00) 
Diabetes duration #  0.95 (0.90–0.97) Strong    
Recent BGLs > 15mmol/L   90.7 0.62 (0.17) Substantial 1.00 (0.40-1.00) 0.90 (0.75-0.97) 0.50 (0.17-0.83) 
HbA1c result #  1.00 (0.99–1.00) Strong    
Hypertension 86.0 0.68 (0.12)  Substantial 0.87 (0.68-0.96) 0.85 (0.54-0.97) 0.93 (0.75-0.99) 
Dyslipidaemia 79.1 0.58 (0.12)  Moderate 0.76 (0.54-0.90) 0.83 (0.58-0.96) 0.86 (0.64-0.96) 
Smoker 88.4 0.69 (0.13)  Substantial 0.73 (0.39-0.93) 0.94 (0.78-0.99) 0.80 (0.44-0.96) 
CVD 79.1 0.58 (0.12)  Moderate 0.71 (0.48-0.88) 0.86 (0.64-0.96) 0.83 (0.58-0.96) 
CKD 86.0 0.65 (0.13)  Substantial 0.69 (0.39-0.90) 0.93 (0.76-0.99) 0.82 (0.48-0.97) 
ESRF 97.7 0.66 (0.32)  Substantial 1.00 (0.05-1.00) 0.98 (0.86-1.00) 0.50 (0.03-0.97) 
Other (non-listed) 79.1 0.19 (0.19) Slight 0.89 (0.73-0.96) 0.29 (0.05-0.7) 0.86 (0.70-0.95) 
High-risk history     
Neuropathy 93.0 0.73 (0.15)  Substantial 0.95 (0.80-0.99) 0.83 (0.36-0.99) 0.97 (0.84-1.00) 
PAD  86.0 0.72 (0.10)  Substantial 0.76 (0.52-0.91) 0.95 (0.75-1.00) 0.94 (0.69-1.00) 
Previous foot ulcer 79.1 0.28 (0.18)  Fair 0.84 (0.67-0.93) 0.50 (0.14-0.86) 0.91 (0.75-0.98) 
Current foot ulcer 97.7 -- -- 1.00 (0.90-1.00) 0 (0 – 0.95) 0.98 (0.86-1.00) 
New foot ulcer 97.4 -- -- 0.90 (0.76-0.97) 0 (0 – 0.95) 0.97 (0.85-0.99) 
Previous amputation 95.3 0.90 (0.07)  Near Perfect 0.88 (0.62-0.98) 1.00 (0.84-1.00) 1.00 (0.75-1.00) 
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Clinical diagnoses of high-risk factors    
Neuropathy 100 1.00 (0.01)  Near Perfect 1.00 (0.89-1.00) 1.00 (0.46-1.00) 1.00 (0.89-1.00) 
Any PAD  95.3 0.91 (0.06) Near Perfect 0.91 (0.69-0.98) 1.00 (0.81-1.00) 1.00 (0.80-1.00) 
Acute Charcot 100 1.00 (0.01)  Near Perfect 1.00 (0.05-1.00) 1.00 (0.90-1.00) 1.00 (0.05-1.00) 
Foot deformity 93.0 0.80 (0.11) Substantial 0.97 (0.82-1.00) 0.80 (0.44-0.96) 0.94 (0.79-0.99) 
Acute Risk Classify 97.7 -- -- 1.00 (0.90-1.00) 0 (0 – 0.95) 0.98 (0.86-1.00) 
Clinical diagnoses of foot disease     
Ulcer type: Neuropathic 
(Neuropathic or neuroisch.) 
83.7 0.55 (0.14) Moderate 1.00 (0.86-1.00) 0.46 (0.20-0.74) 0.81 (0.64-0.91) 
Ulcer Type is Ischaemic 
(Neuroisch. or ischaemic) 
79.1  0.57 (0.13) Moderate 0.74 (0.48-0.90) 0.83 (0.62-0.95) 0.78 (0.52-0.93) 
Combined surface area mm
2
#  0.99 (0.99–1.00) Strong    
Any clinical infection   81.4 0.58 (0.13) Moderate 0.71 (0.42-0.90) 0.86 (0.67-0.95) 0.71 (0.42-0.90) 
UTWCS (Grade 1A) 81.4 0.61 (0.12) Substantial 0.86 (0.56-0.97) 0.79 (0.60-0.91) 0.69 (0.41-0.86) 
Deep ulcer (Grade 2 or 3)  93.0 0.73 (0.15) Substantial 0.71 (0.30-0.95) 0.97 (0.84-1.00) 0.83 (0.36-0.99) 
Clinical management principles performed     
Ulcer debridement is required 95.3 0.39 (0.22) Fair 1.00 (0.89-1.00) 0.50 (0.03-0.97) 0.98 (0.86-1.00) 
Dressing is optimum  97.7 -- -- 0.98 (0.86-1.00) -- 1.00 (0.90-1.00) 
Antibiotics are required 90.7 0.76 (0.11) Substantial 0.75 (0.43-0.93) 0.97 (0.81-1.00) 0.90 (0.54-0.99) 
Off-loading is optimum  79.1 0.50 (0.14) Moderate 0.80 (0.44-0.96) 0.79 (0.60-0.90) 0.53 (0.27-0.78) 
Footwear is optimum  79.1 0.47 (0.15) Moderate 0.70 (0.35-0.92) 0.82 (0.64-0.92) 0.54 (0.26-0.80) 
Educated patient  100 -- -- 1.00 (0.90-1.00) -- 1.00 (0.90-1.00) 
K = Kappa; (SE) = Standard Error; % = Percentage agreement; PPV = Positive Predictive Value;  -- = Measure of agreement was unable to be calculated because at least one variable was a constant;  GP = General 
Practitioner; CVD = Cardiovascular Disease; ESRF = End Stage Renal Failure; PAD = Peripheral Arterial Disease; UTWCS = University of Texas Wound Classification System; *= Weighted Kappa used for ordinal 
data;  # = Intraclass correlation (ICC) (Standard Deviation (SD)) for continuous data; ^ = Depth was determined from the UTWCS score. 
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Table 4-6:  Reliability measure of agreement summary statistics: Inter-rater (Senior clinician & clinician) & Intra-rater (Clinician)  
 Inter-rater reliability Intra-rater reliability 
QHRFF Field % K (SE) 
 
Strength of  
Agreement [280] 
% K (SE) 
 
Strength of  
Agreement [280] 
General demographics        
Indigenous Status *  83.7 -- -- 100 1.00 (0.01) Near Perfect 
Health professionals attending (in the past week)    
Podiatrist 88.4 -- -- N/A N/A N/A 
GP 81.4 0.45 (0.15) Moderate N/A N/A N/A 
Nurse 81.4 0.47 (0.14)  Moderate N/A N/A N/A 
Orthotist 100 -- -- N/A N/A N/A 
Physician 90.7 -- -- N/A N/A N/A 
Surgeon 90.7 0.45 (0.23) Moderate N/A N/A N/A 
Other 97.7 -- -- N/A N/A N/A 
Medical co-morbidity history     
Medical (diabetes) history 95.3 0.94 (0.05) Near Perfect 100 1.00 (0.01) Near Perfect 
Diabetes duration #  0.94 (0.87–0.97) Strong  1.00 (0.99–1.00) Strong 
Recent BGLs >15mmol/L*  83.7 0.67 (0.12) Substantial N/A N/A N/A 
HbA1c result #  1.00 (1.00–1.00) Strong  1.00 (1.00–1.00)  
Hypertension 88.4 0.73 (0.11)  Substantial 89.5 0.78 (0.15) Substantial 
Dyslipidaemia 83.7 0.67 (0.11)  Substantial 94.7 0.90 (0.10) Near Perfect 
Smoker 88.4 0.64 (0.15)  Substantial 94.7 0.83 (0.17) Near Perfect 
CVD 88.4 0.76 (0.10)  Substantial 84.2 0.69 (0.17) Substantial 
CKD 86.1 0.58 (0.15) Moderate 94.7 0.86 (0.14) Near Perfect 
ESRF 97.7 0.66 (0.32)  Substantial 100 -- -- 
Other (non-listed) 69.1 0.34 (0.11)  Fair 78.9 0.57 (0.19) Moderate 
High-risk history     
Neuropathy 90.7 0.66 (0.16)  Substantial 94.7 -- -- 
PAD 83.7 0.67 (0.11)  Substantial 78.9 0.60 (0.16) Moderate 
Previous foot ulcer 90.7 0.72 (0.13)  Substantial 94.7 0.64 (0.33) Substantial 
Current foot ulcer 97.7 -- -- 100 -- -- 
New foot ulcer 97.4 -- -- 100 -- -- 
Previous amputation 97.7 0.95 (0.05) Near Perfect 100 1.00 (0.01) Near Perfect 
Clinical diagnoses of high-risk factors     
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Neuropathy 97.7 0.90 (0.10) Near Perfect 94.7 -- -- 
PAD * 97.9 0.97 (0.03) Near Perfect 84.2 0.69 (0.16) Substantial 
Acute Charcot 100 1.00 (0.01) Near Perfect 100 -- -- 
Foot deformity 83.7 0.38 (0.18) Fair 84.2 0.31 (0.30) Fair 
Risk classification 100 -- -- 100 -- -- 
Clinical diagnoses of foot disease     
Ulcer type * 88.4 0.81 (0.08) Near Perfect 84.2 0.77 (0.14) Substantial 
Combined surface area mm
2
#  0.94 (0.89–0.97) Strong  1.00 (1.00–1.00) Strong 
Clinical signs infection * 76.7 0.60 (0.12)  Moderate 89.5 0.46 (0.32) Moderate 
UTWCS grade #  0.90 (0.83–0.95) Strong  0.98 (0.94–0.99) Strong 
Ulcer depth ^ 95.3 0.90 (0.10) Near Perfect 94.7 0.79 (0.23) Substantial 
Clinical management principles performed     
Debrided ulcer/callus *  97.7 0.66 (0.32)  Substantial 94.7 -- -- 
Dressing optimum * 97.7 -- -- 100 -- -- 
Antibiotics required *  79.1 0.54 (0.12) Moderate 89.5 0.44 (0.33) Moderate 
Off-loading optimum * 72.1 0.36 (0.13) Fair 68.4 0.32 (0.23) Fair 
Footwear optimum * 67.4 0.33 (0.14) Fair 68.4 0.37 (0.21) Fair 
Educated patient * 97.7 -- -- 89.5 -- -- 
K = Kappa; (SE) = Standard Error; -- = Measure of agreement was unable to be calculated because at least one variable was a constant; GP = General Practitioner; CVD = Cardiovascular Disease; ESRF = End Stage 
Renal Failure; N/A = Not applicable due to unstable rating environment; PAD = Peripheral Arterial Disease; UTWCS = University of Texas Wound Classification System; *= Weighted Kappa used for ordinal data;  
# = Intraclass correlation (ICC) (Standard Deviation (SD)) for continuous data; ^ = Depth was determined from the UTWCS score. 
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4.6 DISCUSSION 
The QHHRF appears to be the first multi-item tool developed and tested to 
identify multiple high-risk factors and foot disease complications in multiple at risk 
populations. Our findings indicate that the majority of the tool’s items demonstrates 
at least moderate categories of validity (face, content and criterion validity) and 
reliability (inter-rater and intra-rater); particularly those in the domains of identifying 
relevant medical co-morbidity history, and clinical diagnoses of high-risk factors and 
foot disease complications. However, some items in the domains of identifying 
different health professionals previously attending the patient and general clinical 
management principles performed appear to have weaker categories of validity and 
reliability that need addressing in future versions of the tool. 
The QHRFF went through a number of developmental, validity and reliability 
tests to determine its status as a valid and reliable tool. The magnitude of validity (or 
accuracy) in this study was evaluated via the methods of face, content and 
importantly criterion validity. Face and content validity are considered the least 
robust of the validity tests due to their inherent subjectivity [273, 275]. However, 
they are considered important factors in the development phase to ensure the tool can 
actually measure the general identified construct [273, 275]; in this case foot disease. 
At the completion of phase one, the expert panel and network stakeholders 
endorsements implied high practicality, face and content validity. 
Criterion validity is considered to be the most objective validity test [273, 275]. 
To test concurrent criterion validity, as used by this study, a satisfactory criterion 
measure must be used. In this study the criterion measure to test criterion validity 
was an expert’s clinical diagnosis. Overall, the 'expert’ criterion measures used for 
this study were rated as having at least moderate categories of reliability for all but 
three items; any other (non-listed) co-morbidity, optimum footwear and UTWCS 
grade. The other (non-listed) co-morbidity and optimum footwear items rated in the 
weak categories in most other inter- or intra-rater reliability agreement tested and 
should be reviewed or removed in future versions of the QHRFF. The weak-
moderate agreement between experts for the UTWCS grade was somewhat 
unexpected as this tool has been validated in one previous well-known study [303] 
and is arguably the most used foot ulcer classification tool across the world [262]. 
However, although the agreement between experts was weak, all other inter- and 
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intra-rater agreements on the UTWCS were rated as having substantial/strong 
categories of reliability. Thus, it is recommended that the UTWCS grade be retained 
in future with more emphasis applied on the UTWCS grading system in the training 
sessions provided to help improve the reliability of completion. It is certainly 
possible that the criterion measure for each item may have been more robust if the 
individual gold standard test for each individual item were used; for example an 
angiogram to diagnose peripheral arterial disease [263] or nerve conduction studies 
to diagnose neuropathy [286]. However, such an approach would have been 
particularly resource and time intensive and was thus not practical within the 
resources available to this study. 
The QHRFF items were tested for concurrent criterion validity by using two 
different blinded representative general clinicians’ ratings compared to the criterion 
measure (a reliable expert’s diagnosis) on the same patients. Positive predictive 
values from this testing indicated the majority of QHRFF items had at least moderate 
validity when used by clinicians with different levels of expertise. The high positive 
predictive values suggest that the proportion of people with a positive test result for 
individual QHRFF items actually had the relevant medical co-morbidity, high-risk 
factor or foot disease complication of interest. Although there were a few notable 
exceptions such as identifying different health professionals attending previously, 
recent blood glucose levels (BGLs) > 15 mmol/L, ESRF, optimal offloading and 
optimum footwear. However, overall the QHRFF tool appears to demonstrate 
acceptable validity in the majority of its items to be considered a valid tool to test the 
foot disease construct in multiple at risk populations. 
Reliability (or consistency) is a major prerequisite of any useful items to be 
measured [273, 275]. In this study inter-rater and intra-rater measures of agreement 
were used for reliability. Inter-rater reliability was primarily assessed using three 
clinicians with different representative levels of expertise in managing foot disease. 
Overall, all items consistently displayed at least moderate categories of reliability, 
except for any other (non-listed) co-morbidity, optimum footwear and previous foot 
ulcer. Optimum footwear was also identified to have weak categories of intra-rater 
reliability; along with identifying foot deformity and optimum offloading. Thus, the 
QHRFF tool appears to demonstrate satisfactory reliability to collect the majority of 
items in the foot disease construct. However, the authors recognise that it would have 
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been preferable to test reliability with more clinicians across a larger sample of 
patients, yet this was beyond the resourcing available for this study. 
Notwithstanding, the aforementioned methodological limitations, the study 
does incorporate many best practice research design methods for testing validity and 
reliability. These methods included testing the reliability of the criterion measure to 
diagnose and measure each item, testing the subsequent concurrent criterion validity 
of representative clinicians, and testing the reliability of the tool when used by 
clinicians with different levels of expertise. Furthermore, the study employed patient 
samples that were highly representative of the demographics and co-morbidity 
prevalence rates found in multiple 'at risk’ populations for high risk factors and foot 
disease complications. These high prevalence rates not only suggest the tool was 
tested in the construct it was designed to measure, but literature suggests higher 
prevalence rates improve the statistical robustness of validity and reliability results 
[273]. Lastly, many existing validated single-item tools [265, 287, 301, 303] were 
incorporated within the QHRFF tool and this potentially adds weight to the validity 
reported in this study. Thus, overall the QHRFF tool appears to be a valid and 
reliable tool to collect the vast majority of items contained within the foot disease 
construct and can be used as a general tool to complement existing specific tools in 
the field of foot disease. 
 
Limitations 
Several limitations have already been outlined in this study including the use of 
a general criterion measure of experts’ clinical diagnoses for each item, only using a 
limited number of representative clinicians and testing intra-rater reliability on one 
clinician in a small sample. Other limitations include: not performing a systematic 
literature review and thus some evidence based items and tools may have been 
overlooked; using an expert panel that contained predominantly diabetic foot disease 
experts; using foot infection criteria that have had questionable reliability in 
excluding acute Charcot foot; using only podiatrists as the clinical raters; potential 
observer bias occurring as the raters were aware of the reason for testing the tool and 
that they were being observed; using historically defined strength categories for 
validity and reliability; not testing the tool for construct validity, predictive validity, 
or factor analysis; and the settings used were existing HRFS only. It is recommended 
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that any future research into this tool should address these methodological limitations 
by investigating the factor analysis, construct and predictive criterion validity of the 
tool’s items in a much larger and broader sample of patients with more multi-
disciplinary clinician raters. Furthermore, if resources permit, the use of individual 
gold standard criterion measures and/or existing concurrent validated single-item 
tools should be considered. 
However, there are a number of recommendations from this study’s findings 
that should be considered for implementation in future versions of the QHRFF tool. 
Firstly, those items reporting weaker categories of validity or reliability and that 
potentially collect duplicate information to other more reliable items should be 
removed; including any other (non-listed) co-morbidity, combined surface area 
(change), recent BGLs greater than 15 mmol/L and new ulcer. Secondly, some items’ 
definitions should be reviewed in an attempt to improve the item’s future reliability 
and validity. For example, previous foot ulcer definition could be modified to 
identify a previously “healed” foot ulcer, 'health professionals attending’ previously 
requires an exact retrospective time period that patients were in attendance in 
alignment with similar literature (such as “in the previous two weeks”) [97, 305] and 
optimum offloading should have a more explicit definition referring directly to non-
removable offloading definitions in the existing literature [262]. Thirdly, the 
validation of criteria for identifying a foot deformity and optimum footwear are 
urgently required for these 'at risk’ populations. To the best of the author’s 
knowledge such tools for these items have been developed [262, 291] yet are to be 
validated and this study was no exception. However, in the meantime the authors 
recommend adding the numerical foot deformity score to the QHRFF to improve 
accuracy and test for validity. Lastly, a systematic literature review for other reported 
independent associates for foot disease (such as cancer, arthritis, depression, trauma, 
vision impairment, mobility impairment and social determinant factors) and other 
outcome measures for foot disease (such as quality of life measures) should be 
performed to ensure all 'at risk’ populations and outcome measures for foot disease 
are identified, considered and potentially included in the next QHRFF version. 
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4.7 CONCLUSIONS 
The QHRFF tool appears to be the first multi-item tool developed and tested to 
identify multiple high-risk factors and foot disease complications in multiple at risk 
populations. Acceptable validity and reliability were demonstrated for the majority of 
items; particularly in the domains of identifying relevant medical co-morbidity 
history and clinically diagnosing high-risk factors and foot disease complications. 
However, recommendations to remove, add or redefine items registering weak 
validity or reliability scores should be implemented to improve future versions of the 
QHRFF tool; particularly in the domains of health professionals attending and 
clinical management principles. Overall, the QHRFF tool appears to demonstrate the 
practicality, validity and reliability required to facilitate robust clinical assessment 
and data capture to measure the large burden of foot disease facing our multiple at 
risk populations. 
Chapter 5: Direct inpatient burden caused by foot-related conditions: a multi-site point-prevalence study 111 
Chapter 5: Direct inpatient burden caused by 
foot-related conditions: a multi-site 
point-prevalence study 
This chapter begins with a preface section that briefly explains the manuscript 
that makes up this methodology and initial results chapter (section 5.1).  An adapted 
version of the manuscript published in the BMJ Open journal, “Direct inpatient 
burden caused by foot-related conditions: a multi-site point-prevalence study” is then 
presented; including: abstract and article summary (section 5.2), introduction (section 
5.3), methods (section 5.4), results (section 5.5), discussion (section 5.6) and 
conclusion sections (section 5.7). 
 
5.1 PREFACE 
Chapter 5 describes the methodology and initial results of the major study of 
this thesis, which was informed by the literature reviewed in Chapters 2 and 3 and 
the data collection instrument tested in Chapter 4.  Chapters 2 and 3 identified that 
while foot disease prevalence and associated factors had been investigated in specific 
inpatient populations, it had yet to be fully investigated in a representative inpatient 
population using appropriate methodology.  These chapters also identified that a foot 
disease data collection instrument designed to capture the multiple co-morbidities, 
foot disease disorders and foot risk factors necessary to perform such a study had yet 
to be reported.  Chapter 4 saw the development and testing of a new data collection 
instrument designed to reliably and accurately capture multiple co-morbidities, foot 
disease and foot risk factors in representative populations; the Queensland High Risk 
Foot Form (QHRFF) data collection instrument.  After testing the QHRFF on 
clinicians with different levels of foot disease experience in different patient 
populations, it was reported to have appropriate inter- and intra-rater reliability and 
validity to fulfil this task for the majority of items.   
The manuscript presented in Chapter 5 used the findings of Chapters 2–4 to 
design the major study of this thesis to address these identified gaps in the literature.  
The study was a multi-site observational cross-sectional point-prevalence study and 
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the chapter described in detail the methodology employed to address these gaps and 
optimise the generalizability of findings.  It used the recommendations identified in 
Chapter 4 to enact changes to improve the QHRFF data collection instrument and 
retested a new improved data collection instrument; the Queensland Foot Disease 
Form (QFDF) (Appendix E).  Finally, Chapter 5 reports the initial results from this 
thesis on the burden of people hospitalised for the reason of a foot-related condition, 
including those due to foot disease and foot trauma. The manuscript that forms the 
basis of this chapter has been adapted from the manuscript published in the BMJ 
Open journal:  
Lazzarini PA, Hurn SE, Kuys SS, Kamp MC, Ng V, Thomas C, Jen S, 
Kinnear EM, d'Emden MC, Reed L.  Direct inpatient burden caused by foot-related 
conditions: a multi-site point-prevalence study. BMJ Open 2016; 6: e010811 [39]. 
 
5.2 ABSTRACT AND ARTICLE SUMMARY 
Objective:  The aims of this point-prevalence study were to investigate a 
representative inpatient population to determine the prevalence of people admitted to 
hospital for the reason of a foot-related condition, and identify associated 
independent factors. 
Methods:  Participants were all adult inpatients present on the day of data 
collection in five different representative hospitals.  Maternity, mental health and 
cognitively impaired inpatients were excluded.  Participants were surveyed on a 
range of self-reported demographic, social determinant, medical history, foot disease 
history, self-care, footwear, past foot treatment prior to hospitalisation and reason for 
admission variables.  Physical examinations were performed to clinically-diagnose a 
range of foot disease and foot risk factor variables.  Independent factors associated 
with being admitted to hospital for the primary or secondary reason of a foot-related 
condition were analysed using multivariate logistic regression. 
Results:  Overall, 733 participants were included; mean(SD) age 62(19) years, 
male 55.8%.   Foot-related conditions were the primary reason for admission in 54 
participants (7.4% (95% CI: 5.7-9.5)); 36 for foot disease (4.9%), 15 foot trauma 
(2.1%).  Being admitted for the primary reason of a foot-related condition was 
independently associated with foot infection, critical peripheral arterial disease, foot 
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trauma and past foot treatment by a general practitioner and surgeon (p < 0.01).   
Foot-related conditions were a secondary reason for admission in 28 participants 
(3.8% (2.6-5.6)) and were independently associated with diabetes and current foot 
ulcer (p < 0.01).    
Conclusions: This study, the first in a representative inpatient population, 
suggests the direct inpatient burden caused by foot-related conditions is significantly 
higher than previously appreciated.  Findings indicate one in every thirteen inpatients 
was primarily admitted because of a foot-related condition with most due to foot 
disease or foot trauma.  Future strategies are recommended to investigate and 
intervene in the considerable inpatient burden caused by foot-related conditions. 
 
Article Summary:  Strengths and limitations of this study 
o This is the first study to investigate the prevalence of people admitted to 
hospital because of any foot-related condition within a representative 
inpatient population 
o This study investigated inpatients from five different hospitals considered 
to be representative of inpatient populations in Australia. 
o Data collectors had specific training and high accuracy in collecting 
standard self-reported medical history and clinically-diagnosed foot-related 
condition variables   
o As a point-prevalence study, findings are reliant on the days surveyed being 
representative of standard activity and are unable to determine causal 
relationships  
 
5.3 INTRODUCTION 
Foot-related conditions can cause high burdens of disease due to high rates of 
hospitalisation and amputation [1, 2, 36, 37, 186, 306].  In the context of 
hospitalisation, foot-related conditions typically refer to deteriorating chronic foot 
disease or acute foot trauma [1, 2, 4, 10, 15, 16, 36, 37, 186, 306].  Foot disease 
typically refers collectively to ulcers, infections, ischaemia and Charcot foot and is 
usually precipitated by the foot risk factors of peripheral arterial disease, neuropathy 
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and deformity [1, 2, 5, 10, 17, 36, 37].  Foot trauma typically refers to limb-
threatening injuries to the foot caused by high energy trauma [15, 16]. 
Foot-related conditions have been reported to be present in considerable 
proportions of specific inpatient populations [1, 2, 4, 36, 37, 186, 306].  Yet, recent 
reviews conclude the direct foot-related inpatient burden has yet to be studied; that is 
the total prevalence of all hospitalisations caused by any foot-related condition 
within a representative inpatient population [36, 37].  One large retrospective study 
of a national hospital discharge dataset reported that 1.2% of all admissions were 
caused by foot disease; however, it did not report foot trauma [186]. Therefore, there 
is a distinct gap in information to quantify the direct inpatient burden caused by foot-
related conditions [36, 37].  Without this information it is difficult for clinicians, 
researchers and policy makers to comprehend, compare and address a burden of 
disease [35].   
Thus, the primary aim of this point-prevalence study was to investigate a 
representative inpatient population to determine the prevalence of people admitted to 
hospital for the primary or secondary reason of a foot-related condition.  A secondary 
aim was to investigate the independent factors associated with being admitted to 
hospital for the reason of a foot-related condition. 
 
5.4 METHODS 
Study design  
This study was the first in the Foot Disease in Inpatients Study (FDIS) research 
project.  The main objective of the FDIS project was to investigate the prevalence, 
and associated factors, of different foot disease disorders and foot risk factors in a 
representative inpatient population.  This was a multi-site observational point-
prevalence cross-sectional study set in five public hospitals in Queensland, Australia.  
The authors have adhered to the STROBE reporting checklist for cross-sectional 
studies (See Supplementary Table S5-1).  This multi-site study received ethical 
approval from two Australian Human Research Ethics Committee (HREC); The 
Prince Charles Hospital HREC (Ethics No. HREC/13/QPCH/5) and the Queensland 
University of Technology HREC (Ethics No. 1300000367) (Appendix C).  Site 
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specific authority was also obtained from each hospital (Appendix C) and written 
informed consent was voluntarily obtained from all participants (Appendix D). 
 
Settings  
Five public hospitals made up the sites for this study: i) a major metropolitan 
hospital (> 500 beds) with a catchment population of 900,000 in south Queensland; 
ii) major metropolitan speciality hospital (> 500 beds) with a catchment population 
of 900,000 in south Queensland;  iii) major regional hospital (200-500 beds) with a 
catchment population of 220,000 in central Queensland; iv) large metropolitan 
hospital (200-500 beds) with a catchment population of 250,000 in south 
Queensland; and v) large regional hospital (50-99 beds) with a catchment population 
of 30,000 in north Queensland. These hospitals were purposively selected by the 
authors to maximise the population-based generalizability of any findings by 
representing each of the different defined categories of peer-group hospitals in 
Australia according to the National Health Performance Authority [307]; major 
metropolitan, major regional, large metropolitan, large regional and medium 
hospitals [307].  Specialist hospitals are unable to be defined into these peer-groups 
[307], thus, the authors decided to include a major metropolitan specialist hospital 
instead of a medium hospital to further maximise generalizability. 
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Supplementary Table S5-1: STROBE Checklist of items that should be included in reports of cross-sectional studies  
Section/Topic 
Item 
# 
Recommendation 
Reported on 
page # 
Title and abstract 1 (a) Indicate the study’s design with a commonly used term in the title or the abstract 112 
(b) Provide in the abstract an informative and balanced summary of what was done and what was found 112-113 
Introduction  
Background/rationale 2 Explain the scientific background and rationale for the investigation being reported 113-114 
Objectives 3 State specific objectives, including any prespecified hypotheses 114 
Methods  
Study design 4 Present key elements of study design early in the paper 114 
Setting 5 Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and data collection 115 
Participants 6 (a) Give the eligibility criteria, and the sources and methods of selection of participants 119 
Variables 7 Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if 
applicable 
120-124 
Data sources/ 
measurement 
8*  For each variable of interest, give sources of data and details of methods of assessment (measurement). Describe 
comparability of assessment methods if there is more than one group 
120-124 
Bias 9 Describe any efforts to address potential sources of bias 122-125 
Study size 10 Explain how the study size was arrived at 119 
Quantitative variables 11 Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and 
why 
123-124 
Statistical methods 12 (a) Describe all statistical methods, including those used to control for confounding 125-126 
 
 
 
 
(b) Describe any methods used to examine subgroups and interactions 125-126 
(c) Explain how missing data were addressed 126 
(d) If applicable, describe analytical methods taking account of sampling strategy NA 
(e) Describe any sensitivity analyses 125-126 
Results    
Participants 13* (a) Report numbers of individuals at each stage of study—e.g. numbers potentially eligible, examined for eligibility, 
confirmed eligible, included in the study, completing follow-up, and analysed 
127-129 
  (b) Give reasons for non-participation at each stage 127-129 
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  (c) Consider use of a flow diagram NA 
Descriptive data 14* (a) Give characteristics of study participants (e.g. demographic, clinical, social) and information on exposures and potential 
confounders 
127-133 
  (b) Indicate number of participants with missing data for each variable of interest 129-133 
Outcome data 15* Report numbers of outcome events or summary measures 127-133 
Main results 16 (a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision (e.g., 95% confidence 
interval). Make clear which confounders were adjusted for and why they were included 
134-136 
  (b) Report category boundaries when continuous variables were categorized 134-136 
  (c) If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time period NA 
Other analyses 17 Report other analyses done—e.g. analyses of subgroups and interactions, and sensitivity analyses 137-138 
Discussion    
Key results 18 Summarise key results with reference to study objectives 138-139 
Limitations 19 Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and 
magnitude of any potential bias 
143-144 
Interpretation 20 Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from 
similar studies, and other relevant evidence 
139-143 
Generalizability 21 Discuss the generalizability (external validity) of the study results 139-143 
Other information    
Funding 22 Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which 
the present article is based 
145 
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As a point-prevalence study each hospital had data collected on one day.  
Practical resource implications meant the same day could not be chosen for all 
hospitals.  After consultation with senior hospital management a mid-week day 
(Tuesday-Thursday) was considered to be most representative of standard hospital 
activity.  The designated day for each hospital was decided by the authors according 
to resource, travel and data collector availability.  Data collection days for hospitals 
in similar regions were separated by two months to minimise the possibility of the 
same participant admission being captured twice.   Data collection days were in 
2013: major metropolitan (September), major metropolitan speciality (July), major 
regional (June), large metropolitan (December) and large regional hospital (June).   
 
Participants 
Eligible participants were all adult inpatients (>18 years) present between 8am 
and 5pm in one of the five hospitals on the designated day of data collection.  An 
inpatient was defined as a person hospitalised for any reason for at least one night of 
hospital care, on either a night prior to or the night of the designated data collection 
day, as confirmed by the treating medical officer.  Exclusion criteria included those 
younger than 18 years of age, those with a cognitive deficit as determined by the 
Nurse Unit Manager, or those in a paediatric, maternity or psychiatric ward.  These 
criteria are typical of point-prevalence inpatient studies [31-34].   
 
Sample size calculation 
An inpatient prevalence of 4.6% was chosen as the basis for the sample size 
calculation [37].  This was chosen as a recent systematic review reported that foot 
wounds had been the most investigated of all inpatient foot-related conditions and 
4.6% was the reported pooled prevalence estimate for inpatient foot wounds from 
this review [37]. Therefore, a sample size of 750 participants was calculated for this 
study based on an inpatient prevalence of 4.6%, a 95% Confidence Interval (95% CI) 
of 3.1 to 6.1%, and an alpha level of 0.05.   
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Data collection instrument 
A Queensland Foot Disease Form (QFDF) data collection instrument was used 
to collect all variables (Figure 5-1 and Appendix E).  The QFDF was modified from 
a similar validated data collection instrument, the Queensland High Risk Foot Form 
(QHRFF) [38].  In brief the QHRFF collects 46-items via self-reported history and 
clinically-diagnoses of foot-related conditions [38, 308].  Modifications to the 
QHRFF to develop the QFDF included: enacting any changes recommended by its 
original authors [38]; removing variables not applicable to this study; and adding 
variables identified from recent systematic reviews to be applicable to foot-related 
conditions in inpatients [36, 37, 257] such as reason for admission [37, 186, 192].  
The 57-item QFDF contained 36 (78%) of the 46-items that were extensively tested 
for reliability and validity in the QHRFF [38].  The authors decided to further test the 
QFDF by testing the accuracy of data collectors using the QFDF against simulated 
cases, and testing the concurrent validity of a sub-sample of study data collected 
using the QFDF compared with medical records audited for the same data.  Both 
testing procedures are described below. 
 
Variables collected 
Table 5-1 outlines the criteria, definitions and supporting citations used for 
each individual variable collected by the QFDF in this study.  Patient explanatory 
variables were self-reported and grouped into ward, demographic, social 
determinant, medical condition history, self-care ability, past foot treatment and foot 
disease history variables.  Foot explanatory variables were clinically-diagnosed and 
grouped into foot risk factors, foot disease and foot risk status.  The outcome variable 
of interest for this study was the self-reported identification of a foot-related 
condition as the participant’s primary or secondary reason for admission. From those 
participants’ reporting a foot-related condition as a reason for admission, the foot 
explanatory variable considered to most likely have caused the admission was 
identified and termed the predominant foot-related condition causing admission.  
Trained data collectors administered all variables. 
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Figure 5-1:  Queensland Foot Disease Form Data Collection Instrument 
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Data collection procedure 
Data collector training  
Data collectors were 27 publicly employed podiatrists who routinely used the 
QHRFF in their existing clinical practice.  Data collectors were assisted by 25 final 
year undergraduate podiatry students and four publicly employed other staff.  The 
role of the assistants was to help the data collectors with administering the 
consenting and self-reported history processes only.  All data collectors and 
assistants participated in a 3-hour training session less than one month prior to their 
designated data collection day.   
 
Data collector testing 
All data collectors were tested on their use of the 57-item QFDF, using 
simulated cases to assess their data collection accuracy immediately pre- and post-
training session.  A minimum of 80% accuracy on the 57-item simulated cases was 
required to be endorsed as a data collector and differences in pre- and post-training 
scores were analysed.   
 
Data Collection 
Data collection occurred between 8am and 5pm on the designated day.  Data 
collection teams of up to eight people were allocated up to five wards of potentially 
eligible participants for data collection.  After completing the voluntary consenting 
procedure, included participants were questioned to determine their self-report 
history variables.  Participants were then shown a footwear form (modified with 
permission from Barton et al. [309] (Appendix E)) containing 16 footwear styles to 
identify their main footwear worn inside and outside the house in the previous 12 
months.  All participants then underwent a non-invasive physical examination by a 
data collector to determine their clinically diagnosed variables.  All participant data 
were recorded on the QFDF and all completed QFDF data collection forms were 
checked at the conclusion of each hospital data collection day by the authors for 
errors or omissions.  Any missing data or potential data errors were clarified with the 
data collector concerned. 
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Table 5-1: Definitions for each item of the Queensland Foot Disease Form  
QFDF Item Definition  
Ward  [310] 
Surgical Ward Participant is in a ward for the purpose of a surgical procedure  
Medical Ward Participant is in a ward not for the purpose of a surgical procedure   
General Demographics  [38, 257, 310, 311] 
Age Participant’s age in whole years at time of data collection  
Sex Participant is male, female or other  
Social Determinants [257, 310-314] 
Socioeconomic status  Participant’s postcode of usual residence was used to determine Australian Index of Relative Social Disadvantage status  
Geographical remoteness  Participant’s postcode of usual residence was used to determine Accessibility/Remoteness Index of Australia status  
Highest education level achieved What is the highest education qualification level you have achieved?  
Born overseas In which country were you born?  
Indigenous status Are you of Aboriginal or Torres Strait Islander origin?  
Medical Conditions History [15, 16, 38, 176, 257, 311, 314] 
Diabetes  Have you ever been told by a doctor or nurse that you have had diabetes? (Should have lasted or likely to last for 6+ months)  
Diabetes type If yes to diabetes, which type of diabetes do you have: type 1 or type 2?  
Hypertension Have you ever been told by a doctor or nurse that you have had hypertension or high blood pressure? (Should have lasted or likely to last for 6+ months)  
Dyslipidaemia Have you ever been told by a doctor or nurse that you have had dyslipidaemia or high cholesterol? (Should have lasted or likely to last for 6+ months)  
Myocardial infarct (MI) Have you ever been told by a doctor or nurse that you have had myocardial infarct or heart attack? (Should have lasted or likely to last for 6+ months)  
Cardiovascular accident (CVA) Have you ever been told by a doctor or nurse that you have had cardiovascular attack or stroke? (Should have lasted or likely to last for 6+ months)  
Chronic kidney disease (CKD) Have you ever been told by a doctor or nurse that you have had chronic kidney disease? (Should have lasted or likely to last for 6+ months)  
End stage kidney disease (ESKD) Have you ever been told by a doctor or nurse that you have had kidney failure or do you need dialysis? (Should have lasted or likely to last for 6+ months)  
Cancer Have you ever been told by a doctor or nurse that you have had cancer? (Should have lasted or likely to last for 6+ months)  
Arthritis Have you ever been told by a doctor or nurse that you have had arthritis? (Should have lasted or likely to last for 6+ months)  
Depression Have you ever been told by a doctor or nurse that you have had depression? (Should have lasted or likely to last for 6+ months)  
Acute foot trauma Have you had major trauma to your feet that resulted in a fracture, burn, wound or infection that required hospital treatment?   
Smoker Are you a current smoker?  
Ex-smoker If no to smoker, did you ever smoke?  
Self-care Ability [17, 257, 291, 309] 
Mobility impairment Are you able to walk without the help of an aide?  
Vision impairment Are you able to read a newspaper (with glasses if needed))  
Footwear worn: Inside From a sheet displaying 16 different types of footwear: What is the type of shoes you have worn most Inside the house over the past 12 months?  
Footwear worn: Outside From a sheet displaying 16 different types of footwear: What is the type of shoes you have worn most Outside the house over the past 12 months?  
Low risk footwear Participant identified picture of walking shoe, runner, oxford shoe, boot or bespoke footwear as footwear worn most  
Moderate risk footwear Participant identified picture of moccasin, ugg boot, slipper or backless slipper as footwear worn most  
High risk footwear Participant identified picture of high heels, flip flop, court shoe, mule or sandal as footwear worn most  
No footwear worn Participant identified picture of socks only or barefoot as footwear worn most  
Past Foot Treatment [38, 305] 
Yes Have you been treated for a foot problem in the past 12 months (excluding in the current admission)   
Podiatry Have you been treated for a foot problem by a podiatrist in the past 12 months (excluding in the current admission)   
General Practitioner (GP) Have you been treated for a foot problem by a GP in the past 12 months (excluding in the current admission)   
Physician Have you been treated for a foot problem by another medical physician in the past 12 months (excluding in the current admission)   
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Surgeon Have you been treated for a foot problem by a surgeon in the past 12 months (excluding in the current admission)   
Nurse Have you been treated for a foot problem by a nurse in the past 12 months (excluding in the current admission)   
Orthotist Have you been treated for a foot problem by an orthotist in the past 12 months (excluding in the current admission)   
Other Have you been treated for a foot problem by any other health professional/s in the past 12 months (excluding in the current admission)   
Foot Disease History [38, 257] 
Previous peripheral neuropathy  Have you ever been told by a doctor or nurse that you have had peripheral neuropathy? (Should have lasted or likely to last for 6+ months)  
Previous peripheral arterial disease Have you ever been told by a doctor or nurse that you have had peripheral arterial disease? (Should have lasted or likely to last for 6+ months)  
Previous foot ulcer Have you ever had a foot ulcer that has healed?  
Previous amputation Have you ever had an amputation?  Plus, a clinical examination to verify previous healed lower extremity amputation site  
Foot Risk Factors [10, 17, 38, 176, 262, 263, 291, 295, 315, 316] 
Peripheral neuropathy (PN) A lack of protective sensation to a 10 gram monofilament on at least 2 of 3 plantar forefoot locations on at least one foot  
Peripheral arterial disease (PAD) Absence of at least one palpable foot pulse and a toe systolic pressure <70mmHg on at least one foot  
Mild PAD Toe systolic pressure = 51-70 mmHg  
Moderate PAD Toe systolic pressure = 31-50 mmHg  
Critical PAD Toe systolic pressure = <30 mmHg   
Foot deformity  A score of at least 3 using the six-point foot deformity score on at least one foot (one point each allocated for small muscle wastage, bony prominence, prominent 
metatarsal heads, hammer/claw toes, limited joint mobility and Charcot deformity)  
Foot Disease [38, 176, 262, 295, 301-303] 
Acute Charcot A red, hot, swollen, unilateral neuropathic foot without a local foot wound on at least one foot  
Current foot ulcer Do you have a current foot ulcer or sore?  Plus, a clinical examination to verify a full thickness wound beneath the ankle  
Current foot infection At least two manifestations of inflammation beneath the ankle (purulence, erythema, pain, tenderness, warmth or induration)  
Foot Risk Status [38, 262] 
Low risk Nil foot disease history or clinical diagnosis of current foot disease, peripheral neuropathy or peripheral arterial disease identified during the clinical examination  
At risk Clinical diagnosis of peripheral neuropathy and/or peripheral arterial disease (excluding critical PAD) identified during the clinical examination  
High risk Clinical diagnosis of critical PAD, or 
Foot deformity with peripheral neuropathy and/or PAD, or 
Self-reported previous foot ulcer or amputation   
Acute  Current foot wound or acute Charcot  
Foot-related Condition Admission  [186, 192, 308, 310] 
Primary reason for admission Is a foot condition the main reason for your hospital admission?  
Secondary reason for admission Is a foot condition another reason for your hospital admission?  
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Data collector audit 
As aforementioned, a sub-sample of data collected from participants (‘study 
data’) was tested for concurrent validity with the participants’ medical records 
(‘medical records’). As the study was conducted in different regions a random 
sample was unable to be tested due to resource constraints.  Therefore, to be 
representative of the different wards and hospitals in the study a sub-sample 
(approximately 5% of the required study sample size) was taken from one general 
medical and one general surgical ward located in the large metropolitan hospital, 
which was the third-largest (middle-sized) hospital.  The process for the audit 
involved firstly collecting the study data from the sub-sample of participants as per 
the data collection procedure.  The hospital medical records of those participants 
included in the sub-sample were then audited on the same day by two authors who 
were blinded to the sub-sample study data collected.  The authors were instructed to 
review the medical record and complete all applicable variables if noted anywhere in 
the medical record using a QFDF.  The applicable variables recorded from the 
medical records were then compared with the study data collected for agreement. 
 
Statistical analysis  
All data were analysed using SPSS 22.0 for Windows (SPSS Inc., Chicago, IL, 
USA) or GraphPad Software.  Descriptive statistics were used to display all 
variables; using means and standard deviations (SD) for continuous variables or 
proportions for categorical variables.  Prevalence with 95% Confidence Intervals 
(95% CI) were calculated using a modified Wald method for outcome variables 
[317].  Chi-squared or Kruskal-Wallis tests were used to test differences between 
hospitals for categorical variables and t-tests or ANOVA to test differences between 
hospitals for continuous variables [273].   Univariate logistic regression analyses 
were undertaken to test for crude explanatory variable associations with the outcome 
[273, 318, 319].   
Multivariate logistic regression was used to analyse for independent 
associations [318, 319].  As this study was investigating a new field a data driven 
backwards stepwise method was chosen [318, 319].  All variables achieving crude 
associations (p<0.2), except those deemed illogical, were entered into the backwards 
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stepwise model, non-significant variables (p>0.05) were removed at each step, until 
only variables achieving statistical significance remained (p<0.05) and their Odds 
Ratios (OR) reported (Unadjusted Model) [318, 319].  This model method was 
consistent with similar foot-related studies [305, 316, 320-322].  Collinearity was 
tested for all models using the following collinearity statistics: correlation matrix (> 
0.9), Tolerance (< 0.1) and Variance Inflation Factor (> 10) [318, 319].  If 
collinearity was identified between variables, the variable with the lowest Odds Ratio 
(OR) in the univariate analysis was removed from the analysis.  The Hosmer and 
Lemeshow Goodness of Fit, Omnibus and Negelkerke Pseudo R2 tests were used at 
each step of all models to indicate the goodness of fit, significance, parsimony, and 
potential variance of the outcome variable explained by the model respectively [318, 
319].  The final unadjusted model was then tested for potential confounding by 
individually re-entering in each non-included explanatory variable to see if it 
confounded the effect of the independent explanatory variables in the unadjusted 
model [318, 319].  A confounder was defined, and remained in the model, as 
changing the Beta effect estimates of at least one unadjusted independent explanatory 
variables by > 20% (Adjusted Model) [318].  Two different multivariate models were 
assessed for each outcome variable.  The first used all available explanatory 
variables, except the summarised foot risk status variable (Model 1).  The second 
used the summarised foot risk status variable, instead of foot disease history, foot 
risk factors and foot disease explanatory variables (Model 2).  Missing data were 
treated by excluding cases with missing data as missing data were minimal (<5% in 
all models) [318]. 
Lastly, Kappa (K) for dichotomous variables, weighted Kappa (wK) for ordinal 
variables and intra-class correlation (ICCs) (model 2, 1) for continuous variables 
were used to test for measures of agreement for the data collector testing and audit 
[273, 279, 280].  Kappa and wK value (Standard Errors (SE)) strengths were 
categorised as: no agreement < 0; slight agreement = 0 – 0.20; fair agreement = 0.21 
- 0.40; moderate agreement = 0.41 – 0.6; substantial agreement = 0.61 – 0.8; and 
near perfect agreement = 0.81 – 1.0 [273, 279, 280]. ICC (SD) strengths were 
categorised as: weak-moderate agreement < 0.75 and strong agreement > 0.75 [273]. 
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5.5 RESULTS 
Characteristics 
Supplementary Table S5-2 reports the demographic characteristics of the 1,146 
total inpatients present during the study.  Of these, 263 (23%) patients were non-
eligible and excluded; 248 due to cognitive impairment and 15 for other reasons 
(including children, non-English speaking or unavailable).  Non-eligible patients 
were older (p<0.001) with no differences in sex (p=0.717).  Of the 883 eligible 
patients, 733 (83%) consented.  There were no differences in age (p=0.187) or sex 
(p=0.198) between those consenting and non-consenting.   
Table 5-2 reports the characteristics of the 733 included participants.  Overall, 
mean age(SD) was 62.0(18.6) years and 55.8% were males.  Differences were 
evident between hospitals for demographic, social determinant, medical history, self-
care ability, past foot treatment, foot disease history and foot risk status variables 
(p<0.05).  No differences between hospitals were recorded for foot risk factor and 
foot disease variables (p<0.05).   
 
Prevalence 
The primary reason for admission being a foot-related condition was identified 
in 54 participants (7.4% (95% CI: 5.7-9.5)) and 15 of those had diabetes (2.0% (1.2-
3.4)) (Table 5-2).  The predominant causes of these were foot disease in 36 
participants (4.9% (3.6-6.7)) (17foot infection, 13 critical PAD, six foot ulcer), foot 
trauma in 15 participants (2.1% (1.2-3.4)) and three others were unable to be 
determined with the variables collected.  Higher proportions of primary foot-related 
admissions existed in the major regional (12.2%) and major metropolitan general 
hospitals (10.7%) as compared to the other hospitals (p<0.05).   
The secondary reason for admission being a foot-related condition was 
identified in 28 participants (3.8% (2.6-5.5)) and 19 of those had diabetes (2.6% (1.6-
4.0)) (Table 5-2).  The predominant causes of these were foot disease in 13 
participants (1.8% (1.0-3.0)) (nine foot ulcers, three foot infections, one critical 
PAD), foot trauma in one (0.1% (0-0.8)) and 14 others were unable to be determined.  
No differences in proportions of secondary foot-related admissions between hospitals 
were identified.   
 Chapter 5: Direct inpatient burden caused by foot-related conditions: a multi-site point-prevalence study 128 
Independent Associated Factors 
Table 5-3 reports unadjusted and adjusted OR (95% CIs) for variables 
achieving significance for primary reason for admission for foot-related conditions.  
Univariate analyses (p<0.2) identified 20 variables eligible for Model 1 and 12 for 
Model 2 (Supplementary Table S5-3).  Current foot ulcer was excluded as 
collinearity was identified with current foot infection.  Model 1 identified six 
unadjusted independent associated factors: critical PAD, current foot infection, acute 
foot trauma, past surgeon treatment, past GP treatment and myocardial infarct history 
(MI) (all p<0.05).  Identified confounders were: socio-economic status, diabetes, 
CKD and dyslipidaemia.  After adjusting, all factors remained significant (all 
p<0.01), except MI (p>0.2).  Model 2 identified four unadjusted independent 
associated factors:  acute foot risk status, high foot risk status, past surgeon treatment 
and past GP treatment (all p<0.05).  Identified confounders were: diabetes, MI, CKD, 
acute foot trauma and past podiatry treatment.  After adjusting, all factors remained 
significant (all p<0.001). 
Table 5-4 reports unadjusted and adjusted OR (95% CIs) for variables 
achieving significance for secondary reason for admission for foot-related 
conditions.    Univariate analyses (p<0.2) identified 16 variables eligible for Model 1 
and 10 for Model 2 (Supplementary Table S5-3).  Current foot infection was 
excluded as collinearity was identified with current foot ulcer. Model 1 identified 
two unadjusted independent associated factors: diabetes and current foot ulcer (both 
p<0.001).  Identified confounders were: mobility impairment and previous foot ulcer.  
After adjusting, both factors remained significant (both p<0.01).  Model 2 identified 
two unadjusted independent associated factors: diabetes and acute foot risk status 
(both p<0.001).  No adjustment was performed as no confounders were identified. 
 
Data collector testing and audit results 
Supplementary Table S5-4 reports an improvement in the data collectors post-
training scores compared with pre-training scores (p<0.001).  All participants scored 
>90% in the post-test.  Supplementary Table S5-5 reports the strengths of agreement 
between the study data and medical records data for the 44 eligible and 28 
consenting participants in the sub-sample.  Of the 19 applicable variables tested, 12 
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(63%) had near perfect/strong, two (11%) substantial, three (16%) moderate and two 
(11%) had fair agreement.  In variables reporting less than near perfect/strong 
agreement, study data identified more cases than medical records. 
 
Supplementary Table S5-2:  Demographic characteristics of total inpatients; 
including non-eligible, eligible non-consenting and eligible consenting subgroups 
(number (%) unless otherwise stated) 
 Total  Large  
Regional 
(General) 
Major  
Regional  
(General) 
Large  
Metro.  
(General) 
Major  
Metro. 
(Speciality) 
Major  
Metro.  
(General) 
Total Inpatients 1146 26 110 151 340 519 
Age (SD) years 63(19) 52(19) 66(19) 66(20) 67(19) 59(19) 
Missing data 222 (19%) 2 (8%) 8 (7%) 0 68 (20%) 144 (28%) 
Male sex  549 (55%) 16 (64%) 66 (60%) 81 (54%) 161 (51%) 225 (57%) 
Missing data 152 (13%) 1 (4%) 0 0 25 (7%) 126 (24%) 
Non-eligible 263 (23%) 5 (19%) 18 (16%) 31 (21%) 68 (20%) 141 (27%) 
Age (SD) years 71(20) 64(27) 76(14) 73(22) 80(11) 59(22) 
Missing data 149 (54%) 2 (40%) 3 (17%) 0 38 (56%) 106 (75%) 
Male sex  82 (57%) 3 (75%) 10 (56%) 15 (48%) 24 (48%) 30 (73%) 
Missing data 119 (45%) 1 (20%) 0 0 18 (26%) 100 (71%) 
Eligible  883 (77%) 21 (81%) 92 (84%) 120 (79%) 272 (80%) 378 (73%) 
Age (SD) years 62(19) 50(18) 64(19) 64(19) 65(19) 59(19) 
Missing data 72 (8%) 0 5 (5%) 0 30 (11%) 37(10%) 
Male sex  467 (55%) 13 (62%) 56(61%) 66(55%) 137 (52% 195 (55%) 
Missing data 32(4%) 0 0 0 7 (3%) 35 (9%) 
Non-consenting  150 (17%) 0 10 (11%) 30 (25%) 40 (15%) 70 (19%) 
Age (SD) years 59(22) 0 67(14) 66(20) 62(29) 51(19) 
Missing data 70 (47%) 0 5 (50%) 0 29 (73%) 36 (51%) 
Male sex  59 (49%) 0 4 (40%) 20 (67%) 10 (30%) 25 (53%) 
Missing data 30 (20%) 0 0 0 7 (17%) 23 (33%) 
Consenting  733 (83%) 21 (100%) 82 (89%) 90 (75%) 232 (85%) 308 (81%) 
Age (SD) years 62(19) 50(18) 64(19) 63(18) 66(18) 60(18) 
Missing data 2 (<1%) 0 0 0 1 (<1%) 1 (<1%) 
Male sex (%) 408 (56%) 13 (62%) 52 (63%) 46 (51%) 127 (55%) 170 (56%) 
Missing data 2 (<1%) 0 0 0 1 (<1%) 1 (<1%) 
Metro: Metropolitan; SD: Standard deviation. 
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Table 5-2: Participant characteristics for each hospital site (number (%) unless otherwise stated) 
 n Total 
 
Large Regional 
 
Major Regional  Large Metro.  Major Metro. 
Speciality 
Major Metro. 
General  
p Value 
Participants 733 733 21 82 90 232 308  
Ward         
Medical 733 459 (62.6% ) 16 (76.2%) 49 (59.8%) 57 (63.3%) 171 (73.7%) 166 (53.9%)  
Surgical 733 274 (37.4%) 5 (23.8%) 33 (40.2%) 33 (36.7%) 61 (26.3%) 142 (46.1%) <0.001* 
Demographics         
Age (SD) years  731 62.0(18.6) 50.0(18.0)* 63.5(19.1) 63.2(18.3) 65.5(18.3) 59.5(18.3)* <0.001* 
Age range years 731 18 - 99 20 – 85 18 - 91 21 - 96 18 - 99 18 - 94  
Age Groups 731        
18-40 years  110 (15.0%) 6 (28.6%) 12 (14.6%) 12 (13.3%) 28 (12.1%) 52 (16.9%)  
41-60 years  188 (25.7%) 8 (38.1%) 20 (24.4%) 23 (25.6%) 54 (23.4%) 83 (27.0%)  
61-80 years  316 (43.2%)  6 (28.6%) 36 (43.9%) 37 (41.1%) 94 (40.7%) 143 (46.6%)  
81+ years  117 (16.0%) 1 (4.8%) 14 (17.1%) 18 (20.0%) 55 (23.8%) 29 (9.4%) <0.001* 
Male sex 731 408 (55.8%) 13 (61.9%) 52 (63.4%) 46 (51.1%) 127 (54.7%) 170 (55.6%) 0.531 
Social Determinants         
Socioeconomic Status  711        
Most disadvantaged  102 (14.3%) 6 (28.6%) 4 (5.1%) 30 (34.1%) 23 (10.2%) 39 (13.1%)  
Second most disadvantaged  159 (22.4%) 2 (9.5%) 41 (51.9%) 40 (45.5%) 27 (11.9%) 49 (16.5%)  
Middle  98 (13.8%) 12 (57.1%) 27 (34.2%) 10 (11.4%) 22 (9.7%) 27 (9.1%)  
Second least disadvantaged  240 (33.8%) 1 (4.8%) 5 (6.3%) 8 (9.1%) 131 (58.0%) 95 (32.0%)  
Least disadvantaged  112 (15.8%) 0 2 (2.5%) 0 23 (10.2%) 87 (29.3%) <0.001* 
Geographic Remoteness  711        
Major city  435 (61.2%) 1 (4.8%) 1 (1.3%) 54 (61.4%) 179 (79.2%) 200 (67.3%)  
Inner regional area  153 (21.5%) 0 40 (50.6%) 26 (29.5%) 36 (15.9%) 51 (17.2%)  
Outer regional area  66 (9.3%) 1 (4.8%) 21 (26.6%) 8 (9.1%) 5 (2.2%) 31 (10.4%)  
Remote area  30 (4.2%) 2 (9.5%) 13 (16.5%) 0 5 (2.2%) 10 (2.4%)  
Very remote area  27 (3.8%) 17 (81.0%) 4 (5.1%) 0 1 (0.4%) 5 (1.7%) <0.001* 
Highest Education Level 731  21 82 90 230 308  
Year 10 and under  395 (54.0%) 14 (66.7%) 58 (70.7%) 54 (60.0%) 124 (53.9%) 145 (47.1%)  
Year 12  132 (18.1%) 3 (14.3%) 9 (11.0%) 18 (20.0%) 38 (16.5%) 64 (20.8%)  
Certificate in trade or business  74 (10.1%) 2 (9.5%) 9 (11.0%) 10 (11.1%) 25 (10.9%) 28 (9.1%)  
Diploma or associate degree  46 (6.3%) 0 5 (6.1%) 5 (5.6%) 17 (7.4%) 19 (6.2%)  
Bachelor degree  48 (6.6%) 0 0 1 (1.1%) 12 (5.2%) 35 (11.4%)  
Graduate diploma  or certificate  15 (2.1%) 1 (4.8%) 0 2 (2.2%) 6 (2.6%) 6 (1.9%)  
Postgraduate degree      18 (2.5%) 1 (4.8%) 1 (1.2%) 0 7 (3.0%) 9 (2.9%)  
Other  3 (0.4%) 0 0 0 1 (0.4%) 2 (0.6%) <0.001* 
Born overseas 731 161 (22.0%) 2 (9.5%) 11 (13.4%) 20 (22.5%) 53 (22.8%) 75 (24.4%) 0.159 
Indigenous  732 34 (4.6%) 10 (47.6%) 5 (6.1%) 3 (3.4%) 8 (3.4%) 8 (2.6%) <0.001* 
Medical Condition History         
Diabetes  733 172 (23.5%) 6 (28.6%) 20 (24.4%) 18 (20.0%) 66 (28.4%) 62 (20.1%) 0.195 
Type 2 Diabetes#  162 (22.1%) 6 (28.6%) 20 (24.4%) 18 (20.0%) 59 (25.4%) 59 (19.2%) 0.139 
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Hypertension 733 359 (49.0%) 11 (52.4%) 40 (48.8%) 52 (57.8%) 129 (55.6%) 127 (41.2%) 0.006* 
Dyslipidaemia 733 234 (31.9%) 6 (28.6%) 30 (36.6%) 34 (37.8%) 91 (39.2%) 73 (23.7%) 0.001* 
Myocardial Infarct 733 146 (19.9%) 4 (19.0%) 10 (12.2%) 18 (20.0%) 67 (28.9%) 47 (15.3%) 0.001* 
Cerebrovascular Accident 733 85 (11.6%) 1 (4.8%) 10 (12.2%) 10 (11.1%) 36 (15.5%) 28 (9.1%) 0.173 
Chronic Kidney Disease  733 89 (12.1%) 1 (4.8%) 9 (11.0%) 15 (16.7%) 31 (13.4%) 33 (10.7%) 0.431 
End Stage Kidney Disease# 733 9 (1.2%) 0 3 (3.7%) 1 (1.1%) 0 5 (1.6%) NA 
Cancer 733 174 (23.7%) 1 (4.8%) 19 (23.2%) 26 (28.9%) 43 (18.5%) 85 (27.6%) 0.021* 
Arthritis 733 274 (37.4%) 5 (23.8%) 36 (44.4%) 40 (44.4%) 91 (39.2%) 102 (33.1%) 0.100 
Depression 733 191 (26.1%) 2 (9.5%) 29 (35.4%) 28 (31.1%) 55 (23.7%) 77 (25.0%) 0.069 
Acute foot trauma 733 26 (3.5%) 1 (4.8%) 4 (4.9%) 6 (6.7%) 2 (0.9%) 13 (4.2%) 0.079 
Smoker 733 104 (14.2%) 7 (33.3%) 18 (22.0%) 17 (18.9%) 12 (5.2%) 50 (16.2%) <0.001* 
Ex-Smoker 733 304 (41.5%) 10 (47.6%) 34 (41.5%) 35 (38.9%) 109 (47.0%) 116 (37.7%) 0.256 
Self-care Ability          
Mobility impairment 729 242 (33.2%) 4 (19.0%) 36 (43.9%) 37 (41.1%) 78 (33.8%) 87 (28.5%) 0.020* 
Vision impairment 730 110 (15.1%) 2 (9.5%) 10 (12.2%) 12 (13.5%) 41 (17.7%) 45 (14.7%) 0.637 
Footwear worn: Inside  728        
Low risk footwear  81 (11.1%) 0 9 (11.0%) 5 (5.6%) 29 (12.7%) 38 (12.4%)  
Moderate risk footwear  263 (36.1%) 2 (9.5%) 35 (42.7%) 28 (31.1%) 108 (47.2%) 90 (29.4%)  
High risk footwear  139 (19.1%) 11 (52.4%) 12 (14.6%) 17 (18.9%) 33 (14.4%) 66 (21.6%)  
No footwear worn  245 (33.7%) 8 (38.1%) 26 (31.7%) 40 (44.4%) 59 (25.8%) 112 (36.6%) <0.001* 
Footwear worn: Outside 726        
Low risk footwear  386 (53.2%) 12 (57.1%) 46 (56.1%) 50 (55.6%) 118 (51.5%) 160 (52.6%)  
Moderate risk footwear  75 (10.3%) 1 (4.8%) 8 (9.8%) 10 (11.1%) 34 (14.8%) 22 (7.2%)  
High risk footwear  250 (34.4%) 8 (38.1%) 26 (31.7%) 29 (32.2%) 74 (32.3%) 113 (37.2%)  
No footwear worn  15 (2.1%) 0 2 (2.4%) 1 (1.1%) 3 (1.3%) 9 (3.0%) 0.405 
Past Foot Treatment 733        
Yes   256 (34.9%) 6 (28.6%) 38 (46.3) 31 (34.4%) 83 (35.8%) 98 (31.8%) 0.167 
Podiatrist  180 (24.6%) 4 (19.0%) 21 (25.6%) 23 (25.6%) 70 (30.2%) 62 (20.1%) 0.105 
GP  93 (12.7%) 3 (14.3%) 22 (26.8%) 8 (8.9%) 19 (8.2%) 41 (13.3%) <0.001* 
Surgeon  36 (4.9%) 0 6 (7.3%) 2 (2.2%) 6 (2.6%) 22 (7.1%) 0.050 
Physician  21 (2.9%) 2 (9.5%) 7 (8.5%) 0 4 (1.7%) 8 (2.6%)  0.002* 
Nurse  20 (2.7%) 1 (4.8%) 3 (3.7%) 0 6 (2.6%) 10 (3.2%) 0.486 
Orthotist  4 (0.5%) 0 1 (1.2%) 1 (1.1%) 0 2 (0.6%) NA 
Other  9 (1.2%) 3 (14) 0 1 (1.1%) 0 5 (1.6%) NA 
Foot Disease History         
Previous Peripheral Neuropathy 728 99 (13.6%) 0 9 (11.0%) 13 (14.4%) 20 (8.7%) 57 (18.8%) 0.004* 
Previous PAD 728 97 (13.3%) 1 (4.8%) 7 (8.5%) 13 (14.4%) 17 (7.4%) 59 (19.4%) 0.001* 
Previous foot ulcer 731 72 (9.8%) 1 (4.8%) 6 (7.3%) 9 (10.0%) 17 (7.4%) 39 (12.7%) 0.228 
Previous amputation 731 30 (4.1%) 0 2 (2.4%) 3 (3.3%) 6 (2.6%) 19 (6.2%) 0.181 
Foot Risk Factors         
Peripheral Neuropathy 728 160 (22.0%) 3 (14.3%) 24 (29.6%) 16 (17.8%) 58 (25.1%) 59 (19.3%) 0.137 
PAD 728        
Mild PAD  69 (9.5%) 2 (9.5%) 7 (8.5%) 8 (8.9%) 25 (10.8%) 27 (8.9%)  
Moderate PAD  51 (7.0%) 0  5 (6.1%) 7 (7.8%) 18 (7.8%) 21 (6.9%)  
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Critical PAD  33 (4.5%) 1 (4.8%) 2 (2.4%) 3 (3.3%) 8 (3.5%) 19 (6.3%) 0.887 
Foot deformity  706 158 (22.4%) 2 (9.5%) 13 (16.0%) 20 (22.7%) 51 (22.5%) 72 (24.9%) 0.293 
Foot Disease          
Acute Charcot 730 2 (0.3%) 0 0 0 2 (0.9%) 0  NA 
Current foot ulcer 732 46 (6.3%) 0 6 (7.3%) 5 (5.6%) 10 (4.3%) 25 (8.1%) 0.298 
Current foot infection  723 24 (3.3%) 0 5 (6.2%) 3 (3.3%) 5 (2.2%) 11 (3.6%) 0.405 
Foot Risk Status 731        
Low risk  445 (60.9%) 15 (71.4%) 43 (52.4%) 59 (65.6%) 132 (57.1%) 196 (63.8%)  
At risk  111 (15.2%) 1 (4.8%) 20 (24.4%) 9 (10.0%) 50 (21.6%) 31 (10.1%)  
High risk   109 (14.9%) 4 (19.0%) 8 (9.8%) 16 (17.8%) 37 (16.0%) 44 (14.4%)  
Acute   66 (9.0%) 1 (4.8%) 11 (13.4%) 6 (6.7%) 12 (5.2%) 36 (11.7%) 0.001* 
Foot-related Condition Admission  732 82 (11.2%) 1 (4.8%) 13 (15.9%) 6 (6.7%) 14 (6.0%) 48 (15.6%) 0.002* 
[95% CI]  [9.1 – 13.7]       
Primary reason 732 54 (7.4%)  1 (4.8%) 10 (12.2%) 5 (5.6%) 5 (2.2%) 33 (10.7%) 0.002* 
[95% CI]  [5.7 – 9.5]       
Secondary reason 732 28 (3.8%  0 3 (3.7%) 1 (1.1%) 9 (3.9%) 15 (4.9%) NA 
[95% CI]  [2.6 – 5.5]       
*p Value of < 0.05; # Numbers also included in overall condition; 95% CI: 95% Confidence interval; IQR: Interquartile Range; GP: General Practitioner; Metro: Metropolitan; NA: Not applicable to test as the 
assumption of Chi-squared test is violated as 2 cells had expected count < 5; PAD: Peripheral Arterial Disease; SD: Standard deviation. 
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Supplementary Table S5-3:  Univariate analyses for participants with a foot-related condition as a primary or secondary reason for admission 
Variables Primary Foot-related Condition Admission Secondary Foot-related Condition Admission 
 n (%) Odds ratio [95% CI] p Value n (%) Odds ratio [95% CI] p Value 
Participants 54 (7.4%)   28 (3.8%)   
Medical Ward 18 (33.3%) 1.00  22 (78.6%) 1.00  
Surgical Ward 36 (66.7%) 3.71 [2.06-6.67] <0.001** 6 (21.4%) 0.45 [0.17-1.11] 0.083* 
Demographics       
Age (SD) years 621.(17.0) 1.00 [0.99-1.02] 0.962 63.5(19.3) 1.01 [0.98-1.03] 0.663 
Age groups   0.488   0.952 
18-40 years 6 (11.1%) 1.00  4 (14.3%) 1.00  
41-60 years 14 (25.9%) 1.40 [0.52-3.74] 0.509 6 (21.4%) 0.87 [0.24-3.17] 0.837 
61-80 years 28 (51.9%) 1.69 [0.68-4.19] 0.261 13 (46.4%) 1.14 [0.36-3.56] 0.826 
81+ years 6 (11.1%) 0.94 [0.29-3.00] 0.913 5 (17.9%) 1.18 [0.31-4.52] 0.806 
Male sex 33 (61.1%) 1.27 [0.72-2.23] 0.416 14 (50.0%) 0.78 [0.37-1.67] 0.528 
Social Determinants       
Socioeconomic Status    0.635   0.714 
Most disadvantaged 9 (17.6%) 1.00  5 (17.9%) 1.00  
Second most disadvantaged 15 (29.4%) 1.08 [0.45-2.56] 0.868 4 (14.3%) 0.50 [0.29-3.72] 0.311 
Middle 6 (11.8%) 0.67 [0.23-1.97] 0.471 5 (17.9%) 1.04 [0.29-3.72] 0.948 
Second least disadvantaged 14 (27.5%) 0.64 [0.27-1.53] 0.316 11 (39.3%) 0.93 [0.32-2.75] 0.898 
Least disadvantaged 7 (13.7%) 0.69 [0.25-1.92] 0.477 3 (10.7%) 0.53 [0.12-2.29] 0.399 
Geographic Remoteness    0.291   0.592 
Major city 27 (52.9%) 1.00  18 (64.3%) 1.00  
Inner regional area 12 (23.5%) 1.29 [0.64-2.61] 0.485 4 (14.3%) 0.62 [0.21-1.87] 0.397 
Outer regional area 9 (17.6%) 2.39 [1.07-5.33] 0.034 5 (17.9%) 1.90 [0.68-5.30] 0.221 
Remote area 0 0 NA 1 (3.6%) 0.80 [0.10-6.20] 0.830 
Very remote area 3 (5.9%) 1.89 [0.54-6.67] 0.323 0 0 NA 
<Year 10 Education Level 34 (63.0%) 1.49 [0.84-2.64] 0.174* 15 (53.6%) 0.98 [0.46-2.09] 0.960 
Indigenous  3 (5.6%) 1.23 [0.36-4.15] 0.741 0 0 NA 
Born overseas 6 (11.1%) 0.42 [0.18-1.00] 0.051* 5 (17.9%) 0.76 [0.26-2.04] 0.588 
Medical Condition History       
Diabetes 15 (27.8%) 1.28 [0.69-2.38] 0.438 19 (67.9%) 7.62 [3.38-17.17] <0.001** 
Hypertension 27 (50.0%) 1.05 [0.60-1.82] 0.876 15 (53.6%) 1.21 [0.57-2.58] 0.620 
Dyslipidaemia 13 (24.1%) 0.66 [0.35-1.25] 0.201 10 (35.7%) 1.19 [0.54-2.63] 0.661 
Myocardial Infarct 7 (13.0%) 0.58 [0.26-1.31] 0.189* 6 (21.4%) 1.10 [0.44-2.77] 0.838 
Cerebrovascular Accident 7 (13.0%) 1.15 [0.50-2.63] 0.745 3 (10.7%) 0.91 [0.27-3.09] 0.882 
Chronic Kidney Disease  6 (11.1%) 0.90 [0.37-2.16] 0.810 7 (25.0%) 2.53 [1.04-6.14] 0.040** 
Cancer 11 (20.4%) 0.81 [0.41-1.61] 0.546 6 (21.4%) 0.87 [0.35-2.19] 0.770 
Arthritis 23 (42.6%) 1.27 [0.72-2.22] 0.412 11 (39.3%) 1.09 [0.50-2.36] 0.832 
Depression 17 (31.5%) 1.33 [ 0.73-2.43] 0.347 10 (35.7%) 1.61 [ 0.73-3.55] 0.239 
Acute foot trauma 15 (27.8%) 23.36 [10.06-54.23] <0.001** 3 (10.7%) 3.56 [1.00-12.64] 0.050* 
Smoker 11 (20.4%) 1.61 [0.80-3.24] 0.180* 6 (21.4%) 1.69 [0.67-4.27] 0.268 
Ex-Smoker 21 (38.9%) 0.89 [0.51-1.57] 0.689 10 (35.7%) 0.78 [0.35-1.71] 0.529 
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Self-care Ability       
Mobility impairment 24 (44.4%) 1.68 [0.96-2.94] 0.071* 17 (60.7%) 3.27 [1.51-7.10] 0.003** 
Vision impairment 9 (16.7%) 1.14 [0.54-2.40] 0.733 6 (21.4%) 1.57 [0.62-3.96] 0.341 
Footwear worn: Inside   0.984   0.293 
Low risk footwear 6 (11.3%) 1.00  3 (11.1%) 1.00  
Moderate risk footwear 18 (34.0%) 0.92 [0.35-2.40] 0.862 14 (51.9%) 1.46 [0.41-5.22] 0.559 
High risk footwear 10 (18.9%) 0.97 [0.34-2.77] 0.953 2 (7.4%) 0.38 [0.06-2.32] 0.294 
No footwear worn 19 (35.8%) 1.05 [0.41-2.73] 0.919 8 (29.6%) 0.88 [0.23-3.39] 0.850 
Footwear worn: Outside   0.929   0.558 
Low risk footwear 28 (53.8%) 1.00  11 (40.7%) 1.00  
Moderate risk footwear 4 (7.7%) 0.72 [0.25-2.12] 0.551 4 (14.8%) 1.92 [0.50-6.20] 0.275 
High risk footwear 19 (36.5%) 1.05 [0.57-1.93] 0.871 12 (44.4%) 1.72 [0.75-3.96] 0.203 
No footwear worn 1 (1.9%) 0.91 [0.12-7.20] 0.913 0 0 NA 
Past Foot Treatment       
Yes 34 (63.0%) 3.50 [1.97-6.22] <0.001** 19 (67.9%) 4.17 [1.86-9.36] 0.001** 
Podiatry 20 (37.0%) 1.91 [1.07-3.41] 0.029** 14 (50.0%) 3.25 [1.52-6.95] 0.002** 
GP 25 (46.3%) 7.75 [4.29-13.98] <0.001** 9 (32.1%) 3.50 [1.53-7.99] 0.003** 
Surgeon 19 (35.2%) 21.14 [10.11-44.19] <0.001** 3 (10.7%) 2.44 [0.70-8.51] 0.160* 
Physician 4 (7.4%) 3.12 [1.01-9.61] 0.048** 2 (7.1%) 2.78 [0.61-12.56] 0.185* 
Nurse 10 (18.5%) 15.21 [6.01-38.46] <0.001** 3 (10.7%) 4.86 [1.34-17.65] 0.016** 
Orthotist 4 (7.4%) NA NA 0 0 NA 
Other 0 0 NA 0 0 NA 
Foot Disease History       
Previous Peripheral Neuropathy 29 (37.0%) 4.43 [2.43-8.07] <0.001** 6 (21.4%) 1.78 [0.70-4.51] 0.224 
Previous PAD 28 (51.9%) 9.44 [5.24-17.02] <0.001** 9 (32.1%) 3.29 [1.45-7.51] 0.005** 
Previous foot ulcer 26 (48.1%) 12.74 [6.91-23.49] <0.001** 12 (42.9%) 8.04 [2.63-17.78] <0.001** 
Previous amputation 15 (27.8%) 16.97 [2.74-37.22] <0.001** 3 (10.7%) 3.00 [0.85-10.57] 0.086* 
Foot Risk Factors       
Peripheral Neuropathy 24 (45.3%) 3.28 [1.85-5.82] <0.001** 11 (40.7%) 2.55 [1.16-5.61] 0.020** 
PAD    <0.001**   <0.001** 
Nil PAD 25 (47.2%) 1.00  12 (44.4%) 1.00  
Mild PAD 0 0 NA 4 (14.8%) 2.89 [0.91-9.21] 0.073* 
Moderate PAD 10 (18.9%) 5.37 [2.41-11.93] <0.001** 7 (25.9%) 7.46 [2.80-19.91] <0.001** 
Critical PAD 18 (34.0%) 26.40 [11.94-58.39] <0.001** 4 (14.8%) 6.47 [1.97-21.30] 0.002** 
Foot deformity 16 (32.0%) .170 [0.91-3.18] 0.094* 7 (25.9%) 1.22 [0.51-2.95] 0.653 
Foot Disease        
Current foot ulcer 24 (44.4%) 23.86 [12.03-47.30] <0.001** 12 (42.9%) 14.78 [6.48-33.69] <0.001** 
Current foot infection  19 (40.4%) 91.06 [31.70-261.58] <0.001** 3 (11.5%) 4.20 [1.17-15.09] 0.028** 
Foot Risk Status   <0.001**   <0.001** 
Low risk  2 (3.7%) 1.00  5 (17.9%) 1.00  
At risk  1 (1.9%) 2.01 [0.18-22.41] 0.569 4 (14.3%) 3.29 [0.87-12.46] 0.080* 
High risk  12 (22.2%) 27.40 [6.04-124.41] <0.001** 5 (17.9%) 4.23 [1.20-14.88] 0.025** 
Acute  39 (72.2%) 319.94 [73.33-1395.90] <0.001** 14 (50.0%) 23.69 [8.20-68.44] <0.001** 
*p < 0.2; **p < 0.05; GP: General Practitioner; PAD: Peripheral Arterial Disease; SD: Standard deviation. 
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Table 5-3:   Independent associated factors for primary admissions for foot-related 
conditions using multivariate logistical regression (Odds Ratios [95% CI]) 
Risk Factor Unadjusted p Value Adjusted p Value 
Model 1     
Myocardial Infarct  0.15 [0.03-0.70] 0.016* 0.34 [0.06-1.90] 0.219 
Acute foot trauma 29.49 [7.28-119.48] <0.001* 73.32 [15.86-338.92] <0.001* 
PAD   <0.001*  <0.001* 
Nil PAD Referent  Referent  
Mild PAD 0 NA 0 NA 
Moderate PAD 2.37 [0.62-9.04] 0.207 5.45 [1.05-28.23] 0.044 
Critical PAD 53.60 [16.82-170.84] <0.001* 140.56 [30.82-641.04] <0.001* 
Current foot infection  29.39 [7.52-114.83] <0.001* 53.11 [9.89-285.17] <0.001* 
Past GP treatment 4.65 [1.64-13.20] 0.004* 7.61 [2.30-25.19] 0.001* 
Past surgeon treatment 5.88 [1.66-20.81] 0.006* 6.98 [1.91-25.54] 0.003* 
Model 1 Results: Pseudo R2: 0.602; 
Omnibus: df = 8, p<0.001 
Missing: 14 (1.9%);  
H&L: p = 0.013 
Pseudo R2: 0.657; 
Omnibus: df = 15, p<0.001 
Missing: 36 (4.9%);  
H&L: p = 0.880 
Model 2 + Past Foot Treat    
Foot risk status  <0.001*  <0.001* 
Low risk  Referent  Referent  
At risk  1.66 [0.15-18.76] 0.682 2.01 [0.18-23.16] 0.574 
High risk  23.12 [5.05-105.95] <0.001* 39.57 [8.15-192.05] <0.001* 
Acute  181.44 [40.52-812.51] <0.001* 158.63 [30.34-829.51] <0.001* 
Past GP treatment 2.70 [1.17-6.25] 0.020* 6.40 [2.36-17.40] <0.001* 
Past surgeon treatment 4.31 [1.49-12.44] 0.007* 11.62 [3.46-39.03] <0.001* 
Model 2 Results: Pseudo R2: 0.582; 
Omnibus: df = 5, p<0.001 
Missing: 2 (0.3%);  
H&L: p = 0.861 
Pseudo R2: 0.638; 
Omnibus: df = 10, p<0.001 
Missing: 2 (0.3%);  
H&L: p = 0.954 
*p < 0.05; df: degrees of freedom; H&L: Hosmer and Lemeshow Test; Missing: Excluded missing cases; NA: Not applicable; 
Omnibus: Omnibus Tests of Model Coefficients; Pseudo R2: Nagelkerke R2; GP: General Practitioner; PAD: Peripheral Arterial 
Disease. 
 
 
 
Table 5-4:  Independent associated factors for secondary admissions for foot-related 
conditions using multivariate logistical regression (Odds Ratios [95% CI]) 
Risk Factor Unadjusted p Value Adjusted p Value 
Model 1     
Diabetes 5.46 [2.33-12.78] <0.001* 4.89 [2.07-11.57] <0.001* 
Current foot ulcer 9.84 [4.13-23.45] <0.001* 4.94 [2.12-16.67] 0.001* 
Model 1 Results: Pseudo R2: 0.233; 
Omnibus: df = 2, p <0.001 
Missing: 1 (0.1%);  
H&L: p = 0.755 
Pseudo R2: 0.259; 
Omnibus: df = 4, p = <0.001 
Missing: 5 (0.7%);  
H&L: p = 0.425 
Model 2     
Diabetes 5.27 [2.23-12.45] <0.001* No confounders identified  
Foot risk status  <0.001*   
Low risk  Referent    
At risk  2.19 [0.56-8.55] 0.258   
High risk  2.81 [0.78-10.18] 0.116   
Acute  16.12 [5.40-48.11] <0.001*   
Model 2 Results: Pseudo R2: 0.261; 
Omnibus: df = 4, p <0.001 
Missing: 2 (0.3%);  
H&L: p = 0.680 
  
*p < 0.05; df: degrees of freedom; H&L: Hosmer and Lemeshow Test; Missing: Excluded missing cases; NA: Not applicable; 
Omnibus: Omnibus Tests of Model Coefficients; Pseudo R2: Nagelkerke R2. 
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Supplementary Table S5-4:  Data collector testing pre- and post-training  
QFDF Field Pre-Training Post-Training p Value 
 n % n %  
Data Collectors Completing 22  27   
Demographics       
Study Code 3 13.6 27 100 NA 
Hospital 15 68.2 27 100 0.002* 
Ward 13 59.1 27 100 <0.001* 
Eligible 20 90.9 27 100 0.196 
Consent 21 95.5 27 100 0.449 
Sex 22 100 27 100 1.00 
Age 22 100 27 100 1.00 
Social Determinants      
Postcode 22 100 27 100 1.00 
Indigenous 20 90.9 27 100 0.196 
Born Overseas 22 100 27 100 1.00 
Highest Education Level 19 86.4 27 100 0.084 
Medical Conditions History    
Diabetes  22 100 27 100 1.00 
Diabetes duration # 22 100 27 100 1.00 
HbA1c result # 21 95.5 26 96.3 1.00 
Hypertension 22 100 27 100 1.00 
Dyslipidaemia 22 100 27 100 1.00 
Myocardial Infarct 17 77.3 27 100 0.014* 
CVA 21 95.5 27 100 0.449 
CKD 20 90.9 27 100 0.196 
ESKD 22 100 27 100 1.00 
Cancer 22 100 27 100 1.00 
Arthritis 21 95.5 27 100 0.449 
Depression 22 100 27 100 1.00 
Acute foot trauma 22 100 22 81.5 0.056 
Smoker 22 100 27 100 1.00 
Ex-smoker 21 95.5 27 100 1.00 
Other (non-listed) 17 77.3 27 100 0.014* 
Self-care Ability    
Mobility impairment 22 100 26 96.3 1.00 
Vision impairment 11 50.0 27 100 <0.001* 
Footwear worn: Inside 20 90.9 27 100 0.196 
Footwear worn: Outside 19 86.4 27 100 0.084 
Past Foot Treatments      
Yes 22 100 27 100 1.00 
Podiatrist 20 90.9 27 100 0.196 
GP 22 100 27 100 1.00 
Nurse 21 95.5 27 100 0.449 
Orthotist 22 100 27 100 1.00 
Physician 22 100 27 100 1.00 
Surgeon 19 86.4 27 100 0.084 
Other 20 90.9 27 100 0.196 
Foot Disease History      
Previous Peripheral Neuropathy 22 100 26 96.3 1.00 
Previous PAD 20 90.9 27 100 0.196 
Previous foot ulcer 22 100 27 100 1.00 
Previous amputation 22 100 27 100 1.00 
Foot Risk Factors    
Peripheral Neuropathy 22 100 26 96.3 1.00 
PAD  20 90.9 26 96.3 0.581 
Foot deformity 21 95.5 21 77.8 0.112 
Foot Disease    
Acute Charcot 22 100 26 96.3 1.00 
Current foot ulcer 22 100 27 100 1.00 
Current foot infection * 18 81.8 27 100 0.034* 
Current amputation 21 95.5 26 96.3 1.00 
Foot risk status classification 19 86.4 27 100 0.084 
Ulcer type * 14 63.6 23 85.2 0.104 
Ulcer location:  1 4.5 23 85.2 NA 
Ulcer surface 1 4.5 23 85.2 NA 
Combined surface area mm2# 19 86.4 25 92.6 0.646 
UTWCS grade # 10 45.5 25 92.6 <0.001* 
Foot-related Condition Admission      
Reason for admission 21 95.5 27 100 0.449 
Total      
Mean %  87.2% 97.7% < 0.001* 
Mean Score (SD) 49.7(4.2) 55.7(1.8) < 0.001* 
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Median (IQR) 51 
(48.75 - 52.25) 
56 
(55.0 – 57.0) 
< 0.001* 
*p Value of < 0.05; CKD: Chronic Kidney Disease; CVA: Cardiovascular Accident; ESKD End Stage Kidney Disease; GP: 
General Practitioner; IQR: Interquartile Range; NA: Not applicable to test as the assumption of Chi-squared test is violated as 2 
cells had expected count < 5; PAD: Peripheral Arterial Disease; SD: Standard Deviation; UTWCS: University of Texas Wound 
Classification System. 
 
 
Supplementary Table S5-5:  Agreement between sub-sample of participants’ study 
data and medical records 
QHRFF Item n Study  
Data 
Medical 
Records 
% K (SE) 
 
Strength of  
Agreement 
Demographics       
Age# 44 -- --  1.00 (1.00 – 1.00) Strong 
Male Sex 44 25 25 100 1.00 (0.01) Near Perfect 
Social Determinants       
Postcode* 40 -- -- 92.5 0.92 (0.05) Near Perfect 
Indigenous Status   28 1 1 100 1.00 (0.01) Near Perfect 
Born overseas 27 5 5 100 1.00 (0.01) Near Perfect 
Medical Condition History       
Diabetes  28 7 6 96.4 0.90 (0.10) Near Perfect 
Hypertension 28 17 14 82.1 0.64 (0.14) Substantial 
Dyslipidaemia 28 11 9 92.9 0.85 (0.10) Near Perfect 
Myocardial Infarct 28 8 4 85.7 0.59 (0.17) Moderate 
CVA 28 3 2 89.3 0.34 (0.29)  Fair 
CKD 28 3 4 96.4 0.84 (0.16) Near Perfect 
ESKD 28 0 0 100 -- -- 
Cancer 28 7 3 85.7 0.53 (0.19) Moderate 
Arthritis 28 12 11 89.3 0.78(0.12) Substantial 
Depression 28 8 5 82.1 0.51 (0.18) Moderate 
Acute foot trauma 28 1 0 96.4 -- -- 
Smoker 28 8 8 100 1.0 (0.01) Near Perfect 
Ex-smoker 28 11 2 67.9 0.23 (0.13) Fair 
Foot-related Condition Admission       
Reason for admission* 28 1 1 100 1.00 (0.01) Near Perfect 
*Weighted Kappa used for ordinal data; #Intraclass correlation (Standard Deviation (SD)) for continuous data; -- = Measure of 
agreement was unable to be calculated because at least one variable was a constant or was a continuous variable; % = 
Percentage agreement; CKD: Chronic Kidney Disease; CVA: Cerebrovascular Accident; ESKD: End Stage Kidney Disease; K 
= Kappa (Standard Error (SE)  
 
 
5.6 DISCUSSION 
Principal findings 
We believe this is the first study to investigate the direct inpatient burden 
caused by all foot-related conditions within a representative inpatient population.  
Our findings indicate 7.4% of all inpatients were hospitalised for the primary reason 
of a foot-related condition; including 4.9% for foot disease and 2.1% foot trauma.  
Interestingly only 28% of those had diabetes.  An additional 3.8% were hospitalised 
with a foot-related condition as a secondary reason for admission; including 1.8% for 
foot disease and 0.1% foot trauma.  Being admitted for the primary reason of a foot-
related condition was independently associated with having critical PAD, foot 
infection, acute foot trauma or past foot treatment by a surgeon or GP.  Whereas, 
being admitted for a secondary reason of a foot-related condition was independently 
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associated with having diabetes or a current foot ulcer.  Overall, these findings 
suggest the direct inpatient burden caused by foot-related conditions is significantly 
higher than previously reported, affecting one in 13 inpatients with the majority not 
related to diabetes.   
 
Interpretations of findings 
The large disparity between our 7.4% direct foot-related inpatient burden 
finding and the 1.2% in the only previous similar study [186] may be explained by a 
number of methodological differences.  The previous study identified patients by 
retrospectively investigating a standard generic hospital discharge dataset to identify 
if only foot disease codes were recorded [186], whereas our study prospectively 
examined all inpatients to identify if any possible foot-related conditions were 
present.  Yet, our study still reported a much higher rate for those hospitalised for 
foot disease only (4.9%) compared to the previous study (1.2%) [186].    
Retrospective analyses compared to prospective examinations have been found to 
under-report foot-related admissions in the same Australian inpatient population by 
three-fold [5].  Additionally, the previous study investigated only the number of 
hospital admissions [186], regardless of the length of hospital stay during these 
admissions, whereas our study investigated a single representative occupied hospital 
bed day period.  As foot-related admissions’ length of stay uses three-fold the 
number of occupied hospital bed days than the average hospital admissions’ length 
of stay in Australia [2, 306], our use of a single occupied hospital bed day period 
enables us to control for different lengths of stay, and are thus, a much more specific 
measure of the inpatient resources used by hospitals than using crude admission 
numbers only.   These methodological improvements compared to the previous study 
suggest our findings are plausible and much higher than previously reported.  
We found only 28% of foot-related hospitalisations were in people with 
diabetes which was similar to the 15% reported in the previous study [186].  This 
suggests the majority of the inpatient foot-related burden may not be caused by 
diabetes as has been traditionally considered [1, 2].  Our findings equate to 2.0% of 
all inpatients, on a given day, are in hospital because of diabetes-related foot disease 
in Queensland.  Considering a recent retrospective study of the Queensland hospital 
discharge dataset identified that 0.9% of all occupied hospital bed days in 
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Queensland were primarily used to manage diabetes-related foot disease [306], plus 
the under-reporting in retrospective studies [5], our findings again seem plausible.  
Our study’s findings also appear generalizable to Australian and other 
developed nations’ populations.  First, we purposively investigated hospitals that 
were representative of each of the different Australian peer-group hospital categories 
as defined by the National Health Performance Authority [307].  Second, we 
reported a high consenting rate of all inpatients present on a representative day and 
found no demographic differences between our consenting and non-consenting 
eligible participants.  Third, the mean maximum temperatures during the months of 
recruitment at the five hospitals ranged from 20-30 degrees Celsius and were 
considered temperate and generalizable [323]. Fourth, and perhaps most importantly, 
our study’s inpatient population had very similar socio-demographic characteristics 
to those reported for the Australian national general population [324] and Australian 
national inpatient population [30].  These similarities included our study reporting 
5% indigenous Australians versus 3% for the national general population and 4% for 
the national inpatient population; 61% major city residents versus 60% general and 
64% inpatient, and, 4% very remote residents versus 3% general and 2% inpatient; 
36% socio-economically disadvantaged versus 40% general and 44% inpatient; 46% 
year 12 high school educated versus 52% general and not reported inpatient; and 
22% born overseas versus 26% general and not reported inpatient [30, 324].  
Although, our study’s mean age of 62 years was older than the median age of 37 
years in the general population and not reported in the inpatient population, and, had 
56% males compared to 50% in the general and 46% in the inpatient population [30, 
324], this can be explained by our study excluding children and the large female 
maternity inpatient cohort.  Last, the 23.5% inpatient diabetes prevalence found in 
our Queensland study was similar to the 24.7% reported in Victoria (Australia) [32], 
26.2% in the United States (US) [325, 326], but higher than 15.8% in the United 
Kingdom (UK) [327].  The diagnosed diabetes population prevalence in Queensland 
is 4.5% and 5.0% in Victoria [328]; whilst the estimated national diabetes population 
prevalence for Australia is 7.8%, 9.2% in the US and 4.9% in the UK [329].  Also 
diabetes-related amputation rates that are often used as a surrogate measure of the 
foot disease burden also showed similar national trends; with 15 per 100,000 people 
reported in Queensland [306], 18 in Australia, 36 in the US and 9 in the UK [330, 
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331].  Overall, these interpretations suggest our findings are not only plausible, but 
are also highly representative for the Australian population and potentially 
generalizable to other developed nations’ populations. 
Our study also found that nearly all those primarily hospitalised for a foot-
related condition were due to foot disease (67%) or foot trauma (28%).  These 
findings were supported by our multivariate models reporting they were 
independently associated with a foot disease disorder (critical PAD, foot infection or 
foot ulceration), acute foot trauma or had previous foot treatment from a GP or 
surgeon. These same independent associates have been consistently identified in 
diabetes inpatient populations [10, 17, 301, 303]; however, our findings adjusted for 
diabetes in a representative inpatient population.  Furthermore after adjustment, 
inpatients classified with acute foot risk status were much more likely to be in 
hospital for the primary reason of a foot-related condition than those of lower foot 
risk status.  This suggests, regardless of diabetes, that using a diabetes foot risk status 
system [38, 262] may be useful to identify people highly likely to be admitted to 
hospital because of a foot-related condition.   
In addition to those primarily hospitalised for a foot-related condition, 3.8% of 
participants reported a foot-related condition as a secondary reason for their 
admission. This meant the participant had been primarily admitted for another health 
condition, yet also required treatment in hospital to manage a foot-related condition 
[310].  To the best of the authors’ knowledge, no study has investigated the 
prevalence of secondary foot-related admissions.  Participants with a secondary foot-
related condition were more likely to have diabetes or a current foot ulcer.  This is 
not surprising considering people with diabetes have very high rates of foot-related 
conditions compared to other disease processes in the population [4, 37, 186].  
Furthermore, those with a current foot ulcer typically require frequent wound 
dressing changes [1, 262] within the average length of hospital admission [2, 186, 
306].  Overall, the primary and secondary reason for admission findings indicates 
that 11.2% of all inpatients need treatment for a foot-related condition during their 
hospitalisation. 
The type of hospital and ward also appeared to impact on the prevalence of 
people admitted due to a foot-related condition.  Our findings indicate major general 
hospitals have higher prevalence of people admitted with a foot-related condition 
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than other hospital types.  Those admitted with a foot-related condition as the 
primary reason were also more likely to be in a surgical ward, whereas those 
admitted as a secondary reason were mostly found in a medical ward.  These findings 
may be explained by major general hospitals housing more of the necessary surgical 
disciplines needed to effectively manage complex foot-related conditions [5, 10, 16, 
17, 262, 295, 332], and thus more of these patients being transferred to these 
hospitals. Although this study has focussed on inpatient explanations, the impact of 
available outpatient services cannot be discounted [306].  This is especially the case 
considering recent significant reductions in Australian state-based diabetes-related 
foot admission and amputation rates have been reportedly associated with improved 
access to outpatient multidisciplinary foot services [306] and podiatry care via 
government-funded care plans in Australia [320]. 
 
Implications for policy makers, clinicians and researchers  
Our findings have significant potential implications for policy makers.  To 
contextualise these finding, an ‘average’ 600-bed hospital could expect to manage 44 
inpatients each night for the primary reason of a foot-related condition; including 29 
for foot disease and 13 for acute foot trauma.  This equates to an annual direct cost of 
AU$15.6 million for an average hospital if assuming AU$971 (2015) per Australian 
hospital bed day [333].  Forecasting this across Australia’s 49,153 public hospital 
beds [334], suggests Australia would need 3,637 hospital beds each night, or 1.33 
million beds each year, at an annual cost of AU$1.29 billion to primarily manage 
foot-related conditions.  Assuming a conservative 13-day average length of stay for 
foot-related conditions [1, 2, 36, 186, 306], indicates Australia has over 102,000 
annual primary admissions for foot-related conditions; including 67,600 for foot 
disease and 27,600 for acute foot trauma.  With cellulitis ranked as the 10
th
 leading 
cause of Australian public hospital admissions with 35,248 admissions [30], these 
figures would place foot-related conditions in the top 10 causes of hospital admission 
in Australia.  Interestingly, two thirds of these reported cellulitis admissions were 
infections in the lower leg and foot [30].  These figures are likely to be conservative 
as they do not account for private hospitals, surgical procedures, secondary foot-
related admissions and any other foot-related inpatient management.  
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These findings also suggest clinicians should focus their inpatient foot-related 
strategies on foot disease and foot trauma, regardless of diabetes.  First, we 
recommend using a simple foot risk screening tool [38, 262], or foot ulcer visual 
inspection, as admission triage strategies to improve identification of inpatient foot-
related conditions.  Like recent amputation prediction tools [10], these tools could 
also be enhanced by including critical PAD in the acute foot category to further 
improve identification.  Second, our findings indicate those people hospitalised for a 
foot-related condition had not previously attended the recommended outpatient 
multi-disciplinary foot team members [1, 17, 262, 306].  Thus, we recommended all 
people with foot-related conditions have access to outpatient multi-disciplinary foot 
teams, regardless of diabetes status.   Third, our findings support other authors 
recommending episodes of foot-related hospitalisation should be an opportunity to 
triage inpatients into multi-disciplinary foot teams for best practice care [26, 176, 
192].  Last, it is suggested strategies already demonstrated to reduce the inpatient 
diabetic foot burden should be considered for all inpatients admitted for foot-related 
conditions, such as triaging foot-related admissions into specialist multi-disciplinary 
foot wards [1, 17, 26, 176].   
Our findings also support further research.  First, to confirm the findings of this 
study we recommend implementing methodologically similar research in other 
regions [17, 26, 37].  Second, our findings support recommendations that hospital 
discharge data coders are trained to more accurately identify and code foot-related 
condition admissions to enable more effective monitoring of standard hospital 
discharge datasets [5, 37].  Third, we recommend reporting the use of occupied 
hospital bed days, rather than whole admissions, to more specifically measure the 
burden of hospitalisation.  Fourth, the foot disease and foot trauma factors identified 
in this study should be investigated for ‘up stream’ factors that may predict these 
foot-related hospitalisations. Last, it is recommended that clinical trials implementing 
strategies demonstrated to reduce the inpatient diabetic foot disease burden should be 
evaluated on all inpatients admitted for foot-related conditions. 
 
Strengths and weaknesses 
This study has several strengths.  First, the study’s findings are readily 
generalizable as we purposively investigated hospitals representative of the different 
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peer-group categories of Australian hospitals [307] and our resulting study 
population reported similar demographic, social determinant and medical history 
characteristics to those reported for Australia’s and other developed nations’  
populations [30, 32, 324].  Second, this study recruited total participant numbers 
<3% of the original sample size calculated, reported a robust consent rate >80% [31], 
and reported no differences in demographic characteristics between consenting and 
non-consenting inpatients.  Third, the study used a data collection instrument 
modified from a very similar valid and reliable data collection instrument [38] that 
captured a range of internationally defined self-reported or clinically diagnosed foot-
related variables [335].  Fourth, data collectors had previous similar data collection 
experience, further specific training and reported high accuracy and validity when 
tested against simulated cases and medical records.  Last, the multivariate models 
used in this study were recommended to identify independent associated factors after 
adjusting for identified confounders and the sample size was large enough to account 
for over 50 variables [318, 319]. 
This study also had a number of limitations.  First, the study was cross-
sectional and can only report on associated factors and not causal relationships [273].  
Second, as a point-prevalence study, it relies on the day of data collection being 
representative of standard inpatient activity [273].  Third, whilst excluding 
cognitively impaired patients is standard [31-34], this may have introduced a 
selection bias towards under-reporting foot-related conditions as excluded patients 
were mostly older cognitively impaired patients that have higher foot disease rates 
than cognitively intact patients [336].   Fourth, although standard self-reported 
medical history and clinically-diagnosed foot-related variables were used these were 
not gold standard biomedical criteria and may under-report medical conditions [10, 
32, 332].  Fifth, whilst the study used a data collection instrument modified from an 
existing valid and reliable instrument it was only retested against simulated cases and 
medical records, which limits our knowledge on its validity and reliability for 
capturing this data [273].  Last, as this study used over 100 statistical tests there is 
the likelihood of a type 1 statistical error [273, 318, 319].  
 
 Chapter 5: Direct inpatient burden caused by foot-related conditions: a multi-site point-prevalence study 145 
5.7 CONCLUSIONS 
This is the first study to investigate the burden caused by people admitted to 
hospital because of foot-related conditions within a representative inpatient 
population.  Findings indicate the burden is significantly higher than previously 
reported with one in every 13 inpatients in hospital for the primary reason of a foot-
related condition.  These patients were mostly affected by foot disease or foot 
trauma, in major general hospitals and most did not have diabetes.  It is 
recommended that serious consideration be given to future strategies to investigate 
and intervene in this considerable, yet historically under-appreciated, inpatient 
burden. 
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Chapter 6: The silent overall burden of foot 
disease in a representative 
hospitalised population 
This chapter begins with a preface section that briefly explains the manuscript 
that makes up this results chapter (section 6.1).  An adapted version of the 
manuscript published in the International Wound Journal, “The silent overall burden 
of foot disease in a representative hospitalised population” is then presented; 
including: abstract and key messages (section 6.2), introduction (section 6.3), 
methods (section 6.4), results (section 6.5) and discussion sections (section 6.6). 
 
6.1 PREFACE 
Chapter 5 described in detail the methodology employed by this thesis’ major 
study and reported initial results on the proportion of people admitted to hospital 
because of a foot-related condition and the factors associated with those admissions.  
The chapter identified that 7.4% of the direct inpatient burden was caused by foot-
related conditions in a representative inpatient population, which is much higher than 
previously appreciated.  Of those patients approximately two thirds were admitted 
because of foot disease disorders, specifically foot ulcers, foot infections and critical 
PAD (ischaemia).  The remaining one third was admitted for acute foot trauma such 
as fractures, burns or other acute wounds. 
Chapter 6 uses the new knowledge gleaned from Chapter 5 to investigate the 
proportion of the overall inpatient burden that is associated with the presence of foot 
disease or foot trauma.  To be present these foot-related conditions had to be 
clinically-diagnosed on physical examination by one of the study’s data collectors; 
the condition could be either the cause of the admission (direct burden) or an 
incidental finding (indirect burden). The chapter summarises the methodology used 
in Chapter 5 and then investigates additional detailed foot-related condition outcome 
variables representing foot disease (foot ulcers, foot infections and critical ischaemia) 
and foot trauma (acute traumatic foot wounds).  Lastly, the prevalence and associated 
factors of new amputation procedures undertaken during admission are investigated.  
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Amputation procedures in this context are representative of the most severe foot-
related conditions in inpatient populations.  The manuscript that forms the basis of 
this chapter has been adapted from the manuscript published in the International 
Wound Journal: 
Lazzarini PA, Hurn SE, Kuys SS, Kamp MC, Ng V, Thomas C, Wills J, Jen 
S, Kinnear EM, d'Emden MC, Reed L. The silent overall burden of foot disease in a 
representative hospitalised population. International Wound Journal 2016; 
doi:10.1111/iwj.12683 [40]. 
 
6.2 ABSTRACT 
The aims of this study were to investigate the point-prevalence, and 
independent factors associated, for foot disease (ulcers, infections and ischaemia) in 
a representative hospitalised population.  We included 733 (83%) of 883 eligible 
adult inpatients across five representative Australian hospitals on one day.  We 
collected an extensive range of self-reported characteristics from participants.  We 
examined all participants to clinically diagnose foot disease (ulcers, infections, 
ischaemia) and amputation procedures.  Overall, 72 participants (9.8%) (95% CI: 
7.2-11.3%) had foot disease.  Foot ulcers, in 49 participants (6.7%), were 
independently associated with peripheral neuropathy, peripheral arterial disease, 
previous foot ulcers, acute foot trauma and past surgeon treatment (p<0.05).  Foot 
infections, in 24 (3.3%), were independently associated with previous foot ulcers, 
acute foot trauma and past surgeon treatment (p<0.01).  Ischaemia, in 33 (4.5%), was 
independently associated with older age, smokers and past surgeon treatment 
(p<0.01).  Amputation procedures, in 14 (1.9%), were independently associated with 
foot infections (p<0.01). We found one in every ten inpatients had foot disease and 
less than half of those had diabetes.  After adjusting for diabetes, factors linked with 
foot disease were similar to those identified in diabetes-related literature.  The overall 
inpatient foot disease burden is similar in size to more well-known medical 
conditions and should receive similar attention.    
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Key Messages 
o the prevalence and factors associated with foot disease is well-known in 
hospitalised patients with diabetes; yet, unknown in all hospitalised 
patients.  
o we examined a representative sample of 733 hospitalised patients in 5 
Australian hospitals to investigate for foot disease and amputation 
procedures 
o foot disease was clinically-diagnosed in 10% of all hospitalised patients 
and 2% of all patients were recovering from an amputation procedure 
o of those with foot disease (ulcers, infections or ischaemia) most did not 
have diabetes 
o foot disease was linked to similar independent factors that have been found 
in diabetes-related foot disease literature; yet, we adjusted for diabetes 
 
6.3 INTRODUCTION 
Foot-related conditions have been frequently reported to be a leading cause of 
diabetes-related hospitalisation [1, 2, 186].  Our recent study went a step further and 
found that foot-related conditions, and in particular foot disease, were a leading 
cause of all hospitalisation [39].  We reported foot-related conditions were the 
primary reason for hospitalisation in 7.4% of a representative Australian inpatient 
population [39].  Two-thirds of those were for the foot disease disorders of ulcers, 
infections and ischaemia; whilst the remainder were for acute foot trauma and 
amputation [39]. While our previous study was the first to quantify the direct 
inpatient burden [39], the overall foot-related inpatient burden made up of the direct 
burden (causing admission) and indirect burden (present during admission) remains 
to be quantified [36, 37].  
Two recent reviews have interrogated the existing literature investigating the 
foot-related conditions present in inpatients [36, 37].  A narrative review confirmed 
foot disease, and specifically foot ulcers, to be the leading foot-related conditions 
present in both specific and representative inpatient populations [36].  Additionally, a 
systematic review could only identify enough literature to calculate a pooled 
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prevalence estimate for one sub-group of foot-related conditions present in 
representative inpatient populations, that was, 4.7% for diabetes-related foot disease 
in representative inpatient populations [37].  However, this pooled prevalence 
estimate reported very high heterogeneity due to included studies reporting a variety 
of definitions for foot disease with none including ischaemia in their definition [37].  
The contemporary definition of foot disease is now well-recognised to include foot 
ulcers, infections and ischaemia [10, 37].   Thus, neither review was able to identify 
any studies investigating the prevalence, or associated factors, for foot disease or all 
foot-related conditions in a representative inpatient population [36, 37].   
In order for policy makers, clinicians and researchers to fully appreciate the 
overall inpatient burden related to foot conditions, it seems necessary to investigate 
the common foot-related conditions that are most likely to make up this burden in 
representative inpatient populations.  According to the literature this burden is most 
likely to be made up predominantly of foot disease (ulcers, infections and 
ischaemia); with acute traumatic foot wounds and amputation procedures 
contributing the rest of this burden [36, 37, 39].  Thus, the primary aims of this study 
were to investigate the point-prevalence, and independent factors associated, for foot 
disease (ulcers, infection and ischaemia) in a representative hospitalised population.  
The secondary aims were to investigate the point-prevalence, and independent 
factors associated, for major foot-related conditions (foot disease, acute wounds and 
amputation procedures) present in the same population.   
 
6.4 METHODS 
Study design and settings 
This study was part of the Foot Disease in Inpatients Study, a multi-site 
observational point-prevalence study carried out in five public hospitals in 
Queensland, Australia [39].  The five hospitals have been described in detail 
elsewhere [39].  In brief, each hospital was purposively selected to be representative 
of different categories of one of the five categories of peer-group hospitals in 
Australian according to the National Health Performance Authority, including a: 
major metropolitan general hospital (>500 beds in South Queensland), major 
metropolitan specialist hospital (>500 beds in South Queensland), major regional 
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general hospital (>200 beds in Central Queensland), large metropolitan general 
hospital (>200 beds in South Queensland), and a large regional general hospital (>50 
beds in North Queensland) [39].  Institutional ethics committees approved this study 
and all participants gave written informed consent [39].  This study’s design, 
methodology and definitions have been described previously [39]. 
 
Participants 
Eligible participants were all adult inpatients present on the designated day of 
data collection at each of the five hospitals.  Excluded were those younger than 18 
years; cognitively impaired; or in a paediatric, maternity or psychiatric ward [39].  
Sample size calculations determined that 750 participants were required to 
adequately power this study [39].  Briefly, 1,146 inpatients were present during data 
collection days; 883 met the inclusion criteria and 733 (83%) and were included in 
this study [39].   
 
Variables collected  
The explanatory variables used for this study have been defined in detail 
elsewhere and included self-reported and clinically diagnosed variables [39].  In 
brief, the self-reported explanatory variables were grouped into demographic (age 
and sex); social determinant (socioeconomic status, geographical remoteness, 
education levels achieved, country of birth and Australian indigenous status);  
medical condition history (diabetes, hypertension, dyslipidaemia, myocardial infarct, 
cerebrovascular accident, chronic kidney disease, cancer, arthritis, depression, acute 
foot trauma and smoking history); self-care ability (mobility impairment, vision 
impairment, main footwear worn outside and main footwear worn inside house); and 
past foot treatment in the previous 12 months prior to hospitalisation (by podiatrist, 
general practitioner, specialist physician, surgeon, nurse, orthotist and other) 
variables [39].  Main footwear worn variables were then collapsed into low-risk 
footwear (walking shoe, runner, oxford shoe, boot or bespoke footwear), moderate-
risk footwear (moccasin, ugg boot, slipper or backless slipper), high-risk footwear 
(high heels, flip flops, court shoe, mule or sandal) and no footwear (socks only or 
barefoot) [39].  The clinically diagnosed explanatory variables included  previous 
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foot ulcer (self-reported with clinical examination to confirm); previous amputation 
(self-reported with clinical examination to confirm); peripheral neuropathy (absence 
of sensation to a 10-gram monofilament on two or more of three plantar forefoot 
locations); peripheral arterial disease (absence of at least one foot pulse and a toe 
systolic pressure <70mmHg) and foot deformity (three or more of small muscle 
wastage, bony prominence, prominent metatarsal heads, hammer/claw toes, limited 
joint mobility and Charcot deformity) on at least one foot [39].  Peripheral arterial 
disease (PAD) was further categorised into mild PAD (toe systolic pressure of 51-
70mmHg), moderate PAD (toe systolic pressure 31-50mmHg) and critical 
PAD/ischaemia (toe systolic pressure <30mmHg) [39]. The outcome variables for 
this study were clinically diagnosed foot-related conditions (ulcers, infections and 
ischaemia), acute foot wounds and new amputation procedures.  Table 6-1 outlines 
the exact detailed criteria, definitions and supporting citations for each outcome 
variable used in this study [9-11, 38, 39, 295, 301, 302]. 
 
Table 6-1:  Definitions for each outcome variable 
Outcome variable Definition  
Foot-related conditions [39] Any foot ulcer, foot infection, ischaemia, acute foot wound or amputation 
procedure present 
Foot disease  [38, 39] Any foot ulcer, foot infection or ischaemia present 
Foot ulcer [38, 295] An existing full thickness wound beneath the ankle of primarily 
neuropathic, ischaemic, pressure injury origin or post-foot ulcer 
amputation site  
Foot infection [38, 295, 301, 302] At least two manifestations of inflammation (purulence, erythema, pain, 
tenderness, warmth or induration)  
Mild foot infection A foot infection with erythema extending <2 cm from the edge of the 
wound  
Moderate foot infection A foot infection with erythema extending >2 cm from the edge of the 
wound  
Severe foot infection Any foot infection with signs of systemic inflammatory response 
syndrome  
Ischaemia [10, 38, 295] At least one absent foot pulse and a toe systolic pressure <30 mmHg   
Acute foot wound [38] An existing full thickness wound beneath the ankle of primarily traumatic 
or post-surgical origin (excluding amputation procedures due to foot 
ulcer)  
Amputation procedures [9, 11] A new lower extremity amputation procedure performed as part of the 
current inpatient admission, plus, a clinical examination to verify a post-
surgical amputation wound site  
Minor amputation procedure An amputation procedure distal to the ankle   
Major amputation procedure An amputation procedure proximal to the ankle   
  
Data collection procedure 
The data collection procedure has been described in detail elsewhere [39].  In 
brief, the Queensland Foot Disease Form (QFDF) [39] was developed from a similar 
validated data collection instrument [38].  The QFDF captured all variables via a 
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survey of participants’ self-reported history and a physical examination for clinically 
diagnosed foot-related conditions [38, 39].   Data collectors were publicly employed 
podiatrists who received extensive training and scored at least 90% accuracy on 
assessment [39].  Data were collected by teams of data collectors between 8am and 
5pm on each hospital’s single data collection day between June and December 2013 
[39].  A 5% sub-sample of study data collected were tested against audited medical 
records and high levels of agreement were reported [39].    
 
Statistical analysis  
All data were analysed using SPSS 22.0 for Windows (SPSS Inc., Chicago, IL, 
USA) or GraphPad Software.  Prevalence proportions with 95% confidence intervals 
(95% CI) were calculated for all outcomes.  Differences between groups were tested 
using Chi-squared, Kruskal-Wallis tests, t-tests or ANOVA [39, 273].   Univariate 
logistic regression analyses tested for crude associations with outcomes (p < 0.05) 
[39, 318, 319].  Two different multivariate models were used for each outcome:  
Model 1 used all variables, and Model 2 used all available variables except past foot 
treatment variables.  All variables crudely associated in the univariate analyses (p < 
0.2) were included in the multivariate logistic regression analyses [39, 318, 319].  A 
backwards stepwise method was employed to remove non-significant variables (p > 
0.05) at each step until only variables reaching statistical significance remained (p < 
0.05) (Unadjusted Model) [39, 318, 319].  Collinearity, goodness of fit, significance, 
parsimony, and potential variance were assessed at each step [39, 318, 319].  Omitted 
variables were re-entered back into the models and retained as confounders if they 
changed the Beta estimates of any independent explanatory variable by > 20% 
(Adjusted Model) [39, 318].  Cases with missing data were excluded as missing data 
cases made up < 5% in all models [318]. 
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6.5 RESULTS 
Descriptive data for all 733 participants’ outcome variables is displayed for 
each hospital in Table 6-2.  Additionally all explanatory variables and univariate 
analyses are summarised in Tables 6-3 and 6-4.  Table 6-2 shows a foot-related 
condition was present in 86 participants (11.8% (95% CI: 9.6-14.3%)) and 34 of 
those had diabetes (4.6% (3.3-6.4%)).  Foot disease was present in 72 participants 
(9.8% (7.2-11.3%)) and 33 of those had diabetes (4.5% (3.2-6.3%)).  Foot wounds 
was present in 66 participants (9.0% (7.2-11.3%)) and 27 of those had diabetes (3.7% 
(2.5-5.3%)).  No differences existed between hospitals for any foot-related condition 
outcome (p > 0.1).   
 
Foot disease 
Foot ulcers were present in 49 participants (6.7% (5.1-8.8%)) and 26 (3.6% 
(2.4-5.2%)) of those had diabetes (Tables 6-2 and 6-3).  Foot ulcers made up 74% of 
the 66 participants with any type of foot wound (9.0% (7.2-11.3%)).  After univariate 
analysis, 15 potential explanatory variables were associated with foot ulcers (all, p < 
0.05) (Table 6-3).  Foot infection was excluded from foot ulcer models as foot 
infection was only present in wounds.  Table 6-5 shows after adjustment for socio-
economic status, foot ulcers were independently associated with acute foot trauma, 
previous foot ulcers, moderate-critical peripheral arterial disease (PAD), peripheral 
neuropathy (PN) and past surgeon treatment in Model 1 (all, p < 0.05).  All 
independent variables remained significant in Model 2 (all p < 0.001). 
Foot infections were present in 24 participants (3.3% (2.2-4.9%)) and 12 (1.7% 
(0.9-2.9%)) of those had diabetes (Tables 6-2 and 6-3).  Of participants with foot 
infections, 11 (46%) were mild, seven (29%) moderate and six (25%) were severe 
foot infections (Table 6-2).  After univariate analysis, 13 variables were associated 
with foot infection (all, p < 0.05) (Table 6-3). Foot wounds (foot ulcers and acute 
foot wounds) were excluded from infection models as infection as only present in 
wounds.  Table 6-6 shows after adjustment for socio-economic status and PAD, foot 
infections were independently associated with previous foot ulcer, acute foot trauma 
and past surgeon treatment in Model 1 (all, p < 0.01).  All independent variables 
remained significant in Model 2 (all p < 0.001). 
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Table 6-2:  Participant outcome variables for each hospital (number (%) unless otherwise stated)  
 n TOTAL [95% CI] Large Regional 
(General) 
(n = 21) 
Major Regional  
(General) 
(n = 82) 
Large Metro. 
(General) 
(n = 90) 
Major Metro. 
(Speciality) 
(n = 232) 
Major Metro.  
(General) 
(n = 308) 
p Value 
Foot-related conditions 732 86 (11.8%) [9.6 – 14.3] 2 (9.5%) 12 (14.6%) 8 (8.9%) 19 (8.2%) 45 (14.7%) 0.147 
Foot disease 732 72 (9.8%) [7.9-12.2] 1 (4.8%) 9 (11.0%) 7 (7.8%) 19 (8.2%) 36 (11.7%) 0.546 
Foot ulcers 732 49 (6.7%) [5.1 – 8.8] 0 7 (8.5%) 4 (4.4%) 11 (4.8%) 27 (8.8%) 0.183 
Foot infections 723 24 (3.3%) [2.2 – 4.9] 0 5 (6.2%) 3 (3.3%) 5 (2.2%) 11 (3.6%) NA 
Mild foot infections 723 11 (1.5%) [0.8 – 2.7] 0 2 (2.5%) 2 (2.2%) 1 (0.4%) 6 (2.0%) NA 
Moderate foot infections 723 7 (1.0%) [0.4 – 2.0] 0 2 (2.5%) 0 2 (0.9%) 3 (1.0%) NA 
Severe foot infections 723 6 (0.8%) [0.3 – 1.8] 0 1 (1.3%) 1 (1.1%) 2 (0.9%) 2 (0.7%) NA 
Ischaemia 728 33 (4.5%) [3.2 – 6.3] 1 (4.8%) 2 (2.4%) 3 (3.3%) 8 (3.5%) 19 (6.3%) NA 
Acute foot wounds 732 17 (2.3%) [1.4 – 3.7] 1 (4.8%) 4 (4.9%) 2 (2.2%) 1 (0.4%) 9 (2.9%) NA 
Amputation procedures 732 14 (1.9%) [1.1 – 3.2] 0 2 (2.4%) 0 2 (0.9%) 10 (3.2%) NA 
Minor  amputation procedures 732 8 (1.1%) [0.5 – 2.2] 0 1 (1.2%) 0 1 (0.4%) 6 (1.9%) NA 
Major amputation procedures 732 6 (0.8%) [0.3 – 1.8] 0 1 (1.2%) 0 1 (0.4% 4 (1.3%) NA 
*p Value of < 0.05; 95% CI: 95% Confidence interval; NA: Not applicable to test as the assumption of Chi-squared test is violated as 2 cells had expected count <5. 
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Table 6-3:  Univariate analysis for participants with foot ulcer, foot infection or ischaemia  
Variables All Foot Ulcer Foot Infection Ischaemia 
  n (%) Odds ratio 
[95% CI] 
p Value n (%) Odds ratio  
[95% CI] 
p Value n (%) Odds ratio  
[95% CI] 
p Value 
Participants^ 733 49 (6.7%) [5.1 – 8.7%]  24 (3.3%) [2.2 – 4.9%]  33 (4.5%) [3.2 – 6.3%]  
Ward           
Medical 459 (62.6%) 26 (53.1%) 1.00  13 (54.2%) 1.00  16 (48.5%) 1.00  
Surgical 274 (37.4%) 23 (46.9%) 1.53 [0.85-2.74] 0.153*# 11 (45.8%) 1.46 [0.65-3.32] 0.361# 17 (51.5%) 1.83 [0.91-3.69] 0.090*# 
Demographics           
Age (SD) years 62.0(18.6) 66.0(15.7) 1.01 [0.99-1.03] 0.128* 61.1(18.8) 1.00 [0.98-1.02] 0.799 71.1(13.4) 1.03 [1.01-1.06] 0.005** 
Age groups    0.124*   0.450   0.069* 
18-40 years 110 (15.0%) 4 (8.2%) 1.00  3 (12.5%) 1.00  1 (3.0%) 1.00  
41-60 years 188 (25.7%) 11 (22.4%) 1.67 [0.52-5.36] 0.392 7 (29.2%) 1.36 [0.34-5.36] 0.664 5 (15.2%) 3.01 [0.35-26.11]  
61-80 years 316 (43.2%) 29 (59.2%) 2.68 [0.92-7.80] 0.071 13 (54.2%) 1.51 [0.42-5.41] 0.535 18 (54.5%) 6.65 [0.88-50.42] 0.067 
81+ years 117 (16.0%) 5 (10.2%) 1.18 [0.31-4.52] 0.806 1 (4.2%) 0.30 [0.03-2.92] 0.299 9 (27.3%) 9.08 [1.13-72.93] 0.038 
Male sex 408 (55.8) 28 (57.1%) 1.06 [0.59-1.90] 0.848 16 (66.7%) 1.61 [0.68-3.82] 0.278 20 (60.6%) 1.22 [0.60-2.50] 0.580 
Social Determinants           
Socioeconomic Status  711   0.328   0.586   0.181* 
Most disadvantaged 102 (14.3%) 10 (22.2%) 1.00  3 (14.3%) 1.00  8 (25.8%) 1.00  
Second most disadvantaged 159 (22.4%) 12 (26.7%) 0.74 [0.31-1.79] 0.507 7 (33.3%) 1.52 [0.38-6.02] 0.552 6 (19.4%) 0.46 [0.15-1.36] 0.159 
Middle 98 (13.8%) 4 (8.9%) 0.39 [0.12-1.28] 0.120 1 (4.8%) 0.34 [0.03-3.30] 0.350 3 (9.7%) 0.36 [0.09-1.41] 0.144 
Second least disadvantaged 240 (33.8%) 15 (33.3%) 0.61 [0.26-1.41] 0.246 8 (38.1%) 1.13 [0.29-4.33] 0.864 13 (41.9%) 0.66 [0.27-1.65] 0.375 
Least disadvantaged 112 (15.8%) 4 (8.9%) 0.34 [0.10-1.11] 0.074 2 (9.5%) 0.60 [0.10-3.66] 0.579 1 (3.2%) 0.10 [0.01-0.84] 0.034 
Geographic Remoteness  711   0.907   0.807   0.345 
Major city 435 (61.2%) 26 (57.8%) 1.00  13 (61.9%) 1.00  17 (54.8%) 1.00  
Inner regional area 153 (21.5%) 9 (20.0%) 0.99 [0.62-3.97] 0.975 4 (19.0%) 0.90 [0.29-2.81] 0.858 5 (16.1%) 0.84 [0.30-2.31] 0.729 
Outer regional area 66 (9.3%) 6 (13.3%) 1.57 [0.62-3.97] 0.341 2 (9.5%) 1.02 [0.27-4.64] 0.976 6 (19.4%) 2.44 [0.93-6.44] 0.071 
Remote area 30 (4.2%) 2 (4.4%) 1.12 [0.25-4.97] 0.881 0 0 NA 1 (3.2%) 0.84 [0.11-6.55] 0.869 
Very remote area 27 (3.8%) 2 (4.4%) 1.26 [0.28-5.59] 0.765 2 (9.5%) 2.58 [0.55-12.06] 0.229 2 (6.5%) 1.95 [0.43-8.93] 0.388 
<Year 10 Education Level 395 (54.0%) 32 (65.3%) 1.65 [0.91-3.04] 0.105* 14 (58.3%) 1.21 [0.53-2.76] 0.652 25 (75.8%) 2.79 [1.24-6.28] 0.013** 
Indigenous  34 (4.6%) 3 (6.1%) 1.37 [0.40-4.64] 0.616 2 (8.3%) 1.89 [0.43-8.40] 0.402 2 (6.1%) 1.34 [0.31-5.82] 0.701 
Born overseas 161 (22.0%) 5 (10.2%) 0.38 [0.15-0.98] 0.045** 2 (8.3%) 0.31 [0.07-1.32] 0.113* 4 (12.1%) 0.47 [0.16-1.36] 0.164* 
Medical Condition History           
Diabetes 172 (23.5%) 26 (53.1%) 4.15 [2.30-7.49] <0.001** 12 (50.0%) 3.45 [1.52-7.84] 0.003** 12 (36.4%) 1.93 [0.93-4.00] 0.079* 
Hypertension 359 (49.0%) 29 (59.2%) 1.56 [0.86-2.80] 0.141* 12 (50.0%) 1.04 [0.46-2.34] 0.929 22 (66.7%) 2.15 [1.03-4.50] 0.042** 
Dyslipidaemia 234 (31.9%) 17 (34.7%) 1.15 [0.62-2.11] 0.661 6 (25.0%) 0.71 [0.28-1.81] 0.468 17 (51.5%) 2.37 [1.18-4.78] 0.016** 
Myocardial Infarct 146 (19.9%) 9 (18.4%) 0.90 [0.42-1.89] 0.771 4 (16.7%) 0.79 [0.27-2.35] 0.674 12 (36.4%) 2.42 [1.16-5.03] 0.019* 
Cerebrovascular Accident 85 (11.6%) 6 (12.2%) 10.7 [0.44-2.58] 0.889 4 (16.7%) 1.55 [0.52-4.64] 0.436 7 (21.2%) 2.13 [0.90-5.07] 0.088* 
Chronic Kidney Disease  89 (12.1%) 10 (20.4%) 1.96 [0.94-4.07] 0.073* 3 (12.5%) 1.03 [0.31-3.53] 0.960 7 (21.2%) 2.04 [0.86-4.85] 0.106* 
Cancer 174 (23.7%) 15 (30.6%) 1.45 [0.77-2.73] 0.249 7 (29.2%) 1.31 [0.54-3.22] 0.553 6 (18.2%) 0.71 [0.29-1.75] 0.453 
Arthritis 274 (37.4%) 23 (46.9%) 1.55 [0.86-2.75] 0.147* 12 (50.0%) 1.68 [0.74-3.79] 0.213 17 (51.5%) 1.85 [0.92-3.72] 0.086* 
Depression 191 (26.1%) 11 (22.4%) 0.81 [0.40-1.61] 0.545 6 (25.0%) 0.94 [0.37-2.40] 0.897 8 (24.2%) 0.91 [0.40-2.05] 0.818 
Acute foot trauma 26 (3.5%) 10 (20.4%) 10.67 [4.55-25.06] <0.001** 6 (25.0%) 16.31 [5.62-47.30] <0.001** 1 (3.0%) 0.84 [0.11-6.38] 0.864 
 Chapter 6: The silent overall burden of foot disease in a representative hospitalised population 157 
Smoker 104 (14.2%) 7 (14.3%) 1.02 [0.44-2.33] 0.968 7 (29.2%) 2.65 [1.07-6.56] 0.035** 8 (24.2%) 2.02 [0.89-4.61] 0.095* 
Ex-Smoker 304 (41.5%) 19 (38.8%) 0.89 [0.49-1.61] 0.694 10 (41.7%) 1.00 [0.44-2.29] 0.997 12 (36.4%) 0.800 [0.39-1.65] 0.542 
Self-care Ability           
Mobility impairment 242 (33.2%) 29 (59.2%) 3.17 [1.75-5.74] <0.001** 11 (45.8%) 1.77 [0.78-4.00] 0.173* 17 (51.5%) 2.25 [1.12-4.54] 0.023** 
Vision impairment 110 (15.1%) 10 (20.4%) 1.49 [0.72-3.08] 0.284 6 (25.0%) 1.92 [0.74-4.95] 0.177* 12 (36.4%) 3.51 [1.67-7.37] 0.001** 
Footwear worn: Inside    0.655   0.202   0.470 
Low risk footwear 81 (11.1%) 6 (12.5%) 1.00  4 (16.7%) 1.00  2 (6.1%) 1.00  
Moderate risk footwear 263 (36.1%) 20 (41.7%) 1.03 [0.40-2.66] 0.953 6 (25.0%) 0.45 [0.12-1.63] 0.224 16 (48.5%) 2.56 [0.58-11.37] 0.217 
High risk footwear 139 (19.1%) 6 (12.5%) 0.57 [0.18-1.82] 0.342 2 (8.3%) 0.28 [0.05-1.57] 0.149 5 (15.2%) 1.50 [0.28-7.90] 0.635 
No footwear worn 245 (33.7%) 16 (33.3%) 0.87 [0.33-2.31] 0.785 12 (50.0%) 0.99 [0.31-3.17] 0.988 10 (30.3%) 1.68 [0.36-7.84] 0.509 
Footwear worn: Outside    0.885   0.888   0.224 
Low risk footwear 386 (53.2%) 23 (47.9%) 1.00  12 (50.0%) 1.00  15 (45.5%) 1.00  
Moderate risk footwear 75 (10.3%) 6 (12.5%) 1.37 [0.54-3.49] 0.507 3 (12.5%) 1.27 [0.35-4.63] 0.713 7 (21.2%) 2.55 [1.00-6.48] 0.050 
High risk footwear 250 (34.4%) 18 (37.5%) 1.23 [0.65-2.33] 0.525 8 (33.3%) 1.02 [0.41-2.53] 0.967 10 (30.3%) 10.4 [0.46-2.35] 0.926 
No footwear worn 15 (2.1%) 1 (2.1%) 1.13 [0.14-8.95] 0.910 1 (4.2%) 2.19 [0.27-17.99] 0.468 1 (3.0%) 1.77 [0.22-14.33] 0.594 
Past Foot Treatment           
Yes 256 (34.9%) 39 (79.6%) 8.36 [4.10-17.05] <0.001** 19 (79.2%) 7.65 [2.82-20.74] <0.001** 24 (72.7%) 5.39 [2.47-11.79] <0.001** 
Podiatry 180 (24.6%) 25 (51.0%) 3.54 [1.97-6.38] <0.001** 11 (45.8%) 2.72 [1.20-6.18] 0.017** 17 (51.5%) 3.50 [1.73-7.08] 0.001** 
GP 93 (12.7%) 26 (53.1%) 10.38 [5.61-19.20] <0.001** 16 (66.7%) 16.64 [6.89-40.19] <0.001** 9 (27.3%) 2.77 [1.24-6.15] 0.013** 
Surgeon 36 (4.9%) 19 (38.8%) 24.78 [11.71-52.43] <0.001** 10 (41.7%) 20.09 [8.10-49.80] <0.001** 12 (36.4%) 16.70 [7.34-37.99] <0.001** 
Physician 21 (2.9%) 6 (12.2%) 6.21 [2.29-16.79] <0.001** 2 (8.3%) 3.44 [0.75-15.75] 0.112* 2 (6.1%) 2.30 [0.51-10.30] 0.278 
Nurse 20 (2.7%) 12 (24.5%) 27.32 [10.53-70.93] <0.001** 6 (25.0%) 17.59 [6.01-51.52] <0.001** 5 (15.2%) 8.10 [2.75-23.85] <0.001** 
Orthotist 4 (0.5%) 2 (4.1%) 14.47 [1.99-105.01] 0.008 2 (8.3%) 31.68 [4.27-235.36] 0.001 1 (3.0%) 7.21 [0.73-71.24] 0.091* 
Other 9 (1.2%) 0 0 NA 0 0 NA 0 0 NA 
Foot Disease History           
Previous foot ulcer 72 (9.8%) 33 (67.3%) 33.95 [17.22-66.95] <0.001** 18 (75.0%) 38.00 [14.45-99.93] <0.001** 16 (48.5%) 10.94 [5.24-22.83] <0.001**# 
Previous amputation 30 (4.1%) 14 (29.2%) 17.14 [7.73-37.98] <0.001** 7 (29.2%) 13.25 [4.97-35.37] <0.001** 9 (27.3%) 12.64 [5.21-30.65] <0.001**# 
Foot Risk Factors           
Peripheral Neuropathy 160 (22.0%) 30 (62.5%) 7.05 [3.81-13.04] <0.001** 15 (62.5%) 6.55 [2.81-15.27] <0.001** 14 (42.4%) 2.79 [1.37-5.70] 0.005** 
PAD     <0.001**   <0.001**    
Nil PAD 575 (79.0%) 18 (37.5%) 1.00  12 (50.0%) 1.00  -- -- -- 
Mild PAD 69 (9.5%) 2 (4.2%) 0.92 [0.21-4.07] 0.916 0 0 NA -- -- -- 
Moderate PAD 51 (7.0%) 15 (31.3%) 12.89 [6.00-27.67] <0.001** 8 (33.3%) 8.84 [3.43-22.82] <0.001** -- -- -- 
Ischaemic (Critical PAD) 33 (4.5%) 13 (27.1%) 20.11 [8.67-46.65] <0.001** 4 (16.7%) 6.88 [2.08-22.73] 0.002** -- -- -- 
Foot deformity  158 (22.4%) 19 (41.3%) 2.64 [1.43-4.88] 0.002** 8 (34.8%) 1.92 [0.80-4.61] 0.146* 11 (36.7%) 2.10 [0.98-4.51] 0.058*# 
Foot Disease Disorders           
Foot ulcer 49 (6.7%) -- -- -- 21 (87.5%) 196.29 [54.8-703.5] <0.001** 13 (39.4%) 12.26 [5.64-26.65] <0.001**# 
Acute foot wound 17 (2.3%) -- -- -- 3 (12.5%) 12.30 [3.05-49.70] <0.001** 0 0 NA 
Foot infection  24 (3.3%) 21 (46.7%) 196.29 [54.8-703.5] <0.001**# -- -- -- 4 (12.9%) 4.95 [1.58-15.48] 0.006**# 
*p < 0.2; **p < 0.05; ^ 95% CI are for prevalence figure; # Explanatory variable excluded from multivariate model as considered not on causal pathway for outcome; GP: General Practitioner; PAD: Peripheral Arterial 
Disease; SD: Standard deviation. 
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Table 6-4:  Univariate analysis for participants with acute foot wound or amputation procedure 
Variables All Acute Foot Wound  Amputation Procedure  
  n  
(%) 
Odds ratio  
[95% CI] 
p Value n 
 (%) 
Odds ratio   
[95% CI] 
p Value 
Participants^ 733 17 (2.3%) [1.4 – 3.7%]  14 (1.9%) [1.1 – 3.2%]  
Medical ward 459 (62.6%) 6 (35.9%) 1.00  5 (35.7%) 1.00  
Surgical ward 274 (37.4%) 11 (64.7%) 3.61 [1.16-8.65] 0.025**# 9 (64.3%) 3.08 [1.02-9.28] 0.046*# 
Demographics        
Age (SD) years 62.0(18.6) 42.4(19.4) 0.95 [0.93-0.97] <0.001** 65.5(12.7) 1.01 [0.98-1.04] 0.481 
Age groups    0.002**   0.702 
18-40 years 110 (15.0%) 9 (52.9%) 1.00  0 1.00  
41-60 years 188 (25.7%) 4 (23.5%) 0.24 [0.07-0.82] 0.023 4 (28.6%) 0 NA 
61-80 years 316 (43.2%) 3 (17.6%) 0.11 [0.03-0.41] 0.001 9 (64.3%) 0 NA 
81+ years 117 (16.0%) 1 (5.9%) 0.10 [0.01-0.78] 0.028 1 (7.1%) 0 NA 
Male sex 408 (55.8) 13 (76.5%) 2.62 [0.85-8.12] 0.094* 9 (64.3%) 1.44 [0.48-4.33] 0.519 
Social Determinants        
Socioeconomic Status  711   0.657   0.983 
Most disadvantaged 102 (14.3%) 1 (5.9%) 1.00  3 (21.4%) 1.00  
Second most disadvantaged 159 (22.4%) 5 (29.4%) 3.25 [0.37-28.20] 0.286 4 (28.6%) 0.85 [0.19-3.87] 0.836 
Middle 98 (13.8%) 3(17.6%) 3.16 [0.32-30.89] 0.323 0 0 NA 
Second least disadvantaged 240 (33.8%) 4 (1.7%) 1.70 [0.19-15.42] 0.636 5 (35.7%) 0.71 [0.17-3.01] 0.637 
Least disadvantaged 112 (15.8%) 4 (1.7%) 3.70 [0.41-33.70] 0.245 2 (14.3%) 0.60 [0.10-3.67] 0.580 
Geographic Remoteness  711   0.741   0.942 
Major city 435 (61.2%) 9 (52.9%) 1.00  8 (57.1%) 1.00  
Inner regional area 153 (21.5%) 6 (35.3%) 1.94 [0.68-5.55] 0.216 4 (28.6%) 1.43 [0.42-4.82] 0.564 
Outer regional area 66 (9.3%) 1 (5.9%) 0.73 [0.09-5.83] 0.764 1 (7.1%) 0.82 [0.10-6.66] 0.852 
Remote area 30 (4.2%) 0 0 NA 0 0 NA 
Very remote area 27 (3.8%) 1 (5.9%) 1.82 [0.22-14.89] 0.578 1 (7.1%) 2.05 [0.25-17.00] 0.507 
<Year 10 Education Level 395 (54.0%) 8 (47.1%) 0.75 [0.29-1.97] 0.560 11 (78.6%) 3.17 [0.88-11.46] 0.078* 
Indigenous  34 (4.6%) 1 (5.9%) 1.29 [0.17-10.00] 0.809 1 (7.1%) 1.59 [0.20-12.56] 0.658 
Born overseas 161 (22.0%) 2 (11.8%) 0.11-2.05] 0.311 2 (14.3%) 0.58 [0.13-2.64] 0.484 
Medical Condition History        
Diabetes 172 (23.5%) 1 (5.9%) 0.20 [0.03-1.51] 0.118* 10 (71.4%) 8.58 [2.66-27.72] <0.001** 
Hypertension 359 (49.0%) 4 (23.5%) 0.31 [0.10-0.97] 0.044** 8 (57.1%) 1.40 [0.48-4.08] 0.535 
Dyslipidaemia 234 (31.9%) 2 (11.8%) 0.28 [0.06-1.23] 0.092* 7 (50.5%) 2.16 [0.75-6.24] 0.153* 
Myocardial Infarct 146 (19.9%) 0 0 NA 4 (28.6%) 1.62 [0.50-5.25] 0.419 
Cerebrovascular Accident 85 (11.6%) 1 (5.9%) 0.47 [0.06-3.58] 0.465 3 (21.4%) 2.12 [0.58-7.74] 0.258 
Chronic Kidney Disease  89 (12.1%) 0 0 NA 4 (28.6%) 2.98 [0.91-9.71] 0.070* 
Cancer 174 (23.7%) 0 0 NA 4 (28.6%) 1.29 [0.40-4.14] 0.671 
Arthritis 274 (37.4%) 3 (17.6%) 0.35 [0.10-1.25] 0.106* 4 (28.6%) 0.67 [0.21-2.15] 0.498 
Depression 191 (26.1%) 8 (47.1%) 2.58 [0.98-6.78] 0.055* 2 (14.3%) 0.47 [0.10-2.10] 0.321 
Acute foot trauma 26 (3.5%) 14 (82.4%) 273.0 [69.28-1075.75] <0.001 4 (28.6%) 12.66 [3.68-43.50] <0.001** 
Smoker 104 (14.2%) 4 (23.5%) 1.91 [0.61-5.98] 0.266 3 (21.4%) 1.67 [0.46-6.08] 0.439 
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Ex-Smoker 304 (41.5%) 7 (41.2%) 0.99 [0.37-2.63] 0.982 6 (42.9%) 1.06 [0.37-3.10] 0.911 
Self-care Ability        
Mobility impairment 242 (33.2%) 4 (23.5%) 0.61 [0.20-1.90] 0.394 10 (71.4%) 5.21 [1.62-16.77] 0.006** 
Vision impairment 110 (15.1%) 0 0 NA 3 (21.4%) 1.55 [0.43-5.66] 0.505 
Footwear worn: Inside    0.152*   0.589 
Low risk footwear 81 (11.1%) 2 (12.5%) 1.00  2 (16.7%) 1.00  
Moderate risk footwear 263 (36.1%) 1 (6.3%) 0.15 [0.01-1.69] 0.124 6 (50.0%) 0.92 [0.18-4.66] 0.922 
High risk footwear 139 (19.1%) 6 (37.5%) 1.18 [0.35-9.11] 0.480 2 (16.7%) 0.58 [0.08-4.17] 0.586 
No footwear worn 245 (33.7%) 7 (43.8%) 1.16 [0.24-5.71] 0.854 2(16.7%) 0.33 [0.05-2.35] 0.265 
Footwear worn: Outside    0.957   0.613 
Low risk footwear 386 (53.2%) 9 (56.3%) 1.00  8 (66.7%) 1.00  
Moderate risk footwear 75 (10.3%) 1 (6.3%) 0.57 [0.07-4.54] 0.592 2 (16.7%) 1.30 [0.27-6.22] 0.747 
High risk footwear 250 (34.4%) 6 (37.5%) 1.03 [0.36-2.94] 0.950 2 (16.7%) 0.38 [0.08-1.81] 0.225 
No footwear worn 15 (2.1%) 0 0 NA 0 0 NA 
Past Foot Treatment        
Yes 256 (34.9%) 3 (17.6%) 0.39 [0.11-1.37] 0.142* 13 (92.9%) 25.41 [3.31-195.39] 0.002** 
Podiatry 180 (24.6%) 1 (5.9%) 0.19 [0.03-1.42] 0.105* 9 (64.3%) 5.76 [1.90-17.41] 0.002** 
GP 93 (12.7%) 1 (5.9%) 0.42 [0.06-3.22] 0.406 11 (78.6%) 28.44 [7.77-104.05] <0.001** 
Surgeon 36 (4.9%) 1 (5.9%) 1.21 [0.16-9.41] 0.854 9 (64.3%) 46.07 [14.46-146.78] <0.001** 
Physician 21 (2.9%) 0 0 NA 2 (14.3%) 6.13 [1.28-29.32] 0.023** 
Nurse 20 (2.7%) 1 (5.9%) 2.29 [0.29-18.14] 0.434 4 (28.6%) 17.55 [4.97-61.93] <0.001** 
Orthotist 4 (0.5%) 1 (5.9%) 14.81 [1.46-150.24] 0.023 1 (7.1%) 18.33 [1.77-188.18] 0.014 
Other 9 (1.2%) 0 0 NA 0 0 NA 
Foot Disease History        
Previous foot ulcer 72 (9.8%) 1 (5.9%) 0.57 [0.07-4.33] 0.583 10 (71.4%) 26.41 [8.05-86.68] <0.001** 
Previous amputation 30 (4.1%) 0 0 NA 7 (50.0%) 30.17 [9.78-93.13] <0.001** 
Foot Risk Factors        
Peripheral Neuropathy 160 (22.0%) 1 (6.3%) 0.23 [0.03-1.77] 0.159* 10 (83.3%) 18.87 [4.09-87.03] <0.001** 
PAD     NA   <0.001** 
Nil PAD 575 (79.0%) 16 (100%) 1.00  4 (33.3%) 1.00  
Mild PAD 69 (9.5%) 0 0 NA 0 0 NA 
Moderate PAD 51 (7.0%) 0 0 NA 4 (33.3%) 12.15 [2.94-50.13] 0.001** 
Ischaemic (Critical PAD) 33 (4.5%) 0 0 NA 4 (33.3%) 19.69 [4.69-82.71] <0.001** 
Foot deformity (score >3) 158 (22.4%) 3 (18.8%) 0.80 [0.22-2.83] 0.725 7 (63.6%) 6.31 [1.82-21.82] 0.004** 
Foot Disease Disorders        
Foot ulcer 49 (6.7%) -- -- -- 12 (85.7%) 110.27 [23.80-510.82] <0.001** 
Acute foot wound 17 (2.3%) -- -- -- 2 (14.3%) 7.80 [1.60-37.94] 0.011** 
Foot infection  24 (3.3%) 3 (27.3%) 12.30 [3.05-49.70] <0.001**# 6 (66.7%) 77.22 [17.88-333.44] <0.001** 
*p < 0.2; **p < 0.05; ^ 95% CI are for prevalence figure; # Explanatory variable excluded from multivariate model as considered not on causal pathway for outcome; GP: General Practitioner; PAD: Peripheral Arterial 
Disease; SD: Standard deviation. 
 
 
Chapter 6: The silent overall burden of foot disease in a representative hospitalised population 160 
Table 6-5:  Independent associated factors for foot ulcers using multivariate 
logistical regression (Odds Ratios [95% CI]) 
Risk Factor Unadjusted p Value Adjusted p Value 
Model 1     
Acute foot trauma 25.35 [6.57-97.85] <0.001 33.03 [7.29-149.67] <0.001 
Previous foot ulcer 18.84 [7.50-47.33] <0.001 22.68 [8.27-62.15] <0.001 
Peripheral Neuropathy 3.79 [1.59-9.00] 0.003 5.12 [2.01-13.05] 0.001 
PAD   <0.001  <0.001 
Nil PAD Referent  Referent  
Mild PAD 0.23 [0.03-1.62] 0.141 0.27 [0.04-1.83] 0.177 
Moderate PAD 11.47 [3.95-33.30] <0.001 15.91 [4.95-51.15] <0.001 
Ischaemia (Critical PAD) 3.79 [1.03-13.93] 0.045 5.02 [1.24-20.24] 0.024 
Past surgeon treatment 14.79 [4.52-48.33] <0.001 12.01 [3.28-43.92] <0.001 
Model 1 Results: Pseudo R2:0.600 
Omnibus: df =7 , p <0.001  
Missing: 7 (1.0%);  
H&L: p = 0.495 
Pseudo R2: 0.622 
Omnibus: df = 11, p <0.001  
Missing: 29 (4.0%);  
H&L: p = 0.691 
Model 2     
Acute foot trauma 18.73 [4.93-71.20] <0.001 23.29 [5.27-103.04] <0.001 
Previous foot ulcer 19.85 [8.51-46.29] <0.001 24.39 [9.42-63.15] <0.001 
Peripheral Neuropathy 4.19 [1.87-9.40] 0.001 5.73 [2.37-13.85] <0.001 
PAD   <0.001  <0.001 
Nil PAD Referent  Referent  
Mild PAD 0.35 [0.07-1.85] 0.219 0.38 [0.07-2.08] 0.262 
Moderate PAD 10.71 [3.88-29.60] <0.001 15.37 [5.03-46.91] <0.001 
Ischaemia (Critical PAD) 8.36 [2.75-25.39] <0.001 10.13 [3.03-33.84] <0.001 
Model 2  Results: Pseudo R2:0.544 
Omnibus df =6 , p <0.001  
Missing: 7 (1.0%);  
H&L: p = 0.869 
Pseudo R2: 0.579 
Omnibus: df = 10, p < 0.001 
Missing: 29 (4.0%);  
H&L: p = 0.890 
*p < 0.05; Pseudo R2: Nagelkerke R2; Omnibus: Omnibus Tests of Model Coefficients; df: degrees of freedom; Missing: 
Excluded missing cases; H&L: Hosmer and Lemeshow Test; PAD: Peripheral Arterial Disease. 
 
Table 6-6:  Independent associated factors for foot infections using multivariate 
logistical regression (Odds Ratios [95% CI]) 
Risk Factor Unadjusted p Value Adjusted p Value 
Model 1     
Acute foot trauma 16.67 [3.73-74.43] <0.001 19.16 [2.82-130.12] 0.003 
Previous foot ulcer 23.01 [7.97-66.44] <0.001 39.81 [10.94-144.90] <0.001 
Past surgeon treatment 8.68 [2.71-27.83] <0.001 19.88 [3.56-110.98] 0.001 
Model 1 Results: Pseudo R2:0.452 
Omnibus: df =3, p<0.001  
Missing: 12 (1.6%);  
H&L: p = 1.00 
Pseudo R2: 0.536 
Omnibus: df =10 , p<0.001  
Missing: 37 (5.0%);  
H&L: p = 0.904 
Model 2     
Acute foot trauma 13.65 [3.24-57.45] <0.001 No confounders identified  
Previous foot ulcer 35.95 [13.11-98.56] <0.001   
Model 2  Results: Pseudo R2:0.391 
Omnibus: df =2 , p<0.001  
Missing: 12 (1.6%);  
H&L: p = 1.00 
  
*p < 0.05; Pseudo R2: Nagelkerke R2; Omnibus: Omnibus Tests of Model Coefficients; df: degrees of freedom; Missing: 
Excluded missing cases; H&L: Hosmer and Lemeshow Test. 
 
Ischaemia was present in 33 participants (4.5% (3.2-6.3%)), and 12 (1.7% (0.9-
2.9%)) of those had diabetes (Tables 6-2 and 6-3).   After univariate analysis, 16 
variables were associated with foot infection (all, p < 0.05) (Table 6-3).  No 
confounders were identified.  Table 6-7 shows ischaemia was independently 
associated with older age, current smoking and past surgeon treatment in Model 1 
(all, p < 0.01); however, no independent variables remained significant in Model 2 
(all p > 0.05). 
 
 Chapter 6: The silent overall burden of foot disease in a representative hospitalised population 161 
Table 6-7:  Independent associated factors for ischaemia using multivariate logistical 
regression (Odds Ratios [95% CI]) 
Risk Factor Unadjusted p Value Adjusted p Value 
Model 1      
Age (Continuous year) 1.06 [1.03-1.09] <0.001 No confounders identified  
Current Smoker 4.92 [1.71-14.17] 0.003   
Past surgeon treatment 21.02 [8.51-51.91] <0.001   
Model 1 Results: Pseudo R2:0.235 
Omnibus: df = 3, p < 0.001  
Missing: 7 (1.0%) 
H&L: p = 0.141 
  
Model 2     
Nil All >0.05 All >0.05 
Model 1  Results:     
*p < 0.05; Pseudo R2: Nagelkerke R2; Omnibus: Omnibus Tests of Model Coefficients; df: degrees of freedom; Missing: 
Excluded missing cases; H&L: Hosmer and Lemeshow Test. 
 
Acute foot wounds 
Acute foot wounds were present in 17 participants (2.3% (1.4-3.7%)) and one 
(0.1% (0-0.9%)) of those had diabetes (Tables 6-2 and 6-4).  Acute foot wounds 
made up 26% of the 66 participants with any type of foot wound (Table 6-2).  After 
univariate analysis, five variables were associated with acute foot wounds (all, p < 
0.05) (Table 6-4).  Acute foot trauma was excluded from acute foot wound models as 
all participants with acute foot wounds had acute foot trauma.  Table 6-8 shows acute 
foot wounds were not independently associated any variables in Model 1 (all p > 
0.05).  However, in Model 2 after adjustment for inside footwear worn and foot 
deformity, acute foot wounds was independently associated with younger age (< 40 
years) (p < 0.05). 
 
Table 6-8:  Independent associated factors for acute foot wounds using multivariate 
logistical regression (Odds Ratios [95% CI]) 
Risk Factor Unadjusted p Value Adjusted p Value 
Model 1     
Nil All >0.05 All >0.05 
Model 1 Results:     
Model 2     
Age Groups  0.002  0.006 
18-40 years Referent  Referent  
41-60 years 0.25 [0.07-0.82] 0.023 0.24 [0.07-0.82] 0.023 
61-80 years 0.11 [0.03-0.41] 0.001 0.07 [0.01-0.38] 0.002 
81+ years 0.10 [0.01-0.78] 0.028 0.11 [0.01-1.04] 0.054 
Model 2  Results: Pseudo R2:0.103 
Omnibus: df =3 , p = 0.002 
Missing: 4 (0.5%);  
H&L: p = 1.00 
Pseudo R2: 0.166 
Omnibus: df = 7, p = 0.002  
Missing:  30 (4.1%);  
H&L: p = 0.642 
*p < 0.05; Pseudo R2: Nagelkerke R2; Omnibus: Omnibus Tests of Model Coefficients; df: degrees of freedom; Missing: 
Excluded missing cases; H&L: Hosmer and Lemeshow Test. 
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Amputation procedures 
Amputation procedures were present in 14 participants (1.9% (1.1-3.2%)) and 
10 (1.4% (0.7-2.5%)) of those had diabetes (Tables 6-2 & 6-4); eight (1.1%) were 
minor and six (0.8%) were major amputations (Table 6-2).  Minor and major 
amputation procedures were combined for regression due to the limited number of 
amputation procedures. The reason for the amputation procedure was foot disease in 
12 participants and one each for acute foot trauma and multi-organ failure.  After 
univariate analysis, 17 variables were associated with having an amputation 
procedure (all, p < 0.05) (Table 6-4).  Foot ulcers and acute foot wounds were 
excluded as collinearity was identified with foot infection and acute foot trauma 
respectively.  Table 6-9 shows amputations were not independently associated with 
any variables in Model 1 (all p > 0.05).  However, in Model 2 after adjustment for 
previous foot ulcer, amputation procedures were independently associated with a foot 
infection (p < 0.01). 
 
Table 6-9:  Independent associated factors for amputation procedures using 
multivariate logistical regression (Odds Ratios [95% CI]) 
Risk Factor Unadjusted p Value Adjusted p Value 
Model 1     
Nil All >0.05 All >0.05 
Model 1 Results:     
Model 2     
Infection 77.22 [17.88-333.43] <0.001 18.14 [2.97-110.76] 0.002 
Model2 Results: Pseudo R2:0.336 
Omnibus: df =1 , p< 0.001  
Missing: 11 (1.5%); 
H&L: p = 1.00 
Pseudo R2: 0.390 
Omnibus: df = 2 , p < 0.001  
Missing: 12 (1.6%);  
H&L: p = 1.00 
*p < 0.05; Pseudo R2: Nagelkerke R2; Omnibus: Omnibus Tests of Model Coefficients; df: degrees of freedom; Missing: 
Excluded missing cases; H&L: Hosmer and Lemeshow Test. 
 
 
6.6 DISCUSSION 
Our study is the first to investigate the overall inpatient burden of foot-related 
conditions within a representative inpatient population. Our findings indicate that 
11.8% of representative inpatients had a major foot-related condition present.  Foot 
disease was present in 9.8% (6.7% ulcers, 3.3% infections and 4.5% ischaemia), 
2.3% had acute foot wounds and 1.9% new amputation procedures.  Interestingly, 
46% of participants with foot disease had diabetes; whilst 70% of those undergoing 
an amputation procedure had diabetes.  Foot ulcers and infections were more likely 
 Chapter 6: The silent overall burden of foot disease in a representative hospitalised population 163 
in inpatients with a previous foot ulcer, acute foot trauma, peripheral arterial disease 
(PAD), peripheral neuropathy (PN) or those who had past foot treatment by a 
surgeon.  Ischaemia was more likely to be found in inpatients of older age, smokers 
or those who had past foot treatment by a surgeon.  Amputation procedures were 
more likely in those with foot infection; whereas, acute foot wounds were much 
more likely in younger inpatients.  These findings suggest the overall foot-related 
inpatient burden is considerably larger than historically appreciated and is mostly 
made up of foot disease.   
Although this is the first study of its kind, our prevalence findings are generally 
consistent with the limited available previous reports on specific or sub-groups of 
foot disease disorders from a recent systematic review [37].  First, our 9.8% foot 
disease finding fell within the review’s crude heterogeneous range (0.2-11.9%), as 
did our 6.7% foot ulcer (0.3-13.5%) and 3.3% foot infection finding (0.1-6.4%) [37]. 
Our 4.5% ischaemia finding was much lower than the 7.2% from the only previous 
similar study [37]. However, this may be explained by the previous study 
investigating only people over 40 years using ankle brachial indices and medical 
records audits which have a higher false positive rate than the toe systolic pressures 
used by our study [185].  Second, our 4.5% diabetes-related foot disease finding was 
remarkably consistent with the 4.7% pooled prevalence estimate from the review 
[37].  Also our finding of 1.4% for diabetes-related amputation procedures 
prevalence was very similar to the 1.5% reported from the review [37].  Whilst our 
3.5% diabetes-related foot ulcer prevalence was higher than the 2.4% pooled 
prevalence estimate, our 1.7% diabetes-related foot infections was lower than the 
3.4% pooled estimate [37].  Lastly, consistent with diabetes-related foot infection 
studies, all foot infections in our study were present within foot wounds, regardless 
of diabetes [37, 301]. .  Additionally, our infection severity findings were similar to 
the largest previous prospective diabetes-related foot infection study [301]; 46% for 
mild (versus 47% in the previous study), 29% moderate (versus 34%) and 25% 
severe infections (versus 18%) [301].   
This general consistency with the available findings from the literature 
reassures us to the reliability and validity of our overall findings.   In our previous 
study we found 4.9% of all inpatients were in hospital for the primary reason of foot 
disease [39].  The 9.8% findings from this study, in combination with the findings of 
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our previous study [39], suggests one in every ten representative inpatients (9.8%) 
has foot disease present and half (4.9%) of those are in hospital because of their foot 
disease [39].  Interestingly the equivalent diabetes-related foot disease findings from 
these studies suggest one in every 22 representative inpatients (4.5%) has diabetes-
related foot disease present and nearly half (2.0%) of those are in hospital because of 
their foot disease [39].  Alternatively, these findings suggest that within the 23.5% of 
inpatients with diabetes, one in every five diabetes inpatients (19.2%) has foot 
disease present and nearly one in every ten diabetes inpatients (8.7%) are in hospital 
because of their foot disease [39]. 
When interpreted against other Australian inpatient literature our previous 
findings indicated that foot disease was a top 10 direct cause of hospitalisation in 
Australia [39].  The valid and reliable self-reported medical history findings of this 
study now allows for a more direct comparison of the size of the overall burden of 
foot disease compared to other medical conditions in a representative sample of 
inpatients.  This study identified that similar proportions of inpatients had a self-
reported foot ulcer (disease) history (10%) to those reporting a chronic kidney 
disease history (12%) or cerebrovascular disease history (12%).  This suggests that 
the overall inpatient burden imposed by foot disease is comparable in size to those 
imposed by the more well-known and resourced conditions of kidney and 
cerebrovascular disease.  Furthermore, it is highly likely that our study under-
reported those with a foot disease history as some patients with previous amputations 
did not also have previous foot ulcers, and we did not capture those with previous 
foot infections or previous ischaemia.  Considering our previous study reported foot 
disease to be a leading cause of hospitalisation in Australia when compared to other 
inpatient disease in similar inpatient literature [30, 36], this paper reinforces the need 
for policy makers, clinicians and researchers to be addressing the overall inpatient 
burden of foot disease at least to the extent they already do for other leading causes 
of the overall inpatient burden [39].  This recommendation is further reinforced when 
considering the population we investigated has been reported to have very similar 
socio-demographic and medical history characteristics to those reported in other 
large Australian and international inpatient studies [39]. 
This is one of the first studies to investigate associations with foot-related 
conditions [10, 37, 334].  Interestingly, even though we adjusted for diabetes, our 
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findings are consistent with studies reporting factors associated with diabetes-related 
foot disease [257, 292].  First, studies investigating diabetes-related foot ulcers 
consistently identify the common risk factors of PN, PAD, previous foot ulcer and 
trauma [257, 292]. After controlling for diabetes, these factors were also 
independently associated with foot ulcers in our study.  Second, consistently reported 
risk factors for diabetes-related foot infection are foot ulcers, previous foot ulcers and 
trauma, and again after controlling for diabetes, these were the factors identified in 
our study for all-cause foot infection [301, 302].  Third, we identified older age and 
smoking to be independently associated with inpatient ischaemia which was 
consistent with the only previous similar inpatient study of ischaemia [185].  Fourth, 
whilst acute foot wounds in inpatients had yet to be studied, the independent factor of 
younger age identified in our study is consistent with similar trauma-related 
amputation literature [3, 9, 11, 175].  Lastly, nearly all amputation procedures were 
performed in patients with foot disease, regardless of whether it was a minor or 
major amputation procedure, which has also been consistently identified in the 
literature [9-11, 301, 337].  However, of interest was that 70% of these amputation 
procedures were in inpatients with diabetes-related foot disease, yet people with 
diabetes only represented 46% of the inpatients with foot disease.  This finding 
suggests that diabetes inpatients with foot disease have worse hospitalisation 
outcomes than non-diabetes inpatients with foot disease.  It could be hypothesised 
that this was because inpatients with diabetes present with an increased severity of 
foot disease which wasn’t reflected in the limited severity measures reported in our 
study (such as ischaemia or infection severity); or perhaps inpatients with foot 
disease are treated differently if they have diabetes compared to those that don’t have 
diabetes while they are in hospital.  Nonetheless it is recommended that future 
research investigates if there are any differences in risk factor profiles between minor 
amputations and major amputations as these procedures are typically performed for 
different clinical reasons and may have different long-term outcomes on patients’ 
morbidity and mortality. 
In addition to exploring the demographic, social determinant, co-morbidity and 
foot disease history factors typically investigated in similar diabetes-related foot 
disease studies, our study also explored associations with previous foot treatment, 
footwear and self-care ability.  Past foot treatment by a surgeon in the year prior to 
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hospitalisation was the only factor identified from these modifiable variables to be 
independently associated with foot disease.  This is not surprising considering 
surgeons are key members of recommended outpatient multi-disciplinary foot 
disease teams [17, 39, 262, 306].  Perhaps more surprising was that no other 
footwear, self-care or past foot treatment factors were also independently associated 
with inpatient foot disease disorders.  In particular, there was no association found in 
our study with any other recommended outpatient multi-disciplinary team members 
(medical, podiatry, nursing and orthotist [1, 17, 176, 262, 306, 337-339]).  It may be 
hypothesised that inpatients with foot disease may be more likely to be in hospital 
because they had not attended such a multi-disciplinary foot disease team prior to 
hospitalisation [1, 17, 39, 262, 337, 339].  This hypothesis is reinforced when 
considering Australian regions implementing improved access to outpatient multi-
disciplinary foot disease and community podiatrists have demonstrated significant 
reductions in hospitalisation and amputation rates in diabetes populations [306, 320]. 
Regardless, as per previous recommendations, hospitalisation is seen as an ideal 
opportunity to triage inpatients with foot disease into the recommended care of 
multi-disciplinary foot disease teams to reduce future inpatient burdens from re-
admission and amputation that occur without this care [39, 306, 337-339].   
The findings of this study also have other potentially significant future policy, 
clinical and research implications.  First, our findings suggests an average hospital 
with 600 beds could expect to house at any given time 71 inpatients with a major 
foot-related condition present, including 59 with foot disease and 11 recovering from 
an amputation procedure.  Forecasting, this across Australia’s 49,153 available 
overnight public hospital beds [334], suggests 4,817 hospital beds each night host a 
patient with foot disease including 934 with a patient recovering from an amputation 
procedure. With the cost of an Australian hospital bed on average AU$971 [333], it 
can be extrapolated that each year foot disease contributes to an overall cost burden 
(directly and indirectly) on the Australian hospital system of AU$4.7 billion. Second, 
with such a comparatively large inpatient burden of foot disease, policy makers 
should consider implementing similar inpatient continuum of care strategies that are 
commonly used in other large inpatient burdens such as chronic kidney disease and 
cerebrovascular disease.  Furthermore, strong consideration should be given to 
expanding coverage of multidisciplinary diabetic foot disease teams to all inpatients 
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with foot disease regardless of if they have diabetes.  Third, with a self-reported 
previous foot ulcer history being found to be independently associated with many 
foot disease disorders, simply asking all inpatients if they have had a previous foot 
ulcer on admission to hospital may be a very effective and efficient recommendation 
to identify the vast majority of inpatients with foot disease.  Last, further research is 
recommended to investigate both the predictors and successful interventions for the 
very large inpatient population with foot disease and particularly those with non-
diabetes foot disease. 
 
Strengths and limitations 
This study should be read cognisant of several strengths and limitations as 
previously reported [39].  In brief, strengths included using existing literature to 
adequately power the study [37, 39]; investigating an inpatient population that was 
highly representative of reported Australian general and inpatient populations [30, 
32, 39] and comparable to other developed nations’ inpatient populations particularly 
for diabetes prevalence [32, 39, 324, 326, 327]; employing trained and tested data 
collectors [38, 39] who used a valid and reliable data collection instrument  [38, 39] 
to collect internationally-accepted outcome measure definitions for foot disease 
[335]; and, analysing data using recommended regression models adjusting for a 
range of confounders [273, 318, 319].  Limitations included using a cross-sectional 
study design that can only report associated factors; excluding older cognitively 
impaired patients reported to have higher foot disease prevalence; only including 
full-thickness wounds which under-reports Stage 1 pressure ulcers [37]; and using 
self-reported past foot treatment variables.  Additionally, new amputation procedures 
that occurred after the study data collection day were not captured and this may 
under-report all new amputation procedures occurring during the entire admission 
period.  The new amputation procedures captured were also aggregated and this may 
have affected our regression findings as minor and major amputation procedures are 
generally performed for different clinical reasons [3, 10, 11, 301].  Finally, it is 
acknowledged that performing a large number of statistical comparisons, and using 
regression on outcomes with less than 20 cases, does increase the likelihood of a type 
1 statistical error [39, 318, 319]. 
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In conclusion, our methodologically robust point-prevalence study is the first 
to report the overall inpatient foot-related burden.  Our study identified that foot-
related conditions, particularly foot disease, caused an overall inpatient burden that is 
comparable to other well-known inpatient burdens such as those caused by chronic 
kidney disease and cerebrovascular disease.  Furthermore, although our study 
adjusted for diabetes, we still found similar independent factors associated with foot 
disease that had been previously found for diabetes-related foot disease.  It is 
recommended that policy makers, clinicians and researchers seriously consider 
adopting inpatient strategies that have been used with success in other large 
comparable well-known diseases so as to reduce this large, yet, seemingly silent 
overall inpatient burden caused by foot disease.  
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Chapter 7: Previous foot disease and foot risk 
factors in representative inpatients 
This chapter begins with a preface section that briefly explains the manuscript 
that makes up this results chapter (section 7.1).  The manuscript, “Previous foot 
disease and foot risk factors in representative inpatients” is then described as ready to 
submit for publication; including: abstract (section 7.2), background (section 7.3), 
methods (section 7.4), results (section 7.5), discussion (section 7.6) and conclusion 
sections (section 7.7). 
 
7.1 PREFACE 
Chapter 5 identified that 7.4% of the direct inpatient burden was due to foot-
related conditions; 4.9% of participants were admitted for foot disease and 2.1% for 
acute foot trauma.  Chapter 6 identified that 11.8% of the overall inpatient burden 
(direct and indirect) was associated with foot-related conditions; 9.8% had foot 
disease present, 2.3% acute foot trauma and 1.9% of representative inpatients had 
undergone an amputation procedure during their admission with nearly all of these 
due to foot disease.  Additionally, Chapter 6 identified that the largest proportion of 
inpatients with a foot-related condition present were those with foot disease (83%) 
and these foot disease disorders were more likely in those with a history of previous 
foot disease or other common foot risk factors. Whereas, the inpatients with acute 
foot trauma made up a much smaller proportion of inpatients with foot-related 
conditions (17%) and the only independent associated factor identified was the non-
modifiable factor of younger age. 
Chapter 7 now investigates those with previous foot disease or foot risk factors 
to determine their prevalence and explore any potential ‘up stream’ modifiable 
factors that may prevent them in the first place.  Methodology used in Chapters 5 and 
6 is summarised and outcome variables representing previous foot disease (previous 
amputations and previous foot ulceration) and foot risk factors (PAD, PN and foot 
deformity) are investigated.  The manuscript that forms the basis of this chapter is 
ready to be submitted for publication: 
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Lazzarini PA, Hurn SE, Kuys SS, Kamp MC, Ng V, Thomas C, Wills J, Jen 
S, Kinnear EM, d'Emden MC, Reed L. Previous foot disease and foot risk factors in 
representative inpatients. Manuscript in preparation [41]. 
 
7.2 ABSTRACT 
Background: Foot disease is present in one in every ten inpatients.   Few 
studies have investigated previous foot disease and other foot risk factors in 
inpatients.  The aim of this study was to investigate the prevalence and associates of 
previous foot disease and foot risk factors in a representative inpatient population. 
Methods: This study was a secondary analysis of data collected as part of the 
Foot Disease in Inpatients Study, a multi-site point-prevalence study of 733 
representative inpatients.   Demographic, medical history, foot disease history, self-
care ability and past foot treatment characteristics were obtained from all 
participants.  Previous foot disease (previous amputation, previous foot ulceration) 
and foot risk factor (peripheral arterial disease (PAD), peripheral neuropathy (PN), 
foot deformity) outcomes were clinically-diagnosed in all participants.  Multivariate 
logistic regression was used to identify independent factors associated with each 
outcome. 
Results:  Overall 336 participants (46.0% (95% CI: 42.4-49.7%)) had either 
previous foot disease 81 (11.1%) or at least one foot risk factor 255 (34.9%).  
Previous amputation, present in 30 participants (4.1%), was independently associated 
with previous foot ulceration, foot deformity, cerebrovascular accident history and 
past surgeon treatment (p < 0.01).   Previous foot ulceration, present in 72 
participants (9.8%), was independently associated with PN, PAD, past podiatry and 
past nurse treatment (p < 0.02).  PAD, present in 153 participants (21.0%), was 
independently associated with PN, older age, males, indigenous peoples, cancer 
history and past surgeon treatment (p < 0.02).  PN, present in 160 participants 
(22.0%), was independently associated with PAD, older age, diabetes and mobility 
impairment (p < 0.05).  Foot deformity, present in 158 participants (22.4%), was 
independently associated with PN, older age, mobility impairment and past podiatry 
treatment (p < 0.01). 
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Conclusions:  One in every two inpatients had a foot risk factor for developing 
foot disease and one in nine had a history of previous foot disease.  Those with 
previous foot disease were more likely to have had a cerebrovascular accident 
history, foot risk factor and past foot treatment.  Foot risk factors were more likely to 
be in those of older age, male, indigenous, have diabetes, mobility impairment, other 
foot risk factors and past foot treatment.   
 
7.3 BACKGROUND 
Approximately 12% of representative inpatients at any point in time have a 
major foot-related condition present, and half of those have been hospitalised 
because of that foot-related condition [36, 37, 39, 40].  Foot disease disorders have 
been reported to make up 80% of the overall inpatient foot-related burden and 
specifically include foot ulcers, infections and ischaemia [36, 37, 39, 40].  These foot 
disease disorders are typically reported to be precipitated by previous foot disease 
(previous amputations or previous foot ulcers) or other common foot risk factors 
(peripheral arterial disease (PAD), peripheral neuropathy (PN) and foot deformity) 
[36, 37, 39, 40].  Previous foot disease and foot risk factors not only increase the 
likelihood of developing foot disease, but also increase the risk of other adverse 
events such as pressure injuries and falls [37, 64, 67, 68, 308].  Thus, it seems 
important for clinicians, researchers and policy makers to understand how often these 
factors present in inpatients, and understand if other factors may precipitate them in 
representative inpatient populations so as to potentially prevent foot disease in future.   
Studies investigating previous foot disease and foot risk factors in inpatient 
populations have mainly focussed within geriatric and diabetes specific populations 
[64, 67, 68, 85, 91, 93, 308].  These studies suggest that up to 50% of geriatric 
inpatients and up to 80% of diabetes inpatients have at least one foot risk factor [64, 
67, 68, 85, 91, 93, 308].  However, a recent systematic review revealed that no 
previous study has collectively investigated these previous foot disease and foot risk 
factors in representative inpatient populations [37].  This review found that most 
studies have either investigated an individual foot risk factor in a representative 
inpatient population (such as PAD) or collective foot risk factors related to a specific 
condition (such as diabetes-related foot risk factors) [37].  The review concluded up 
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to 36% of representative inpatients may have a foot risk factor, however, further 
robust studies are required to provide precise estimates of the prevalence of previous 
foot disease and foot risk factors in inpatients [37].  Thus, the aim of this study was 
to investigate the prevalence and associates of previous foot disease and foot risk 
factors in a representative inpatient population. 
 
7.4 METHODS 
This study was a secondary analysis of data collected from the Foot Disease in 
Inpatients Study (FDIS), a multi-site observational point-prevalence study with the 
aim of investigating the prevalence and independent factors associated with foot 
disease disorders in representative inpatient populations [37, 39].  The design and 
rationale of FDIS has been described in detail elsewhere [39].   
In brief, all adult inpatients present in five representative public hospitals in 
Queensland (Australia) on one designated day each were invited to participate; 
excluding those with a cognitive deficit, or those in a maternity or psychiatric ward 
[39].  Of a total of 1,146 inpatients present on those days, 883 were eligible for the 
study and 733 consented to participate [39].  Data on all participants were collected 
using a survey of participants’ self-reported history and a clinical foot examination 
by trained and tested data collectors [37, 39].  All data were captured on a validated 
Queensland Foot Disease Form (QFDF) data collection instrument and grouped into 
domains of demographic, social determinant, medical conditions history, foot disease 
history, past foot treatment, foot risk factor and foot disease disorder variables [37, 
39].  All variables have been defined in detail elsewhere [37, 39].     
The outcome variables of interest for the present study were all clinically-
diagnosed and included previous foot disease (previous amputation and previous foot 
ulceration) and foot risk factors (PAD, PN and foot deformity) [37, 39].  In brief, 
previous amputation was clinically-diagnosed as a healed amputation site on the 
lower extremity via a clinical examination [38, 39, 257].  Previous foot ulceration 
was defined as a self-reported foot ulcer that had healed and this was verified via a 
clinical examination [38, 39, 257].  PAD was clinically-diagnosed as the absence of 
at least one foot pulse with a toe systolic pressure of <70mmHg [10, 38, 39, 295].  
Peripheral neuropathy was clinically-diagnosed as the failure to perceive the 
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sensation of a 10-gram monofilament on at least two of three plantar forefoot sites on 
one foot [38, 39, 262, 295, 335].  Foot deformity was clinically-diagnosed as having 
at least three of the following deformity characteristics on one foot: small muscle 
wastage, bony prominence, prominent metatarsal heads, hammer or claw toes, 
limited joint mobility or Charcot deformity [38, 39, 262, 291].   
 
Statistical analysis  
All data were analysed using SPSS 22.0 for Windows (SPSS Inc., Chicago, IL, 
USA) or GraphPad Software.  Descriptive statistics were used to display all 
variables.  Prevalence with 95% Confidence Intervals (95% CI) was evaluated for all 
outcome variables.   Chi-squared, Kruskal-Wallis tests, t-tests or ANOVA were used 
to test differences between groups [39, 273].   Crude associations between 
explanatory and outcome variables were analysed using univariate logistic regression 
(p < 0.05) [39, 318, 319].   
All variables achieving a statistical significance of p < 0.2, except those 
deemed illogical to be potentially on a causal pathway,  were included in backwards 
stepwise multivariate logistic regression analysis until only variables reaching 
statistical significance remained (p < 0.05) (Unadjusted Model) [39, 318, 319].  All 
omitted variables from the unadjusted models were re-entered and retained in the 
models as confounders if the Beta effect estimates of any unadjusted independent 
explanatory variable changed by > 20% (Adjusted Model) [39, 318].  Missing data 
were treated by excluding cases in all models as the proportion of missing data cases 
was minimal (< 5% in most cases) [39, 318]. Two multivariate logistic regression 
models were used for each outcome variable: Model 1 used all explanatory variables 
and Model 2 used all explanatory variables except past foot treatment variables. 
 
7.5 RESULTS 
Participant characteristics, prevalence proportions (95% CI) and univariate 
analyses for the 733 participants are presented in Tables 7-1 and 7-2.  Overall, 336 
participants (46.0% (42.4-49.7%)) had previous foot disease or a foot risk factor, 
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including 81 participants (11.1% (9.0-13.6%)) with previous foot disease and 255 
(34.9% (31.5-38.4%)) with at least one foot risk factor. 
 
Previous Amputation 
Previous amputations were present in 30 participants (4.1% (2.9-5.8%)) and 16 
(2.2% (1.3-3.6%)) of these had diabetes (Table 7-1).  After univariate analysis, 19 
explanatory variables were associated with previous amputations (all, p < 0.05) 
(Table 7-1).  After adjustment for the identified confounder of geographical 
remoteness, having a previous amputation was independently associated with 
previous foot ulcer, past surgeon treatment, cerebrovascular accident (CVA) history 
and foot deformity in Model 1 in order of odds ratio magnitude (all, p < 0.01) (Table 
7-3).  After removing past foot treatment variables no confounders were identified in 
Model 2.  Previous amputation was independently associated with previous foot 
ulcer, CVA history and foot deformity in Model 2 (all p < 0.01) (Table 7-3). 
 
Previous Foot Ulcer 
Previous foot ulcers were present in 72 participants (9.8% (7.9-12.2%)) and 35 
(4.8% (3.4-6.6%)) of these had diabetes (Table 7-1).  After univariate analysis, 14 
explanatory variables were associated with previous foot ulcers (all, p < 0.05) (Table 
7-1).  After adjustment for the identified confounders of geographical remoteness 
and socio-economic status, having a previous foot ulcer was independently 
associated with past nurse treatment, PAD, PN, and past podiatry treatment in Model 
1 in order of odds ratio magnitude (all, p < 0.05) (Table 7-4).  After removing past 
foot treatment variables, no confounders were identified in Model 2.  Previous foot 
ulcer was independently associated with PAD, PN and arthritis in Model 2 (all p < 
0.05) (Table 7-4). 
 
Peripheral Arterial Disease 
Peripheral arterial disease (PAD) was present in 153 participants (21.0% (18.2-
24.1%)) and 60 (8.2% (6.5-10.5%)) of these had diabetes (Table 7-2).  After 
univariate analysis, 22 explanatory variables were associated with previous foot 
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ulcers (all, p < 0.05) (Table 7-2).  After adjustment for the identified confounders of 
past podiatry treatment, having PAD was independently associated with older age 
groups (>41 years), past surgeon treatment, indigenous status, PN, male gender and 
cancer history in Model 1 in order odds of ratio magnitude (all, p < 0.05) (Table 7-5).  
After removing past foot treatment variables and adjusting for the identified 
confounders of diabetes and mobility impairment, PAD was independently 
associated with older age groups (>41 years), PN and cancer history in Model 2 (all p 
< 0.05) (Table 7-5). 
 
Peripheral Neuropathy 
Peripheral neuropathy (PN) was present in 160 participants (22.0% (19.1-
25.1%)) and 74 (10.2% (8.2-12.6%)) of these had diabetes (Table 7-2).  After 
univariate analysis, 16 explanatory variables were associated with previous foot 
ulcers (all, p < 0.05) (Table 7-2).  After adjustment for the identified confounder of 
geographical remoteness, having PN was independently associated with older age 
groups (>41 years), diabetes, mobility impairment and PAD in Model 1 in order of 
odds ratio magnitude (all, p < 0.05) (Table 7-6).  After removing past foot treatment 
variables, Model 2 produced the same findings as Model 1 (all p < 0.05) (Table 7-6). 
 
Foot Deformity 
Foot deformity was present in 158 participants (22.4% (19.5-25.6%)) and 51 
(7.2% (5.5-9.5%)) of these had diabetes (Table 7-2).  After univariate analysis, 18 
explanatory variables were associated with foot deformity (all, p < 0.05) (Table 7-2).  
No confounders were identified in either multivariate model.  Foot deformity was 
independently associated with older age groups (>61 years), PN, past podiatry 
treatment and mobility impairment in Model 1 in order of odds ratio magnitude (all, 
p < 0.01) (Table 7-7).  After removing past foot treatment variables, foot deformity 
was independently associated with older age groups (>61 years), PN, mobility 
impairment and arthritis in Model 2 (all p < 0.05) (Table 7-7). 
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Table 7-1:  Characteristics and univariate analysis for participants with previous amputation and previous foot ulcer 
Variables All Previous Amputation Previous Foot Ulcer 
  n (%) Odds ratio [95% CI] p Value n (%) Odds ratio [95% CI] p Value 
Participants^ 733 30 / 731 (4.1%)  
[2.9 – 5.8%] 
 72 / 731 (9.8%)  
[7.9 – 12.2%] 
 
Ward        
Medical 459 (62.6%) 13 (43.3%) 1.00  42 (58.3%) 1.00  
Surgical 274 (37.4%) 17 (56.7%) 2.26 [1.08-4.73] 0.030**# 30 (41.7%) 1.22 [0.74-1.99] 0.440# 
Demographics        
Age (SD) years 62.0(18.6) 71.4(11.1) 1.04 [1.01-1.06] 0.006** 65.8(15.6) 1.01 [1.00-1.03] 0.074* 
Age groups    NA   0.110 
18-40 years 110 (15.0%) 0 1.00  5 (6.9%) 1.00  
41-60 years 188 (25.7%) 6 (20.0%)   19 (26.4%) 2.38 [0.86-6.55] 0.095 
61-80 years 316 (43.2%) 17 (56.7%)   39 (54.2%) 2.97 [1.14-7.73] 0.026 
81+ years 117 (16.0%) 7 (23.3%)   9 (12.5%) 1.75 [0.57-5.39] 0.330 
Male sex 408 (55.8) 19 (63.3%) 1.38 [0.65-2.95] 0.400 46 (63.9%) 1.46 [0.88-2.42] 0.142* 
Social Determinants        
Socioeconomic Status  711   0.638   0.064* 
Most disadvantaged 102 (14.4%) 6 (20.7%) 1.00  16 (22.9%) 1.00  
Second most disadvantaged 159 (22.4%) 7 (24.1%) 0.74 [0.24-2.26] 0.593 17 (24.3%) 0.64 [0.31-1.34] 0.239 
Middle 98 (13.8%) 2 (6.9%) 0.33 [0.07-1.69] 0.185 4 (5.7%) 0.23 [0.07-0.72] 0.011 
Second least disadvantaged 240 (33.8%) 11 (37.9%) 0.78 [0.28-2.16] 0.626 26 (37.1%) 0.66 [0.34-1.28] 0.218 
Least disadvantaged 112 (15.8%) 3 (10.3%) 0.44 [0.11-1.81] 0.255 7 (10.0%) 0.36 [0.14-0.91] 0.031 
Geographic Remoteness  711   0.589   0.304 
Major city 435 (61.2%) 18 (62.1%) 1.00  41 (58.6%) 1.00  
Inner regional area 153 (21.5%) 4 (13.8%) 0.62 [0.21-1.86] 0.392 15 (21.4%) 1.04 [0.56-1.94] 0.904 
Outer regional area 66 (9.3%) 5 (17.2%) 1.89 [0.68-5.28] 0.224 12 (17.1%) 2.13 [1.05-4.29] 0.036 
Remote area 30 (4.2%) 1 (3.4%) 0.80 [0.10-6.17] 0.826 0 0 NA 
Very remote area 27 (3.8%) 1 (3.4%) 0.89 [0.11-6.90] 0.909 2 (2.9%) 0.77 [0.18-3.35] 0.722 
<Year 10 Education Level 395 (54.0%) 19 (63.3%) 1.48 [0.70-3.16] 0.307 41 (56.9%) 1.13 [0.69-1.85] 0.621 
Indigenous  34 (4.6%) 1 (3.3%) 0.70 [0.09-5.27] 0.727 4 (5.6%) 1.23 [0.42-3.60] 0.704 
Born overseas 161 (22.0%) 5 (16.7%) 0.70 [0.26-1.85] 0.467 11 (15.3%) 0.61 [0.31-1.19] 0.146* 
Medical Condition History        
Diabetes 172 (23.5%) 16 (53.3%) 3.99 [1.91-8.36] <0.001** 35 (48.6%) 3.60 [2.19-5.94] <0.001** 
Hypertension 359 (49.0%) 21 (70.0%) 2.54 [1.15-5.61] 0.022** 38 (52.8%) 1.18 [0.73-1.93] 0.497 
Dyslipidaemia 234 (31.9%) 12 (40.0%) 1.44 [0.68-3.04] 0.341 27 (37.5%) 1.31 [0.79-2.17] 0.294 
Myocardial Infarct 146 (19.9%) 12 (40.0%) 2.82 [1.33-6.00] 0.007** 17 (23.6%) 1.27 [0.71-2.26] 0.417 
Cerebrovascular Accident 85 (11.6%) 9 (30.0%) 3.52 [1.59-7.97] 0.002** 8 (11.1%) 0.95 [0.44-2.05] 0.885 
Chronic Kidney Disease  89 (12.1%) 11 (36.7%) 4.62 [2.12-10.08] <0.001** 19 (26.4%) 3.02 [1.69-5.39] <0.001** 
Smoker 104 (14.2%) 3 (10.0%) 0.66 [0.20-2.22] 0.501 12 (16.7%) 1.23 [0.64-2.38] 0.533 
Ex-Smoker 304 (41.5%) 14 (46.7%) 1.25 [0.60-2.60] 0.554 28 (38.9%) 0.89 [0.54-1.46] 0.642 
Cancer 174 (23.7%) 8 (26.7%) 1.17 [0.51-2.68] 0.707 17 (23.6%) 0.99 [0.56-1.75] 0.968 
Arthritis 274 (37.4%) 18 (60.0%) 2.64 [1.25-5.57] 0.011** 41 (56.9%) 2.43 [1.49-3.99] <0.001** 
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Depression 191 (26.1%) 6 (20.0%) 0.70 [0.28-1.75] 0.447 21 (29.2%) 1.18 [0.69-2.03] 0.537 
Acute foot trauma 26 (3.5%) 1 (3.3%) 0.93 [0.12-7.12] 0.946 7 (9.7%) 3.63 [1.47-8.95] 0.005** 
Self-care Ability        
Mobility impairment 242 (33.2%) 21 (70.0%) 5.07 [2.29-11.25] <0.001** 38 (52.8%) 2.48 [1.52-4.05] <0.001** 
Vision impairment 110 (15.1%) 12 (40.0%) 4.09 [1.91-8.75] <0.001** 20 (27.8%) 2.42 [1.38-4.25] 0.002** 
Footwear worn: Inside    0.158*   0.580 
Low risk footwear 81 (11.1%) 6 (20.7%) 1.00  11 (15.5%) 1.00  
Moderate risk footwear 263 (36.1%) 13 (44.8%) 0.65 [0.24-1.77] 0.399 27 (38.0%) 0.73 [0.34-1.54] 0.407 
High risk footwear 139 (19.1%) 2 (6.9%) 0.18 [0.04-0.93] 0.041 12 (16.9%) 0.61 [0.25-1.45] 0.259 
No footwear worn 245 (33.7%) 8 (27.6%) 0.42 [0.14-1.26] 0.121 21 (29.6%) 0.60 [0.27-1.30] 0.193 
Footwear worn: Outside    0.116*   0.235 
Low risk footwear 386 (53.2%) 21 (75.0%) 1.00  36 (50.7%) 1.00  
Moderate risk footwear 75 (10.3%) 1 (3.6%) 0.23 [0.03-1.77] 0.159 11 (15.5%) 1.67 [0.81-3.44] 0.168 
High risk footwear 250 (34.4%) 5 (17.9%) 0.35 [0.13-0.95] 0.039 21 (29.6%) 0.89 [0.51-1.56] 0.682 
No footwear worn 15 (2.1%) 1 (3.6%) 1.24 [0.16-9.87] 0.840 3 (4.2%) 2.42 [0.65-8.99] 0.186 
Past Foot Treatment        
Yes 256 (34.9%) 22 (73.3%) 5.52 [2.42-12.60] <0.001** 56 (77.8%) 8.03 [4.50-14.35] <0.001** 
Podiatry 180 (24.6%) 18 (60.0%) 50.3 [2.37-10.67] <0.001** 41 (56.9%) 4.95 [2.99-8.18] <0.001** 
GP 93 (12.7%) 14 (46.7%) 6.89 [3.24-14.65] <0.001** 27 (37.5%) 5.39 [3.14-9.26] <0.001** 
Surgeon 36 (4.9%) 14 (46.7%) 27.01 [11.73-62.15] <0.001** 17 (23.6%) 10.41 [5.12-21.18] <0.001** 
Physician 21 (2.9%) 5 (16.7%) 8.56 [2.91-25.23] <0.001** 7 (9.7%) 4.96 [1.93-12.73] 0.001** 
Nurse 20 (2.7%) 7 (23.3%) 16.11 [5.88-44.15] <0.001** 12 (16.7%) 16.28 [6.40-41.37] <0.001** 
Orthotist 4 (0.5%) 3 (10.0%) 77.78 [7.83-772.35] <0.001** 2 (2.8%) 9.39 [1.30-67.67] 0.026** 
Other 9 (1.2%) 0 0 NA 1 (1.4%) 1.15 [0.14-9.30] 0.898 
Foot Disease History        
Previous foot ulcer 72 (9.8%) 21 (70.0%) 30.33 [13.20-69.72] <0.001** -- -- -- 
Foot Risk Factors        
Peripheral Neuropathy 160 (22.0%) 21 (72.4%) 10.65 [4.62-24.56] <0.001** 39 (54.9%) 5.39 [3.24-8.95] <0.001** 
PAD  153 (21.0%) 20 (69.0%) 9.44 [4.20-21.20] <0.001** 40 (56.3%) 6.20 [3.72-10.34] <0.001** 
Foot deformity  158 (22.4%) 17 (65.4%) 7.27 [3.17-16.66] <0.001** 29 (42.0%) 2.85 [1.70-4.77] <0.001** 
*p < 0.2; **p < 0.05; ^ 95% CI are for prevalence figure; # Explanatory variable excluded from multivariate model as considered not on causal pathway for outcome; GP: General Practitioner;  
PAD: Peripheral Arterial Disease; SD: Standard deviation. 
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Table 7-2:  Characteristics and univariate analysis for participants with peripheral arterial disease, peripheral neuropathy and foot deformity  
Variables All Peripheral Arterial Disease Peripheral Neuropathy Foot Deformity 
  n (%) Odds ratio  
[95% CI] 
p Value n (%) Odds ratio  
[95% CI] 
p Value n (%) Odds ratio  
[95% CI] 
p Value 
Participants^ 733 153 / 728 
(21.0%) 
 
[18.2 - 24.1%] 
 160 / 728 
(22.0%) 
 
[19.1 - 25.1%] 
 158 / 706 
(22.4%) 
 
[19.5 – 25.6%] 
 
Ward           
Medical 459 (62.6%) 88 (57.5%) 1.00  96 (60.0%) 1.00  105 (66.5%) 1.00  
Surgical 274 (37.4%) 65 (42.5%) 1.31 [0.91-1.89] 0.141*# 64 (40%) 1.16 [9.81-1.67] 0.411# 53 (33.5%) 0.84 [0.58-1.22] 0.353# 
Demographics           
Age (SD) years 62.0(18.6) 70.5(13.3) 1.04 [1.03-1.05] <0.001** 70.1(14.1) 1.04 [1.02-1.05] <0.001** 72.3(14.4) 1.05 [1.04-1.06] <0.001** 
Age groups    <0.001*   <0.001**   <0.001** 
18-40 years 110 (15.0%) 4 (2.6%) 1.00  6 (3.8%) 1.00  5 (3.2%) 1.00  
41-60 years 188 (25.7%) 28 (18.3%) 4.70 [1.60-13.78] 0.005 29 (18.2%) 3.22 [1.29-8.03] 0.012 19 (12.1%) 2.33 [0.84-6.43] 0.103 
61-80 years 316 (43.2%) 82 (53.6%) 9.41 [3.36-26.34] <0.001 87 (54.7%) 6.64 [2.81-15.69] <0.001 88 (56.1%) 7.84 [3.09-19.91] <0.001** 
81+ years 117 (16.0%) 39 (25.5%) 13.25 [4.55-38.62] <0.001 37 (23.3%) 8.02 [3.23-19.93] <0.001 45 (28.7%) 12.60 [4.76-33.36] <0.001** 
Male sex 408 (55.8) 97 (63.4%) 1.48 [1.03-2.14] 0.037** 93 (58.1%) 1.12 [0.79-1.60] 0.525 74 (46.8%) 0.62 [0.44-0.89] 0.009** 
Social Determinants           
Socioeconomic Status  711   0.020**   0.798   0.274 
Most disadvantaged 102 (14.4%) 32 (21.8%) 1.00  24 (15.5%) 1.00  22 (14.5%) 1.00  
Second most disadvantaged 159 (22.4%) 34 (23.1%) 0.59 [0.33-1.04] 0.066 34 (21.9%) 0.88 [0.48-1.59] 0.661 35 (23.0%) 1.03 [0.56-1.89] 0.927 
Middle 98 (13.8%) 13 (8.8%) 0.33 [0.16-0.67] 0.002 21 (13.5%) 0.86 [0.44-1.68] 0.666 16 (10.5%) 0.67 [0.33-1.36] 0.264 
Second least disadvantaged 240 (33.8%) 49 (33.3%) 0.55 [0.32-0.93] 0.025 56 (36.1%) 0.97 [9.56-1.68] 0.910 49 (32.2%) 0.89 [0.51-1.58] 0.698 
Least disadvantaged 112 (15.8%) 19 (12.9%) 0.43 [0.23-0.83] 0.012 20 (12.9%) 0.69 [0.35-1.34] 0.272 30 (19.7%) 1.40 [0.74-2.65] 0.300 
Geographic Remoteness  711   0.604   0.556   0.180* 
Major city 435 (61.2%) 87 (59.2%) 1.00  98 (63.2%) 1.00  103 (67.8%) 1.00  
Inner regional area 153 (21.5%) 30 (20.4%) 0.98 [0.62-1.56] 0.943 32 (20.6%) 0.93 [0.59-1.46] 0.742 28 (18.4%) 0.73 [0.46-1.17] 0.196 
Outer regional area 66 (9.3%) 17 (11.6%) 1.38 [0.76-2.51] 0.297 10 (15.2%) 0.61 [0.30-1.24] 0.173 15 (9.9%) 0.92 [0.50-1.71] 0.793 
Remote area 30 (4.2%) 5 (3.4%) 0.79 [0.30-2.13] 0.646 9 (5.8%) 1.47 [0.65-3.30] 0.357 2 (1.3%) 0.23 [0.05-0.97] 0.046 
Very remote area 27 (3.8%) 8 (5.4%) 1.67 [0.71-3.94] 0.242 6 (3.9%) 0.98 [0.38-2.49] 0.961 4 (2.6%) 0.53 [0.18-1.58] 0.256 
<Year 10 Education Level 395 (54.0%) 97 (63.4%) 1.64 [1.14-2.37] 0.008** 92 (57.9%) 1.23 [0.86-1.76] 0.252 98 (62.0%) 1.54 [1.07-2.21] 0.020** 
Indigenous  34 (4.6%) 12 (7.9%) 2.16 [1.04-4.46] 0.039** 9 (5.6%) 1.29 [0.59-2.83] 0.521 7 (4.5%) 0.94 [0.40-2.20] 0.881 
Born overseas 161 (22.0%) 33 (21.6%) 0.96 [0.62-1.47] 0.839 29 (18.1%) 0.73 [0.47-1.14] 0.164* 35 (22.3%) 1.02 [0.67-1.56] 0.925 
Medical Condition History           
Diabetes 172 (23.5%) 60 (39.2%) 2.70 [1.84-3.96] <0.001** 74 (46.3%) 4.18 [2.86-6.11] <0.001** 51 (32.3%) 1.76 [1.20-2.63] 0.004** 
Hypertension 359 (49.0%) 97 (63.4%) 2.10 [1.45-3.03] <0.001** 92 (57.5%) 1.55 [ 1.09-2.20] 0.016** 95 (60.1%) 1.75 [1.22-2.50] 0.002** 
Dyslipidaemia 234 (31.9%) 66 (43.1%) 1.87 [1.30-2.70] 0.001** 65 (40.6%) 1.63 [1.13-2.34] 0.008** 53 (33.5%) 1.09 [0.75-1.58] 0.671 
Myocardial Infarct 146 (19.9%) 42 (27.5%) 1.73 [1.15-2.62] 0.009** 38 (23.8%) 1.33 [0.87-2.02] 0.187* 43 (27.2%) 1.66 [1.10-2.50] 0.016** 
Cerebrovascular Accident 85 (11.6%) 29 (19.0%) 2.17 [1.33-3.54] 0.002** 24 (15.0%) 1.47 [0.88-2.44] 0.140* 21 (13.3%) 1.22 [0.72-2.08] 0.456 
Chronic Kidney Disease  89 (12.1%) 38 (24.8%) 3.47 [2.17-5.54] <0.001** 32 (20.0%) 2.24 [1.40-3.61] 0.001** 28 (17.7%) 1.79 [1.09-2.91] 0.020** 
Smoker 104 (14.2%) 21 (13.7%) 0.96 [0.57-1.60] 0.866 18 (11.3%) 0.72 [0.42-1.24] 0.235 10 (6.3%) 0.35 [0.18-0.69] 0.002** 
Ex-Smoker 304 (41.5%) 69 (45.1%) 1.21 [0.84-1.73] 0.308 66 (41.3%) 0.98 [0.69-1.40] 0.914 68 (43.0%) 1.07 [0.75-1.53] 0.717 
Cancer 174 (23.7%) 29 (19.0%) 0.71 [0.45-1.10] 0.127* 45 (28.1%) 1.35 [0.90-2.00] 0.143* 39 (24.7%) 1.09 [0.72-1.64] 0.694 
 Chapter 7: Previous foot disease and foot risk factors in representative inpatients 179 
Arthritis 274 (37.4%) 77 (50.3%) 1.99 [1.39-2.86] <0.001** 73 (45.6%) 1.57 [1.10-2.24] 0.013** 82 (51.9%) 2.24 [1.55-3.19] <0.001** 
Depression 191 (26.1%) 36 (23.5%) 0.85 [0.56-1.29] 0.440 41 (25.6%) 0.97 [0.65-1.45] 0.877 44 (27.8%) 1.09 [0.74-1.63] 0.660 
Acute foot trauma 26 (3.5%) 5 (3.3%) 0.89 [0.33-2.40] 0.820 9 (5.6%) 1.93 [0.84-4.42] 0.119* 6 (3.8%) 1.04 [0.41-2.64] 0.931 
Self-care Ability           
Mobility impairment 242 (33.2%) 78 (51.0%) 2.66 [1.84-3.83] <0.001** 95 (59.4%) 4.23 [2.93-6.12] <0.001** 89 (56.3%) 3.59 [2.49-5.19] <0.001** 
Vision impairment 110 (15.1%) 37 (24.2%) 2.22 [1.42-3.46] <0.001** 33 (20.6%) 1.68 [1.07-2.64] 0.026** 37 (23.6%) 2.14 [1.37-3.34] 0.001** 
Footwear worn: Inside    0.002**   0.006**   0.007** 
Low risk footwear 81 (11.1%) 19 (12.4%) 1.00  27 (17.0%) 1.00  22 (13.9%) 1.00  
Moderate risk footwear 263 (36.1%) 74 (48.4%) 1.28 [0.72-2.28] 0.408 66 (41.5%) 0.67 [0.39-1.16] 0.151 73 (46.2%) 1.07 [0.61-1.87] 0.813 
High risk footwear 139 (19.1%) 19 (12.4%) 0.53 [0.26-1.06] 0.074 25 (15.7%) 0.44 [0.24-0.83] 0.012 23 (14.6%) 0.56 [0.29-1.08] 0.083 
No footwear worn 245 (33.7%) 41 (26.8%) 0.66 [0.36-1.21] 0.178 41 (25.8%) 0.40 [0.23-0.71] 0.002 40 (25.3%) 0.56 [0.31-1.01] 0.054 
Footwear worn: Outside    0.065*   0.015**   0.316 
Low risk footwear 386 (53.2%) 89 (58.6%) 1.00  91 (57.2%) 1.00  85 (54.1%) 1.00  
Moderate risk footwear 75 (10.3%) 19 (12.5%) 1.13 [0.64-2.01] 0.670 16 (10.1%) 0.88 [0.48-1.60] 0.674 22 (14.0%) 1.43 [0.82-2.49] 0.207 
High risk footwear 250 (34.4%) 39 (25.7%) 0.62 [0.41-0.94] 0.026 44 (27.7%) 0.70 [0.47-1.05] 0.081 47 (29.9%) 0.81 [0.55-1.21] 0.313 
No footwear worn 15 (2.1%) 5 (3.3%) 1.67 [0.56-5.01] 0.361 8 (5.0%) 3.71 [1.31-10.50] 0.014 3 (1.9%) 0.92 [0.25-3.38] 0.901 
Past Foot Treatment           
Yes 256 (34.9%) 83 (54.2%) 2.80 [1.95-4.04] <0.001** 86 (53.8%) 2.77 [1.93-3.96] <0.001** 86 (54.4%) 2.80 [1.95-4.02] <0.001** 
Podiatry 180 (24.6%) 62 (40.5%) 2.67 [1.82-3.91] <0.001** 67 (41.9%) 2.93 [2.01-4.27] <0.001** 73 (46.2%) 3.71 [2.54-5.42] <0.001** 
GP 93 (12.7%) 36 (23.5%) 2.85 [1.79-4.54] <0.001** 37 (23.1%) 2.81 [1.77-4.45] <0.001** 25 (15.8%) 1.42 [0.86-2.25] 0.168* 
Surgeon 36 (4.9%) 20 (13.1%) 5.61 [2.80-11.26] <0.001** 18 (11.3%) 4.11 [2.07-8.18] <0.001** 14 (8.9%) 2.71 [1.33-5.53] 0.006** 
Physician 21 (2.9%) 9 (5.9%) 2.93 [1.21-7.09] 0.017** 8 (5.0%) 2.25 [0.92-5.52] 0.078* 9 (5.7%) 2.95 [1.20-7.25] 0.018** 
Nurse 20 (2.7%) 10 (6.5%) 3.95 [1.61-9.68] 0.003** 11 (6.9%) 4.59 [1.87-11.27] 0.001** 9 (5.7%) 3.25 [1.30-8.14] 0.012** 
Orthotist 4 (0.5%) 1 (0.7%) 1.25 [0.13-12.14] 0.845 3 (1.9%) 10.83 [1.12-104.88] 0.040 1 (0.6%) 1.74 [0.16-19.30] 0.652 
Other 9 (1.2%) 2 (1.3%) 1.08 [0.22-5.23] 0.929 1 (0.6%) 0.44 [0.06-3.55] 0.441 3 (1.9%) 1.75 [0.43-7.07] 0.433 
Foot Risk Factors           
Peripheral Neuropathy 160 (22.0%) 62 (40.5%) 3.35 [2.27-4.95] <0.001** -- -- -- 66 (42.0%) 3.69 [2.50-5.45] <0.001** 
PAD  153 (21.0%) -- -- -- 62 (39.0%) 3.35 [2.27-4.95] <0.001** 53 (33.8%) 2.43 [1.63-3.62] <0.001** 
Foot deformity  158 (22.4%) 52 (35.8%) 2.43 [1.63-3.62] <0.001**# 66 (42.3%) 3.69 [2.50-5.45] <0.001**# -- -- -- 
*p < 0.2; **p < 0.05; ^ 95% CI are for prevalence figure; # Explanatory variable excluded from multivariate model as considered not on causal pathway for outcome; GP: General Practitioner; PAD: Peripheral Arterial 
Disease; SD: Standard deviation. 
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Table 7-3:  Independent associated factors for previous amputations using 
multivariate logistical regression (Odds Ratios [95% CI]) 
Risk Factor Unadjusted p Value Adjusted p Value 
Model 1     
CVA history 4.83 [1.48-15.74] 0.009* 6.85 [1.86-25.21] 0.004 
Previous foot ulcer 17.92 [6.51-49.29] <0.001* 22.01 [6.89-70.38] <0.001 
Foot deformity 4.50 [1.70-11.90] 0.002 5.59 [1.89-16.55] 0.002 
Past surgeon treatment 8.09 [2.50-26.20] <0.001* 10.73 [2.87-40.15] <0.001 
Model 1 Results: Pseudo R2:0.447 
Omnibus: df =4, p <0.001  
Missing: 29 (4.0%); 
H&L: p = 0.955 
Pseudo R2:0.516 
Omnibus: df =8, p <0.001  
Missing: 50 (6.8%); 
H&L: p = 0.628 
Model 2     
CVA history 5.36 [1.80-15.95] 0.003* No confounders identified  
Previous foot ulcer 26.70 [10.20-69.85] <0.001*   
Foot deformity 5.17 [2.06-13.02] <0.001*   
Model 2  Results: Pseudo R2:0.394 
Omnibus: df =3 , p <0.001  
Missing: 29 (4.0%);  
H&L: p = 0.817 
  
*p < 0.05; Pseudo R2: Nagelkerke R2; Omnibus: Omnibus Tests of Model Coefficients; df: degrees of freedom; Missing: 
Excluded missing cases; H&L: Hosmer and Lemeshow Test; CVA: Cardiovascular Accident; PN: Peripheral Neuropathy. 
 
 
Table 7-4:  Independent associated factors for previous foot ulcers using multivariate 
logistical regression (Odds Ratios [95% CI]) 
Risk Factor Unadjusted p Value Adjusted p Value 
Model 1     
Vision impairment 2.10 [1.09-4.03] 0.026 1.89 [0.95-3.77] 0.069 
PN 3.17 [1.81-5.56] <0.001 3.75 [2.06-6.85] <0.001 
PAD 3.77 [2.15-6.62] <0.001 3.88 [2.14-7.06] <0.001 
Past podiatry treatment 3.16 [1.80-5.55] <0.001 2.88 [1.59-5.22] <0.001 
Past nurse treatment 8.45 [2.88-24.84] <0.001 18.80 [5.15-68.66] <0.001 
Model 1 Results: Pseudo R2:0.305 
Omnibus: df =5 , p <0.001  
Missing: 9 (1.2%);  
H&L: p = 0.154 
Pseudo R2: 0.364 
Omnibus: df =13 , p < 0.001  
Missing: 31 (4.2%);  
H&L: p = 0.601 
Model 2     
Arthritis 1.92 [1.13-3.26] 0.016 No confounders identified  
PN 3.92 [2.29-6.69] <0.001   
PAD 4.39 [2.57-7.49] <0.001   
Model 2  Results: Pseudo R2:0.217 
Omnibus: df =3 , p <0.001  
Missing: 7 (1.0%);  
H&L: p = 0.669 
  
*p < 0.05; Pseudo R2: Nagelkerke R2; Omnibus: Omnibus Tests of Model Coefficients; df: degrees of freedom; Missing: 
Excluded missing cases; H&L: Hosmer and Lemeshow Test; PAD: Peripheral Arterial Disease; PN: Peripheral Neuropathy. 
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Table 7-5:  Independent associated factors for peripheral arterial disease using 
multivariate logistical regression (Odds Ratios [95% CI]) 
Risk Factor Unadjusted p Value Adjusted p Value 
Model 1     
Age groups  <0.001  <0.001 
18-40 years Referent  Referent  
41-60 years 4.98 [1.64-15.14] 0.005 4.69 [1.55-14.23] 0.006 
61-80 years 10.42 [3.56-30.51] <0.001 8.94 [3.04-26.33] <0.001 
81+ years 15.61 [5.10-47.80] <0.001 12.72 [4.10-39.40] <0.001 
Male Sex 1.55 [1.04-2.32] 0.031 1.70 [1.13-2.56] 0.012 
Indigenous 3.23 [1.40-7.43] 0.006 3.12 [1.36-7.18] 0.007 
Cancer history 0.52 [0.32-0.85] 0.009 0.52 [0.32-0.84] 0.008 
PN 2.38 [1.56-3.61] <0.001 2.26 [1.48-3.45] <0.001 
Past surgeon treatment 6.01 [2.74-13.18] <0.001 5.16 [2.32-11.47] <0.001 
Model 1  Results: Pseudo R2:0.213 
Omnibus: df =8 , p <0.001  
Missing: 11 (1.5%);  
H&L: p = 0.498 
Pseudo R2: 0.222 
Omnibus: df = 9 , p < 0.001  
Missing: 11 (1.5%);  
H&L: p = 0.038 
Model 2     
Age groups  <0.001*  <0.001 
18-40 years Referent  Referent  
41-60 years 4.46 [1.51-13.16] 0.007 4.31 [1.45-12.83] 0.009 
61-80 years 8.46 [2.99-23.98] <0.001 7.58 [2.66-21.63] <0.001 
81+ years 11.02 [3.73-32.54] <0.001 9.00 [3.00-27.02] <0.001 
Cancer history 0.55 [0.34-0.88] 0.013 0.56 [0.35-0.90] 0.016 
PN 2.75 [1.84-4.12] <0.001 1.98 [1.28-3.05] 0.002 
Model 2 Results: Pseudo R2:0.155 
Omnibus: df =5 , p <0.001  
Missing: 8 (1.1%);  
H&L: p = 0.457 
Pseudo R2:0.187 
Omnibus: df = 7, p <0.001  
Missing: 11(1.5%);  
H&L: p = 0.315 
*p < 0.05; Pseudo R2: Nagelkerke R2; Omnibus: Omnibus Tests of Model Coefficients; df: degrees of freedom; Missing: 
Excluded missing cases; H&L: Hosmer and Lemeshow Test; PN: Peripheral Neuropathy. 
 
 
Table 7-6:  Independent associated factors for peripheral neuropathy using 
multivariate logistical regression (Odds Ratios [95% CI]) 
Risk Factor Unadjusted p Value Adjusted p Value 
Model 1     
Age groups  0.007*  0.008* 
18-40 years Referent  Referent  
41-60 years 2.93 [1.07-8.01] 0.037* 2.77 [1.01-7.62] 0.048* 
61-80 years 4.66 [1.80-12.08] 0.002* 4.55 [1.75-11.80] 0.002* 
81+ years 4.73 [1.70-13.15] 0.003* 4.42 [1.59-12.32] 0.004* 
Diabetes 3.91 [2.57-5.97] <0.001* 3.94 [2.55-6.07] <0.001* 
Mobility impairment 3.37 [2.22-5.11] <0.001* 3.41 [2.24-5.20] <0.001* 
PAD 1.93 [1.25-2.99] 0.003* 2.08 [1.33-3.25] 0.001* 
Outside footwear worn  0.017*  0.055 
Low risk  Referent  Referent  
Moderate risk  0.58 [0.29-1.15] 0.117 0.57 [0.28-1.13] 0.108 
High risk  0.71 [0.45-1.11] 0.132 0.72 [0.45-1.14] 0.158 
No footwear  3.99 [1.19-13.35] 0.025* 3.01 [0.85-10.65] 0.088 
Model 1 Results: Pseudo R2:0.284 
Omnibus: df =9 , p <0.001  
Missing: 15 (2.0%);  
H&L: p = 0.100 
Pseudo R2: 0.289 
Omnibus: df =13 , p < 0.001  
Missing: 33 (4.5%);  
H&L: p = 0.189 
Model 2     
 As per Model 1 above  As per Model 1 above  
Model 2 Results:      
*p < 0.05; Pseudo R2: Nagelkerke R2; Omnibus: Omnibus Tests of Model Coefficients; df: degrees of freedom; Missing: 
Excluded missing cases; H&L: Hosmer and Lemeshow Test; PAD: Peripheral Arterial Disease. 
 
 
 
   Chapter 7: Previous foot disease and foot risk factors in representative inpatients 182 
Table 7-7:  Independent associated factors for foot deformity using multivariate 
logistical regression (Odds Ratios [95% CI]) 
Risk Factor Unadjusted p Value Adjusted p Value 
Model 1     
Age groups  <0.001* No confounders identified  
18-40 years Referent    
41-60 years 1.76 [0.62-4.99] 0.289   
61-80 years 4.67 [1.79-12.17] 0.002   
81+ years 5.68 [2.05-15.71] 0.001   
Mobility impairment 2.04 [1.35-3.08] 0.001   
PN 2.20 [1.44-2.36] <0.001   
Past podiatry treatment 2.06 [1.36-3.12] 0.001   
Model 1 Results: Pseudo R2:0.233 
Omnibus: df =6 , p <0.001  
Missing: 32 (4.4%);  
H&L: p = 0.938 
  
Model 2     
Age groups  <0.001 No confounders identified  
18-40 years Referent    
41-60 years 1.68 [0.59-4.75] 0.332   
61-80 years 4.76 [1.83-12.41] 0.001   
81+ years 6.23 [2.27-17.14] <0.001   
Arthritis 1.58 [1.07-2.35] 0.022   
Mobility impairment 2.12 [1.41-3.19] <0.001   
PN 2.34 [1.53-3.57] <0.001   
Model 2  Results: Pseudo R2:0.221 
Omnibus: df =6 , p <0.001  
Missing: 32 (4.4%); 
H&L: p = 0.460 
  
*p < 0.05; Pseudo R2: Nagelkerke R2; Omnibus: Omnibus Tests of Model Coefficients; df: degrees of freedom; Missing: 
Excluded missing cases; H&L: Hosmer and Lemeshow Test; PN: Peripheral Neuropathy. 
 
 
7.6 DISCUSSION 
This appears to be the first study to investigate a representative inpatient 
population to determine the prevalence of, and factors independently associated with, 
people with previous foot disease or foot risk factors for developing foot disease.  
Our findings indicate that 46% of representative inpatients had an increased 
likelihood of developing foot disease via previous foot disease (11%) or at least one 
foot risk factor (35%).  Previous foot disease, consisting of previous amputation 
(4%) or previous foot ulceration (10%), was mainly associated with other previous 
foot disease, foot risk factors or past foot treatment.  Foot risk factors, consisting of 
PAD (21%), PN (22%) or foot deformity (22%), were mainly associated with older 
age, other foot risk factors or past foot treatment.  Other independent factors 
associated included male gender, indigenous status, diabetes, cerebrovascular 
accident history, cancer history, arthritis and mobility impairment.  Overall, these 
findings suggest that nearly one in every two inpatients has a foot risk factor for 
developing foot disease and one in nine has a history of previous foot disease. 
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The prevalence of previous foot disease in representative inpatients appears to 
have received little attention to date [37].  However, existing studies have reported 
previous foot disease in specific inpatient populations and our findings appear at the 
higher end of the reported ranges in comparison [36].  In the diabetes specific 
inpatient population, we found a previous amputation prevalence of 9% (16/172) 
which was high when compared to the 1-8% range reported in other diabetes specific 
inpatient studies [28, 36, 86].  Previous foot ulcer prevalence in our study was 20% 
(35/172) and also high compared to the 12-20% range reported in diabetes specific 
inpatient literature [7, 26, 36, 90].  In inpatients over 60 years of age, we found a 
previous amputation prevalence of 5.5% (24/433) compared with the 0.4-7.0% range 
reported in similar literature [4, 36, 68].  Also previous foot ulcer prevalence was 
11.1% (48/433) in our study compared with the 0.6-15.0% range reported in geriatric 
inpatient literature [4, 36, 67].  Possible reasons for these disparities in findings may 
be that our study investigated previous foot disease as a primary outcome using 
validated clinical diagnoses, but used a self-reported history to identify diabetes.  
Whereas, in contrast, previous studies have typically investigated previous foot 
disease as a secondary outcome using audits of medical records, but used biomedical 
criteria to identify diabetes [36, 37].  Thus, it could be hypothesised that our study 
had increased accuracy in identifying the previous foot disease numerator, yet in 
contrast decreased accuracy in identifying the diabetes inpatient population 
denominator compared to other studies [36, 37].  However, this was not the case for 
older age groups where the findings of our study appear to align more closely with 
previous literature. 
Independent factors associated with previous foot disease have received little 
attention in the inpatient literature.  However, our major findings align with findings 
in the diabetes outpatient literature even though we controlled for diabetes in an 
inpatient population.  We found previous amputation was most strongly associated 
with previous foot ulcers which have already been consistently identified in the 
diabetes outpatient literature [9, 262, 291, 295, 320, 340].  Other factors 
independently associated in our study were foot deformity, CVA history and past 
foot treatment by a surgeon.  The independent association with foot deformity is 
most plausibly explained by a minor amputation procedure often producing a foot 
deformity in the remaining partial foot and a major amputation procedure often 
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precipitating a compensatory foot deformity in the contralateral foot [262, 291].  
Perhaps the most unlikely independent associate for previous amputation found was 
a CVA history.  However, interestingly a CVA history has also been associated with 
amputation in other recent studies [320, 341].  It could be hypothesised that this is 
explained by the similar macrovascular pathophysiology that result in both CVA and 
PAD which can subsequently result in amputation [320, 341].  The last independent 
factor associated with previous amputation was past foot treatment by a surgeon in 
the year prior to hospitalisation. This is not surprising considering any previous 
amputation procedure could only be performed by a surgeon.  However, we only 
captured past foot treatment up to one year prior to hospitalisation and did not record 
the duration since the previous amputation was performed.  Thus, further research 
would be required to determine if people with a previous amputation maintain 
ongoing treatment with their surgeon.    
The independent factors associated with previous foot ulceration after 
controlled for diabetes in our inpatient study were also consistent with those 
identified in previous diabetes outpatient literature, including PAD, PN and past foot 
treatment by a podiatrist or nurse [20, 262, 291].  Again our findings indicate that 
these foot risk factors and past foot treatment factors are important factors in the 
development of foot disease independent of diabetes status [20, 262, 291].  
Furthermore, our recent inpatient study investigating active foot ulcers identified 
similar independent associated factors of PAD and PN regardless of diabetes, but 
also identified an association with past foot treatment by a surgeon rather than a 
podiatrist or nurse [40].  This adds weight to previous recommendations that a 
podiatrist and nurse should be involved with a surgeon and other health practitioners 
as part of the recommended outpatient multi-disciplinary foot team to prevent 
inpatient admissions [262, 281, 337].  Nevertheless it can by hypothesised from these 
findings that the foot risk factors of PAD, PN and foot deformity lead to foot disease 
and potentially amputation in both diabetes and non-diabetes populations.   
The prevalence of common foot risk factors in representative inpatients has 
also received little attention to date [37].  On first appearance our 21% prevalence for 
PAD seemed low when compared to the 29%-36% reported in previous 
representative inpatient literature [41, 184, 185].  However, an interrogation of these 
findings suggests closer alignment, as the previous studies used an ankle brachial 
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index to diagnose PAD in inpatients over 40 years of age, whilst our study used toe 
systolic pressures to diagnose PAD in inpatients over 18 years of age [184, 185].  
The PAD prevalence in our cohort over 40 years was 24% (149/623).  In addition, 
toe pressures have been reported to decrease false positive PAD identification 
compared with ankle brachial indices due to reduced medial arterial calcification in 
the digital arteries as opposed to the lower leg arteries [10, 262, 295].  Thus, it could 
be hypothesised that our findings may deliver the most precise prevalence estimates 
to date for PAD in a representative inpatient population.   PAD in our study was 
independently associated with older age, male gender and PN, which is also 
consistent with previous literature [184, 185, 342].  However, our study is one of the 
first studies to investigate Australian indigenous status as a potential explanatory 
variable for PAD, and we found very similar findings to the only other two 
population-based reports indicating that indigenous status is associated with PAD [6, 
343].  The independent associated factor of past surgical treatment for PAD is a 
welcome finding and suggests patients with PAD are being assessed by vascular 
surgeons as recommended by best practice PAD guidelines [10, 262, 295].  The final 
independent associated factor for PAD identified in our study was that a history of 
cancer decreased the likelihood of also having PAD.  This is a potentially novel 
finding and is most likely explained by the average younger age at which cancer 
sufferers are admitted to hospital compared to non-cancer sufferers, and thus, being 
less likely to be of a sufficient age to have developed PAD [30].  However, the 
definition of cancer history in our study was broad and heterogeneous, and included 
any cancers in a participant’s history regardless of their origin or severity.  Thus, any 
further research of this association is recommended to include capturing the different 
cancer origins, severity, duration and treatments to investigate if the association is 
with particular cancers. 
This study appears to be the first to investigate the prevalence of PN in a 
representative inpatient population [37].  Again our findings appear consistent with 
those previous studies investigating PN in diabetes or geriatric inpatient populations.  
For example, in the diabetes inpatient population in our study, PN prevalence was 
43% (74/172) compared to a 12-81% range reported in previous studies [36, 78, 85].  
Whilst in inpatients over 60 years of age in our study, PN prevalence was 29% 
(124/433) compared to 26% in two similar studies [64, 67].  Furthermore in our 
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study PN was found to be independently associated with older age, diabetes and 
mobility impairment, all of which are also reported to be strongly associated with PN 
in the outpatient literature [20, 344-346].  In contrast to the best practice guideline 
recommendations that people with PN should receive regular foot treatment in a foot 
protection service that includes a podiatrist, our study found no past foot treatment 
variables were independently associated with PN [262, 281].  PN has been reported 
to be the most important foot risk factor to precipitate foot disease, pressure injuries 
and falls [37, 64, 67, 68, 308].  Thus, our findings suggesting that one in every five 
inpatients in hospital have PN and are unlikely to have received past foot treatment, 
highlights that further strategies are necessary to identify and monitor these patients 
in both the inpatient and outpatient settings [262, 281, 337]. 
This is also the first time foot deformity has been investigated in representative 
inpatients.  This may be because a global foot deformity score relevant to foot 
disease has yet to be validated and the different foot deformities reported have the 
lowest effects sizes of all the common foot risk factors in the development of foot 
disease [20, 262, 291, 295].  Foot deformity in our study required the participant to 
have at least three characteristics of a foot deformity [262, 291].  Thus, it could be 
argued the definition of foot deformity in our study was a much more stringent 
definition compared to similar geriatric inpatient studies requiring one characteristic 
for a foot deformity [66, 68].   This may have contributed to our much lower foot 
deformity prevalence finding of 31% (133/433) in our geriatric cohort compared with 
the 43-50% range reported in other geriatric inpatient studies [36, 66, 68].  The 
independent associated factors for foot deformity of older age, PN, arthritis, mobility 
impairment and past podiatry treatment identified in our inpatient study are also 
consistent with population-based findings for foot deformity [291, 305, 344, 347, 
348].   
The overall findings of this study suggest that 46% of representative inpatients 
have at least one foot risk factor for foot disease.  More importantly it found that 
11% of representative inpatients had previous foot disease.  Inpatients with previous 
foot disease have been strongly associated with developing future active foot disease 
[39, 40].  Thus, it is recommended that policy makers and clinicians consider 
adopting a hospital triage process, independent of diabetes, to identify inpatients with 
previous foot disease early to ensure they do not develop future foot disease, falls or 
   Chapter 7: Previous foot disease and foot risk factors in representative inpatients 187 
pressure injuries whilst in hospital [39, 40, 176, 337-339].  This could be as simple as 
questioning all inpatients on admission as to their self-reported previous foot ulcer 
and amputation history or using a simple foot screening tool to identify PN and PAD 
[39, 40, 262, 337].  Nevertheless clinicians and policy makers should continue to 
recommend inpatients identified with previous foot disease be comprehensively 
assessed and managed whilst in an inpatient facility, and referred to outpatient multi-
disciplinary foot teams on discharge for ongoing monitoring to prevent future foot-
related hospitalisation [39, 40, 176, 337-339].   
Additionally, this study is one of the first to look at foot disease risk factors 
independent of diabetes status, and indicates that these previous foot disease and foot 
risk factors are useful to identify foot disease in all inpatient populations irrespective 
of diabetes status.  Furthermore, whilst the independent association between past foot 
treatment prior to hospitalisation and most previous foot disease and foot risk factors 
appears encouraging, this was not the case for PN.  It could be argued that PN is the 
most critical foot risk factor in the development of foot disease, and thus, requires 
ongoing monitoring in both the inpatient and outpatient setting to ensure patients 
lacking sensation to detect foot disease are assisted to identify these problems early 
before they may require hospitalisation [20, 262, 281, 291, 337, 338].  However, 
further research is recommended to more precisely determine the causal relationships 
for previous foot disease and foot risk factors in non-diabetes populations.  Lastly, to 
monitor and address the increased risk of adverse events that foot risk factors impose 
on an inpatient population it is recommended that policy makers and hospital 
managers incorporate these common foot risk factors [39, 40] in their regular 
inpatient bed-side audit programs that already exist for diabetes, pressure injuries and 
falls [26, 30, 51, 242]. 
 
Strengths and limitations 
This study has a number of strengths and limitations as reported elsewhere [39, 
40].  In brief the strengths were this study investigated a highly representative 
Australian inpatient population [30, 32, 324]; data collectors were highly 
experienced, trained and reliable in collecting validated and internationally agreed 
clinically-diagnosed previous foot disease and foot risk factor outcome measure 
definitions [38, 335]; and multivariate logistic regression models were used to adjust 
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for confounding variables [37, 39].  The limitations were this study was a cross-
sectional study and unable to test for causal relationships; excluded a large number of 
older cognitively impaired patients that were more likely to have higher rates of foot 
risk factors; aggregated minor and major previous amputations together that are 
arguably the result of different causal pathways; did not exclude patients with active 
foot disease; and was a secondary analysis of a large FDIS dataset which increases 
the likelihood of type 1 statistical error [37, 39]. 
 
7.7 CONCLUSIONS 
This study, the first in representative inpatients, has identified that one in every 
two inpatients has a foot risk factor for developing foot disease, pressure injuries or 
falls whilst in hospital.  The findings of this study also suggest previous foot disease 
is strongly associated with foot risk factors, regardless of diabetes status.  It is 
recommended that all inpatients are questioned as to their self-reported previous foot 
disease history on admission, and assessed, managed and referred accordingly to 
potentially prevent the large burden that foot disease imposes on both the inpatient 
and outpatient populations. 
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Chapter 8: Discussion and conclusions 
This chapter begins with a summary of each chapter’s findings (section 8.1).  
The key findings are then discussed and include some additional results that were 
unable to be presented in the chapter manuscripts to further highlight these findings 
(section 8.2).  The chapter then revisits the conceptual framework (section 8.3), 
outlines strengths and limitations (section 8.4) and makes key recommendations 
(section 8.5) before a conclusion summarises this thesis (section 8.6). 
 
8.1 SUMMARY OF CHAPTER FINDINGS 
Table 8-1 summarises the aims and findings of each chapter under each of the 
original four objectives of this thesis.    
 
8.2 KEY FINDINGS  
The purpose of this thesis was to improve the understanding of the overall 
burden of foot disease in inpatient populations. This section synthesises the chapter 
findings into 10 key findings that improve this understanding and that specifically 
address the three original research questions:    
 
Question 1: What is the proportion of representative inpatient populations that 
have been hospitalised because of foot disease at one point in time? 
1. Foot disease is the reason why 1 in every 20 inpatients is in hospital 
This thesis found that at one point in time 4.9% of representative inpatients had 
been hospitalised for the primary reason of foot disease [39].  Foot disease was 
identified to cause two thirds of the 7.4% of inpatients that were hospitalised for the 
primary reason of a foot-related condition, with acute foot trauma causing the 
remainder [36, 37, 39].   These findings indicate that foot disease is the primary 
reason why one in every 20 inpatients at any point in time is in hospital which is 
considerably larger than previously reported [186].   
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Table 8-1:  Summary of thesis objectives, chapter aims and findings 
Chapter Aim Findings 
 
Objective 1:  To review previous literature investigating the prevalence of foot disease disorders and foot risk factors in inpatient populations 
 
Chapter 1.   
Introduction 
 
 
This introduction outlines the background, context and 
concepts, purpose and significance of this thesis.    
 
A cursory review of the literature indicated a precise understanding of the total burden 
imposed by foot disease on representative inpatient populations was unknown.  
Literature reviews were recommended to confirm if this was the case. 
Chapter 2.   
Foot-related conditions in hospitalised 
populations  
 
 
This broad narrative literature review aimed to review 
studies reporting the prevalence of any foot-related 
conditions in any inpatient populations. 
 
This broad review indicated that foot disease disorders were the main foot-related 
conditions in hospitalised populations.  The review reported up to 25% of 
representative inpatient populations had a foot risk factor for foot disease, up to 8% 
had foot disease and up to 1.5% an amputation.  These rates were higher in specific 
inpatient populations such as geriatric, diabetes, other chronic disease, trauma-related 
and infection-related inpatient populations.  
Chapter 3.   
Prevalence of foot disease and risk factors 
in general (representative) inpatient 
populations 
 
 
This systematic review aimed to specifically review only 
studies reporting the prevalence of foot disease disorders 
or foot risk factors in representative inpatient populations 
 
This specific review reported up to 36% of representative inpatients had a foot risk 
factor, up to 13% had a foot disease disorder and up to 1.2% had been hospitalised 
because of a foot disease disorder.  Pooled prevalence estimates were able to be 
calculated for pressure ulcer-related foot wounds (4.6%), diabetes-related foot wounds 
(2.4%), diabetes-related foot infections (3.4%) and diabetes-related foot disease 
(4.7%).  However, the review was unable to identify a study that had investigated the 
total burden of foot disease, or had used a validated data collection instrument to 
capture relevant foot disease items, in representative inpatient populations. 
 
 
Objective 2:  To develop a valid and reliable data collection instrument to capture foot disease disorders and foot risk factors in representative populations 
 
Chapter 4.   
The Queensland High Risk Foot Form 
(QHRFF) – is it a reliable and valid clinical 
research tool for foot disease? 
 
 
This study aimed to develop and test the validity and 
reliability of a new foot disease data collection 
instrument. 
 
The QHRFF was developed and reported to have acceptable validity and reliability, 
when tested on clinicians with different foot disease expertise, across the majority of 
items; particularly items identifying relevant co-morbidities, foot risk factors and foot 
disease disorders.  Recommendations were made to improve or remove identified 
weaker items for future QHRFF versions. Overall, the QHRFF possessed suitable 
practicality, validity and reliability to assess and capture relevant foot disease items in 
representative populations. 
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Chapter Aim Conclusions 
 
Objective 3:  To investigate the overall prevalence of foot disease disorders and foot risk factors in a large representative inpatient population 
 
Objective 4:  To investigate the associations between representative inpatients with foot disease disorders and a range of factors 
 
Chapter 5.  
Direct inpatient burden caused by foot-
related conditions 
 
 
The aims of this point-prevalence study were to 
investigate a representative inpatient population to 
determine the prevalence of people admitted to hospital 
for the reason of a foot-related condition, and identify 
associated independent factors. 
 
This study reported that 7.4% of representative inpatients had been admitted to 
hospital for the primary reason of a foot-related condition, including 4.9% for foot 
disease and 2.1% for acute foot trauma.  Those patients hospitalised because of a foot-
related condition were independently associated with foot infections, ischaemia, 
ulcers, trauma and past foot treatment by a surgeon or GP prior to hospitalisation. 
Chapter 6.  
The silent overall burden of foot disease in 
a representative hospitalised population  
 
The aims of this study were to investigate the point 
prevalence, and associated independent factors, for foot 
disease (ulcers, infections and ischaemia) in a 
representative hospitalised population. 
 
This study reported that 11.8% of representative inpatients had a major foot-related 
condition present; including 9.8% with foot disease (6.7% ulcers, 3.3% infections and 
4.5% ischaemia), 2.3% acute wounds and 1.9% had a new amputation procedure.  
Those inpatients with foot disease present were independently associated with 
previous foot ulcers, acute foot trauma and past foot treatment from a surgeon prior to 
hospitalisation.  Amputation procedures were nearly all associated with foot disease. 
Chapter 7.   
Previous foot disease and foot risk factors 
in representative inpatients 
 
 
The aims of this study were to investigate the prevalence 
and associates of previous foot disease and foot risk 
factors in a representative inpatient population. 
 
This study reported that 46% of representative inpatients had at least one foot risk 
factor, including 11.1% with previous foot disease.  Those inpatients with previous 
foot disease were independently associated with foot risk factors and past foot 
treatment.  Those inpatients with foot risk factors were independently associated with 
older age, diabetes, arthritis, cerebrovascular accident history, trauma, mobility 
impairment, previous ulceration, other foot risk factors and past foot treatment by a 
surgeon or podiatrist.   
Chapter 8.   
Discussion 
 
 
This discussion outlines the key findings, conceptual 
framework, strengths and limitations, key 
recommendations and conclusions of this thesis. 
 
These findings confirm that the vast majority of foot-related hospitalisation are due to 
foot disease and indicate that people with diabetes make up less than half of those 
patients.  Overall, the direct inpatient burden caused by foot disease is much larger 
than previously reported and is estimated to be in the top 10 leading causes of 
hospitalisation in Australia with direct annual costs estimated to be $AU1.6 billion.  
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As discussed in Chapter 5, the methodological improvements used in this thesis 
provide arguably the most robust findings to date of the direct inpatient burden 
caused by foot disease [39].  These methodological improvements included that it 
was a prospective cross-sectional designed study, used valid and reliable foot disease 
data collection procedures in a highly representative Australian inpatient population 
during a single occupied bed day period [39].  In contrast the only previous study in 
this area was a retrospective analysis of a standard generic hospital discharge dataset 
that investigated whole admissions [186].  The previous study reported that foot 
disease caused 1.2% of all primary admissions [186], whereas this thesis reported 
that foot disease caused the use of 4.9% of occupied bed days [39].  Retrospective 
analyses of generic hospital discharge datasets identify only one-third of the foot 
disease-related hospitalisations identified by prospective studies [5].  Additionally, 
average hospital admissions use only one-third of the occupied bed days per 
admission than the average foot disease admissions [2, 6, 30, 306].   Thus, these 
interpretations suggest that the major finding from this thesis, that ‘foot disease is the 
reason why one in every 20 patients is in hospital’, is the most robust, plausible and 
generalizable finding to date of the direct inpatient burden caused by foot disease. 
 
2. Foot disease is estimated to be a top 10 cause of hospitalisation    
The plausible and generalizable major findings of this thesis now enable 
comparisons to be made with the direct inpatient burdens caused by other diseases, 
such as heart disease.  Foot disease has been likened to heart disease due to the 
similarities in their critical natures on limb and life, respectively [349, 350].  Heart 
disease is a well-known contributor to the direct inpatient burden and comprises the 
disorders of heart attacks, angina and heart failure [6, 30, 334].  Australian hospital 
admission reports using retrospective analyses of the Australian national standard 
hospital discharge dataset show heart disease to be the primary reason for 103,000 
admissions each year or 4.0% of all Australian public hospital admissions (heart 
attacks 1.5%, heart failure 1.4% and angina 1.1%) [30]. These same reports suggest 
heart disease is the 2
nd
 leading cause of hospitalisation in Australia behind child birth 
[30].  They also ranked cellulitis as the 10
th
 leading cause of Australian public 
hospital admissions with 35,248 or 1.4% of all primary admissions [30].  In 
comparison, as discussed in Chapter 5, a conservative forecast of the major finding 
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of this thesis to the entire Australian pubic hospital inpatient population indicates an 
estimated 67,600 primary admissions are for foot disease or 2.6% of all Australian 
public hospital admissions [39].  Therefore, these comparisons suggest foot disease 
would also rank comfortably in the top 10 causes of hospitalisation in Australia.   
The plausibility of these estimations are strengthened when interpreting a 
recent retrospective diabetic foot study that investigated the same standard hospital 
discharge dataset as that used in the Australian hospital admission reports above 
[306].  This recent study reported that diabetes-related foot disease was the primary 
reason for 0.3% of all Queensland hospital admissions [306].  Yet, this study also 
reported diabetes-related foot disease to be the primary reason for the use of 0.9% of 
all available Queensland occupied bed days [306].  This disparity is due to the 3-fold 
longer average length of stay for foot disease admissions than average admissions 
[306].  Therefore, if using only standard Australian admission figures, it could be 
simply concluded that diabetes-related foot disease (0.3%) [306] causes an inpatient 
admission burden approximately 7% of the size caused by heart disease (4.0%) [30].  
However, this simple conclusion does not take into account: a) the average admission 
for diabetes-related foot disease is three-times as long as heart disease [2, 30, 306]; 
b) diabetes-related foot disease has been reported to be significantly under-coded in 
hospital discharge datasets by three-fold that identified in prospective studies [5, 39]; 
and c) diabetes-related foot disease made up less than half of the inpatient foot 
disease burden reported in this thesis [39, 186].  Thus, it can be plausibly inferred 
using this thesis’ findings that foot disease more realistically causes 2.6% of the 
direct inpatient burden, and, more like 65% of the burden caused by heart disease. 
With such a seemingly large inpatient burden it poses the question why foot 
disease has received such little attention in hospital inpatient reports.  One significant 
reason may be that foot disease disorders are generally coded and reported under 
other overarching diseases processes in standard hospital discharge datasets [5, 7, 32, 
186].  A good example of this is the coding and reporting of foot infection under 
“cellulitis” in standard hospital discharge dataset reports [6, 30, 306].  An 
interrogation of sub-codes for “cellulitis” in these datasets reveals that two thirds of 
cellulitis admissions are for cellulitis of the lower legs [30, 306] and previous studies 
report the majority of lower leg cellulitis originates from foot infections [186, 301, 
302].  Thus, although foot infections may be the actual cause of over half of all 
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“cellulitis” admissions, foot infections have not been reported in these standard 
hospital discharge dataset reports.  An additional similar example is the coding and 
reporting of foot wounds under “pressure injuries” or “leg wounds” in these same 
reports [6, 34, 37, 183, 351].  This is again despite more than one third of all pressure 
injuries, and more than half of all leg wounds, being located on the foot [30, 306].    
In summary, these interpretations highlight that the inpatient burden of foot 
disease has been historically under-appreciated for a number of reasons, including 
foot disease disorders are typically: a) coded and reported under other disease 
processes in standard hospital discharge datasets; b) rarely aggregated and reported 
together as foot disease; c) mainly investigated in diabetes specific inpatient 
populations only; and d) reported as admissions rather than occupied hospital bed 
days used which doesn’t take into account the long lengths of stay caused by foot 
disease admissions.  These findings suggest foot disease should be re-considered as a 
leading cause of hospitalisation, and thus, should be reported and monitored as a 
stand-alone item in standard national hospital discharge dataset reports. 
 
3. Inpatient foot disease is estimated to cost Australia $1.6 billion annually  
There are no known estimates for the direct inpatient costs incurred by all-
cause foot disease.  Table 8-2 uses the highly plausible and generalizable inpatient 
foot disease findings of this thesis and applies some simplistic health economic 
assumptions to forecast the hospital bed days used and associated estimated costs 
incurred by foot disease in a range of different scenarios; including in an average 
600-bed Australian hospital, across all public Australian hospitals, all Australian 
hospitals and the entire Australian healthcare system.  These forecasted findings 
indicate an average hospital requires 29 hospital beds each day to primarily manage 
foot disease at an annual cost of $AU10.3 million in 2015.  Extending these forecasts 
across all Australian hospitals indicates 4,385 occupied hospital beds each day (the 
equivalent of four entire major public hospitals and three private hospitals) are 
required to primarily manage foot disease in Australia at an annual direct inpatient 
cost of $AU1.6 billion.  Lastly, forecasting these findings across the entire Australian 
healthcare system indicates an estimated direct cost of $AU3.8 billion, or the 
equivalent of 2.6% of the entire $145.5 billion recurrent national healthcare 
expenditure in Australia [352], is expended on foot disease annually.   
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Table 8-2:  Estimated direct hospital bed day use and costs for foot-related 
conditions, all-cause foot disease and diabetes-related foot disease  
 Foot-related  
conditions 
All-cause 
Foot Disease 
Diabetes-related  
Foot Disease 
Thesis Findings*    
Prevalence (%) 7.4% 4.9% 2.0% 
Average Hospital**     
Beds per day (n) 44 29 12 
Costs per day ($)^ $42,724  $28,159  $11,652 
Beds per year (n) 16,060  10,585  4,380 
Costs per year ($)^ $15.59M $10.28M $4.25M 
Public Australian Hospitals#    
Beds per day (n) 3,637  2,408  983 
Costs per day ($)^ $3.53M $2.34M $0.95M 
Beds per year (n) 1.33M 0.88M 0.36M 
Costs per year ($)^ $1.29B $853M $348M 
All Australia Hospitals##    
Beds per day (n) 6,622 4,385 1,790 
Costs per day ($)^ $6.43M $4.26M $1.74M 
Beds per year (n) 2.42B 1.60B 653M 
Costs per year ($)^ $2.35B $1.55B $634M 
Australian Health System^^    
Costs per year ($)^^^ $5.80B $3.83B $1.57B 
* Prevalence of the primary reason for admission from the representative inpatients identified from this thesis;  ** Assuming 
600 beds for an average hospital; # 49,153 available overnight public hospital bed days in Australia [334]; ## 89,487 available 
hospital beds in Australia (includes public and private, overnight and same-day) [334]; ^ $AU971 (2015) for costs per day of 
Australian overnight hospital bed  [39, 333]; ^^Total recurrent health system expenditure is 2.47 x total recurrent hospital 
expenditure in Australia (i.e. Total recurrent health system expenditure in Australia = $145.5B; Total recurrent hospital 
expenditure in Australia = $58.8B) [352]; ^^^Australian health system costs = 2.47 x All Australian Hospital costs; B: billion; 
M: million;  
 
However, the accuracy of our estimated costs outlined in Table 8-2 should be 
read cognisant of the inherent limitations of any health economic analyses; that are 
the reliance on the quality of the data source and assumptions made [333, 353-356].  
Whilst, the data from this thesis is arguably the most valid and reliable foot disease 
inpatient data published to date, the assumptions made are simplistic and may not 
properly account for the natural variations in large populations [353-356].  These 
assumptions include: using a standard ‘average’ occupied hospital bed day cost; 
attributing all costs to foot disease without factoring in attributable costs to other co-
morbidities that may also require treatment whilst in hospital (such as diabetes); and 
not adjusting for the natural socio-demographic and co-morbidity variation of a large 
population.  Thus, until formal expert cost modelling can be performed our estimated 
costs should be seen as a guide to the costs that the burden of foot disease imposes on 
the Australian hospital and health systems. 
Bearing these limitations in mind, there have been a number of previous 
national diabetic foot health economic studies [353-356] that allow comparisons to 
be made with our findings to determine the plausibility of our estimated costs.  
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However, to enable more direct comparisons with these previous studies’ findings 
we converted their cost estimations into Australian dollars ($AU) [357] and inflated 
them from the year they reported into $AU(2015) [358].  Therefore, we have 
reported all estimates in $AU(2015) to allow more appropriate comparisons.  First, 
our estimated $AU350 million incurred for direct annual diabetes-related foot 
disease costs in the Australian public hospital system was reassuringly similar to the 
estimated $AU349 million from a previous Australian health economic study 
reporting the same outcome ($US239 million in 2012 [354]).  Second, our estimated 
$AU634 million finding for direct annual diabetes-related foot disease costs across 
the entire Australian hospital system was similar to the estimated $AU580 million in 
the UK (£UK262.3 million in 2010 [355]), but much lower than the $AU12.2 billion 
in the US ($US8.8 billion in 2014 [356]).  Third, our $AU1.57 billion findings for 
the estimated annual diabetes-related foot disease costs incurred by the entire 
Australian healthcare system was also similar to the $AU1.28 billion in the UK 
(£UK580 million in 2010 [355]).  Last, our $AU1.57 billion was higher than the 
$AU0.95 billion ($AU0.91 million in 2013 [353]) reported in a recently published 
Australian health economic study that estimated expenditure for annual Australian 
diabetic foot ulcer care.  However, this recent study potentially under-estimates the 
diabetes-related foot disease costs as it accounted only for diabetes-related foot 
ulcers and not other disorders such as ischaemia [353].  In summary, although our 
simplistic economic analyses do have limitations they are reassuringly similar to 
other more sophisticated diabetic foot health economic studies which adds weight to 
the plausibility of our estimated all-cause foot disease costs.   
These above national estimations in the UK, US and Australia [39, 355, 356], 
suggest that per capita  $AU9 is spent on direct inpatient costs for diabetes-related 
foot disease for each resident of the UK, $AU26 in Australia and $AU38 in the US 
(estimated national costs divided by the national population) [359].  Similar 
comparative trends were also noted in Chapter 5 for the diabetes population, diabetes 
inpatient and diabetes-related amputation rates for these nations; UK with lower 
rates, US higher rates and Australia mid rates [39].  For example, there were 9 
diabetes-related amputations reported per 100,000 people in the UK, 18 in Australia 
and 36 in the US [330, 331].  Interestingly, these estimated per capita expenditure 
and amputation rates suggests nations spending more money on foot disease achieve 
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worse outcomes, or alternatively national health systems that have focussed on 
efficient multi-disciplinary evidence-based foot care achieve better outcomes at 
lower costs, such as has been reported in the UK [355].  The latter hypothesis aligns 
with assertions made in a two recent Australian wound and diabetic foot health 
economic papers that improved wound management can be achieved at lower cost  in 
Australia [353, 360].  Overall, these national comparisons indicate our cost 
estimations for foot disease from this thesis are plausible in the Australian context 
and potentially generalizable to other nations when accounting for currency 
conversion, inflation, national diabetes rates and national resident population.   
 
 
4. Diabetes inpatients caused less than half of the foot disease burden 
This thesis found that of all inpatients hospitalised for the primary reason of 
foot disease (4.9%), 40% were in people with diabetes and 60% in people without 
diabetes [39, 186]. Whilst studies suggest a small proportion of inpatients may have 
undiagnosed diabetes [361], this would still indicate that less than half of inpatients 
admitted because of foot disease had diabetes.   
Previous studies have reported 0.3-1.1% of all inpatients were admitted for 
diabetes-related foot disease [37, 55, 192] compared to the 2.0% found in this thesis.  
It is again likely that this difference is explained by the improved methodology used 
in this thesis.  First, this thesis investigated foot disease as a primary outcome using 
standard objective clinical measures [39], in contrast to previous studies that 
investigated foot disease as a secondary outcome using documentation in standard 
medical records [37, 55, 192].  Second, as highlighted in the aforementioned recent 
retrospective analysis of a standard hospital discharge dataset, diabetes-related foot 
disease admissions in Queensland use three-fold the occupied bed days as that used 
by average hospital admissions [306].  Last, retrospective analyses of this kind 
identify only one-third of the foot-related admissions identified by clinical 
examinations [5].  These explanations reinforce the plausibility that at least 2% of 
representative inpatients are in hospital because of diabetes-related foot disease [39].   
The only previous similar study investigating the direct inpatient burden of foot 
disease also identified people with non-diabetes made up more than half of the foot 
disease burden [186] which reinforces the validity of our non-diabetes foot disease 
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findings.  When contextualising these non-diabetes foot disease findings to an 
average hospital, all public hospitals, all hospitals and the healthcare system in 
Australia these non-diabetes findings have significant ramifications (Table 8-2).  It 
suggests non-diabetes foot disease may be the primary reason for the use of 17 of the 
29 hospital beds required each night to manage people with foot disease in an 
average 600-bed hospital.  Additionally, it suggests 40,000 of the estimated 67,600 
public hospital admissions for foot disease in Australia are not in people with 
diabetes [38].  Lastly, these findings suggest 60% of annual direct foot disease costs 
($AU0.9 billion of direct inpatient costs and $AU2.3 billion of Australian health care 
system costs) are incurred by people without diabetes.  These findings highlight a 
real need to not only increase the national focus on the inpatient burden of diabetes-
related foot disease, but this is equally so for non-diabetes foot disease. 
 
 
Question 2: What is the proportion of representative inpatient populations that 
have a foot disease disorder or foot risk factor present at one point in time? 
5. Foot disease is present in 1 in every 10 inpatients  
Findings from this thesis demonstrate that 9.8% of representative inpatient 
populations had a foot disease disorder present at one point in time; this included 
6.7% with an ulcer, 4.5% ischaemia, 3.3% infection and 0.3% acute Charcot foot 
[39, 40].  As discussed in previous chapters these findings are plausible when 
interpreted against existing literature [37, 40].  First, the 9.8% foot disease finding 
was within the 0.2-11.9% crude range reported from the systematic review 
undertaken as part of this thesis [37].  Second, the 6.7% foot ulcer finding was also 
within the 0.3-13.5% range reported in the review [37].  Third, again the 3.3% foot 
infection finding was within the 0.1-6.4% reported range from the review [37].  
Fourth, whilst the 4.5% ischaemia finding was lower than the 7.2% reported in the 
only similar previous study, the previous study only investigated inpatients over 40 
years of age and used a less specific method of clinical examination [185].  Last, 
prevalence of acute Charcot foot in inpatients has yet to be investigated; however, 
general literature suggests it is a rare diabetes-related complication and the fact it was 
identified in only 0.3% of inpatients and all had diabetes in this thesis supports this 
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suggestion [362].  Overall, these findings indicate 59 inpatients in an average 600-
bed hospital have a foot disease disorder present at any given time [36, 40].    
 
6. Amputations occur in 1 in every 50 inpatients, mostly due to foot disease  
The findings of this thesis identified 1.9% of representative inpatients had a 
lower extremity amputation procedure (1.1% minor and 0.8% major amputation) 
during their hospital admission, with 86% the result of deteriorating foot disease 
[40].  Again, the literature reviews undertaken as part of this thesis were unable to 
identify any studies reporting the prevalence of new amputations in a representative 
inpatient population [36, 37].  However, the 1.4% diabetes-related amputation 
finding of our study was similar to the 1.5% also reported for diabetes-related 
amputations in the systematic review undertaken in this thesis [37].  Additionally, the 
proportion of inpatients with foot disease undergoing an amputation during their 
admission from our findings was 17% (12 of 72) [40].  This is reassuringly similar to 
the 18% of inpatients with diabetes-related foot disease that were reported to have 
undergone an amputation procedure in a recent large retrospective Queensland study 
[306].  Overall, these findings indicate in an average 600-bed hospital, 11 inpatients 
(6 minor and 5 major amputations) have had an amputation procedure during their 
current admission, eight of which were due to diabetes.  Interestingly this also 
indicates people with diabetes make up the majority of new amputation procedures, 
yet not the majority of the foot disease hospitalisation burden.  It could be 
hypothesised that diabetes-related foot disease may be of higher severity than non-
diabetes foot disease or alternatively clinicians are more inclined to amputate in 
inpatients with diabetes. 
 
7. Major risk factors for foot disease are present in 1 in every 2 inpatients 
This thesis reports that 46% of all inpatients in a representative inpatient 
population had a major foot risk factor present for the development of foot disease; 
this included 11% with a history of previous foot disease and 35% with at least one 
major risk factor for foot disease [41].  Furthermore, nearly one quarter (23.9%) of 
representative inpatients had multiple foot risk factors and would be classified as 
being at high risk of developing foot disease [39].  A foot disease history identified 
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in this study included previous amputations (4.1%) and previous foot ulcers (9.8%) 
[41]. However, our findings are most likely to under-report previous foot disease as 
data on those with a history of revascularisation, indicating previous ischaemia, were 
not collected.  As discussed in previous chapters, there does not appear to be any 
other representative inpatient study that has investigated previous foot disease which 
makes interpretation challenging [273].  However, our findings align with previous 
amputation studies indicating the majority of previous amputations are precipitated 
by a previous foot ulcer [3, 9, 11, 320].  Our findings indicate that 70% of inpatients 
with a previous amputation also had a previous foot ulcer.  It could be hypothesised 
the remaining 30% of those with a history of previous amputations in our study were 
due to ischaemia, trauma or malignancy as identified in other studies [3, 9, 11].   
This thesis also found that 21% of representative inpatients had peripheral 
arterial disease ((PAD) including ischaemia)), 22% peripheral neuropathy (PN) and 
22% a foot deformity [41].  As discussed in previous chapters, there have been 
limited studies investigating these foot risk factors in representative inpatient 
populations [41].  PAD was the most reported foot risk factor in the previous 
literature, and it could be argued that our 21% finding is a more valid estimate than 
the 29-36% findings of previous studies [36, 37, 41, 184, 185].  This is because our 
study used toe systolic pressures to diagnose PAD, which when compared to ankle 
brachial indices used in previous studies, reports far fewer false positive recordings 
[36, 37, 41, 184, 185].  In relation to the other two foot risk factors of PN and foot 
deformity, this appears to be the first study to investigate these foot risk factors in a 
representative inpatient population [41], and thus, our findings present the most 
precise estimates to date.   
Overall, the findings in this thesis suggests nearly half of all inpatients had a 
foot risk factor for foot disease [41], of those a fifth had foot disease present [40], of 
those half were hospitalised because of their foot disease, and one third of those 
underwent a new amputation procedure [39].  In the context of an average 600-bed 
hospital these equates to at any given time 276 inpatients have a foot risk factor for 
foot disease present, of those 59 have foot disease present, of those 29 have been 
hospitalised because of their foot disease and of those 11 underwent a new 
amputation procedure during their hospitalisation. 
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8. Non-diabetes inpatients also have high burdens of inpatient foot disease 
As aforementioned, the vast majority of the existing literature to date has 
investigated diabetes-related foot disease.  Reassuringly, the prevalence of diabetes-
related foot disease disorders in representative inpatients findings from our major 
study (Table 8-3 & Chapter 6) was similar to the pooled prevalence findings from 
our meta-analyses (Chapter 3).  Findings included diabetes-related foot disease 
(4.5% in the major study versus 4.7% in the meta-analyses), diabetes-related foot 
ulcers (3.6% versus 2.4%), diabetes-related foot infections (1.7% versus 3.4%) and 
diabetes-related amputations (1.4% versus 1.5%) [37, 40].  This again adds 
plausibility to the overall findings reported from this thesis.   
 
Table 8-3:  Proportion of representative inpatients with foot disease disorders and 
foot risk factors made up by diabetes and non-diabetes inpatient populations 
Disorder Total Diabetes Non-diabetes 
 % of all  
Inpatients* 
% of all 
Inpatients** 
% of Disorder 
or Factor^ 
% of all 
Inpatients*** 
% of Disorder 
or Factor^^ 
Foot Disease Admissions 6.7  3.4  51% 3.3  49% 
Primary admissions 4.9  2.0  42% 2.0  58% 
Secondary admissions 1.8  1.4  77% 0.4  23% 
Foot Disease Disorder 9.8  4.5  46% 5.3  54% 
Foot ulcers 6.7 3.6  53% 3.1 47% 
Foot infections 3.3 1.7  50% 1.7 50% 
Ischaemia 4.5 1.6  36% 2.9 64% 
Amputation procedures 1.9  1.4  71% 0.5 29% 
Previous Foot Disease 11.1  5.2  47% 5.9 53% 
Previous amputation 4.1  2.2  53% 1.9 47% 
Previous foot ulcer 9.8  4.8  49% 5.1 51% 
Foot Risk Factors 46.0  15.3  33% 30.7 67% 
PAD 21.0  8.2 39% 12.8  61% 
PN 22.0  10.2 46% 11.8 54% 
Foot deformity 22.4  7.2 32% 15.2 68% 
*Prevalence in a representative inpatient population of a foot disease disorder or foot risk factor; **Prevalence in a 
representative inpatient population of a diabetes-related foot disease disorder or foot risk factor; ***Prevalence in a 
representative inpatient population of a non-diabetes-related foot disease disorder or foot risk factor; ^Proportion of total foot 
disease disorder or foot risk factor made up by diabetes inpatients; ^^Proportion of total foot disease disorder or foot risk factors 
made up by non-diabetes inpatients; PAD: Peripheral Arterial Disease; PN: Peripheral Neuropathy. 
 
Furthermore, existing literature suggests diabetes inpatients have higher rates 
of foot disease than non-diabetes inpatients [36, 37].  The findings from the major 
study of this thesis also suggest that inpatients with diabetes have 2-3-fold higher 
rates of foot disease disorders than inpatients without diabetes (Table 8-4).  
However, this thesis allows for the first time a direct comparison of the proportion of 
representative inpatients with foot disease disorders that have diabetes compared 
with those without diabetes.  Our findings demonstrate that the 2-3-fold higher foot 
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disease prevalence in diabetes populations is cancelled out by the 3-fold higher 
number of people with non-diabetes in representative inpatient populations (Table 8-
4).  Therefore, non-diabetes inpatients made up 54% of the inpatients that had active 
foot disease, 53% previous foot disease and 67% that had foot risk factors for 
developing foot disease.  These findings suggest that whilst diabetes inpatients are 
indeed a population that present with much higher rates of foot disease, overall more 
inpatients with foot disease do not have diabetes.  This supports the need to focus 
more resources on inpatients with foot disease, irrespective of their diabetes status. 
 
Table 8-4:  Proportion of the diabetes (n = 172) and non-diabetes (n = 561) inpatient 
populations with foot disease disorders and foot risk factors  
 Diabetes population 
n (%) 
Non-diabetes population 
n (%) 
p Value  
Foot Disease Admissions 25 (14.5%) 24 (4.3%) <0.001 
Primary admissions 15 (8.7%) 21 (3.7%) 0.01 
Secondary admissions 10 (5.8%) 3 (0.5%) <0.001 
Foot Disease Disorder 33 (19.2%) 39 (7.0%) <0.001 
Foot ulcers 26 (15.1%) 23 (4.1%) <0.001 
Foot infections 12 (7.1%) 12 (2.2%) 0.002 
Ischaemia 12 (7.0%) 21 (3.8%) 0.074 
Acute Charcot foot 2 (1.2%) 0 NA 
Amputation procedures 10 (5.8%) 4 (0.7%) <0.001 
Previous Foot Disease 38 (22.1%) 43 (7.7%) <0.001 
Previous amputation 16 (9.3%) 14 (2.5%) <0.001 
Previous foot ulcer 35 (20.3%) 37 (6.6%) <0.001 
Foot Risk Factors 112 (65.5%) 224 (40.1%) <0.001 
PAD 60 (35.1%) 93 (16.7%) <0.001 
PN 74 (43.3%) 86 (15.4%) <0.001 
Foot deformity 51 (30.5%) 107 (19.9%) 0.004 
PAD: Peripheral Arterial Disease; PN: Peripheral Neuropathy. 
 
 
Question 3: What factors are independently associated with foot disease 
disorders or foot risk factors in representative inpatient populations? 
9. Inpatient foot disease is independently associated with a range of factors  
This thesis is the first to investigate associations with inpatient foot disease.  
The findings identified independent associations with a range of demographic, 
medical history, past foot treatment, foot disease history and foot risk factors [39-41].  
Demographic findings suggest inpatients that were of older age, male or indigenous 
were more likely to have foot risk factors for developing foot disease.  Older age was 
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independently associated with ischaemia, PAD, PN and foot deformity; yet, 
interestingly younger age was associated with acute foot wounds.  Males and 
indigenous peoples were also associated with PAD.  These ages, gender and 
indigenous findings are consistent with previous literature [39-41].   
Medical history findings suggest inpatients with a history of diabetes, arthritis, 
cerebrovascular disease, mobility impairment, acute foot trauma and smoking were 
more likely to have foot risk factors or foot disease.  Diabetes was only associated 
with PN and secondary foot-related admissions which is perhaps surprising 
considering the focus on diabetes in previous inpatient foot disease literature [36, 
37].  A history of cerebrovascular accident was associated with previous amputation 
[40], and, smoking was associated with ischaemia [40].  These diabetes, 
cerebrovascular disease and smoking findings are also consistent with previous 
literature [39-41].  Arthritis was associated with foot deformity and previous foot 
ulcers which is partially consistent with previous literature [43, 44].  Seronegative 
arthritis has been the main arthritis type linked to foot ulcers [363, 364], however, we 
grouped all arthritis types together.  Last, mobility impairment was associated with 
PN and foot deformity which is consistent with falls literature in particular [68, 365].   
Past foot treatment factors were used in this thesis to indicate if inpatients had 
received evidence-based foot treatment in the year prior to admission [262, 281, 305, 
337, 338].  The only past foot treatment factors independently associated with foot 
disease were previous foot treatment from a surgeon or GP.  Past foot treatment by a 
surgeon was associated with being admitted for a foot-related condition, having a 
foot ulcer, infection, ischaemia, PAD and previous amputation.  These are welcome 
findings as guidelines suggest all these conditions should be treated by a surgeon 
[262, 281, 337, 338].  Whereas, past foot treatment by a GP was associated with 
being admitted for a foot-related condition only which is not surprising considering 
GPs are the coordinating primary healthcare professionals for all patients in 
Australia.  Of particular surprise, however, was the finding that none of the other 
health professionals recommended by guidelines to make up the necessary multi-
disciplinary footcare services (MDFS) required for evidence-based foot disease 
management, were associated with treating inpatient foot disease.  These findings 
indicate inpatients with foot disease were not receiving recommended MDFS care 
which may have been a factor in their admission.  Inpatients with previous foot 
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disease though did have an association with past foot treatment by a surgeon, nurse 
and podiatrist [262, 281, 337, 338].   
Previous foot disease and foot risk factors were consistently independently 
associated with having active foot disease.  This is of interest as this thesis adjusted 
for diabetes, yet these findings are still consistent with findings from the diabetes-
related foot disease literature [17, 20, 291].  A previous foot ulcer was associated 
with having an active foot ulcer, infection, ischaemia, PAD, PN and previous 
amputation.  PAD and PN were independently associated with each other and active 
and previous foot disease, independent of diabetes.  Again these PN and PAD 
associations have been consistently identified in the diabetes-related foot disease 
literature [17, 20, 291].  PN was also associated with foot deformity which is again 
consistent with the diabetes-related literature [291, 366].  A previous amputation was 
not surprisingly associated with foot deformity as the procedure often creates the 
characteristics of foot deformity [3, 9, 291].   
 
10. Associated factors for all-cause foot disease are very similar to those 
that have been reported for diabetes-related foot disease  
This thesis seems to be one of the first to investigate the independent 
associations with a range of foot disease disorders and foot risk factor outcomes in a 
representative population, rather than diabetes-specific population. Factors 
independently associated with at least two foot disease disorder or foot risk factor 
outcomes in this study were older age, diabetes, arthritis, acute foot trauma, mobility 
impairment, previous foot ulcer, PAD, PN and past foot treatment by a surgeon or 
podiatrist [39-41].  After adjusting for confounders such as diabetes, these findings 
are very similar to literature reporting the risk factors for diabetes-related foot 
disease [17, 20, 291].  Overall, the independent factors associated with foot disease 
and foot risk factors in this thesis, suggest the pathway to amputation in all 
populations may be similar to that consistently demonstrated in diabetes-specific 
populations [17, 20, 291].   This suggests similar screening, assessment and 
management principles may be effectively employed for non-diabetes patients as 
have been successfully used for diabetes patients. 
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8.3 NEW CONCEPTUAL FRAMEWORK 
Figure 8-2 outlines the new conceptual framework for foot-related 
hospitalisation.  The new conceptual framework builds upon the conceptual 
framework for foot disease in inpatients developed in Chapter 3 (Figure 3-2) and 
uses the key findings from this thesis to encompass all foot-related hospitalisation 
causes including foot disease and foot trauma.  The framework consists of domains 
of common factors that have been identified to be strongly linked to other domains of 
common factors.  Each domain is overlaid with past foot treatment factors that were 
also identified to increase the likelihood of developing that domain.  The new 
framework indicates causal relationships between domains in the development of 
foot-related hospitalisation; however these can only be hypothesised from the 
findings of the cross-sectional major study of this thesis.  
First, a demographics domain highlights the age, male gender and indigenous 
factors that were identified in this thesis to be associated with foot risk factors.  
Second, a separate medical history domain highlights the diabetes, cerebrovascular 
disease, arthritis, mobility impairment and smoking factors identified to also be 
associated with foot risk factors.  Third, the foot risk factors domain highlights the 
PAD, PN and foot deformity factors identified to increase the likelihood of also 
having previous foot disease or active foot disease.  Fourth, a foot disease domain 
highlights the foot ulcer, infection and ischaemia disorders that were identified to 
increase the likelihood of being admitted to hospital because of a foot-related 
condition.  Fifth, a foot trauma domain is linked to younger age and highlights the 
second major stream in the pathway to foot-related hospitalisation.  Last, the primary 
foot-related condition admissions domain highlights the foot disease and foot trauma 
conditions that increase the likelihood of requiring an amputation whilst in hospital.   
In summary, the new conceptual framework aims to help explain all foot-
related hospitalisation, rather than just those caused by foot disease.  However, 
findings from this thesis indicate previous conceptual frameworks for amputations in 
diabetes populations [255, 256] may also be similar in representative populations.  
Furthermore, it seems that other chronic conditions, apart from diabetes, are also 
independently associated with foot risk factors for developing foot disease such as 
cerebrovascular disease, arthritis and smoking.     
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Figure 8-2:  Conceptual framework for foot-related hospitalisation 
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8.4 STRENGTHS AND LIMITATIONS 
This thesis has several key strengths as identified in previous chapters [36-41].  
First, the major study’s findings are generalizable to large inpatient populations, as 
we purposively investigated multiple representative Australian hospitals that 
collectively reported similar demographic, social determinant and medical history 
factors to that reported for the Australian national general and inpatient populations 
[30, 32, 324] and other developed nations’ populations [325-327].  In addition, the 
proportion of hospital beds situated in different geographical remoteness areas 
investigated by this thesis were similar to the proportions reported for all Australian 
public hospital beds; major city (68% in this thesis versus 74% in Australia), regional 
(29% versus 23%) and remote (3% versus 3%) hospital beds [334].  Second, total 
participant numbers were <3% of the original sample size calculated to meet the 
objectives of this study and the >80% recruitment rate achieved for eligible 
participants is considered robust in inpatient and diabetes-related foot disease studies 
[31, 335]. Furthermore there were no differences in terms of demographic variables 
between those eligible patients consenting and not consenting in this study.  Third, 
the study used a data collection instrument designed and tested to be valid and 
reliable to collect multiple co-morbidity, foot disease and foot risk factor variables in 
representative inpatient populations [38, 39].  Furthermore, the instrument used a 
range of internationally recommended standard self-reported or clinically-diagnosed 
foot disease-related definitions to elicit all participant variables [38, 257, 335].   
Fourth, data collectors were found to have high reliability in capturing these 
participant variables after extensive previous similar data collection experience, 
specific training and testing of their agreement against simulated cases and medical 
records [38, 39].  Last, the multivariate logistic regression methods and Odds Ratios 
used in this study are comparable to those used in other similar foot-related studies 
[305, 316, 320-322].  These methods are also recommended in statistical texts to 
identify independent associated factors after adjusting for multiple confounding 
factors and the sample size was large enough to account for over 50 variables for 
each outcome [318, 319]. 
This thesis also has a number of limitations as identified in previous chapters 
[36-41].  First, the major study design was cross-sectional and can only report on 
associated factors and not causal relationships.  Second, as a point-prevalence study 
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design, the major study is reliant on the day of data collection being representative of 
a standard inpatient activity.  Third, a number of factors may bias our findings 
towards under-reporting prevalence, such as excluding cognitively impaired and 
psychiatric populations with higher reported foot disease rates; not collecting Stage 1 
pressure ulcer data; collecting amputation procedures at only one point in time of 
admissions; and not using standard biomedical criteria to diagnose medical 
conditions.  In contrast, excluding maternity inpatients may bias findings toward 
over-reporting foot disease as this younger female population is unlikely to have high 
foot disease rates. However, it could be argued the under-reporting bias of not 
investigating cognitively impaired and psychiatric inpatients is balanced out by the 
over-reporting bias of not investigating maternity inpatients.  Fourth, whilst the study 
used a data collection instrument modified from an existing valid and reliable 
instrument it was only retested against simulated cases and medical records, which 
limits our exact knowledge on its validity and reliability for capturing this data.  
However, 36 items had been appropriately tested for reliability and validity in the 
QHRFF, ten items in previous literature and the remaining seven not previously 
tested were tested against simulated cases and medical records in this thesis.  Fifth, 
self-reported reasons for foot-related condition admission outcome variables had yet 
to be validated; however, again there was high agreement with medical records and 
all had clinically-diagnosed active foot disease or acute foot trauma.  Sixth, as there 
were only limited numbers of amputation procedures performed, minor and major 
amputations were aggregated and this may have affected our findings as minor and 
major amputations are generally performed for different clinical reasons and have 
different clinical outcomes.  Seventh, some markers of diabetes-related foot disease 
severity were not reported in this thesis either because there was too much missing 
data (such as diabetes duration and HbA1c) or they were not part of the original 
study design (such as readmission and length of stay).  Last, although this thesis used 
recommended multivariate logistic regression models to determine independent 
associated factors, it did use a large number of univariate analyses and a backwards 
stepwise method to achieve this end.  Thus, with nearly 500 statistical tests 
performed throughout this thesis there is the higher likelihood of a small number of 
type 1 statistical errors or false positives occurring by chance. 
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8.5 KEY RECOMMENDATIONS 
Using the findings of this thesis we have outlined five key recommendations 
each for policy makers, researchers and clinicians that aim to reduce the large 
inpatient burden of foot disease identified by this thesis. 
 
Policy makers 
1. Report foot disease hospitalisation rates  
This thesis has reported foot disease to be in the top 10 causes of 
hospitalisation when using robust methodology, yet foot disease is rarely reported 
when using standard hospital discharge datasets.  To more effectively and efficiently 
monitor inpatient foot disease it is recommended that the coding, analyses and 
reporting of foot disease in standard hospital discharge datasets is optimised.  First, it 
is recommended that hospital clinicians and discharge coders are trained on the 
importance of documenting and coding foot disease.  Second, a set of standard 
hospital discharge dataset codes that are considered to appropriately measure foot 
disease hospitalisation should be agreed to ensure consistency of reporting across 
jurisdictions.  Third, annual foot disease hospitalisation rates per population should 
be published by region to allow policy makers to monitor and address variation in the 
large inpatient foot disease burden as per standard national healthcare variation 
reports.  Last, these rates need to at least include primary admissions and occupied 
bed day usage for foot disease, that are adjusted for age and sex, to more 
comprehensively understand and compare the foot disease inpatient burden to other 
inpatient burdens.  Please refer to the researcher recommendations below for further 
details on optimising the accuracy of reporting foot disease hospitalisation rates.   
 
2. Implement inpatient foot disease continuum of care procedures 
As has occurred in other top 10 causes of hospitalisation, it is recommended 
that inpatient continuum of care procedures for foot disease are developed and 
implemented.  This should be of high priority in major general hospitals where 
higher rates of foot disease hospitalisation were identified and thus the assumed 
benefits from improving care are much greater.  Standard inpatient procedures 
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typically guide evidence-based triage, admission to multi-disciplinary speciality 
wards, treatment checklists and discharge to appropriate outpatient services.  Similar 
continuum of care procedures have been developed for diabetes-related foot disease 
with success in some jurisdictions.  Therefore, these standard and diabetes-related 
foot disease inpatient procedures should be used as templates for the development of 
new inpatient foot disease continuum of care procedures.  Please refer to the clinician 
recommendations below for further details on possible elements to include in such 
inpatient foot disease continuum of care procedures.   
 
3. Enable access to outpatient multi-disciplinary foot services (MDFS) for 
all people with foot disease 
Inpatients admitted for foot disease in this study were found not to be receiving 
recommended outpatient multi-disciplinary foot services (MDFS) in the year prior to 
their admission.  Outpatient MDFS have been consistently demonstrated to reduce 
hospitalisation and amputation in people with diabetes-related foot disease.  Our 
findings indicate that the foot disease burden is similar in both the diabetes and non-
diabetes inpatient populations.  It is therefore, recommended that outpatient MDFS 
are promoted and accessible to both diabetes and non-diabetes patients with foot 
disease to prevent hospitalisation.  Please refer to the researcher recommendations 
below for further details on studies required to demonstrate any effect in non-
diabetes foot disease inpatients.   
 
4. Promote evidence-based MDFS to General Practitioners  
General practitioners (GPs) are the key coordinating primary healthcare 
professionals who triage patients with foot disease according to the findings of this 
study.  Whilst inpatients admitted for foot disease were much more likely to have 
seen a GP for foot treatment prior to admission, this was not the case for the 
recommended disciplines in outpatient MDFS.  Therefore, it is recommended that 
existing evidence-based foot disease guidelines and available local MDFS are 
heavily promoted to GPs to ensure they are most aware of the necessary evidence-
based services available to their patients with foot disease.  Earlier triage to 
outpatient MDFS is likely to prevent foot-related hospitalisation in both diabetes and 
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non-diabetes patients with foot disease.  Please refer to the clinician 
recommendations below for further details on clinical services required for GPs with 
patients with foot disease, foot risk factors and at risk populations.   
 
5. Undertake cost-modelling of the foot-related burden with and without 
evidence-based MDFS   
This thesis estimated foot disease to cost the Australian healthcare system 
$AU3.8 billion annually, with the hospitalisation burden contributing $AU1.6 billion 
of this cost.  With such a large estimated national economic burden it is strongly 
recommended that expert cost modelling is commissioned to comprehensively 
analyse and articulate the economic and societal burden of foot disease.  Assuming 
all foot disease responds to evidence-based MDFS care as has been demonstrated in 
the diabetes-related literature, significant cost savings appear achievable for nations 
who invest in foot disease strategies.  Therefore, it is also recommended that cost-
effective analyses are performed to estimate the economic and social benefits of 
implementing such strategies in both diabetes and non-diabetes patients with foot 
disease.  Please refer to the researcher recommendations below for further details on 
studies required to demonstrate effect in non-diabetes foot disease inpatients.   
 
Researchers 
6. Test the findings of this study in other regions  
Although the findings of this study have been interpreted as robust, valid and 
generalizable, it is still recommended that similar multi-site point-prevalence studies 
be undertaken in different regions to test the findings from this thesis.  Therefore, it 
is recommended that the Queensland Foot Disease Form in conjunction with the 
methodology reported in this thesis is used to investigate the burden of foot disease 
in other representative inpatient populations. Ideally, an abbreviated methodology 
from this thesis could also be incorporated within existing annual national bed-side 
inpatient audits for similar disease processes such diabetes and pressure injuries.  
This may allow annual prospective monitoring of the size of the inpatient foot 
disease burden and comparisons with standard hospital discharge datasets.  
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7.  Test the validity and reliability of hospital discharge dataset coding 
for foot disease 
As identified in this thesis, retrospective analyses of standard hospital 
discharge datasets significantly under-report the inpatient burden of foot disease.  To 
monitor the quality of foot disease data reported from standard hospital discharge 
datasets it is recommended that prospective inpatient foot disease audits be 
implemented to test the concurrent validity of standard hospital discharge datasets. 
These validity tests could be performed and reported periodically on sub-samples of 
representative inpatients, along with sub-samples of hospital coders to test for 
reliability.   This would enable standard hospital discharge datasets to be used with 
known levels of case ascertainment and reliability when analysing foot disease 
hospitalisation trends or when used in population-based clinical trial interventions 
aimed at reducing this large inpatient foot disease burden.   
 
8. Investigate the predictors and severity of inpatient foot disease  
As has previously occurred in diabetes populations, it is now recommended 
that longitudinal studies be undertaken to investigate the predictive risk factors for 
foot disease hospitalisation.  It is recommended that all independent associated 
factors identified in this thesis be investigated in such studies to determine if these 
factors are also predictive for hospitalisation and amputation.  Furthermore, in 
conjunction with the foot disease severity makers used in this study (such as reason 
for admission, infection, ischaemia and amputation severity), it is recommended that 
other severity markers also be investigated (such as re-admission, length of stay and 
mortality) in future longitudinal studies to improve the understanding of the risk 
factors for different levels of foot disease severity in inpatient populations.  This 
would assist to more precisely profile those people most in need of foot disease care 
to prevent hospitalisation and amputation. 
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9. Investigate the predictors of non-diabetes foot disease  
The findings of this study indicate that non-diabetes foot disease causes a large 
inpatient burden, yet non-diabetes foot disease has received limited investigation in 
general.  It is recommended that foot disease researchers begin to focus attention on 
the prevalence and risk factors for non-diabetes foot disease in both outpatient and 
inpatient populations.  As per the recommendations above, it is recommended that 
the independent associated factors identified in this thesis are longitudinally 
investigated in representative non-diabetes populations to determine if the risk 
factors for foot disease in non-diabetes populations show similar profiles to that 
demonstrated in diabetes populations as indicated by the findings of this thesis. 
 
10. Investigate interventions for non-diabetes foot disease in inpatients 
As aforementioned, the non-diabetes foot disease inpatient burden identified in 
this thesis was comparable to the large diabetes-related foot disease burden.  
Previous literature has consistently demonstrated that various MDFS interventions 
have reduced the foot disease burden in diabetes specific inpatient populations.  It 
can only be hypothesised that these interventions will have a similar effect on non-
diabetes foot disease in inpatients due to the similar independent factors identified in 
this thesis to be associated with foot disease.  However, this cannot be concluded 
until clinical trials are also performed in the non-diabetes inpatient population.  Thus, 
it is recommended that clinical trials of similar MDFS interventions are now 
implemented in non-diabetes foot disease populations to test their effect on inpatient 
foot disease outcomes. 
 
Clinicians 
11. Add a foot ulcer history question to admission triage assessments 
A history of foot ulcers (active or previous) was identified in this thesis to be 
independently associated with nearly all foot-related hospitalisation causes, foot 
disease disorders and foot risk factors in inpatients.  Thus, the addition of a self-
reported foot ulcer question into standard hospital admission triage assessments may 
be a very simple, effective and efficient way of identifying most patients with foot 
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disease when they present to hospital.  The question could be as simple as, “have you 
ever had a foot ulcer?” when all patients present to ED or are admitted to a ward.  
Therefore, at a minimum it is recommended that a self-reported foot ulcer history 
question be added to general hospital admission triage assessments. 
 
12. Screen all patients with a self-reported foot ulcer history  
Regardless of diabetes status, a simple diabetes foot risk screening tool was 
found to effectively identify inpatients that needed foot disease management in 
hospital.  This tool could also be further improved by adding ischaemia to the acute 
foot disease category.  Therefore, all inpatients identified to have a foot ulcer history 
at triage should also have a foot screen undertaken using such a standard diabetes 
foot risk screening tool, regardless of diabetes status.  This screen should be able to 
identify those inpatients with foot disease needing immediate treatment, plus, those 
inpatients with foot risk factors that need close monitoring to prevent the 
development of foot disease, pressure injuries and falls whilst in hospital. 
 
13. Admit all inpatients with foot disease into a MDFS  
The inpatient foot disease burden has been identified to be much larger than 
previously considered in both the diabetes and non-diabetes inpatient populations.  
Previous research evaluating inpatient MDFS consistently demonstrates reduced 
hospitalisation, amputation and costs in diabetes inpatients.  Therefore, regardless of 
diabetes status, it is recommended that inpatients identified to be in hospital for the 
primary reason of foot disease should be admitted into a MDFS speciality ward.  
Additionally, those inpatients identified with foot disease present, but not causing 
their admission, should be at least referred to a MDFS on admission.  These MDFS 
should include a surgeon, medical physician, podiatrist and nurse with expertise in 
foot disease, to prevent extended lengths of stay, amputation and re-admission as has 
been demonstrated in existing diabetes-related foot disease literature.  These patients 
also need to be discharged to an outpatient MDFS to prevent re-admission. 
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14. Discharge all inpatients with a foot risk factor to a Foot Protection 
Service 
Our findings suggest that having the foot risk factors of peripheral arterial 
disease and peripheral neuropathy significantly increases the risk of developing foot 
disease, regardless of having a diagnosis of diabetes.  Therefore, all inpatients 
identified to have a foot risk factor should be monitored for foot disease during their 
inpatient stay.  On discharge from hospital it is important to formally refer these 
patients to a Foot Protection Service which should include at minimum a podiatrist 
with expertise in preventing foot disease.  These Foot Protection Services have been 
demonstrated to reduce the incidence of foot disease in diabetes patients. 
 
15. Annually foot screen all patients with specific chronic conditions  
This thesis identified people with specific chronic conditions had increased 
associations with foot risk factors and foot disease.  These specific conditions 
included diabetes, cerebrovascular disease, arthritis, mobility impairment, smokers 
and those of older age.  Thus, as per standard evidence-based recommendations for 
people with diabetes, it is further recommended that clinicians perform annual foot 
screens on people with these chronic conditions to improve identification and 
management of foot risk factors and foot disease in the general population.  All 
patients identified to have foot risk factors should be referred to a Foot Protection 
Service and all patients identified to have foot disease referred to a MDFS.    
 
 
8.6 CONCLUSIONS 
The purpose of this thesis was to improve the understanding of the overall 
burden of foot disease in inpatient populations.  The extensive literature reviews 
undertaken in this thesis could not identify a study that had previously reported on 
the overall burden of foot-related conditions or foot disease in a representative 
inpatient population.  Thus, the aim of this thesis was to investigate the prevalence, 
and associated factors, of people with foot disease disorders or foot risk factors in a 
representative inpatient population.   
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The findings of this thesis appear to be the most robust, valid and generalizable 
results to date on the prevalence and associated factors for foot-related conditions, 
foot disease disorders, amputation, previous foot disease and foot risk factors in 
representative inpatients.   Overall, these findings suggest that nearly half of all 
inpatients have a foot risk factor for developing foot disease, one fifth of those have 
foot disease present, one half of those have been hospitalised because of their foot 
disease, and one third of those underwent an amputation during their admission.  
These findings confirm that the vast majority of foot-related hospitalisations are due 
to foot disease and indicate that people without diabetes make up more than half of 
those inpatients.  Overall, the direct inpatient burden caused by foot disease is 
estimated to put foot disease in the top 10 leading causes of hospitalisation in 
Australia at an annual direct cost of $AU1.6 billion.   
This thesis also appears to be one of the first to investigate the factors 
independently associated with a range of foot disease disorders and foot risk factors 
in a representative population.  The main factors that were independently associated 
with foot disease or foot risk factor outcomes were older age, diabetes, arthritis, 
cerebrovascular disease, acute foot trauma, mobility impairment, previous ulceration, 
PAD, PN and past foot treatment by a surgeon or podiatrist.  Of particular interest 
were that even after controlling for diabetes the majority of these factors were the 
same factors as those identified in the literature to predict foot disease and 
amputations in diabetes specific populations.  These new findings have improved the 
conceptual framework for foot-related hospitalisation.   
This thesis has made a number of recommendations to further investigate and 
intervene in this large, yet under-appreciated, inpatient burden of foot disease.    
Recommendations include annually reporting foot disease hospitalisation rates across 
regions, developing standard inpatient continuum of care pathways from triage to 
discharge for all people with foot disease, and investing in strategies to reduce the 
considerable direct inpatient hospital bed day and cost burden imposed by foot 
disease.  Overall, the findings of this thesis suggest Australia needs to focus much 
more attention on the disease really affecting inpatients ‘down under’ if we are to 
significantly improve hospital outcomes in future.  
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